data_1rjh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rjh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.672 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -71.52 -4.59 27.61 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.608 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 3.1 tt0 -59.17 127.28 31.39 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.7 p -102.72 126.36 49.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.162 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.844 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -156.06 174.37 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 76.2 p -84.18 165.96 17.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.088 0.242 . . . . 0.0 110.611 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -55.62 -49.82 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.94 -41.7 98.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.264 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.55 -45.33 93.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.993 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.844 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -57.06 -42.38 80.46 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.799 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -63.17 -36.53 83.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.66 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -93.76 -33.93 13.4 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.288 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.66 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.7 t70 -56.99 -59.56 4.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.881 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.451 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 47.2 t -59.68 -41.04 89.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.2 mp -60.43 -42.78 92.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.157 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.6 t -68.86 -26.8 65.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.889 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 30.1 mmt180 -73.47 -10.98 60.29 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.792 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.42 43.42 2.54 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.04 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -171.15 -165.48 28.52 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.143 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -134.64 148.65 50.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.2 tt -61.46 136.37 58.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.415 ' N ' HD22 ' A' ' 84' ' ' LEU . 33.7 p -64.1 108.33 1.51 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.992 0.425 . . . . 0.0 111.481 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -109.84 111.12 58.93 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.475 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.34 112.0 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.242 1.962 . . . . 0.0 112.14 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.81 -13.46 24.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.186 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.67 158.6 37.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.63 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.22 95.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.08 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -58.6 -40.98 84.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.326 0.25 . . . . 0.0 111.284 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -64.61 -41.79 95.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.046 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -64.94 -43.95 91.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 109.995 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.51 -46.7 84.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.799 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.94 74.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.309 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 15.7 tp -70.11 -40.67 74.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.303 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -65.51 -40.5 93.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.09 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -67.12 -34.98 78.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.202 0.525 . . . . 0.0 110.91 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -70.76 -25.2 62.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.95 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 58.4 mt -56.09 -55.22 35.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 6.4 mmt180 -51.37 -36.89 45.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.575 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.42 15.06 27.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.99 -170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -153.95 -55.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.74 -27.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.549 0.69 . . . . 0.0 111.04 -171.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.43 127.26 5.68 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -168.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.571 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 3.8 t30 -50.61 -41.29 54.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -94.77 36.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.206 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.58 160.68 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.671 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 22.8 mm-40 -110.31 124.89 52.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.488 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -134.21 154.45 37.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.461 ' HB2' HD11 ' A' ' 84' ' ' LEU . 77.6 m95 -70.9 145.88 49.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -91.36 2.25 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 111.795 -171.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 85.01 9.84 79.79 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.842 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.428 HD11 HD11 ' A' ' 131' ' ' ILE . 4.1 mm? . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.958 0.379 . . . . 0.0 109.991 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -66.89 149.26 50.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.793 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.55 130.37 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 131' ' ' ILE . 14.2 m-20 -74.49 172.95 11.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.778 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 22.7 mmt -64.8 -24.46 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.059 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 p -82.54 -6.38 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.558 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.42 58.42 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.478 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.93 167.11 10.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.471 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -110.97 123.63 50.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.53 152.75 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 175.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -106.31 -6.1 18.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.263 0.554 . . . . 0.0 110.393 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.32 124.65 44.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.149 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 11.8 mmmm -122.32 108.67 13.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -152.24 111.69 3.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.41 ' HE1' ' HE2' ' A' ' 134' ' ' LYS . 7.7 m95 -136.66 151.11 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.632 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 8.7 tp10 -93.26 -30.68 15.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.0 p . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.604 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.8 107.37 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.483 -173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 166' ' ' LYS . 39.5 t -126.81 154.4 36.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.543 ' HB2' HD22 ' A' ' 112' ' ' LEU . 7.1 tt -111.83 122.59 48.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.0 t -109.21 98.56 7.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.151 0.501 . . . . 0.0 109.969 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -72.63 -23.85 77.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.426 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.11 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.3 -53.23 7.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.65 -41.56 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.101 0.477 . . . . 0.0 110.415 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.68 -2.19 4.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.815 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -88.7 163.89 15.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -78.02 146.13 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.851 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.2 m-85 -135.74 -169.1 2.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.153 -172.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 6.6 p-10 -137.15 152.5 50.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.859 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.528 ' HB2' HG21 ' A' ' 154' ' ' VAL . 34.3 mttp -152.78 -167.16 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.79 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.52 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 48.2 mtm180 -86.53 131.84 34.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 68.7 m -69.06 -11.6 60.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -97.52 5.91 48.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 110.823 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 34.0 m-20 -80.76 134.89 35.89 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -92.56 90.62 7.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.22 0.533 . . . . 0.0 110.508 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -116.83 163.38 22.88 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.913 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 25.0 Cg_exo -64.04 179.92 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.122 2.548 . . . . 0.0 113.106 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.633 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -157.75 163.17 38.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.566 178.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.672 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 79.8 mt -127.29 137.74 56.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 67.6 m -121.45 146.56 46.79 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.607 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.653 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 52.5 m-85 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.12 3.09 11.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.157 0.503 . . . . 0.0 111.168 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.57 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -75.29 137.04 40.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.631 177.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -97.21 129.41 44.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.66 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -161.63 172.45 16.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.755 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 18.3 p -82.31 167.61 18.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.37 -27.3 67.29 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -62.99 -57.29 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 5.9 mp0 -63.69 -36.32 83.47 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.37 87.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.436 . . . . 0.0 110.717 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 78' ' ' ILE . 22.7 t -72.58 -56.06 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.226 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.55 -45.18 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.498 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -64.97 -52.42 56.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.127 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.687 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 12.8 t -66.82 -34.11 77.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.909 0.385 . . . . 0.0 111.209 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -68.11 -34.0 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.184 0.516 . . . . 0.0 110.331 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -28.26 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.281 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.687 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 10.7 ptp180 -80.26 0.63 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 110.612 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.99 52.16 8.26 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.032 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.51 -166.93 13.26 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -153.54 139.35 18.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.884 0.342 . . . . 0.0 110.233 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.6 mp -61.08 137.63 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -62.75 108.03 1.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.194 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 7.5 m -106.52 109.24 62.99 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.8 Cg_exo -75.51 117.28 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.749 2.299 . . . . 0.0 112.258 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.79 -5.01 20.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.134 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 173.15 12.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.438 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.82 -39.17 97.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.654 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -56.34 -48.4 76.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.582 0.229 . . . . 0.0 111.51 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.3 -51.59 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.411 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.48 -43.22 73.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.376 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.81 70.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -64.48 -48.79 73.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.24 -43.31 87.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.848 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.547 ' OE2' ' HD3' ' A' ' 101' ' ' ARG . 9.9 tp10 -63.44 -43.42 97.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.344 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -63.4 -34.96 78.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.921 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 77.3 mt -54.35 -45.54 72.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.547 ' HD3' ' OE2' ' A' ' 98' ' ' GLU . 52.2 mtp180 -58.5 -30.93 67.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.618 -173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -109.43 10.4 25.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.923 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.0 m -138.78 -57.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 110' ' ' ILE . 25.1 t -103.43 -37.83 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.691 0.757 . . . . 0.0 110.55 -171.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.02 126.43 2.57 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.46 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -53.21 -37.13 61.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.698 0.285 . . . . 0.0 110.752 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -104.39 34.7 2.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.443 0.639 . . . . 0.0 111.404 -176.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.51 161.72 13.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.278 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 54.8 mt-10 -121.12 126.24 49.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.62 HG23 ' HA ' ' A' ' 174' ' ' TYR . 2.6 mp -124.27 146.73 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.578 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 83.1 m95 -71.3 137.22 48.34 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 112' ' ' LEU . 3.1 mm? -87.2 3.92 44.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.906 0.384 . . . . 0.0 111.393 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 83.81 9.39 82.9 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.514 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.445 HD21 HD13 ' A' ' 131' ' ' ILE . 9.5 mp . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.431 HG22 ' HD3' ' A' ' 130' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.276 0.56 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -68.61 157.36 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.399 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.35 126.7 55.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.843 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.48 163.94 27.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.951 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 9.0 mmt -64.94 -26.65 68.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.071 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -83.89 -4.9 59.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.683 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.66 56.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.846 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.4 168.12 9.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.431 ' HD3' HG22 ' A' ' 122' ' ' THR . 3.4 tmm_? -110.97 125.41 53.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.445 HD13 HD21 ' A' ' 114' ' ' LEU . 23.1 pt -53.88 125.71 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.484 0.659 . . . . 0.0 112.343 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.95 -13.13 29.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.06 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -103.42 127.2 50.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.853 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -131.02 119.35 21.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -149.71 110.02 4.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -127.34 143.98 51.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.709 ' HG2' HD22 ' A' ' 160' ' ' ASN . 10.7 tp10 -91.13 -30.1 16.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 10.2 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.213 173.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 27.5 m . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.14 0.495 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -112.94 146.27 39.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.046 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.63 160.64 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.333 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 112' ' ' LEU . 57.1 tp -100.34 103.07 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 23.3 t -97.17 104.8 16.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.132 0.491 . . . . 0.0 110.554 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.91 -22.15 77.33 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.721 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . . . -73.81 -16.97 61.13 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.337 0.589 . . . . 0.0 110.594 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.141 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.709 HD22 ' HG2' ' A' ' 137' ' ' GLU . 16.7 p30 -174.51 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.692 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 126.18 15.22 2.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 32.8 mmtp -100.48 175.63 5.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -77.4 131.07 37.84 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 50.6 m-85 -127.34 176.73 7.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.838 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -113.8 137.4 51.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.537 . . . . 0.0 111.001 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 9.1 mmmm -150.61 137.01 18.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.487 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -57.68 136.65 56.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.446 0.467 . . . . 0.0 110.978 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.707 ' O ' ' HB ' ' A' ' 69' ' ' THR . 5.3 m -60.21 -14.65 18.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -96.65 13.94 26.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.532 0.206 . . . . 0.0 111.548 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.6 146.27 23.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.12 88.47 6.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 110.979 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 pp -128.09 158.08 72.06 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.62 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.6 Cg_exo -62.58 -178.5 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.367 2.711 . . . . 0.0 113.786 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.653 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 1.3 p90 -152.25 165.91 33.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 79.9 mt -139.4 130.65 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.925 0.393 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 72.0 m -108.92 143.64 37.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.019 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.494 0.664 . . . . 0.0 110.212 -179.766 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 174' ' ' TYR . 1.1 p90 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -2.87 20.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 110.766 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.702 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 34.1 tt0 -56.61 122.51 12.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.875 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -89.94 121.13 31.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.339 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.862 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.53 -175.86 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.318 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 31.7 p -78.42 166.42 22.65 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.319 0.387 . . . . 0.0 110.425 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.35 -35.39 77.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -63.58 -51.14 66.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.928 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 4.7 mm-40 -66.7 -37.98 85.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.104 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -59.74 -40.85 89.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.131 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.422 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 35.4 t -66.79 -56.43 10.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.292 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.39 -48.22 81.34 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 12.2 t70 -59.91 -58.95 6.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.898 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.1 t -61.3 -38.85 88.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.171 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.85 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.597 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.9 m -74.23 -9.15 58.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.999 0.428 . . . . 0.0 110.659 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.701 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -88.43 -10.09 50.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.82 56.26 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.45 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.0 179.77 17.16 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.115 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.605 0.24 . . . . 0.0 110.751 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.501 HD23 ' HA2' ' A' ' 113' ' ' GLY . 15.8 tp -68.68 139.61 55.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 p -62.11 109.77 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 111.487 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 5.2 t -118.87 130.32 24.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 23.6 Cg_endo -93.63 144.24 2.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.364 2.709 . . . . 0.0 113.139 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -108.19 -25.65 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.896 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.681 ' HA ' ' CB ' ' A' ' 133' ' ' TYR . 11.6 t -158.9 -169.99 2.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.128 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.25 -24.93 56.52 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 112.981 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.3 t -56.51 -52.59 64.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.664 0.269 . . . . 0.0 110.62 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -75.99 -37.97 57.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.292 . . . . 0.0 110.332 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 93' ' ' ASN . 0.2 OUTLIER -56.49 -45.21 81.11 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.177 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.51 -46.89 52.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.793 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.25 94.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.098 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.12 -45.69 87.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.88 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.569 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 45.0 t80 -63.89 -34.62 78.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.623 . . . . 0.0 110.297 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -44.13 76.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.851 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.83 -34.08 64.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.394 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.569 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 3.8 pp -71.34 -32.89 69.08 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.402 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.83 -30.85 71.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.56 22.31 13.78 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.078 -0.388 . . . . 0.0 111.642 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -151.69 -64.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.008 -0.432 . . . . 0.0 111.513 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 100' ' ' LEU . 1.7 t -76.25 -32.45 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.176 0.513 . . . . 0.0 109.631 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.14 -74.76 0.29 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.224 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.503 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER 172.98 -62.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -175.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.421 ' OE1' ' HB3' ' A' ' 106' ' ' ASN . 2.0 mp0 -86.3 37.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.13 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -98.1 149.05 22.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.04 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' CD ' ' HZ3' ' A' ' 166' ' ' LYS . 35.4 mt-10 -108.58 127.33 53.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.747 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.572 HG21 ' HA ' ' A' ' 174' ' ' TYR . 4.6 mp -122.03 140.34 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.462 ' HB2' HD22 ' A' ' 84' ' ' LEU . 91.9 m95 -69.69 140.81 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 153' ' ' ALA . 33.5 mt -80.54 0.29 34.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.501 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 86.68 -21.77 17.02 Favored Glycine 0 C--N 1.32 -0.342 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.857 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 121.228 0.537 . . . . 0.0 110.89 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.153 0.501 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.475 ' CE3' HD21 ' A' ' 114' ' ' LEU . 74.9 m95 -85.03 120.13 26.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.631 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.98 129.53 66.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.903 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 5.1 p30 -86.21 -171.47 3.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.443 0.639 . . . . 0.0 112.45 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.422 ' HE3' ' HA ' ' A' ' 74' ' ' SER . 62.7 mtt -78.85 -11.18 59.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.172 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.0 p -93.96 -20.63 19.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.321 0.582 . . . . 0.0 109.95 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.29 24.84 9.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.642 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.8 154.17 18.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 110.551 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -109.26 122.0 46.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.812 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.0 pt -66.11 134.04 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.337 0.589 . . . . 0.0 111.589 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -113.64 17.29 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.61 0.719 . . . . 0.0 109.875 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 60.0 t80 -136.71 117.36 13.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.861 -177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.92 107.54 12.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 0.0 111.009 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.599 ' OD1' ' HG3' ' A' ' 162' ' ' LYS . 29.4 t-20 -133.31 110.22 9.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -123.26 147.04 47.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.993 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.7 tm-20 -89.87 -42.38 11.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 164' ' ' PHE . 9.0 t . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.262 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 92.7 m . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.652 0.739 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.568 ' HB2' HD11 ' A' ' 112' ' ' LEU . . . -84.22 143.55 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.464 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.433 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 11.5 t -125.15 146.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.821 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.426 ' HB2' HD23 ' A' ' 112' ' ' LEU . 69.0 tp -98.8 100.81 12.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.4 m -93.44 98.51 11.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.383 0.611 . . . . 0.0 110.405 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.13 -13.04 76.3 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.439 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . . . -67.78 -18.22 64.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.826 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.75 -63.99 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.062 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -177.72 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.499 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.23 3.59 14.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.256 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.599 ' HG3' ' OD1' ' A' ' 135' ' ' ASN . 0.7 OUTLIER -81.26 154.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -75.35 137.71 41.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.137 0.494 . . . . 0.0 111.301 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.567 ' HA ' HG22 ' A' ' 138' ' ' THR . 21.9 m-85 -121.68 -179.24 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.608 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -135.41 138.74 43.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.145 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.528 ' HZ3' ' CD ' ' A' ' 109' ' ' GLU . 0.2 OUTLIER -153.8 162.89 40.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 168.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -62.7 144.7 56.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.819 0.342 . . . . 0.0 110.758 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 69' ' ' THR . 12.3 m -59.99 -11.74 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -100.74 8.97 42.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.546 ' OD2' HD22 ' A' ' 172' ' ' LEU . 29.4 t70 -74.76 139.04 43.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.699 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 66.9 mm-40 -92.6 83.05 4.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.817 -174.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.546 HD22 ' OD2' ' A' ' 170' ' ' ASP . 3.7 pp -125.13 161.69 48.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.518 ' O ' HD13 ' A' ' 172' ' ' LEU . 24.3 Cg_exo -63.11 -177.92 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.594 2.863 . . . . 0.0 113.713 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.702 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 7.4 p90 -155.04 178.03 10.66 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.036 -0.415 . . . . 0.0 110.352 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 96.6 mt -145.23 135.27 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.529 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 93.9 m -108.52 147.08 32.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.577 0.703 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 13.5 t -74.99 -0.29 18.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.202 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -64.6 124.93 23.14 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.426 0.631 . . . . 0.0 111.416 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -91.01 122.29 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.291 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.689 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.81 -175.4 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -81.74 166.89 19.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -62.45 -31.31 72.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.05 -52.37 43.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.93 -38.6 89.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.922 0.392 . . . . 0.0 110.366 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.689 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -60.61 -30.41 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.087 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.471 ' OG ' ' HE1' ' A' ' 126' ' ' MET . 30.6 m -74.48 -63.6 1.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.305 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.5 -42.61 99.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.332 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.73 -25.03 61.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 34.9 t -87.16 -43.12 12.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.61 -43.58 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.274 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -71.4 -13.66 61.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.901 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -92.22 11.01 27.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.45 35.21 81.21 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.222 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.74 175.87 21.52 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -142.41 138.87 31.42 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.128 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -58.86 127.3 31.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.404 ' OG ' HD23 ' A' ' 96' ' ' LEU . 23.0 t -55.04 122.49 11.05 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.393 0.433 . . . . 0.0 110.953 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.574 ' HB ' ' OD1' ' A' ' 125' ' ' ASP . 52.3 p -108.94 108.9 60.97 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.213 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 93' ' ' ASN . 70.8 Cg_endo -84.87 110.75 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.378 2.052 . . . . 0.0 112.529 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -101.96 -16.19 16.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.732 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.3 p -129.89 167.99 17.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.226 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.59 91.61 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.271 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.9 m -64.34 -28.75 69.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.11 -34.14 43.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -71.25 -55.85 7.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.002 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -68.02 -17.42 64.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.9 78.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.447 . . . . 0.0 110.309 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.404 HD23 ' OG ' ' A' ' 85' ' ' SER . 64.8 mt -66.98 -38.92 86.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.204 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.554 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 89.9 t80 -59.17 -35.87 74.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.32 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -71.11 -46.89 60.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.91 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -67.18 -43.76 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.488 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.579 ' HB3' HD13 ' A' ' 175' ' ' ILE . 2.9 pp -63.0 -31.0 72.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 32.5 ttp-105 -65.32 -36.33 83.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.031 177.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.58 13.56 25.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 m -149.42 -46.66 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.689 HG13 HD11 ' A' ' 110' ' ' ILE . 3.5 p -106.65 -23.92 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.28 0.562 . . . . 0.0 110.539 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.45 126.26 4.05 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.574 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 8.7 t30 -59.37 -34.03 71.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.424 0.612 . . . . 0.0 111.042 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -88.8 24.06 2.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.385 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB3' HG11 ' A' ' 104' ' ' VAL . . . -98.11 161.48 13.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.985 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.586 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.3 mt-10 -118.38 126.51 52.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.683 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.79 HG22 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -120.2 152.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 76.3 m95 -70.62 146.53 49.98 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 153' ' ' ALA . 40.2 mt -80.88 -2.5 47.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 74.66 6.3 76.75 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.882 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.326 -0.432 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.398 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.505 ' HB ' ' HG2' ' A' ' 130' ' ' ARG . 1.5 p . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.4 157.38 34.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.755 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.6 125.18 54.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.056 0.455 . . . . 0.0 110.651 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.574 ' OD1' ' HB ' ' A' ' 86' ' ' THR . 12.8 m-20 -72.32 162.2 29.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.237 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 18.5 mmt -55.52 -30.73 61.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.884 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -85.23 0.16 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.067 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.33 44.58 9.48 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.583 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.55 165.12 20.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.734 0.302 . . . . 0.0 110.954 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 6.8 mtp85 -112.49 120.07 40.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.106 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -70.68 141.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 111.578 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.2 -21.22 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.832 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -88.4 115.97 26.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.414 ' HB2' ' HZ2' ' A' ' 134' ' ' LYS . 7.8 mtmp? -137.96 107.39 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.686 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -137.8 112.92 9.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -119.38 114.49 22.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.809 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 28.7 tt0 -70.97 -37.0 72.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.823 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 164' ' ' PHE . 6.8 t . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.655 ' HB3' HD12 ' A' ' 112' ' ' LEU . . . -111.82 106.86 15.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.48 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 166' ' ' LYS . 45.9 t -131.96 140.3 48.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.127 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.468 HD23 HD22 ' A' ' 112' ' ' LEU . 1.5 tm? -106.4 100.91 10.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.1 m -98.43 112.03 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.327 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.64 -23.03 68.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.968 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.39 -28.82 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 111.26 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.95 -62.67 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -169.68 -25.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.017 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.87 20.23 7.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.67 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 162' ' ' LYS . 10.4 mmpt? -93.12 -179.18 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.557 ' HH2' HG13 ' A' ' 131' ' ' ILE . 40.3 m0 -82.25 123.91 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.433 . . . . 0.0 111.215 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 87.3 m-85 -126.05 -179.29 4.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -130.1 154.57 47.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.525 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.512 ' HB2' HG23 ' A' ' 154' ' ' VAL . 5.4 tttp -153.69 -152.68 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -100.21 121.9 42.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.532 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 14.2 m -65.33 -2.48 3.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -112.19 -0.47 15.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.788 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.15 149.68 21.35 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.19 107.7 19.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.9 pp -129.41 167.46 19.94 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.426 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 19.3 Cg_exo -67.01 -177.68 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.133 2.555 . . . . 0.0 113.445 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.79 ' HA ' HG22 ' A' ' 110' ' ' ILE . 34.9 p90 -143.87 179.67 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.304 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.579 HD13 ' HB3' ' A' ' 100' ' ' LEU . 76.3 mt -143.1 116.96 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.1 m -112.57 133.73 54.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.146 0.498 . . . . 0.0 112.17 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.177 175.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 56.1 m-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.001 0.429 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -68.34 -13.89 62.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.852 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 15.7 mm100 -60.25 132.65 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 111.029 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.529 ' HB ' ' HG2' ' A' ' 171' ' ' GLN . 41.3 p -101.48 143.22 31.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.668 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.718 ' HZ1' ' HB3' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -166.01 -179.2 5.06 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.229 0.331 . . . . 0.0 110.114 178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 71.8 p -84.93 166.47 16.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.49 0.186 . . . . 0.0 110.524 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.18 -49.69 76.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -70.79 -26.44 63.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 109.636 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 68' ' ' LYS . 36.2 tt0 -76.67 -32.49 57.96 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.704 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.652 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -66.38 -43.17 86.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.415 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.5 p -63.6 -54.21 39.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.651 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.62 -39.56 84.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -64.7 -59.22 4.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.375 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.646 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 22.6 t -61.08 -36.52 79.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 0.0 110.483 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 74' ' ' SER . 1.5 mp -65.82 -34.62 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 -29.13 44.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.646 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 16.3 ptm180 -88.29 1.26 54.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.688 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.68 66.26 1.51 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.493 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.17 167.23 38.77 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.667 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -114.16 133.0 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 85' ' ' SER . 5.5 tt -60.46 134.13 56.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.477 ' N ' HD22 ' A' ' 84' ' ' LEU . 39.6 m -54.09 109.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.805 0.691 . . . . 0.0 112.156 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t -108.23 118.65 51.93 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.52 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.1 Cg_exo -75.75 110.91 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.57 2.18 . . . . 0.0 111.149 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -117.38 -10.19 10.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.619 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.1 p -136.83 164.87 27.27 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.528 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.06 95.3 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.628 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -61.34 -45.13 95.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.876 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.94 -46.51 88.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.517 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -67.75 -37.58 82.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.58 -52.72 64.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.139 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.06 83.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.389 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -61.46 -51.69 67.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.006 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -62.49 -39.69 94.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -64.16 -41.49 97.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -64.07 -35.8 81.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.71 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.9 mt -54.75 -48.99 71.91 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.204 0.526 . . . . 0.0 109.845 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -59.02 -27.81 65.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.375 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -111.36 17.29 20.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.892 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -153.63 -54.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.402 HG13 HD12 ' A' ' 110' ' ' ILE . 2.8 t -100.85 -36.65 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.15 -171.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.5 130.25 3.23 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.106 -171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -35.9 45.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.85 27.83 2.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.848 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.32 161.61 15.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 111.318 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 4.6 pt-20 -122.87 121.64 36.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.643 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.7 HG21 ' HA ' ' A' ' 174' ' ' TYR . 34.3 mm -120.01 153.36 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -70.65 149.26 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 153' ' ' ALA . 73.7 mt -89.08 -1.78 58.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA2' ' HE2' ' A' ' 126' ' ' MET . . . 71.41 9.97 69.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.76 -173.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 131' ' ' ILE . 8.3 mp . . . . . 0 C--N 1.326 -0.427 0 C-N-CA 122.747 0.419 . . . . 0.0 110.286 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -68.11 152.36 45.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.453 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.08 158.19 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.19 175.87 6.44 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.39 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.506 ' HE2' ' HA2' ' A' ' 113' ' ' GLY . 65.6 mtt -67.37 -20.56 65.58 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.5 p -87.25 -7.63 57.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.162 0.437 . . . . 0.0 111.117 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.55 21.16 29.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.837 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.08 164.54 11.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 0.0 110.424 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -108.02 133.63 52.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HD21 ' A' ' 114' ' ' LEU . 42.8 pt -75.96 125.92 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.279 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.34 -22.81 28.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.608 . . . . 0.0 109.727 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -92.3 120.83 33.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.534 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.534 ' HG3' ' CD1' ' A' ' 136' ' ' TRP . 55.1 tttt -144.01 119.1 10.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -156.66 113.17 3.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.534 ' CD1' ' HG3' ' A' ' 134' ' ' LYS . 42.5 m95 -124.31 140.94 52.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.44 -170.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 17.7 mm-40 -89.75 -11.86 41.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.251 174.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 8.3 t . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -76.6 133.24 39.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.567 -171.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.26 164.2 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.629 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 112' ' ' LEU . 55.8 tp -111.75 107.33 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.48 103.77 14.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.976 0.417 . . . . 0.0 110.601 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.7 -32.18 74.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.243 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.54 -22.89 65.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.026 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -54.15 8.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.478 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.508 ' OD1' ' HG2' ' A' ' 162' ' ' LYS . 9.6 p30 175.61 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.029 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 127.16 -11.88 6.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.534 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.508 ' HG2' ' OD1' ' A' ' 160' ' ' ASN . 31.5 mmtp -83.72 176.67 8.79 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.433 0.616 . . . . 0.0 109.981 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.482 ' HB3' HD11 ' A' ' 112' ' ' LEU . 43.1 m0 -85.86 136.85 33.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.576 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 23.6 m-85 -127.55 -168.01 1.83 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.465 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -133.86 140.88 47.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.502 ' HE2' HD22 ' A' ' 172' ' ' LEU . 9.2 ttpt -145.88 146.8 31.24 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 165.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.53 140.34 46.28 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.806 0.812 . . . . 0.0 112.538 -163.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.9 m -56.78 -25.33 55.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.59 -161.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -99.08 15.99 24.1 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.16 -176.24 6.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.529 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 31.7 tt0 -132.33 97.65 4.17 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.544 -171.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.1 pp -130.2 168.01 18.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.681 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 172' ' ' LEU . 17.1 Cg_exo -67.26 -178.98 1.61 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.188 2.592 . . . . 0.0 113.321 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.718 ' HB3' ' HZ1' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -159.05 158.72 33.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.241 -0.287 . . . . 0.0 110.368 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.428 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 58.2 mt -126.49 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.61 126.17 49.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.264 0.554 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.197 178.488 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 70.4 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.044 0.45 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -72.9 -4.07 29.68 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.442 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.565 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 1.2 tm0? -58.1 122.15 12.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.204 0.525 . . . . 0.0 110.083 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -96.56 113.41 24.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.46 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -148.39 177.03 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -77.51 165.7 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 85.5 t80 -59.17 -38.53 79.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -59.73 -53.14 61.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.779 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -63.15 -37.8 88.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.516 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -56.95 -43.29 81.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.43 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.59 ' O ' HD13 ' A' ' 78' ' ' ILE . 19.4 m -66.93 -59.69 3.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.311 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -53.21 -44.38 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.761 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 6.3 t70 -70.36 -41.95 72.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.727 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -62.45 -31.87 72.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.362 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -58.92 -36.47 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.387 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 -14.32 28.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 21.4 mmt180 -87.61 -24.68 23.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.886 0.374 . . . . 0.0 110.968 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.68 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.29 -37.57 0.98 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.889 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -146.83 158.34 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.147 0.473 . . . . 0.0 111.942 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 85' ' ' SER . 5.7 tt -90.8 150.75 21.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.558 ' N ' HD23 ' A' ' 84' ' ' LEU . 20.9 m -60.94 109.05 0.96 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.915 0.388 . . . . 0.0 111.179 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 112' ' ' LEU . 18.0 p -113.14 106.02 55.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.484 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.31 135.23 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.232 1.955 . . . . 0.0 111.858 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 31.7 mm-40 -107.69 -26.02 11.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 110.073 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.1 m -136.15 165.84 24.78 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.903 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.19 -28.13 53.68 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.337 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 p -61.2 -50.05 74.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.635 0.255 . . . . 0.0 111.07 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.76 -39.13 73.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.034 0.445 . . . . 0.0 109.986 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -59.42 -48.37 81.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.328 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.93 -34.88 69.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.691 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.19 -31.04 72.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -45.61 93.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.769 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.696 ' CE2' ' HA2' ' A' ' 161' ' ' GLY . 78.5 m-85 -59.92 -40.78 90.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.287 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 5.3 mm-40 -59.97 -44.68 94.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.294 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -75.81 -39.62 56.51 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.642 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 1.9 pp -67.99 -37.14 81.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.265 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 25.9 mtm180 -69.73 -8.63 49.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 46.7 mt-30 -119.2 17.25 13.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.598 0.237 . . . . 0.0 111.027 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -152.07 -62.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.166 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.4 t -76.76 -35.57 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 146.17 -76.92 0.27 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.146 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.457 HD21 ' HG2' ' A' ' 101' ' ' ARG . 2.7 t-20 173.8 -57.46 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.81 39.65 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.863 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.45 139.81 36.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 111.749 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HB3' HG22 ' A' ' 154' ' ' VAL . 2.9 mp0 -99.55 124.38 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.271 171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.913 HG21 ' HA ' ' A' ' 174' ' ' TYR . 5.2 mp -126.24 143.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.044 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -70.61 150.77 45.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 155' ' ' LEU . 78.7 mt -97.25 6.4 48.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 112.01 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.92 16.39 52.04 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.733 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 122.731 0.412 . . . . 0.0 111.0 -175.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.53 0.681 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -68.6 147.55 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.282 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.87 134.59 48.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.209 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' A' ' 127' ' ' THR . 0.0 OUTLIER -81.64 172.1 13.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.973 0.416 . . . . 0.0 110.532 -178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.3 ptp -55.8 -32.62 63.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.417 ' HG1' ' CG ' ' A' ' 125' ' ' ASP . 32.8 p -84.25 -23.13 30.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.542 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.96 4.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.981 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.34 154.7 21.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.043 0.449 . . . . 0.0 110.827 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -109.01 146.45 33.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.832 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.6 HD11 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -87.46 163.32 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.514 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.88 13.78 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.377 0.608 . . . . 0.0 110.018 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 25.5 t80 -139.39 124.34 18.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.861 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 51.5 pttt -143.32 115.71 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -120.32 113.17 19.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.43 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 55.2 m95 -112.93 128.29 56.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -174.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -88.05 -47.63 8.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.822 -177.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.334 0.588 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.96 145.33 38.18 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.19 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 166' ' ' LYS . 13.2 p -125.94 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.322 0.582 . . . . 0.0 110.618 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 112' ' ' LEU . 7.9 tt -91.73 123.62 35.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.2 t -108.96 121.04 44.29 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.663 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . -74.23 -53.75 6.68 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.218 -170.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.08 -1.05 52.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.734 0.302 . . . . 0.0 111.698 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.21 -35.23 66.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.743 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -177.78 -27.67 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.696 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . 92.28 29.89 10.71 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.481 -171.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 72.6 mmtt -126.49 175.9 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -85.66 138.1 32.38 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.53 171.76 10.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.751 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.9 150.1 39.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.004 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.472 ' HB2' HG13 ' A' ' 154' ' ' VAL . 34.7 tttt -153.51 -174.81 5.09 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -74.07 126.9 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 42.9 t -60.33 -22.99 63.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -99.77 17.65 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.621 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.26 137.51 36.64 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.04 99.52 12.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.284 0.564 . . . . 0.0 111.106 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 2.5 pp -128.88 164.23 40.13 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.605 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 36.8 Cg_endo -64.49 178.2 1.79 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.661 2.241 . . . . 0.0 113.191 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.913 ' HA ' HG21 ' A' ' 110' ' ' ILE . 12.1 p90 -152.69 174.2 14.29 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.554 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mp -131.51 126.89 58.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.608 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 2.4 t -102.21 149.46 24.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.794 0.331 . . . . 0.0 110.873 -172.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.783 -179.104 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.502 HG21 HG12 ' A' ' 104' ' ' VAL . 1.5 m -71.53 -10.39 59.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.887 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 8.1 mm-40 -64.18 141.82 58.63 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.201 0.524 . . . . 0.0 110.258 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -95.61 147.79 23.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.177 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.56 172.29 8.25 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.078 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 80.8 p -82.43 166.52 19.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 67.3 t80 -60.89 -36.4 79.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.626 0.251 . . . . 0.0 111.52 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -59.52 -50.36 74.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.21 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -64.83 -40.74 95.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.222 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.518 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -56.48 -39.85 73.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 78' ' ' ILE . 20.3 m -64.53 -61.9 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.573 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.86 -37.29 86.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.895 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 13.3 t70 -66.84 -47.14 72.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 42.0 t -66.02 -30.35 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.378 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.468 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -59.06 -32.09 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.153 0.501 . . . . 0.0 110.179 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -83.21 -32.37 26.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.888 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.576 ' HB2' ' SG ' ' A' ' 176' ' ' CYS . 29.0 mmt180 -77.99 -26.03 48.4 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.679 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.49 -57.33 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.017 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 140.42 -23.79 2.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 p -141.23 136.45 31.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' N ' ' A' ' 85' ' ' SER . 5.1 tt -77.21 151.83 35.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.594 ' N ' HD21 ' A' ' 84' ' ' LEU . 7.5 t -67.23 108.88 2.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.102 0.477 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 125' ' ' ASP . 55.7 m -113.58 114.75 47.25 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.452 ' HB2' ' HZ2' ' A' ' 163' ' ' TRP . 11.5 Cg_exo -71.82 112.04 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.79 2.326 . . . . 0.0 111.794 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.87 -13.18 16.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.89 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.21 154.91 50.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.527 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.82 -53.09 44.29 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.337 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -56.77 -38.23 72.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.829 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.29 -42.48 93.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.131 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -70.02 -43.09 72.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.98 -39.16 93.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.396 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.84 88.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 20.9 tp -67.11 -45.64 76.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.979 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.53 -40.23 93.9 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.501 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.49 -46.08 90.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.01 -31.61 72.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.026 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.7 mt -56.89 -44.16 82.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.699 0.285 . . . . 0.0 110.658 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 36.0 mtm180 -71.9 -10.07 59.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.995 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.19 18.17 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.5 t -154.87 -58.92 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 110' ' ' ILE . 12.2 t -96.36 -36.61 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.449 0.642 . . . . 0.0 110.086 -170.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.6 128.67 3.19 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 -55.29 -33.88 63.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.013 0.435 . . . . 0.0 110.352 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.696 ' HA ' ' HB3' ' A' ' 158' ' ' ALA . 45.9 mt-10 -93.01 26.18 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.132 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.11 160.16 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.7 124.05 40.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.296 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.772 HG21 ' HA ' ' A' ' 174' ' ' TYR . 42.5 mm -116.03 146.24 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.164 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.516 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 71.6 m95 -71.33 147.71 47.79 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' A' ' 114' ' ' LEU . 3.2 mm? -107.22 8.74 30.12 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.259 -0.276 . . . . 0.0 111.668 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.22 43.48 97.15 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.256 0.462 . . . . 0.0 114.256 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.796 HD22 ' HB1' ' A' ' 153' ' ' ALA . 1.5 pt? . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.418 ' HB2' HD13 ' A' ' 114' ' ' LEU . 13.3 m0 -51.64 153.72 2.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.144 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 t -96.56 132.48 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.638 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.563 ' HB3' HG22 ' A' ' 86' ' ' THR . 5.1 p30 -83.1 -171.82 3.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.142 0.496 . . . . 0.0 111.3 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.4 mtt -82.16 -14.51 55.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t -98.89 0.39 44.05 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.737 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.29 24.32 16.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.431 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.65 166.42 13.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.961 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -100.6 133.22 45.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.469 HD11 ' HZ3' ' A' ' 163' ' ' TRP . 26.5 pt -58.99 124.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 0.0 111.175 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.9 12.59 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.524 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -140.67 127.88 20.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 22.5 mtmt -135.21 118.2 16.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.802 0.334 . . . . 0.0 111.722 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -131.72 111.18 11.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.806 0.812 . . . . 0.0 109.332 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.494 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 38.3 m95 -132.29 137.83 47.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 -174.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.717 ' HB2' ' HD3' ' A' ' 162' ' ' LYS . 20.3 tt0 -97.57 -18.78 18.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.843 177.461 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 94.2 m . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.796 ' HB1' HD22 ' A' ' 114' ' ' LEU . . . -75.26 139.93 42.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.959 0.409 . . . . 0.0 111.466 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 166' ' ' LYS . 28.2 m -129.12 159.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.157 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.75 100.18 9.7 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.4 m -87.97 101.19 13.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.693 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.83 96.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.151 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 107' ' ' GLU . . . -63.27 -25.05 68.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 111.239 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.31 46.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.311 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.82 -40.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.366 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 124.41 2.36 8.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.691 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.717 ' HD3' ' HB2' ' A' ' 137' ' ' GLU . 25.8 mttt -83.62 168.45 16.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.494 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 54.6 m0 -85.17 134.62 34.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.482 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.78 177.06 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.881 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.59 153.5 23.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 0.0 111.623 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.632 ' HG3' HG13 ' A' ' 154' ' ' VAL . 37.8 mmtt -149.87 149.27 30.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.65 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -70.34 129.12 38.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 13.4 m -64.36 -1.1 1.52 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -96.32 2.65 52.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.62 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -77.17 136.37 38.58 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 68' ' ' LYS . 9.6 tt0 -98.49 90.24 4.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.279 0.562 . . . . 0.0 110.888 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.1 pp -125.87 168.83 12.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.576 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' O ' HD12 ' A' ' 172' ' ' LEU . 12.4 Cg_exo -69.31 174.64 8.82 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.79 2.327 . . . . 0.0 112.369 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.772 ' HA ' HG21 ' A' ' 110' ' ' ILE . 1.3 p90 -152.39 172.62 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.97 129.7 54.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 80' ' ' ARG . 8.2 t -102.16 136.3 42.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.043 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.984 -176.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 55.7 m-85 . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 104' ' ' VAL . 2.0 m -73.31 -6.18 44.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 12.3 mm-40 -63.91 134.1 54.52 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.531 0.681 . . . . 0.0 111.289 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -94.01 133.39 37.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.987 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.45 177.23 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.434 175.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -77.61 165.27 24.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.527 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 89.1 t80 -62.28 -37.65 86.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.211 0.529 . . . . 0.0 110.554 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -62.97 -46.51 87.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.16 -38.77 82.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -57.75 -35.92 71.39 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.444 ' O ' HD13 ' A' ' 78' ' ' ILE . 48.1 m -64.67 -58.67 5.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.383 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -57.66 -43.5 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.347 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 23.0 t70 -64.26 -59.09 4.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.98 -30.28 70.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.714 0.293 . . . . 0.0 111.406 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 74' ' ' SER . 1.2 mp -60.82 -29.82 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -98.76 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 32.4 mmt180 -80.4 -25.78 38.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.757 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.71 -50.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.15 -41.03 1.19 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.519 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -142.37 139.6 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.595 0.198 . . . . 0.0 110.867 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 85' ' ' SER . 6.6 tt -77.33 147.11 36.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.481 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.8 m -62.28 108.67 1.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.0 111.048 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 125' ' ' ASP . 15.8 p -107.63 110.53 62.74 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.378 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HG3' HD21 ' A' ' 112' ' ' LEU . 97.5 Cg_endo -80.59 140.94 13.56 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.584 2.189 . . . . 0.0 111.509 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.4 pt20 -129.52 -10.25 4.56 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.305 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.6 p -141.9 177.39 8.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.98 68.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.952 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -61.85 -48.91 78.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.317 0.247 . . . . 0.0 111.271 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -68.84 -37.82 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.539 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.39 -39.74 88.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.15 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 36.0 t70 -68.42 -49.75 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.097 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.95 77.36 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.424 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.59 -42.81 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.6 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.519 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 2.0 t80 -61.17 -36.21 79.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 9.8 mm-40 -70.08 -46.38 65.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.0 -39.7 75.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.216 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 108' ' ' ALA . 4.1 pp -65.55 -34.47 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.677 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 66.8 mtm180 -71.98 -9.58 58.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.698 0.285 . . . . 0.0 111.437 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -111.23 12.09 21.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.748 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -59.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 111.085 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.542 ' HB ' ' HB1' ' A' ' 108' ' ' ALA . 2.1 t -77.94 -33.3 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.163 0.506 . . . . 0.0 109.896 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 138.09 -73.56 0.42 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.579 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 175.29 -54.69 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.837 ' HA ' ' HB1' ' A' ' 158' ' ' ALA . 46.0 mt-10 -78.91 36.48 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.586 ' HB3' HD13 ' A' ' 100' ' ' LEU . . . -79.61 130.38 35.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.095 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.05 121.54 44.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.812 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.5 mp -126.8 141.42 46.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -70.46 148.96 47.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 153' ' ' ALA . 90.1 mt -98.93 5.95 47.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.728 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.53 9.31 43.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 122.437 0.295 . . . . 0.0 111.07 -176.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.751 HG21 ' HB2' ' A' ' 130' ' ' ARG . 21.1 m . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -52.12 141.64 18.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.954 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.16 138.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.519 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -88.24 178.7 6.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.8 ptp -64.52 -32.64 74.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.408 ' HG1' ' CG ' ' A' ' 125' ' ' ASP . 31.9 p -76.56 -22.77 53.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.014 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 113.22 20.6 6.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.61 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.85 160.59 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.751 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -109.81 154.19 23.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.839 177.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.09 143.63 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.15 -18.46 20.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.153 0.501 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 20.3 t80 -119.52 120.7 37.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.644 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -144.34 131.4 20.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 111.151 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -147.99 136.09 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.413 0.625 . . . . 0.0 110.189 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -129.99 123.3 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.066 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 67.3 mm-40 -74.72 -27.05 60.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.285 0.564 . . . . 0.0 109.873 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.624 HG21 ' HD2' ' A' ' 164' ' ' PHE . 11.5 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.236 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.7 m . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 121.148 0.499 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.534 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -91.91 139.17 30.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.878 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 p -133.41 141.43 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.681 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.487 ' HB2' HD22 ' A' ' 112' ' ' LEU . 2.4 tt -91.22 123.53 34.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -108.4 106.19 16.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.175 0.512 . . . . 0.0 110.633 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.18 1.61 84.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.11 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.837 ' HB1' ' HA ' ' A' ' 107' ' ' GLU . . . -101.27 5.38 42.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.104 0.478 . . . . 0.0 110.556 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.8 -53.17 2.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.778 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -173.38 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.296 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 111.74 -2.57 27.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.886 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 34.9 mmtp -76.31 -179.04 4.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.46 ' HZ3' HG13 ' A' ' 131' ' ' ILE . 49.9 m0 -94.39 134.02 37.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.241 0.543 . . . . 0.0 109.796 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.624 ' HD2' HG21 ' A' ' 138' ' ' THR . 91.9 m-85 -126.02 165.28 19.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.883 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.54 144.21 44.63 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.696 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 72.6 tttt -144.93 -171.89 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.696 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 1.2 mmt180 -72.54 125.54 27.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 9.4 t -69.54 -19.82 63.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.386 0.612 . . . . 0.0 110.076 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -94.73 12.31 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.233 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 20.0 t70 -80.59 136.1 36.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -93.8 93.44 7.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.229 0.538 . . . . 0.0 110.945 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.56 169.69 9.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.736 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.77 -179.1 2.27 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.995 2.464 . . . . 0.0 113.049 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.812 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.2 p90 -156.57 171.55 20.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.874 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.15 125.96 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 13.8 t -102.29 133.91 46.42 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.634 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 16.8 p -77.14 -8.54 57.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 13.6 mm-40 -64.96 141.92 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.2 p -99.06 144.49 28.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.769 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.756 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.59 -179.7 3.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.34 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 74.4 p -80.3 164.97 22.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 85.3 t80 -62.34 -35.35 78.84 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -59.37 -52.14 66.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.329 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.6 mt-10 -64.25 -37.14 86.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.756 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -61.52 -43.65 98.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -65.67 -55.92 14.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.805 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -60.92 -34.27 74.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.883 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 17.1 t70 -69.95 -51.63 31.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.45 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.3 t -63.07 -34.33 77.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.502 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -56.85 -31.03 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.498 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 -37.59 20.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.59 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 31.6 mmt180 -71.8 -26.56 62.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 111.072 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.25 -48.95 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.884 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 131.82 -26.37 3.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.972 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 p -135.14 128.09 31.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.924 0.362 . . . . 0.0 111.429 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD21 ' N ' ' A' ' 85' ' ' SER . 6.1 tt -74.88 146.53 41.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.547 ' N ' HD21 ' A' ' 84' ' ' LEU . 5.0 t -65.68 108.94 2.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.155 0.502 . . . . 0.0 110.448 -172.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 125' ' ' ASP . 28.3 m -116.27 114.1 40.94 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.344 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.56 137.97 13.34 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.663 2.242 . . . . 0.0 112.076 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -114.51 -13.55 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.276 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.65 165.08 28.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.981 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.82 -42.97 94.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.755 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.6 p -55.76 -44.53 77.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -42.64 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.85 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -65.38 -45.51 83.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -38.95 91.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.53 84.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.893 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.6 tp -66.07 -43.38 87.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -59.74 -40.78 89.23 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.12 -36.88 77.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.29 -36.8 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 59.7 mt -54.39 -52.08 62.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.0 109.75 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ttm-85 -56.54 -33.35 66.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.006 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -101.4 -1.46 33.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.2 t -140.16 -50.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.768 HG11 HD12 ' A' ' 110' ' ' ILE . 7.3 t -98.02 -30.15 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.605 0.717 . . . . 0.0 110.503 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.37 125.54 3.63 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -49.89 -42.49 48.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 158' ' ' ALA . 45.6 mt-10 -94.21 47.83 1.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 111.263 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.74 145.54 41.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 10.9 mm-40 -98.52 123.82 42.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.862 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.768 HD12 HG11 ' A' ' 104' ' ' VAL . 43.0 mm -121.83 142.85 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.367 -0.133 . . . . 0.0 111.192 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 64.0 m95 -70.61 145.84 50.44 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 155' ' ' LEU . 82.2 mt -111.03 16.49 21.13 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.3 -27.67 0.83 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 123' ' ' TRP . 1.6 pt? . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 118.123 0.962 . . . . 0.0 110.913 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.516 ' HB2' HD12 ' A' ' 114' ' ' LEU . 16.9 m0 -62.3 150.03 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.205 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.47 138.19 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.72 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.643 ' OD2' HG23 ' A' ' 127' ' ' THR . 1.1 p-10 -99.89 -162.12 0.92 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.94 -33.57 51.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.375 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.643 HG23 ' OD2' ' A' ' 125' ' ' ASP . 14.4 t -83.03 -21.4 33.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.024 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.84 32.05 6.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.498 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.19 157.54 15.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 130' ' ' ARG . 0.3 OUTLIER -107.97 118.39 36.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.128 177.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.6 pt -64.34 125.41 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.341 0.591 . . . . 0.0 111.011 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.84 -20.75 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.528 0.68 . . . . 0.0 109.904 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -110.65 127.55 55.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.765 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -129.53 114.44 16.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.617 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -129.41 111.21 12.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.381 0.61 . . . . 0.0 109.772 172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -125.99 124.14 40.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . 7.4 tp10 -77.68 -25.83 49.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.588 175.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 71.6 m . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.14 134.82 41.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 28.7 m -120.46 156.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.497 ' HB2' HD22 ' A' ' 112' ' ' LEU . 1.5 tt -103.63 101.14 10.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.3 m -84.64 91.57 7.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.486 0.66 . . . . 0.0 110.61 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.77 -22.39 78.72 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.523 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.46 ' HA ' ' HG2' ' A' ' 107' ' ' GLU . . . -69.89 -15.83 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.136 0.493 . . . . 0.0 110.27 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.85 -65.27 0.99 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -167.19 -37.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 131.05 -4.15 5.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.364 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -77.34 174.68 10.52 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.112 0.456 . . . . 0.0 110.107 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -89.78 133.49 34.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.85 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 42.1 m-85 -119.78 166.89 12.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -104.62 144.38 31.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.272 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -146.09 150.93 36.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.911 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.12 130.35 39.08 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 6.0 m -65.14 2.96 0.67 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -95.21 -4.58 45.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.01 132.14 41.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.782 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -93.21 97.92 10.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 173' ' ' PRO . 3.2 pp -129.05 166.11 27.48 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 14.8 Cg_exo -67.08 171.13 11.77 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.721 2.281 . . . . 0.0 112.233 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.459 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 3.2 p90 -137.77 174.33 10.69 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 93.2 mt -137.8 123.55 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 10.1 t -102.08 130.51 48.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.019 0.438 . . . . 0.0 109.967 -178.084 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 74.0 m-85 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.057 0.456 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -74.38 0.28 14.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.587 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.543 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -65.98 127.56 32.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -102.29 123.95 47.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.664 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.543 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -150.07 174.73 12.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.606 -177.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 82.5 p -80.61 166.57 20.98 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.382 0.427 . . . . 0.0 110.227 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.556 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -60.95 -41.71 96.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.359 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -54.99 -39.96 69.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.239 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.705 ' O ' HG12 ' A' ' 78' ' ' ILE . 37.7 m -64.09 -69.64 0.27 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.55 -44.6 73.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.752 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 19.9 t70 -60.52 -58.92 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.917 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -58.57 -42.06 87.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.16 0.287 . . . . 0.0 111.215 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.705 HG12 ' O ' ' A' ' 74' ' ' SER . 42.2 mm -57.51 -41.23 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.324 0.583 . . . . 0.0 110.413 175.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 t -72.64 -24.26 61.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.702 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.752 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.1 mmp_? -74.79 -10.33 59.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.386 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.01 37.72 5.63 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.004 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.68 -170.22 27.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.189 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -130.26 146.74 51.9 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 85' ' ' SER . 2.6 tt -63.32 138.03 58.39 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' HD21 ' A' ' 84' ' ' LEU . 30.3 p -61.83 109.33 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.371 0.419 . . . . 0.0 111.579 -174.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.542 HG21 ' HA3' ' A' ' 113' ' ' GLY . 47.2 p -110.0 107.73 58.93 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.969 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 14.6 Cg_exo -68.5 111.33 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.085 1.857 . . . . 0.0 112.576 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -85.41 -27.96 25.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.6 p -129.56 173.18 10.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.61 -38.95 95.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.12 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -59.27 -43.41 92.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 87' ' ' PRO . 7.3 mm-40 -59.6 -47.81 84.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.997 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -64.14 -44.9 90.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.56 . . . . 0.0 110.203 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.02 -49.21 77.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.912 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.16 67.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.718 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.3 tp -70.64 -47.01 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -60.76 -35.55 76.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.317 0.579 . . . . 0.0 109.946 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.164 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 68.5 t80 -68.24 -27.57 66.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.513 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 22.9 mt -58.64 -54.85 42.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -58.83 -33.2 70.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.141 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 9.2 pt20 -91.62 0.98 57.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t -146.32 -59.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 -28.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.623 0.725 . . . . 0.0 110.698 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.3 119.0 4.55 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -165.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 66.9 t30 -51.54 -36.52 45.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.136 0.468 . . . . 0.0 111.749 -173.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.69 32.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.906 0.384 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.46 139.88 32.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 8.6 mm-40 -94.31 122.36 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -136.85 155.1 32.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.39 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.448 ' CE3' HG22 ' A' ' 154' ' ' VAL . 86.8 m95 -71.44 144.87 49.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.924 0.392 . . . . 0.0 110.694 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.491 HD13 HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.69 -7.25 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -174.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.542 ' HA3' HG21 ' A' ' 86' ' ' THR . . . 81.11 -1.66 84.09 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.535 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.491 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 117.238 0.519 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -79.83 156.26 27.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.932 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.13 130.18 71.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.762 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' OD1' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -73.19 164.69 26.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.403 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 17.9 mmt -61.23 -33.39 73.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.55 -5.86 49.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.108 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.75 64.27 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.54 166.72 10.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.061 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -112.53 118.62 35.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.331 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -57.95 150.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.873 174.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -105.79 -5.14 20.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 109.719 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -126.79 115.33 19.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.699 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 1.6 ptmm? -144.41 114.09 7.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.314 . . . . 0.0 111.071 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -136.3 112.31 9.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.568 ' HZ3' ' HB2' ' A' ' 153' ' ' ALA . 4.4 m95 -112.43 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 164' ' ' PHE . 2.8 tp10 -68.88 -27.85 66.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.07 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.9 179.342 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.634 0.73 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.568 ' HB2' ' HZ3' ' A' ' 136' ' ' TRP . . . -82.04 131.36 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.961 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.448 HG22 ' CE3' ' A' ' 111' ' ' TRP . 48.1 t -131.55 147.58 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.48 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 tt -100.98 125.22 47.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.7 t -114.27 98.5 6.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.156 0.503 . . . . 0.0 110.195 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -75.81 -22.24 75.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.294 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.36 -30.48 68.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.106 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.93 -58.68 3.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -176.94 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.384 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.74 -1.38 4.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.025 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.01 167.67 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -87.26 144.26 26.89 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 68.8 m-85 -135.99 177.12 8.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.318 0.58 . . . . 0.0 111.418 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.637 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HB2' HG23 ' A' ' 154' ' ' VAL . 10.7 tttp -152.85 -170.39 3.62 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -80.14 122.7 27.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.35 -25.3 61.81 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.36 8.77 39.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.6 131.83 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -92.95 96.83 10.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.013 0.435 . . . . 0.0 110.755 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 110' ' ' ILE . 3.1 pp -125.89 164.37 33.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.137 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 16.8 Cg_exo -67.04 -178.38 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.164 2.576 . . . . 0.0 113.011 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -160.51 168.08 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.639 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.5 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 4.4 mp -127.53 133.68 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 69.3 m -110.06 139.21 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.117 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.613 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 32.6 m-85 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 p -81.14 -0.95 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.544 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.82 122.72 17.59 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.046 0.451 . . . . 0.0 110.77 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -91.79 111.05 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.377 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.882 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -151.5 -177.14 5.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.372 -177.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.5 p -79.09 167.3 21.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -47.0 84.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.01 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -70.37 -32.64 70.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.38 -43.8 76.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.882 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.51 -38.35 69.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.842 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' HD12 ' A' ' 78' ' ' ILE . 29.5 t -64.81 -65.71 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.775 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.48 -31.38 72.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.92 -44.76 84.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.18 0.514 . . . . 0.0 109.961 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 49.5 t -65.21 -45.05 86.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.367 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.497 HD12 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -60.28 -36.82 71.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.396 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 t -78.6 -19.54 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.629 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.4 ptp180 -91.7 -3.55 56.14 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.016 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.85 45.15 4.0 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.701 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.81 -179.33 36.41 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.104 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 p -135.75 157.41 46.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.718 HD23 ' HE2' ' A' ' 126' ' ' MET . 4.0 mm? -64.27 149.45 48.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -75.05 107.02 6.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.721 HG22 ' HB2' ' A' ' 125' ' ' ASP . 23.4 m -97.61 111.46 58.74 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.488 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 112' ' ' LEU . 3.4 Cg_exo -77.67 119.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.168 2.579 . . . . 0.0 112.271 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -13.64 16.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.786 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 92' ' ' GLU . 45.1 p -130.93 170.01 15.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.317 . . . . 0.0 110.679 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.98 65.63 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.189 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.6 p -66.38 -37.94 86.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.35 0.595 . . . . 0.0 110.718 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.565 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 14.8 tt0 -69.71 -40.3 76.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.155 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -61.87 -45.36 94.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.64 -36.74 79.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.76 99.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.979 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.73 -40.59 88.42 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.479 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 88.0 t80 -57.85 -45.87 85.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 15.7 mm-40 -68.62 -38.95 80.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.235 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -66.19 -48.11 71.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 110' ' ' ILE . 0.9 OUTLIER -65.18 -34.3 78.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 47.5 ttt180 -54.62 -48.78 71.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.092 175.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 98' ' ' GLU . 27.1 pt20 -93.29 11.11 29.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.278 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -134.47 -61.41 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.642 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 175' ' ' ILE . 2.9 t -87.79 -32.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.926 0.87 . . . . 0.0 109.61 -172.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 122.26 122.95 2.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.07 -37.58 4.31 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.745 0.418 . . . . 0.0 112.088 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.28 21.63 2.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.96 161.41 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.015 0.436 . . . . 0.0 111.585 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.455 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 39.6 mt-10 -121.81 122.37 39.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.711 176.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.851 HD12 HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -134.36 150.93 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.027 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.404 ' CE2' HD12 ' A' ' 172' ' ' LEU . 36.7 m95 -72.19 155.22 40.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.792 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' ALA . 55.5 mt -106.61 6.82 30.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.7 79.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 120.771 0.319 . . . . 0.0 111.109 -179.031 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.761 0.791 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.593 ' HH2' ' HA ' ' A' ' 152' ' ' CYS . 28.2 m95 -95.83 156.48 16.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.837 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -118.34 130.32 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.721 ' HB2' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.45 156.78 38.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.718 ' HE2' HD23 ' A' ' 84' ' ' LEU . 9.3 ptp -58.96 -30.25 67.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -173.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 t -106.38 6.75 30.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.239 0.542 . . . . 0.0 111.124 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.5 28.52 9.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.753 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.86 137.99 31.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.012 0.406 . . . . 0.0 110.558 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -91.63 116.14 28.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 38.4 pt -77.78 132.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.05 3.47 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.259 0.552 . . . . 0.0 110.459 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -133.67 116.8 16.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.33 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.01 100.87 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.674 0.749 . . . . 0.0 110.629 172.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -111.14 113.03 25.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.026 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.441 ' HH2' ' HB1' ' A' ' 153' ' ' ALA . 23.8 m95 -112.99 113.45 25.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.366 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.52 -23.83 53.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.62 0.724 . . . . 0.0 109.334 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.677 ' HB ' ' HD2' ' A' ' 164' ' ' PHE . 11.7 t . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.775 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.593 ' HA ' ' HH2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 112' ' ' LEU . . . -75.52 108.81 8.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' A' ' 166' ' ' LYS . 12.3 p -122.07 140.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.511 ' HB2' HD22 ' A' ' 112' ' ' LEU . 31.4 tp -90.03 115.38 27.26 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.0 m -110.74 100.19 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.416 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.98 -19.41 78.76 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.596 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.62 -19.55 65.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 111.412 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.62 -56.48 2.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.44 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -171.58 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 120.13 6.53 9.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.12 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.96 -178.75 6.36 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.621 -0.341 . . . . 0.0 110.381 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -88.98 131.75 35.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.677 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 95.8 m-85 -125.82 171.1 10.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.552 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 5.5 p-10 -113.25 141.23 47.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.501 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 31.5 tttp -145.82 174.87 10.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.659 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 59.7 mtm180 -64.5 124.28 21.42 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.307 0.38 . . . . 0.0 110.25 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.76 -21.49 61.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.69 15.16 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.676 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.659 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 3.8 t0 -87.77 166.01 14.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 68' ' ' LYS . 97.8 mt-30 -122.47 96.01 4.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.124 0.487 . . . . 0.0 111.331 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 173' ' ' PRO . 3.2 pp -126.29 172.32 6.59 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.741 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 14.7 Cg_exo -69.69 -178.63 2.41 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.563 2.175 . . . . 0.0 112.716 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -153.8 172.18 17.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 104' ' ' VAL . 95.9 mt -142.77 115.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 110.597 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.572 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 97.4 m -102.97 155.78 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.13 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.639 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 43.3 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.901 0.382 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -71.53 -12.35 61.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.989 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG2' ' HE1' ' A' ' 174' ' ' TYR . 14.2 pt20 -72.35 135.22 45.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.501 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 p -89.71 138.38 31.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.648 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -168.95 166.04 11.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 169' ' ' ARG . 30.4 p -81.94 168.12 18.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.22 -29.14 60.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.64 0.257 . . . . 0.0 110.571 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -60.6 -59.3 5.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.633 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 8.5 mp0 -65.43 -31.42 72.5 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.79 81.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.52 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 44.5 t -72.64 -56.28 5.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.342 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 3.0 tp10 -56.39 -38.46 71.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.608 -173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -72.1 -52.82 14.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.091 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.641 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 25.2 t -66.42 -37.25 84.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.221 -174.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -62.87 -37.28 78.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 0.0 110.131 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -79.09 -27.03 42.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.738 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.641 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.9 ptp180 -83.23 6.83 18.13 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.757 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.04 43.14 27.55 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.271 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 -171.38 17.57 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 2.1 m -150.43 145.2 25.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.5 mp -58.72 135.81 57.54 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.7 p -70.37 107.52 3.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.235 0.54 . . . . 0.0 110.814 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 95.0 m -99.9 120.95 55.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.05 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 12.1 Cg_exo -70.37 111.48 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.098 1.865 . . . . 0.0 112.219 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -103.64 -18.96 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.918 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -136.05 177.77 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.213 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.93 -35.51 91.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.275 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -56.45 -43.7 79.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.2 mp0 -60.43 -58.61 7.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.7 0.286 . . . . 0.0 111.187 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -66.19 -41.33 90.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.116 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -40.07 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.551 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.42 -31.45 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.38 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 2.5 tt -60.64 -46.11 91.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 88.5 t80 -59.83 -41.84 92.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.689 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.483 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 8.3 tp10 -68.7 -37.73 79.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.103 0.478 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -62.85 -35.62 80.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.513 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 66.5 mt -56.4 -48.98 75.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.483 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 42.9 mtp180 -64.95 -17.3 64.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.951 -173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -116.18 9.94 14.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.0 m -153.58 -46.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.951 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 110' ' ' ILE . 30.1 t -104.77 -37.44 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.532 0.682 . . . . 0.0 110.473 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.38 128.56 3.01 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -55.92 -41.9 75.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.321 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.18 154.78 18.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.207 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 156' ' ' SER . 40.2 mt-10 -122.39 122.39 38.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.984 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.698 HD12 HG11 ' A' ' 104' ' ' VAL . 2.2 mp -121.2 147.51 25.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.069 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.58 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 73.5 m95 -71.65 138.89 48.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 155' ' ' LEU . 2.1 mm? -100.93 12.55 37.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.44 81.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.988 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 131' ' ' ILE . 8.4 mp . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.422 ' HB2' ' CD1' ' A' ' 131' ' ' ILE . 36.4 m95 -62.74 149.21 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.836 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.4 133.95 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.362 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -98.06 -165.47 1.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 0.0 111.123 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.52 ' HE3' ' HB2' ' A' ' 74' ' ' SER . 20.1 mmt -65.37 -37.57 87.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.608 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 78.2 p -82.47 -20.62 36.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.79 0.329 . . . . 0.0 111.317 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.36 28.37 13.2 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.01 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.02 165.4 12.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.05 0.452 . . . . 0.0 110.54 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.33 106.96 19.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.526 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 114' ' ' LEU . 44.8 pt -62.41 124.87 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.257 0.551 . . . . 0.0 110.907 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.98 -10.97 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.447 0.641 . . . . 0.0 109.872 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -104.11 116.03 31.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.204 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -135.08 99.4 4.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.915 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 135' ' ' ASN . 5.3 m120 -121.14 111.51 17.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.059 0.457 . . . . 0.0 110.309 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -122.03 124.71 44.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.837 ' HG2' HD22 ' A' ' 160' ' ' ASN . 5.1 tp10 -75.12 -29.03 60.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.644 0.735 . . . . 0.0 109.352 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.965 178.624 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.918 0.389 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -110.83 150.35 29.27 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 166' ' ' LYS . 28.1 m -143.01 155.91 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.527 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.554 ' N ' HD21 ' A' ' 112' ' ' LEU . 50.8 tp -99.01 103.99 15.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.486 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 20.0 t -96.9 103.64 15.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 -175.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.24 -26.77 67.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.72 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.31 -19.09 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.301 0.572 . . . . 0.0 110.613 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.15 -61.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.189 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.837 HD22 ' HG2' ' A' ' 137' ' ' GLU . 15.3 p30 -174.67 -30.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.12 32.73 1.34 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.711 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 34.3 mmtp -119.66 177.73 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 49.5 m0 -78.42 124.92 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.184 0.516 . . . . 0.0 111.069 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 77.2 m-85 -127.17 178.91 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.493 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -115.92 138.57 51.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.87 0.367 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 154' ' ' VAL . 17.1 mtmt -150.02 161.15 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.649 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.512 ' O ' ' HH2' ' A' ' 111' ' ' TRP . 1.9 mtm105 -60.35 132.48 54.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.58 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -63.47 -17.41 62.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.386 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.413 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 5.7 ptp85 -103.82 29.37 5.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.984 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.3 147.31 23.02 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -91.69 85.14 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.472 . . . . 0.0 110.408 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -128.63 164.44 38.21 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.227 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.45 ' O ' HD11 ' A' ' 172' ' ' LEU . 20.1 Cg_exo -65.79 -177.1 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.48 2.787 . . . . 0.0 113.205 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.654 ' HA ' HG22 ' A' ' 110' ' ' ILE . 1.4 p90 -155.16 167.55 29.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 90.4 mt -141.23 131.0 25.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.934 0.397 . . . . 0.0 110.234 176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.449 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 74.5 m -104.54 157.93 16.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.963 177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.9 pt20 . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 121.505 0.669 . . . . 0.0 109.64 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.439 ' C ' ' H ' ' A' ' 66' ' ' GLN . 77.4 m-85 . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 121.066 0.46 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 t -71.47 13.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 64' ' ' PHE . 12.8 mm100 -71.9 138.65 48.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.332 0.587 . . . . 0.0 110.515 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -93.2 137.22 32.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.578 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -171.26 -178.5 2.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 178.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 15.2 p -77.37 166.09 23.59 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.322 0.389 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.1 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -63.28 -48.19 79.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 6.1 mm-40 -67.44 -40.54 85.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.275 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -54.52 -47.48 73.07 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.061 0.458 . . . . 0.0 110.306 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' HD12 ' A' ' 78' ' ' ILE . 17.5 m -65.03 -56.66 11.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.54 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.68 -41.42 99.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.901 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.575 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 35.0 t70 -71.91 -48.51 45.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.336 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.8 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 46.8 t -64.68 -39.36 93.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -64.4 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.156 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -63.52 -31.9 73.2 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 66.9 mtt180 -66.85 -17.47 64.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 19.04 13.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.699 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -130.93 -169.42 12.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.195 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 p -139.99 161.86 36.59 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 126' ' ' MET . 9.7 mp -75.52 153.61 37.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.556 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.8 t -82.26 107.24 14.79 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 82.7 p -97.47 120.08 61.49 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 6.9 Cg_endo -84.78 113.46 1.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.458 2.105 . . . . 0.0 112.107 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 1.8 pt20 -109.44 -7.25 15.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.183 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.06 169.46 18.63 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.048 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.35 -36.64 92.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.668 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -58.32 -43.25 88.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.1 mp0 -61.25 -48.85 79.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.693 0.282 . . . . 0.0 111.281 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -64.38 -36.04 82.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.294 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.99 -48.44 76.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.645 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -33.6 76.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.158 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.408 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 52.6 mt -60.57 -62.66 1.7 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.222 173.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.729 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 48.9 t80 -53.39 -34.97 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.681 0.613 . . . . 0.0 112.005 -174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.44 -54.94 5.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.453 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 85.4 t80 -57.54 -34.43 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.831 0.824 . . . . 0.0 109.195 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 104' ' ' VAL . 29.4 tp -53.83 -53.78 47.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.516 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 42.9 mtm105 -67.51 -19.06 65.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.969 -176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 3.8 pt20 -111.82 4.14 18.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.08 -44.24 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.968 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.809 HG13 HD12 ' A' ' 110' ' ' ILE . 41.3 t -102.13 -49.62 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 109.679 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.4 129.48 1.56 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.988 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.553 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 t30 -46.01 -49.11 16.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.088 0.471 . . . . 0.0 111.006 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.28 22.85 6.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.662 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.39 161.31 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.002 0.429 . . . . 0.0 110.99 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 41.3 mt-10 -124.47 125.45 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.809 HD12 HG13 ' A' ' 104' ' ' VAL . 1.8 mp -123.25 144.13 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.12 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.41 ' CZ3' HG21 ' A' ' 154' ' ' VAL . 82.7 m95 -71.21 137.77 48.95 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.594 ' HB3' HD23 ' A' ' 114' ' ' LEU . 94.5 mt -83.11 -14.46 53.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . 76.51 15.76 81.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.371 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 111.349 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.568 0.699 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 55.8 m95 -68.37 144.25 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.515 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -110.04 139.94 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -72.43 153.62 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 49.7 mtt -55.95 -25.06 41.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.207 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.2 t -88.51 4.1 47.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.236 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.68 37.92 9.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.341 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.39 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.768 0.284 . . . . 0.0 110.561 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -105.77 127.44 53.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 0.0 110.418 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.9 pt -69.95 151.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.409 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.09 3.11 14.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -141.13 124.29 16.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.805 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.99 130.51 31.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -133.72 111.48 10.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -121.04 128.04 52.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.37 -175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -72.87 -21.2 60.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.446 179.483 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 112' ' ' LEU . . . -75.71 133.44 40.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.402 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.41 HG21 ' CZ3' ' A' ' 111' ' ' TRP . 17.3 t -126.17 141.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.473 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 63.8 tp -98.96 112.53 24.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 p -106.33 109.54 21.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.918 0.389 . . . . 0.0 111.171 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.83 -22.26 78.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.039 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.63 -25.1 67.81 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.0 -60.06 2.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.357 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.0 p30 176.91 -24.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.316 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 123.15 25.81 1.78 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.733 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -111.8 167.6 10.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.704 0.288 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -82.48 135.73 35.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.046 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -126.96 -169.03 1.96 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.071 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -143.02 139.06 30.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.0 110.687 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -139.31 164.98 28.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 167' ' ' ARG . 2.4 tpt180 -71.09 141.22 50.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.565 ' O ' ' HB ' ' A' ' 69' ' ' THR . 51.1 m -63.33 -5.9 4.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.53 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 13.7 ttp85 -112.94 20.19 16.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.9 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -90.94 145.14 24.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 mp0 -93.16 94.47 8.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 111.689 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -129.39 157.84 75.02 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.064 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 22.4 Cg_exo -64.28 179.13 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.006 2.47 . . . . 0.0 113.464 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.8 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -155.24 166.22 34.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.454 177.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.608 HG13 HG12 ' A' ' 110' ' ' ILE . 90.5 mt -124.09 130.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 55.5 m -102.45 132.18 48.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.387 0.613 . . . . 0.0 111.436 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.317 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.616 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.774 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 58.5 m-85 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 p -84.51 5.2 28.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.896 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' OE1' ' HD3' ' A' ' 68' ' ' LYS . 17.5 tm0? -77.97 123.86 27.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -97.66 115.27 27.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.606 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.719 ' HE3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -144.43 179.24 7.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.887 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.1 p -84.55 167.02 16.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.05 -20.27 62.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -72.5 -50.45 25.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.27 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 3.3 mp0 -70.42 -35.34 73.36 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.096 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.719 ' HB1' ' HE3' ' A' ' 68' ' ' LYS . . . -67.81 -18.58 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.747 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.494 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 10.3 p -91.97 -51.54 5.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.713 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.78 -29.6 65.85 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.869 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -65.66 -40.25 92.21 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.936 -175.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.705 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 33.6 m -72.28 -42.94 64.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.634 0.254 . . . . 0.0 111.211 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.72 -41.53 88.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 t -80.32 -15.8 56.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.705 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 9.9 ptp180 -91.7 4.78 51.95 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.67 38.77 31.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.432 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.74 -170.15 18.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.4 p -131.07 153.51 49.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.618 HD21 ' N ' ' A' ' 85' ' ' SER . 4.8 tt -73.4 146.41 45.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.618 ' N ' HD21 ' A' ' 84' ' ' LEU . 19.3 m -62.6 109.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.972 0.415 . . . . 0.0 111.267 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 28.5 p -107.32 119.83 49.62 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.573 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 31.3 Cg_endo -92.36 123.05 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.646 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 3.6 pt20 -127.82 0.91 6.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 92' ' ' GLU . 68.6 p -129.58 173.65 10.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.38 -36.87 89.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.5 t -64.46 -52.63 57.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.0 110.705 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.646 ' OE1' ' HG2' ' A' ' 88' ' ' GLN . 9.3 pt-20 -75.02 -24.63 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.531 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 87' ' ' PRO . 28.2 t-20 -66.59 -48.84 68.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.15 0.5 . . . . 0.0 110.284 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.35 -22.78 32.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.167 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.72 84.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.608 0.242 . . . . 0.0 110.966 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.09 -40.87 95.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.605 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 36.0 t80 -59.23 -43.69 92.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.454 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.36 -47.25 67.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.473 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.08 -38.69 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.51 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 97' ' ' TYR . 2.9 pp -68.01 -29.56 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.363 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 74.6 mtp180 -66.27 -26.31 67.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -98.83 5.84 47.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.877 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -153.67 -47.35 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 100' ' ' LEU . 4.5 t -88.25 -34.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.654 0.74 . . . . 0.0 109.349 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.28 124.2 3.78 Favored Glycine 0 N--CA 1.434 -1.433 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -50.95 -37.14 42.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.05 0.452 . . . . 0.0 111.26 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 158' ' ' ALA . 39.5 mt-10 -85.36 24.12 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.656 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.65 146.13 29.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 110.762 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 2.6 mm-40 -101.82 132.35 47.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.394 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -124.55 138.77 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 110' ' ' ILE . 83.1 m95 -71.01 148.04 48.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 112' ' ' LEU . 3.6 mm? -96.1 5.2 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.98 16.97 69.16 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.317 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.415 ' HB3' ' CE3' ' A' ' 123' ' ' TRP . 7.5 mp . . . . . 0 C--N 1.326 -0.43 0 CA-C-O 120.648 0.261 . . . . 0.0 110.453 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.415 ' CE3' ' HB3' ' A' ' 114' ' ' LEU . 23.5 m95 -62.05 146.59 49.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.501 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.76 162.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.226 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.51 166.29 22.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.494 ' HE1' ' HB3' ' A' ' 74' ' ' SER . 21.0 mmt -54.5 -19.63 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.893 172.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.8 -6.98 34.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 111.434 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.45 34.69 7.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.954 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.61 166.82 10.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -100.76 143.66 30.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.656 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -104.02 148.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 173.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.19 11.57 38.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.863 0.363 . . . . 0.0 111.059 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -107.63 111.06 23.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 98.41 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.989 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.08 111.71 6.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -128.01 127.31 42.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.795 ' HG3' HD22 ' A' ' 160' ' ' ASN . 3.3 tm-20 -66.31 -52.94 42.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 9.0 t . . . . . 0 C--N 1.315 -0.904 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.549 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.611 0.243 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.82 139.69 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -170.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.59 164.61 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.433 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 tt -109.8 103.7 12.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 25.8 p -89.85 108.2 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.89 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.03 -51.42 34.09 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.002 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 107' ' ' GLU . . . -59.67 -20.12 54.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.98 -52.17 11.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.795 HD22 ' HG3' ' A' ' 137' ' ' GLU . 12.3 p30 179.94 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.016 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.42 22.67 6.33 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.137 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 56.1 mmtt -113.76 179.27 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.044 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -77.22 122.57 25.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.545 0.688 . . . . 0.0 111.627 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.525 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 10.7 m-85 -117.2 178.23 4.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.069 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.26 144.59 51.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.105 0.478 . . . . 0.0 111.295 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.58 ' HD2' ' CD2' ' A' ' 172' ' ' LEU . 17.5 ptpt -153.24 -171.0 3.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.075 173.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 167' ' ' ARG . 40.7 ttm180 -83.34 138.28 33.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.797 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.2 m -70.82 -2.79 16.0 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -96.71 -5.42 38.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.457 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.06 133.0 48.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -92.47 97.25 10.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.649 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.58 ' CD2' ' HD2' ' A' ' 166' ' ' LYS . 3.2 pp -128.15 160.62 60.87 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.062 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.571 ' O ' HD13 ' A' ' 172' ' ' LEU . 40.7 Cg_exo -57.69 179.59 0.14 Allowed 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.461 2.774 . . . . 0.0 113.509 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.809 ' HA ' HG22 ' A' ' 110' ' ' ILE . 2.2 p90 -163.36 165.26 24.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.033 -0.417 . . . . 0.0 110.485 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.774 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.1 mt -128.46 116.56 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 5.9 t -104.24 147.36 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 0.0 110.658 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.484 ' HD1' ' CE2' ' A' ' 174' ' ' TYR . 54.6 m-85 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.038 0.446 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.499 HG23 HG11 ' A' ' 104' ' ' VAL . 9.1 p -72.46 -3.54 24.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.785 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 52.3 mt-30 -57.18 129.29 41.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.332 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 p -94.21 125.67 38.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.597 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.791 ' HZ3' ' HB3' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -164.22 174.27 11.39 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.225 177.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -77.75 166.08 23.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.79 -44.19 81.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.493 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.35 -45.77 91.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.084 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.23 -42.24 73.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.406 ' O ' HD12 ' A' ' 78' ' ' ILE . 36.0 m -60.22 -58.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.973 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.84 -16.79 62.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.323 . . . . 0.0 111.28 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 36.7 t70 -75.16 -50.01 17.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.033 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.549 ' HB2' HD13 ' A' ' 84' ' ' LEU . 65.7 m -67.24 -32.94 74.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.143 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -60.2 -41.63 87.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.3 p -79.26 -11.03 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.924 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 14.8 mmp_? -78.62 -14.29 59.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.77 37.77 3.36 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.299 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -177.71 -160.09 23.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.215 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 p -120.73 171.12 8.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.697 HD12 ' HE1' ' A' ' 126' ' ' MET . 9.5 mp -66.82 162.28 21.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 171.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 p -73.65 107.58 5.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 112' ' ' LEU . 35.8 p -110.46 105.81 57.43 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.145 0.498 . . . . 0.0 110.749 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.713 ' HG3' HD13 ' A' ' 96' ' ' LEU . 97.6 Cg_endo -88.03 139.24 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.466 2.111 . . . . 0.0 112.251 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.9 pt20 -135.25 9.03 3.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.748 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 p -141.53 168.64 19.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.906 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.68 98.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.8 m -59.95 -35.41 74.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.104 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -76.16 -37.01 58.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.074 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.93 -41.64 77.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.088 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.65 -36.1 81.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.173 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.03 79.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.713 HD13 ' HG3' ' A' ' 87' ' ' PRO . 22.2 mt -78.57 -4.99 51.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.626 0.25 . . . . 0.0 111.118 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -98.23 -37.66 9.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.57 -52.52 8.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.759 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 71.6 t80 -62.73 -35.27 79.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.519 0.676 . . . . 0.0 109.242 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.48 HD13 ' HB ' ' A' ' 104' ' ' VAL . 8.0 tp -57.94 -48.09 80.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.284 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.02 -19.78 64.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.702 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 17.1 pt20 -110.3 8.06 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.827 -0.546 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 -65.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.608 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 65' ' ' THR . 2.5 t -83.56 -28.69 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 151.12 -77.84 0.22 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.147 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 p-10 173.29 -40.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 6.7 pt-20 -113.39 45.76 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.785 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 146.93 40.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 4.6 mp0 -94.54 130.96 40.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.369 174.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 175' ' ' ILE . 3.8 mp -125.63 145.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.588 177.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.89 132.55 45.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.9 mt -90.38 10.57 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.39 30.89 56.37 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 118.146 0.973 . . . . 0.0 110.26 176.631 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.763 0.316 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -64.16 137.3 57.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -107.9 139.09 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.74 ' OD2' HG23 ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.9 -179.77 4.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 0.0 110.441 -178.042 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.697 ' HE1' HD12 ' A' ' 84' ' ' LEU . 54.1 mtt -69.25 -32.32 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.74 HG23 ' OD2' ' A' ' 125' ' ' ASP . 12.4 t -81.03 -5.21 57.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.263 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.81 37.82 5.11 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.382 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.1 162.09 27.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.075 0.437 . . . . 0.0 110.834 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -99.19 126.14 44.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.64 126.18 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.407 0.623 . . . . 0.0 111.366 -174.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.72 -19.44 35.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.591 0.71 . . . . 0.0 110.02 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 41.1 t80 -120.41 115.23 23.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.305 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -144.0 120.14 10.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.997 0.427 . . . . 0.0 110.069 178.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -125.9 111.07 14.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.582 0.706 . . . . 0.0 110.502 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -111.5 118.49 35.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HG2' HD22 ' A' ' 160' ' ' ASN . 4.1 tp10 -70.0 -41.22 74.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.576 0.703 . . . . 0.0 109.77 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.942 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.16 135.32 39.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.576 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.55 145.63 31.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.674 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 2.3 tm? -89.39 108.89 19.9 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 26.1 t -98.96 100.78 11.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.36 -23.9 74.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.771 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -69.67 -30.46 68.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 110.71 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.87 0.99 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.746 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.423 HD22 ' HG2' ' A' ' 137' ' ' GLU . 14.6 p30 -171.35 -27.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.055 -174.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.23 -2.25 11.5 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.839 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.56 174.18 11.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -83.78 126.84 33.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.307 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.54 -171.84 2.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.97 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.72 146.16 35.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.081 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -147.53 176.8 9.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -72.25 144.09 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 -173.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 28.7 m -68.61 -14.62 63.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.008 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -93.59 -3.21 53.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 17.6 m-20 -73.55 136.06 44.0 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -110.31 106.16 15.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.819 0.819 . . . . 0.0 111.446 -176.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.553 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 1.5 pp -129.24 171.14 9.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.346 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 14.3 Cg_endo -57.12 174.67 0.42 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.552 2.168 . . . . 0.0 113.226 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.791 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 49.1 p90 -140.91 179.59 6.63 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.041 -0.412 . . . . 0.0 110.739 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.521 HG13 HG12 ' A' ' 110' ' ' ILE . 71.6 mt -145.51 132.42 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.463 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 84.9 m -99.49 155.81 17.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 177' ' ' GLN . 6.0 tp60 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 121.512 0.672 . . . . 0.0 110.311 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.72 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 59.3 m-85 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -69.69 -8.11 44.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.003 -177.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.868 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 27.6 mt-30 -53.61 122.03 9.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 0.0 111.733 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 171' ' ' GLN . 17.6 p -97.02 113.53 25.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.511 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.866 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.82 -176.55 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.122 -178.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 169' ' ' ARG . 81.5 p -78.14 165.88 23.43 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.321 0.388 . . . . 0.0 110.129 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.31 -38.79 92.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.675 0.274 . . . . 0.0 110.946 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -63.33 -45.91 89.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -58.88 -37.08 75.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.663 ' HA ' ' HE2' ' A' ' 126' ' ' MET . 29.1 t -63.1 -60.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.41 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 11.2 pt-20 -70.69 -15.21 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.496 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 11.7 t70 -65.06 -59.01 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.3 m -59.28 -36.8 76.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 74' ' ' SER . 28.3 mm -54.17 -44.5 64.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 p -84.39 -14.09 50.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.397 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 20.4 mmt180 -74.46 -23.69 58.93 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.98 25.59 11.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.332 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.78 -170.26 13.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.1 p -116.14 165.81 12.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 175' ' ' ILE . 19.4 tp -81.8 148.74 28.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -66.69 109.17 2.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.866 0.365 . . . . 0.0 111.219 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 4.7 t -117.51 118.5 35.27 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.905 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 2.0 Cg_endo -81.68 120.66 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.063 2.509 . . . . 0.0 112.311 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -104.28 -30.48 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.098 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.0 p -128.02 -171.0 2.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.71 -34.26 82.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.913 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -55.4 -49.81 71.37 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.834 0.454 . . . . 0.0 111.936 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 4.8 mp0 -61.66 -53.22 59.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.11 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.53 -37.75 88.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.92 -44.13 93.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.497 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.49 -32.96 58.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.7 tp -63.06 -47.66 81.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.018 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.467 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 91.4 t80 -60.08 -40.46 89.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.538 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.743 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -64.03 -33.33 75.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.617 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 155' ' ' LEU . 72.6 mt -57.14 -44.72 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.141 0.496 . . . . 0.0 109.901 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 16.5 mtp180 -69.04 -9.38 52.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.62 -172.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -127.47 15.61 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.1 t -151.32 -51.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.359 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 110' ' ' ILE . 2.8 t -105.85 -29.05 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.649 0.737 . . . . 0.0 110.391 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.49 130.49 4.97 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -30.82 64.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.89 ' HA ' ' HB3' ' A' ' 158' ' ' ALA . 5.1 mm-40 -80.44 6.76 11.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.027 -175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.32 15.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 0.0 112.197 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.454 ' C ' HD11 ' A' ' 110' ' ' ILE . 34.0 mt-10 -121.18 123.53 42.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.078 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.601 HG12 HG13 ' A' ' 175' ' ' ILE . 2.6 mp -122.93 138.77 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 110.505 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.476 ' HB2' HD21 ' A' ' 84' ' ' LEU . 73.6 m95 -70.41 145.5 51.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 155' ' ' LEU . 95.3 mt -89.89 -2.31 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.485 ' CA ' HD22 ' A' ' 84' ' ' LEU . . . 82.73 5.81 89.08 Favored Glycine 0 C--N 1.324 -0.124 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.284 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.442 HD21 HD13 ' A' ' 131' ' ' ILE . 7.2 mp . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -72.96 148.18 44.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.014 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.11 129.22 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -83.3 164.31 20.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.771 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' A' ' 74' ' ' SER . 11.5 ptp -61.91 -43.54 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -92.56 -4.79 52.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 0.0 111.084 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.63 13.1 9.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.554 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 125' ' ' ASP . . . -77.85 128.3 33.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.039 0.447 . . . . 0.0 110.777 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -98.34 113.69 25.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.728 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.442 HD13 HD21 ' A' ' 114' ' ' LEU . 43.4 pt -62.05 135.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.977 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -112.48 8.95 19.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.537 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 135' ' ' ASN . 80.2 t80 -105.52 102.95 12.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.246 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 13.9 tptp -105.6 96.78 6.74 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 46.1 t30 -157.6 111.72 2.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.471 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 4.0 m95 -137.98 156.21 48.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.795 -173.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -97.08 -49.97 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.604 -173.359 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.45 140.13 38.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.455 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.761 HG13 ' HG2' ' A' ' 166' ' ' LYS . 14.3 p -136.04 149.32 27.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 100' ' ' LEU . 1.3 tm? -98.66 101.15 12.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.0 m -99.7 109.37 21.83 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.03 -40.17 73.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.806 -175.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 107' ' ' GLU . . . -68.78 -11.51 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 111.287 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.05 -56.46 3.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -171.69 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.864 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.23 -0.97 37.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.946 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -93.5 179.58 5.34 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.408 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 45.4 m0 -79.29 123.4 27.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 0.0 110.62 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -116.52 -168.82 1.51 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.232 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.4 138.21 44.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.761 ' HG2' HG13 ' A' ' 154' ' ' VAL . 12.4 mmmm -137.95 146.37 43.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -60.52 136.35 58.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.3 m -65.07 -7.1 10.66 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.51 ' HA ' HG23 ' A' ' 69' ' ' THR . 37.2 ttp180 -109.0 20.9 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.178 0.513 . . . . 0.0 110.243 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.42 141.22 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.45 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 2.0 mp0 -93.28 93.05 8.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.421 HD22 ' HZ1' ' A' ' 166' ' ' LYS . 3.9 pp -127.85 164.48 36.54 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.671 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.3 Cg_exo -63.41 -178.4 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.263 2.642 . . . . 0.0 113.745 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.868 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 6.5 p90 -154.58 176.92 11.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.15 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 110' ' ' ILE . 74.1 mt -145.63 128.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.584 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 83.6 m -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.555 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 176' ' ' CYS . 29.6 m-85 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 p -84.91 17.31 2.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.194 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 44.9 tt0 -84.97 139.35 31.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.255 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 p -98.05 127.43 43.99 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.646 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -158.28 -178.88 7.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HG1' ' CD ' ' A' ' 72' ' ' GLU . 32.2 p -84.5 166.83 16.92 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.95 0.156 . . . . 0.0 110.868 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -48.26 82.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.476 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -63.32 -43.8 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.694 0.283 . . . . 0.0 110.298 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.442 ' CD ' ' HG1' ' A' ' 69' ' ' THR . 65.9 mt-10 -64.48 -43.58 93.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.54 72.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.472 ' O ' HD12 ' A' ' 78' ' ' ILE . 16.1 t -59.55 -62.57 1.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.96 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.99 -39.44 81.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.272 0.558 . . . . 0.0 110.935 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' CG ' HH12 ' A' ' 80' ' ' ARG . 12.3 t70 -64.94 -47.37 77.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.735 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 42.3 t -79.26 -36.87 39.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.003 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -57.26 -40.22 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.109 0.48 . . . . 0.0 110.457 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -76.44 -31.59 57.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.904 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' NH1' ' HH ' ' A' ' 174' ' ' TYR . 1.3 ptp85 -96.15 -18.02 20.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.053 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.16 -51.18 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.169 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.27 -46.33 0.97 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.112 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 p -145.58 155.64 43.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.608 0.242 . . . . 0.0 111.151 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -72.36 161.78 30.37 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' HD21 ' A' ' 96' ' ' LEU . 28.3 m -79.06 106.09 10.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 37.9 m -111.9 112.33 53.2 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.65 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 2.5 Cg_endo -79.85 117.22 3.57 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.936 2.424 . . . . 0.0 111.869 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.404 ' HB3' HG22 ' A' ' 131' ' ' ILE . 1.8 pt20 -115.89 -13.67 11.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.424 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.0 p -130.9 176.24 8.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.73 -26.32 66.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.745 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -56.21 -56.88 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.896 0.478 . . . . 0.0 111.521 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.663 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 9.6 mp0 -62.73 -48.61 78.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.383 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.57 -40.92 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.33 -39.66 94.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.18 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.035 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.577 HD11 ' HG3' ' A' ' 87' ' ' PRO . 22.5 mt -59.83 -46.11 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -62.19 -29.14 70.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.617 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.21 -42.7 22.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -67.68 -47.25 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.431 ' HA ' HG22 ' A' ' 104' ' ' VAL . 3.1 pp -63.58 -25.83 68.41 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 101' ' ' ARG . 9.6 ttm180 -61.04 -38.63 86.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.448 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.12 0.28 31.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.693 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.8 p -124.32 -50.2 1.78 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 100' ' ' LEU . 3.0 t -98.51 -33.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.672 0.749 . . . . 0.0 109.704 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.97 125.04 3.61 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -55.21 -26.29 38.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.046 0.423 . . . . 0.0 111.504 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.59 ' HA ' ' HB1' ' A' ' 158' ' ' ALA . 38.6 mt-10 -89.18 22.52 2.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.383 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.46 162.25 14.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.057 0.456 . . . . 0.0 110.951 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 10.5 pt-20 -128.46 130.92 48.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.825 HG21 ' HA ' ' A' ' 174' ' ' TYR . 4.0 mp -118.84 154.61 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.988 -174.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -70.08 149.65 47.41 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.903 0.382 . . . . 0.0 110.12 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.5 HD13 ' CE2' ' A' ' 163' ' ' TRP . 0.2 OUTLIER -86.73 -6.11 58.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -171.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.33 6.95 66.68 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.468 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.212 -176.355 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.627 HG21 ' HG3' ' A' ' 130' ' ' ARG . 30.9 m . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.505 ' HB2' HD11 ' A' ' 131' ' ' ILE . 44.4 m95 -59.2 129.47 42.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.576 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.22 131.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 5.1 t70 -73.89 161.09 30.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.468 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.447 ' SD ' HD11 ' A' ' 78' ' ' ILE . 4.4 ptp -53.61 -28.96 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.0 p -92.84 1.26 57.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.095 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.56 27.91 25.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.954 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 125' ' ' ASP . . . -92.63 149.53 21.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.841 0.353 . . . . 0.0 111.197 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.627 ' HG3' HG21 ' A' ' 122' ' ' THR . 28.2 ttm180 -98.14 130.69 44.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.089 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.656 HG13 ' HE3' ' A' ' 134' ' ' LYS . 38.0 pt -92.33 128.46 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.065 0.46 . . . . 0.0 110.156 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.91 -19.84 24.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.243 0.544 . . . . 0.0 110.534 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -113.77 130.45 56.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.516 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.656 ' HE3' HG13 ' A' ' 131' ' ' ILE . 10.4 mptt -130.06 144.26 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.72 114.82 8.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.41 ' NE1' ' HB3' ' A' ' 134' ' ' LYS . 44.4 m95 -126.59 117.54 23.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.193 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.494 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.3 tp10 -71.08 -29.79 65.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.774 177.024 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 121.642 0.734 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 112' ' ' LEU . . . -83.67 139.67 32.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.29 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.5 142.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.918 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 49.6 tp -100.98 101.3 12.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 17.9 m -96.44 113.53 25.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.561 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.49 -30.95 47.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.853 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.59 ' HB1' ' HA ' ' A' ' 107' ' ' GLU . . . -67.52 -24.77 65.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.89 -59.02 2.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.976 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.407 HD22 ' HG2' ' A' ' 137' ' ' GLU . 10.7 p30 -177.58 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.33 19.23 3.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.343 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.494 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 34.4 mmtp -98.73 168.46 10.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.5 ' CE2' HD13 ' A' ' 112' ' ' LEU . 49.6 m0 -84.25 132.61 34.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.248 0.547 . . . . 0.0 110.429 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.02 -179.21 4.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.33 156.64 22.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 167' ' ' ARG . 20.8 ttmm -154.35 167.65 29.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 110.518 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.464 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 33.1 mtm-85 -60.11 125.36 23.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.819 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.94 -22.56 67.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.783 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 169' ' ' ARG . 3.7 tpt180 -101.12 21.77 13.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.14 150.61 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.88 102.5 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.684 0.278 . . . . 0.0 111.23 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -130.49 167.77 19.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.0 Cg_exo -73.6 -179.24 4.32 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.966 2.444 . . . . 0.0 113.035 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.825 ' HA ' HG21 ' A' ' 110' ' ' ILE . 9.7 p90 -150.65 178.65 8.88 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.208 -0.308 . . . . 0.0 110.923 -176.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.5 ' O ' HD12 ' A' ' 84' ' ' LEU . 97.4 mt -144.39 134.73 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 45.0 m -102.79 136.88 41.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 111.984 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.628 178.427 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.557 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 49.8 m-85 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -78.08 -4.06 45.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.664 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 27.0 tt0 -66.89 136.32 55.21 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 p -104.42 134.64 47.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.889 ' HZ1' ' HB3' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -165.64 176.86 7.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 73.6 p -78.33 166.32 22.81 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.305 0.378 . . . . 0.0 110.803 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.78 -35.84 77.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.168 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -64.2 -50.79 66.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.0 mt-10 -64.79 -35.83 82.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.67 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -60.97 -42.34 98.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.577 ' O ' HG12 ' A' ' 78' ' ' ILE . 43.4 m -60.75 -54.13 48.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.082 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.13 -42.36 76.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 14.4 t70 -60.02 -52.44 65.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 0.0 110.289 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.2 m -63.11 -36.4 83.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.975 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.925 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 22.8 mm -57.29 -42.27 79.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.209 0.528 . . . . 0.0 110.683 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -77.15 -19.19 57.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.195 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 59.8 mtt-85 -107.33 15.49 24.94 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.598 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.52 -49.22 0.42 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.639 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.925 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 120.71 7.19 8.95 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.02 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.811 HG21 ' HB2' ' A' ' 126' ' ' MET . 3.0 m -153.47 138.02 16.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.981 0.42 . . . . 0.0 111.439 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 85' ' ' SER . 6.2 tt -85.74 158.9 19.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.609 ' N ' HD22 ' A' ' 84' ' ' LEU . 19.1 m -69.9 108.21 3.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.939 0.399 . . . . 0.0 110.912 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.2 m -110.12 112.83 57.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 66.7 Cg_endo -82.38 124.81 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.3 2.0 . . . . 0.0 111.982 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -5.87 11.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.386 -170.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.81 165.3 27.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.99 -39.02 77.87 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.029 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -54.27 -39.89 67.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.842 0.457 . . . . 0.0 112.134 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.97 -39.89 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.514 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 33.3 m-80 -66.18 -50.14 64.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.6 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.94 -35.36 80.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.8 65.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.106 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.3 tp -66.53 -44.86 81.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.727 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 110.279 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -65.3 -40.98 94.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.22 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.25 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.182 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 79.2 mt -55.96 -47.7 77.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -54.92 -37.7 66.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.543 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -96.1 -11.05 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.186 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -119.21 -64.06 1.32 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.892 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.63 -34.27 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 110.406 -171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.45 125.21 2.99 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -170.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.466 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.85 -39.86 54.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.778 0.323 . . . . 0.0 110.151 177.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.64 15.09 1.82 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.81 160.3 14.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.984 0.421 . . . . 0.0 111.258 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.57 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 40.5 mt-10 -121.42 122.64 40.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.189 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.552 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.4 mp -121.15 148.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.48 ' O ' HG21 ' A' ' 110' ' ' ILE . 87.6 m95 -70.0 151.8 45.15 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD12 ' HB1' ' A' ' 153' ' ' ALA . 72.3 mt -99.54 4.46 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.94 -27.76 1.38 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.465 ' CD1' HD12 ' A' ' 131' ' ' ILE . 1.8 pt? . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.652 0.726 . . . . 0.0 110.935 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.442 ' CZ3' ' HB3' ' A' ' 153' ' ' ALA . 11.5 m0 -54.9 143.53 25.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.865 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.1 m -107.05 148.36 11.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.573 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.19 166.91 21.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.361 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.811 ' HB2' HG21 ' A' ' 83' ' ' THR . 49.0 mtt -58.67 -27.15 64.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.3 p -82.81 -12.09 57.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.738 0.304 . . . . 0.0 111.286 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.55 -0.11 53.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.819 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.17 155.57 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -109.03 149.75 28.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.465 HD12 ' CD1' ' A' ' 114' ' ' LEU . 48.6 pt -95.22 167.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.978 0.418 . . . . 0.0 111.413 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.1 5.22 3.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.888 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -118.92 119.41 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.279 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.679 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 9.7 mtpm? -138.44 98.71 3.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.996 176.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -127.68 111.52 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.53 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 32.9 m95 -125.36 123.21 38.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.69 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 4.3 mm-40 -72.97 -20.69 60.99 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.43 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 13.7 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.379 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.616 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.85 119.37 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 111.6 -175.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.79 140.52 47.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.998 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.494 ' HB2' HD22 ' A' ' 112' ' ' LEU . 4.1 tt -104.45 102.5 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.8 m -96.25 103.9 15.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.701 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.67 -20.55 76.35 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.461 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.43 -8.61 27.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.475 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.03 -66.43 1.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -148.67 -36.84 0.18 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.74 -0.64 36.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.073 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.1 mptm? -87.02 -179.17 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.53 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 34.0 m0 -81.36 131.7 35.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.632 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 90.6 m-85 -126.42 177.12 6.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.709 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -128.52 147.03 50.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.133 0.492 . . . . 0.0 110.665 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.748 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 34.8 ttmt -151.74 179.07 8.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.748 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 11.4 mtp180 -90.27 138.71 31.31 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -66.7 3.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -171.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 169' ' ' ARG . 69.4 mtt-85 -97.58 3.69 50.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.977 0.353 . . . . 0.0 111.743 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -84.52 140.45 31.43 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.597 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.694 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 7.7 mm100 -93.1 91.15 7.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.037 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.2 pp -125.05 167.32 16.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.811 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 32.6 Cg_exo -59.84 179.7 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.589 2.859 . . . . 0.0 114.271 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.889 ' HB3' ' HZ1' ' A' ' 68' ' ' LYS . 28.3 p90 -151.85 163.96 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.557 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.4 mt -139.02 115.43 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 74.5 m -101.9 153.28 20.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.194 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 175' ' ' ILE . 33.7 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -74.7 -8.77 57.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.631 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 23.5 tt0 -59.99 129.5 42.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.763 0.316 . . . . 0.0 110.245 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 p -98.74 131.04 45.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.754 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.834 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.37 179.87 7.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.769 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.8 p -78.77 166.0 22.95 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.46 0.475 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.24 -46.4 89.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.866 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.88 -39.67 79.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 0.0 109.658 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.466 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 87.0 tt0 -61.69 -38.13 86.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.662 176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -65.02 -46.95 79.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.596 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.582 ' O ' HG12 ' A' ' 78' ' ' ILE . 34.0 p -58.44 -57.2 13.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.913 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -60.17 -32.49 71.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 111.31 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 13.2 t70 -63.78 -54.17 39.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.045 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 99.1 m -61.07 -38.97 88.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.702 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 74' ' ' SER . 23.6 mm -52.51 -42.74 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -80.53 -34.16 35.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.137 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 33.3 mtt-85 -91.05 -25.19 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.11 -173.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.49 -40.87 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.416 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.75 -26.36 5.68 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.322 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 p -148.71 155.75 41.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.062 0.458 . . . . 0.0 111.961 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 85' ' ' SER . 6.9 tt -96.33 154.13 17.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.582 ' N ' HD22 ' A' ' 84' ' ' LEU . 31.6 m -70.51 108.53 4.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 0.0 111.306 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.417 ' CG2' ' HB3' ' A' ' 114' ' ' LEU . 33.2 m -110.07 106.7 58.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.455 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 60.4 Cg_endo -84.01 115.95 2.08 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.484 2.123 . . . . 0.0 111.664 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 131' ' ' ILE . 3.7 pt20 -115.99 7.26 14.3 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.257 -171.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.9 p -138.06 176.21 8.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.916 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.58 -42.92 62.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.2 p -56.72 -45.7 81.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.389 . . . . 0.0 111.439 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.91 -29.0 60.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.511 -175.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 15.9 m-80 -81.11 -47.01 14.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.456 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.12 -30.87 71.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.28 62.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.832 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 31.0 tp -72.87 -44.59 61.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.484 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.88 -33.11 73.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 109.941 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.76 -44.98 69.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.558 . . . . 0.0 109.584 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.38 -32.47 72.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.147 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 74.2 mt -56.53 -41.61 77.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 110.146 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -66.57 -15.9 63.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.997 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -117.47 2.09 12.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -55.32 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 110' ' ' ILE . 3.4 t -100.35 -30.97 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.01 127.35 3.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -53.56 -35.93 61.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.929 0.395 . . . . 0.0 109.975 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.65 27.99 2.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.49 161.55 13.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.786 0.327 . . . . 0.0 111.108 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.1 mt-10 -118.65 128.05 54.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.633 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.788 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.9 mp -126.51 145.25 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.68 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.53 ' HZ3' ' HB2' ' A' ' 152' ' ' CYS . 83.1 m95 -70.66 149.9 46.53 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 155' ' ' LEU . 83.7 mt -104.39 11.73 34.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.461 ' HA2' ' HE3' ' A' ' 126' ' ' MET . . . 72.52 -25.35 0.74 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 172.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HG ' ' HE3' ' A' ' 123' ' ' TRP . 1.8 pt? . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 117.958 0.879 . . . . 0.0 111.869 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.444 -0.742 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.446 ' HE3' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m0 -45.88 128.42 8.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.43 155.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 0.0 111.337 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.3 165.07 25.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.461 ' HE3' ' HA2' ' A' ' 113' ' ' GLY . 66.4 mtt -55.57 -30.16 60.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.0 p -80.59 -18.88 46.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 111.148 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.71 1.92 28.91 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.401 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 150.89 45.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.633 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -99.59 159.43 15.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.003 0.43 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 46.2 pt -101.83 146.4 10.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.68 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -123.8 20.42 9.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 109.582 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -137.46 120.42 16.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.973 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.671 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 9.5 mtpm? -135.17 97.29 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.87 110.23 17.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.601 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 46.6 m95 -129.68 135.99 49.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.263 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 61.2 mm-40 -91.9 -20.37 21.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.711 0.767 . . . . 0.0 108.948 171.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.988 179.305 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . 0.53 ' HB2' ' HZ3' ' A' ' 111' ' ' TRP . 5.9 m . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.2 116.03 15.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.242 0.544 . . . . 0.0 112.003 -170.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.38 140.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.86 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 112' ' ' LEU . 3.9 tt -100.23 100.21 11.0 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 14.0 m -88.94 98.55 11.81 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.973 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.68 -29.23 73.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.879 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -68.07 -10.28 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.962 0.411 . . . . 0.0 111.101 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.65 -57.8 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.528 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.5 -33.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.187 -172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 114.65 -5.03 22.85 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.341 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.552 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -86.5 176.93 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.601 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 39.5 m0 -80.79 131.75 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.183 0.516 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.78 172.17 9.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.632 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -124.6 143.09 50.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 27.6 ttmt -146.88 171.74 14.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.52 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 13.8 mtp85 -74.6 141.77 44.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.8 m -66.35 -7.19 17.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -96.81 13.16 29.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -89.2 137.98 31.83 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.094 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.677 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 8.7 mm100 -92.46 87.97 6.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.254 -176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -125.93 165.73 25.52 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.601 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 36.4 Cg_exo -61.44 -179.15 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.403 2.736 . . . . 0.0 113.712 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.788 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.73 169.28 24.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.447 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 76.8 mt -138.44 122.19 20.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 30.9 m -102.57 156.72 17.43 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.218 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.49 0.662 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.66 12.97 2.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.316 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 33.8 tt0 -80.91 137.69 36.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.219 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.8 p -95.2 130.43 41.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -156.11 178.94 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 173.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.718 HG22 ' HD2' ' A' ' 169' ' ' ARG . 46.2 p -85.96 165.98 16.29 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.522 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.91 87.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.647 0.261 . . . . 0.0 111.597 -173.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -60.76 -43.69 97.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 109.966 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.563 ' CD ' ' HG1' ' A' ' 69' ' ' THR . 73.7 mt-10 -64.86 -46.67 80.86 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.277 177.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.26 74.09 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.469 0.481 . . . . 0.0 111.396 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HD12 ' A' ' 78' ' ' ILE . 15.5 t -58.21 -60.1 4.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.085 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.51 -32.93 74.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.02 -38.41 88.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 36.8 t -93.63 -37.03 12.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.271 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.731 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.4 mp -59.65 -36.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.065 0.459 . . . . 0.0 111.406 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -98.88 -0.51 42.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 8.8 ptm180 -105.74 -2.88 22.73 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.99 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.74 -55.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.074 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -174.2 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.741 -1.219 . . . . 0.0 112.778 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.719 HG22 HG23 ' A' ' 127' ' ' THR . 61.6 p -144.16 169.03 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.588 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.98 162.86 23.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -79.76 107.28 12.41 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.758 HG23 ' HB2' ' A' ' 125' ' ' ASP . 18.4 m -100.06 119.03 60.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 68.8 Cg_endo -84.42 121.9 2.71 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.522 2.148 . . . . 0.0 111.949 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -119.09 2.82 11.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.96 177.35 10.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.452 176.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.25 96.34 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.525 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.4 m -53.21 -47.65 68.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 2.8 mp0 -68.54 -37.98 80.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.19 -44.71 94.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.53 -45.72 74.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.35 76.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.844 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 96' ' ' LEU . 23.1 mt -60.41 -52.95 63.04 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.274 -0.17 . . . . 0.0 111.076 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.4 t80 -60.5 -36.39 78.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.925 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.99 -37.53 58.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.295 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -73.98 -42.5 60.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 110' ' ' ILE . 4.2 pp -64.9 -24.23 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 0.0 110.644 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 31.9 ttm-85 -65.74 -26.22 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.373 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.16 11.4 17.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.264 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.1 p -137.83 -52.38 0.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.83 -30.73 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.723 0.773 . . . . 0.0 109.905 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 112.85 126.37 4.55 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 4.8 t30 -59.99 -20.77 59.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.936 0.398 . . . . 0.0 111.146 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.53 17.14 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.299 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.26 161.95 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.653 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.567 ' HG3' ' HB2' ' A' ' 172' ' ' LEU . 10.2 pt-20 -116.24 127.66 54.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.604 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.644 HG21 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -122.12 149.53 25.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 154' ' ' VAL . 76.1 m95 -70.05 154.71 41.6 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -88.47 -0.65 57.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 71.09 12.71 72.14 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.852 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.745 0.307 . . . . 0.0 110.61 -177.508 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.393 0.616 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -78.57 134.37 37.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.32 134.54 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.758 ' HB2' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -87.17 159.82 18.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.601 0.238 . . . . 0.0 110.527 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 6.9 ptp -66.87 -28.61 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.719 HG23 HG22 ' A' ' 83' ' ' THR . 9.2 p -76.45 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.569 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.65 6.08 19.88 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.115 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.7 132.5 47.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -94.74 113.63 25.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -71.71 138.61 21.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 111.824 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.66 -18.2 13.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.842 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -80.9 122.13 26.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.295 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -139.19 122.72 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.085 -174.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.21 113.25 13.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -126.03 122.99 37.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.655 ' HG2' HD22 ' A' ' 160' ' ' ASN . 19.4 tp10 -76.08 -20.63 57.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.448 0.642 . . . . 0.0 109.337 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.597 178.871 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.18 136.97 37.93 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.606 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 166' ' ' LYS . 58.5 t -135.48 143.91 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.968 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.4 tp -98.35 105.04 17.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.83 111.25 23.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 0.0 110.787 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 -28.19 57.08 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.016 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.26 62.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.975 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.44 -60.35 1.97 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.655 HD22 ' HG2' ' A' ' 137' ' ' GLU . 11.6 p30 -173.33 -34.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.447 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 119.35 15.22 5.57 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.604 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 33.2 mmtp -93.58 173.97 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -82.93 129.54 35.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.315 0.579 . . . . 0.0 110.614 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.08 -173.25 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.744 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -124.66 143.55 50.67 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.857 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 1.5 tmmm? -152.51 138.69 18.32 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 69.8 mtm180 -60.35 135.46 57.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.557 0.694 . . . . 0.0 111.826 -169.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.601 ' O ' ' HB ' ' A' ' 69' ' ' THR . 3.0 m -59.93 -21.29 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.338 -169.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.718 ' HD2' HG22 ' A' ' 69' ' ' THR . 16.6 tpt180 -97.52 6.33 48.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.381 . . . . 0.0 111.246 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.857 ' HB3' ' HE3' ' A' ' 166' ' ' LYS . 14.1 t70 -95.27 135.94 36.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -92.85 120.47 33.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -167.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.725 HD21 ' HZ3' ' A' ' 166' ' ' LYS . 3.7 pp -131.31 165.03 38.29 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.215 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.8 Cg_exo -73.05 178.12 6.92 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.366 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.644 ' HA ' HG21 ' A' ' 110' ' ' ILE . 4.5 p90 -147.08 175.77 10.45 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.607 -0.683 . . . . 0.0 111.982 -175.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 98.5 mt -141.18 124.07 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.015 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.02 145.33 29.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 0.0 112.23 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.575 176.338 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.672 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -71.52 -4.59 27.61 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.608 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 3.1 tt0 -59.17 127.28 31.39 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.7 p -102.72 126.36 49.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.162 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.844 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -156.06 174.37 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.447 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 76.2 p -84.18 165.96 17.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.088 0.242 . . . . 0.0 110.611 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.49 ' HZ ' ' HA ' ' A' ' 115' ' ' ASN . 85.9 t80 -55.62 -49.82 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.94 -41.7 98.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.264 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.55 -45.33 93.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.993 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.844 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -57.06 -42.38 80.46 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.799 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.6 p -63.17 -36.53 83.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.66 -176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -93.76 -33.93 13.4 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.288 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.66 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.7 t70 -56.99 -59.56 4.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.881 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.451 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 47.2 t -59.68 -41.04 89.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.2 mp -60.43 -42.78 92.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.157 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.6 t -68.86 -26.8 65.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.889 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 30.1 mmt180 -73.47 -10.98 60.29 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.792 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.42 43.42 2.54 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.04 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -171.15 -165.48 28.52 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.143 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -134.64 148.65 50.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.2 tt -61.46 136.37 58.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.415 ' N ' HD22 ' A' ' 84' ' ' LEU . 33.7 p -64.1 108.33 1.51 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.992 0.425 . . . . 0.0 111.481 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -109.84 111.12 58.93 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.475 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.34 112.0 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.242 1.962 . . . . 0.0 112.14 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.81 -13.46 24.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.186 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.67 158.6 37.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.63 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.22 95.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.08 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -58.6 -40.98 84.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.326 0.25 . . . . 0.0 111.284 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -64.61 -41.79 95.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.046 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -64.94 -43.95 91.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 109.995 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.51 -46.7 84.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.799 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.94 74.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.309 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 15.7 tp -70.11 -40.67 74.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.303 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -65.51 -40.5 93.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.09 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -67.12 -34.98 78.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.202 0.525 . . . . 0.0 110.91 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -70.76 -25.2 62.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.95 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 58.4 mt -56.09 -55.22 35.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 6.4 mmt180 -51.37 -36.89 45.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.575 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.42 15.06 27.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.99 -170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -153.95 -55.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.74 -27.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.549 0.69 . . . . 0.0 111.04 -171.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.43 127.26 5.68 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -168.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.571 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 3.8 t30 -50.61 -41.29 54.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -94.77 36.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.206 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.58 160.68 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.671 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 22.8 mm-40 -110.31 124.89 52.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.488 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -134.21 154.45 37.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.461 ' HB2' HD11 ' A' ' 84' ' ' LEU . 77.6 m95 -70.9 145.88 49.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -91.36 2.25 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 111.795 -171.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 85.01 9.84 79.79 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.842 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.428 HD11 HD11 ' A' ' 131' ' ' ILE . 4.1 mm? -95.16 159.0 15.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.958 0.379 . . . . 0.0 109.991 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.49 ' HA ' ' HZ ' ' A' ' 70' ' ' PHE . 15.8 t-20 -98.87 100.24 11.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -87.52 39.54 0.88 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.928 -172.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -77.95 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.82 -0.55 . . . . 0.0 111.162 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.85 79.28 3.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.857 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.65 126.17 30.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.03 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.91 -70.71 2.98 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.318 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -98.99 106.05 18.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.481 ' HZ3' ' HB3' ' A' ' 116' ' ' ASP . 52.8 m95 -66.89 149.26 50.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.793 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.55 130.37 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 131' ' ' ILE . 14.2 m-20 -74.49 172.95 11.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.778 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 22.7 mmt -64.8 -24.46 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.059 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 p -82.54 -6.38 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.558 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.42 58.42 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.478 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.93 167.11 10.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.471 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -110.97 123.63 50.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.53 152.75 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 175.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -106.31 -6.1 18.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.263 0.554 . . . . 0.0 110.393 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.32 124.65 44.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.149 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 11.8 mmmm -122.32 108.67 13.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -152.24 111.69 3.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.615 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 7.7 m95 -136.66 151.11 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.632 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 8.7 tp10 -93.26 -30.68 15.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.0 p -109.47 24.83 12.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 40.6 tt0 -71.13 102.74 2.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.866 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.88 137.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.296 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.0 p -105.51 -22.84 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.178 0.514 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.07 101.93 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.736 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -70.39 127.85 91.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.501 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.21 -65.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.772 2.315 . . . . 0.0 113.311 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -102.49 -34.87 8.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.75 5.14 3.66 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.504 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.77 34.29 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.89 -1.148 . . . . 0.0 113.872 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 148' ' ' LYS . 13.7 tppt? -77.5 99.57 5.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.9 p -92.7 108.35 19.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -168.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -126.23 84.64 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 116' ' ' ASP . 8.9 t30 -135.63 126.79 28.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.042 -168.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -158.12 129.43 6.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.8 107.37 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.483 -173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 166' ' ' LYS . 39.5 t -126.81 154.4 36.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.543 ' HB2' HD22 ' A' ' 112' ' ' LEU . 7.1 tt -111.83 122.59 48.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.0 t -109.21 98.56 7.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.151 0.501 . . . . 0.0 109.969 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -72.63 -23.85 77.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.426 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.11 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.3 -53.23 7.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.65 -41.56 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.101 0.477 . . . . 0.0 110.415 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.68 -2.19 4.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.815 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -88.7 163.89 15.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -78.02 146.13 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.851 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.2 m-85 -135.74 -169.1 2.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.153 -172.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 6.6 p-10 -137.15 152.5 50.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.859 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.528 ' HB2' HG21 ' A' ' 154' ' ' VAL . 34.3 mttp -152.78 -167.16 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.79 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.52 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 48.2 mtm180 -86.53 131.84 34.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 68.7 m -69.06 -11.6 60.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -97.52 5.91 48.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 110.823 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.52 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 34.0 m-20 -80.76 134.89 35.89 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -92.56 90.62 7.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.22 0.533 . . . . 0.0 110.508 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -116.83 163.38 22.88 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.913 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 25.0 Cg_exo -64.04 179.92 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.122 2.548 . . . . 0.0 113.106 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.633 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -157.75 163.17 38.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.566 178.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.672 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 79.8 mt -127.29 137.74 56.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 67.6 m -121.45 146.56 46.79 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -97.98 110.54 23.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -104.81 150.66 24.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.393 0.616 . . . . 0.0 112.11 -171.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.45 -122.16 0.6 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.43 ' O ' ' HB ' ' A' ' 181' ' ' VAL . 13.4 tt -145.09 -49.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.014 0.407 . . . . 0.0 110.503 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 180' ' ' ILE . 14.2 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.33 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 52.5 m-85 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.12 3.09 11.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.157 0.503 . . . . 0.0 111.168 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.57 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -75.29 137.04 40.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.631 177.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -97.21 129.41 44.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.66 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -161.63 172.45 16.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.755 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 18.3 p -82.31 167.61 18.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.37 -27.3 67.29 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -62.99 -57.29 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 5.9 mp0 -63.69 -36.32 83.47 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.37 87.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.436 . . . . 0.0 110.717 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 78' ' ' ILE . 22.7 t -72.58 -56.06 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.226 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.55 -45.18 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.498 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -64.97 -52.42 56.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.127 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.687 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 12.8 t -66.82 -34.11 77.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.909 0.385 . . . . 0.0 111.209 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -68.11 -34.0 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.184 0.516 . . . . 0.0 110.331 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -28.26 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.281 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.687 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 10.7 ptp180 -80.26 0.63 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 110.612 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.99 52.16 8.26 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.032 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.51 -166.93 13.26 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -153.54 139.35 18.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.884 0.342 . . . . 0.0 110.233 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.6 mp -61.08 137.63 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -62.75 108.03 1.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.194 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 7.5 m -106.52 109.24 62.99 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.8 Cg_exo -75.51 117.28 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.749 2.299 . . . . 0.0 112.258 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.79 -5.01 20.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.134 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 173.15 12.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.438 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.82 -39.17 97.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.654 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -56.34 -48.4 76.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.582 0.229 . . . . 0.0 111.51 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.3 -51.59 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.411 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.48 -43.22 73.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.376 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.81 70.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -64.48 -48.79 73.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.24 -43.31 87.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.848 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' OE2' ' HD3' ' A' ' 101' ' ' ARG . 9.9 tp10 -63.44 -43.42 97.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.344 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -63.4 -34.96 78.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.921 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 77.3 mt -54.35 -45.54 72.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.547 ' HD3' ' OE2' ' A' ' 98' ' ' GLU . 52.2 mtp180 -58.5 -30.93 67.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.618 -173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -109.43 10.4 25.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.923 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.0 m -138.78 -57.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 110' ' ' ILE . 25.1 t -103.43 -37.83 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.691 0.757 . . . . 0.0 110.55 -171.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.02 126.43 2.57 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.46 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -53.21 -37.13 61.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.698 0.285 . . . . 0.0 110.752 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -104.39 34.7 2.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.443 0.639 . . . . 0.0 111.404 -176.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.51 161.72 13.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.278 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 54.8 mt-10 -121.12 126.24 49.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.62 HG23 ' HA ' ' A' ' 174' ' ' TYR . 2.6 mp -124.27 146.73 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.578 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 83.1 m95 -71.3 137.22 48.34 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 112' ' ' LEU . 3.1 mm? -87.2 3.92 44.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.906 0.384 . . . . 0.0 111.393 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 83.81 9.39 82.9 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.514 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.445 HD21 HD13 ' A' ' 131' ' ' ILE . 9.5 mp -94.85 126.25 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.498 HD22 ' HB ' ' A' ' 124' ' ' VAL . 9.7 p30 -94.34 142.37 27.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.838 0.352 . . . . 0.0 110.652 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -87.86 84.63 7.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 0.0 109.898 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 51.5 ttp -119.01 -35.09 3.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.94 116.99 28.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.082 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.36 -4.2 46.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.5 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.95 168.64 17.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.02 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.8 -7.88 50.55 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.614 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.431 HG22 ' HD3' ' A' ' 130' ' ' ARG . 0.8 OUTLIER -90.31 67.06 6.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.276 0.56 . . . . 0.0 111.053 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -68.61 157.36 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.399 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 115' ' ' ASN . 42.7 t -101.35 126.7 55.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.48 163.94 27.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.951 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 9.0 mmt -64.94 -26.65 68.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.071 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -83.89 -4.9 59.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.683 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.66 56.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.846 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.4 168.12 9.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.431 ' HD3' HG22 ' A' ' 122' ' ' THR . 3.4 tmm_? -110.97 125.41 53.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.445 HD13 HD21 ' A' ' 114' ' ' LEU . 23.1 pt -53.88 125.71 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.484 0.659 . . . . 0.0 112.343 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.95 -13.13 29.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.06 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -103.42 127.2 50.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.853 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -131.02 119.35 21.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -149.71 110.02 4.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.412 ' HB2' ' CB ' ' A' ' 139' ' ' GLU . 21.1 m95 -127.34 143.98 51.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -175.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.709 ' HG2' HD22 ' A' ' 160' ' ' ASN . 10.7 tp10 -91.13 -30.1 16.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 10.2 t -94.25 34.6 1.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.213 173.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 136' ' ' TRP . 15.0 tt0 -63.63 101.85 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.83 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tt -76.6 98.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.866 0.841 . . . . 0.0 111.547 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.6 p -121.31 -15.22 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.958 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.65 156.61 42.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.493 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -105.92 108.55 61.85 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.337 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.8 -64.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.905 2.404 . . . . 0.0 111.913 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -131.62 48.34 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.753 0.787 . . . . 0.0 108.977 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.03 -39.83 2.72 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.16 53.13 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.753 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 4.0 pttt -67.41 98.91 0.68 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.463 0.649 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.7 p -139.45 143.78 37.72 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.747 -174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -87.33 148.19 25.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.89 146.42 26.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 27.5 m 83.37 143.9 0.07 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.689 1.243 . . . . 0.0 111.165 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -112.94 146.27 39.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.046 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.63 160.64 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.333 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 112' ' ' LEU . 57.1 tp -100.34 103.07 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 23.3 t -97.17 104.8 16.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.132 0.491 . . . . 0.0 110.554 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.91 -22.15 77.33 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.721 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . . . -73.81 -16.97 61.13 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.337 0.589 . . . . 0.0 110.594 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.141 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.709 HD22 ' HG2' ' A' ' 137' ' ' GLU . 16.7 p30 -174.51 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.692 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 126.18 15.22 2.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 32.8 mmtp -100.48 175.63 5.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -77.4 131.07 37.84 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 50.6 m-85 -127.34 176.73 7.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.838 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -113.8 137.4 51.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.537 . . . . 0.0 111.001 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 9.1 mmmm -150.61 137.01 18.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.487 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -57.68 136.65 56.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.446 0.467 . . . . 0.0 110.978 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.707 ' O ' ' HB ' ' A' ' 69' ' ' THR . 5.3 m -60.21 -14.65 18.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -96.65 13.94 26.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.532 0.206 . . . . 0.0 111.548 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.6 146.27 23.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.12 88.47 6.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 110.979 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 pp -128.09 158.08 72.06 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.62 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.6 Cg_exo -62.58 -178.5 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.367 2.711 . . . . 0.0 113.786 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.653 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 1.3 p90 -152.25 165.91 33.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 79.9 mt -139.4 130.65 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.925 0.393 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 72.0 m -108.92 143.64 37.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.019 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -89.54 111.0 21.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.494 0.664 . . . . 0.0 110.212 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -124.48 129.68 51.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.428 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.95 -168.49 22.42 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.858 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.07 -52.3 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 0.0 110.252 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.218 179.223 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 174' ' ' TYR . 1.1 p90 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -2.87 20.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 110.766 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.702 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 34.1 tt0 -56.61 122.51 12.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.875 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -89.94 121.13 31.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.339 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.862 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.53 -175.86 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.318 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 31.7 p -78.42 166.42 22.65 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.319 0.387 . . . . 0.0 110.425 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.35 -35.39 77.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -63.58 -51.14 66.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.928 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 4.7 mm-40 -66.7 -37.98 85.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.104 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -59.74 -40.85 89.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.131 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.422 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 35.4 t -66.79 -56.43 10.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.292 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.39 -48.22 81.34 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 12.2 t70 -59.91 -58.95 6.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.898 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.1 t -61.3 -38.85 88.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.171 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.85 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.597 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.9 m -74.23 -9.15 58.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.999 0.428 . . . . 0.0 110.659 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.701 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -88.43 -10.09 50.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.82 56.26 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.45 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.0 179.77 17.16 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.115 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.605 0.24 . . . . 0.0 110.751 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.501 HD23 ' HA2' ' A' ' 113' ' ' GLY . 15.8 tp -68.68 139.61 55.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 p -62.11 109.77 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 111.487 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 5.2 t -118.87 130.32 24.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 23.6 Cg_endo -93.63 144.24 2.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.364 2.709 . . . . 0.0 113.139 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -108.19 -25.65 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.896 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.681 ' HA ' ' CB ' ' A' ' 133' ' ' TYR . 11.6 t -158.9 -169.99 2.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.128 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.25 -24.93 56.52 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 112.981 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.3 t -56.51 -52.59 64.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.664 0.269 . . . . 0.0 110.62 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -75.99 -37.97 57.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.292 . . . . 0.0 110.332 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 93' ' ' ASN . 0.2 OUTLIER -56.49 -45.21 81.11 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.177 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.51 -46.89 52.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.793 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.25 94.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.098 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.12 -45.69 87.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.88 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.569 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 45.0 t80 -63.89 -34.62 78.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.623 . . . . 0.0 110.297 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -44.13 76.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.851 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.83 -34.08 64.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.394 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.569 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 3.8 pp -71.34 -32.89 69.08 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.402 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.83 -30.85 71.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.56 22.31 13.78 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.078 -0.388 . . . . 0.0 111.642 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -151.69 -64.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.008 -0.432 . . . . 0.0 111.513 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 100' ' ' LEU . 1.7 t -76.25 -32.45 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.176 0.513 . . . . 0.0 109.631 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.14 -74.76 0.29 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.224 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER 172.98 -62.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -175.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.421 ' OE1' ' HB3' ' A' ' 106' ' ' ASN . 2.0 mp0 -86.3 37.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.13 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -98.1 149.05 22.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.04 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' CD ' ' HZ3' ' A' ' 166' ' ' LYS . 35.4 mt-10 -108.58 127.33 53.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.747 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.572 HG21 ' HA ' ' A' ' 174' ' ' TYR . 4.6 mp -122.03 140.34 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.462 ' HB2' HD22 ' A' ' 84' ' ' LEU . 91.9 m95 -69.69 140.81 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 153' ' ' ALA . 33.5 mt -80.54 0.29 34.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.501 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 86.68 -21.77 17.02 Favored Glycine 0 C--N 1.32 -0.342 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.857 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.903 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -94.05 151.97 19.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.228 0.537 . . . . 0.0 110.89 178.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -117.07 132.57 56.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.488 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.406 ' HB3' ' CZ3' ' A' ' 123' ' ' TRP . 6.1 p-10 -79.08 126.97 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.288 0.565 . . . . 0.0 110.036 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -162.1 1.11 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.58 62.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -70.49 85.25 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -62.47 108.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.2 -14.3 56.98 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.219 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 119' ' ' ALA . 25.6 m -106.36 104.27 13.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.153 0.501 . . . . 0.0 110.307 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.475 ' CE3' HD21 ' A' ' 114' ' ' LEU . 74.9 m95 -85.03 120.13 26.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.631 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.98 129.53 66.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.903 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 5.1 p30 -86.21 -171.47 3.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.443 0.639 . . . . 0.0 112.45 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.422 ' HE3' ' HA ' ' A' ' 74' ' ' SER . 62.7 mtt -78.85 -11.18 59.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.172 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.0 p -93.96 -20.63 19.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.321 0.582 . . . . 0.0 109.95 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.29 24.84 9.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.642 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.8 154.17 18.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 110.551 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -109.26 122.0 46.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.812 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.0 pt -66.11 134.04 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.337 0.589 . . . . 0.0 111.589 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -113.64 17.29 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.61 0.719 . . . . 0.0 109.875 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 60.0 t80 -136.71 117.36 13.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.861 -177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.92 107.54 12.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 0.0 111.009 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.599 ' OD1' ' HG3' ' A' ' 162' ' ' LYS . 29.4 t-20 -133.31 110.22 9.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.46 ' CB ' ' HB2' ' A' ' 139' ' ' GLU . 53.4 m95 -123.26 147.04 47.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.993 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.508 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.7 tm-20 -89.87 -42.38 11.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 164' ' ' PHE . 9.0 t -117.15 34.86 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.262 -172.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.46 ' HB2' ' CB ' ' A' ' 136' ' ' TRP . 41.8 tt0 -69.22 106.13 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.686 -0.634 . . . . 0.0 109.776 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 142' ' ' ALA . 12.8 tt -116.16 134.9 58.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.986 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 p -102.51 0.84 34.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.0 111.236 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -106.69 160.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.906 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -107.1 100.99 35.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.194 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.98 -29.26 5.36 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.927 2.418 . . . . 0.0 113.288 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.78 -49.64 69.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 111.355 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.58 41.7 2.88 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.508 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.47 -42.31 0.72 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -95.97 126.81 41.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.119 0.485 . . . . 0.0 111.88 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.79 125.58 47.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 168.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.673 ' HG2' ' HD3' ' A' ' 167' ' ' ARG . 43.8 mt-10 -95.76 146.58 24.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.324 0.583 . . . . 0.0 111.691 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 22.2 p-10 -126.02 176.94 6.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.351 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 151' ' ' ASN . 92.7 m 78.79 110.8 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.163 0.914 . . . . 0.0 111.033 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.568 ' HB2' HD11 ' A' ' 112' ' ' LEU . . . -84.22 143.55 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.464 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.433 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 11.5 t -125.15 146.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.821 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.426 ' HB2' HD23 ' A' ' 112' ' ' LEU . 69.0 tp -98.8 100.81 12.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.4 m -93.44 98.51 11.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.383 0.611 . . . . 0.0 110.405 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.13 -13.04 76.3 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.439 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . . . -67.78 -18.22 64.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.826 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.75 -63.99 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.062 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -177.72 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.499 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.23 3.59 14.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.256 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.599 ' HG3' ' OD1' ' A' ' 135' ' ' ASN . 0.7 OUTLIER -81.26 154.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -75.35 137.71 41.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.137 0.494 . . . . 0.0 111.301 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.567 ' HA ' HG22 ' A' ' 138' ' ' THR . 21.9 m-85 -121.68 -179.24 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.608 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -135.41 138.74 43.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.145 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.528 ' HZ3' ' CD ' ' A' ' 109' ' ' GLU . 0.2 OUTLIER -153.8 162.89 40.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 168.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.673 ' HD3' ' HG2' ' A' ' 150' ' ' GLU . 8.1 tpt180 -62.7 144.7 56.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.819 0.342 . . . . 0.0 110.758 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 69' ' ' THR . 12.3 m -59.99 -11.74 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -100.74 8.97 42.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.546 ' OD2' HD22 ' A' ' 172' ' ' LEU . 29.4 t70 -74.76 139.04 43.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.699 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 66.9 mm-40 -92.6 83.05 4.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.817 -174.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.546 HD22 ' OD2' ' A' ' 170' ' ' ASP . 3.7 pp -125.13 161.69 48.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.518 ' O ' HD13 ' A' ' 172' ' ' LEU . 24.3 Cg_exo -63.11 -177.92 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.594 2.863 . . . . 0.0 113.713 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.702 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 7.4 p90 -155.04 178.03 10.66 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.036 -0.415 . . . . 0.0 110.352 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 96.6 mt -145.23 135.27 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.529 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 93.9 m -108.52 147.08 32.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 111.34 22.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.577 0.703 . . . . 0.0 109.589 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.73 119.4 36.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.478 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -170.14 174.03 44.21 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.36 118.13 55.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.686 179.316 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.595 ' HZ ' ' HE1' ' A' ' 178' ' ' PHE . 45.4 m-85 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 13.5 t -74.99 -0.29 18.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.202 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -64.6 124.93 23.14 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.426 0.631 . . . . 0.0 111.416 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -91.01 122.29 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.291 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.689 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.81 -175.4 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.106 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -81.74 166.89 19.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 115' ' ' ASN . 81.8 t80 -62.45 -31.31 72.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.05 -52.37 43.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.93 -38.6 89.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.922 0.392 . . . . 0.0 110.366 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.689 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -60.61 -30.41 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.087 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.471 ' OG ' ' HE1' ' A' ' 126' ' ' MET . 30.6 m -74.48 -63.6 1.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.305 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.5 -42.61 99.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.332 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.73 -25.03 61.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 34.9 t -87.16 -43.12 12.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.61 -43.58 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.274 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -71.4 -13.66 61.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.901 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -92.22 11.01 27.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.45 35.21 81.21 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.222 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.74 175.87 21.52 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -142.41 138.87 31.42 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.128 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -58.86 127.3 31.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.404 ' OG ' HD23 ' A' ' 96' ' ' LEU . 23.0 t -55.04 122.49 11.05 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.393 0.433 . . . . 0.0 110.953 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.574 ' HB ' ' OD1' ' A' ' 125' ' ' ASP . 52.3 p -108.94 108.9 60.97 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.213 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 93' ' ' ASN . 70.8 Cg_endo -84.87 110.75 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.378 2.052 . . . . 0.0 112.529 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -101.96 -16.19 16.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.732 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.3 p -129.89 167.99 17.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.226 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.59 91.61 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.271 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.9 m -64.34 -28.75 69.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.11 -34.14 43.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -71.25 -55.85 7.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.002 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -68.02 -17.42 64.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.9 78.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.447 . . . . 0.0 110.309 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.404 HD23 ' OG ' ' A' ' 85' ' ' SER . 64.8 mt -66.98 -38.92 86.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.204 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.554 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 89.9 t80 -59.17 -35.87 74.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.32 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -71.11 -46.89 60.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.91 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -67.18 -43.76 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.488 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.579 ' HB3' HD13 ' A' ' 175' ' ' ILE . 2.9 pp -63.0 -31.0 72.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 32.5 ttp-105 -65.32 -36.33 83.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.031 177.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.58 13.56 25.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 m -149.42 -46.66 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.689 HG13 HD11 ' A' ' 110' ' ' ILE . 3.5 p -106.65 -23.92 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.28 0.562 . . . . 0.0 110.539 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.45 126.26 4.05 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.574 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 8.7 t30 -59.37 -34.03 71.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.424 0.612 . . . . 0.0 111.042 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -88.8 24.06 2.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.385 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB3' HG11 ' A' ' 104' ' ' VAL . . . -98.11 161.48 13.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.985 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.586 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.3 mt-10 -118.38 126.51 52.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.683 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.79 HG22 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -120.2 152.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 76.3 m95 -70.62 146.53 49.98 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 153' ' ' ALA . 40.2 mt -80.88 -2.5 47.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 74.66 6.3 76.75 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.882 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.43 126.91 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 70' ' ' PHE . 39.6 t30 -93.34 130.13 39.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.09 -176.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.61 80.58 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.716 0.77 . . . . 0.0 110.866 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -108.82 -59.34 1.89 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.86 54.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.151 168.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.36 3.05 8.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.42 87.67 6.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.241 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 134' ' ' LYS . . . 81.38 -70.83 3.03 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.787 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.505 ' HB ' ' HG2' ' A' ' 130' ' ' ARG . 1.5 p -99.42 100.82 11.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 -176.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.4 157.38 34.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.755 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.6 125.18 54.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.056 0.455 . . . . 0.0 110.651 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.574 ' OD1' ' HB ' ' A' ' 86' ' ' THR . 12.8 m-20 -72.32 162.2 29.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.237 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 18.5 mmt -55.52 -30.73 61.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.884 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -85.23 0.16 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.067 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.33 44.58 9.48 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.583 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.55 165.12 20.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.734 0.302 . . . . 0.0 110.954 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 6.8 mtp85 -112.49 120.07 40.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.106 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -70.68 141.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 111.578 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.2 -21.22 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.832 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -88.4 115.97 26.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.414 ' HB2' ' HZ2' ' A' ' 134' ' ' LYS . 7.8 mtmp? -137.96 107.39 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.686 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -137.8 112.92 9.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.919 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 5.5 m95 -119.38 114.49 22.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.809 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 28.7 tt0 -70.97 -37.0 72.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.823 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.516 HG23 ' HA ' ' A' ' 164' ' ' PHE . 6.8 t -97.09 22.91 7.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 -176.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 43.2 tt0 -58.5 114.1 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.097 0.475 . . . . 0.0 111.034 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 tt -99.95 104.24 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 121.79 0.805 . . . . 0.0 109.676 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.424 HG21 ' HG2' ' A' ' 139' ' ' GLU . 1.6 p -105.59 12.98 30.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.955 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.77 150.32 20.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.857 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.624 ' NE2' ' HA2' ' A' ' 146' ' ' GLY . 44.2 tt0 -88.33 113.15 53.98 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.63 -62.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.356 2.038 . . . . 0.0 113.599 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.528 ' HB3' ' HG2' ' A' ' 148' ' ' LYS . 34.6 t70 -129.53 48.17 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.168 0.508 . . . . 0.0 112.081 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.624 ' HA2' ' NE2' ' A' ' 143' ' ' GLN . . . 78.29 12.05 84.71 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.784 170.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.71 -42.47 0.71 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.453 -1.355 . . . . 0.0 113.69 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 145' ' ' ASP . 19.2 ptpt -60.09 136.17 57.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.38 0.59 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.8 p -131.8 121.62 24.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.345 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -78.41 105.11 9.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -137.83 148.04 45.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.333 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 5.4 t -172.29 165.94 5.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.655 ' HB3' HD12 ' A' ' 112' ' ' LEU . . . -111.82 106.86 15.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.48 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 166' ' ' LYS . 45.9 t -131.96 140.3 48.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.127 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.468 HD23 HD22 ' A' ' 112' ' ' LEU . 1.5 tm? -106.4 100.91 10.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.1 m -98.43 112.03 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.327 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.64 -23.03 68.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.968 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.39 -28.82 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 111.26 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.95 -62.67 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -169.68 -25.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.017 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.87 20.23 7.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.67 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 162' ' ' LYS . 10.4 mmpt? -93.12 -179.18 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.557 ' HH2' HG13 ' A' ' 131' ' ' ILE . 40.3 m0 -82.25 123.91 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.433 . . . . 0.0 111.215 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 87.3 m-85 -126.05 -179.29 4.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -130.1 154.57 47.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.525 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.512 ' HB2' HG23 ' A' ' 154' ' ' VAL . 5.4 tttp -153.69 -152.68 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -100.21 121.9 42.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.532 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 14.2 m -65.33 -2.48 3.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -112.19 -0.47 15.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.788 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.15 149.68 21.35 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.19 107.7 19.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.9 pp -129.41 167.46 19.94 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.426 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.586 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 19.3 Cg_exo -67.01 -177.68 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.133 2.555 . . . . 0.0 113.445 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.79 ' HA ' HG22 ' A' ' 110' ' ' ILE . 34.9 p90 -143.87 179.67 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.304 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.579 HD13 ' HB3' ' A' ' 100' ' ' LEU . 76.3 mt -143.1 116.96 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.1 m -112.57 133.73 54.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.146 0.498 . . . . 0.0 112.17 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -94.01 122.02 36.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.177 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.595 ' HE1' ' HZ ' ' A' ' 64' ' ' PHE . 45.9 p90 -135.11 151.85 51.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 120.54 -142.6 15.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.657 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.5 tp -164.82 111.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.196 0.522 . . . . 0.0 110.457 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.466 177.393 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 56.1 m-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.001 0.429 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -68.34 -13.89 62.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.852 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 15.7 mm100 -60.25 132.65 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 111.029 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.529 ' HB ' ' HG2' ' A' ' 171' ' ' GLN . 41.3 p -101.48 143.22 31.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.668 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.718 ' HZ1' ' HB3' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -166.01 -179.2 5.06 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.229 0.331 . . . . 0.0 110.114 178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 71.8 p -84.93 166.47 16.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.49 0.186 . . . . 0.0 110.524 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.18 -49.69 76.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -70.79 -26.44 63.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 109.636 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 68' ' ' LYS . 36.2 tt0 -76.67 -32.49 57.96 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.704 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.652 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -66.38 -43.17 86.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.415 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.5 p -63.6 -54.21 39.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.651 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.62 -39.56 84.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -64.7 -59.22 4.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.375 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.646 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 22.6 t -61.08 -36.52 79.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 0.0 110.483 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 74' ' ' SER . 1.5 mp -65.82 -34.62 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 -29.13 44.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.646 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 16.3 ptm180 -88.29 1.26 54.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.688 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.68 66.26 1.51 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.493 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.17 167.23 38.77 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.667 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -114.16 133.0 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.477 HD22 ' N ' ' A' ' 85' ' ' SER . 5.5 tt -60.46 134.13 56.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.477 ' N ' HD22 ' A' ' 84' ' ' LEU . 39.6 m -54.09 109.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.805 0.691 . . . . 0.0 112.156 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t -108.23 118.65 51.93 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.52 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.1 Cg_exo -75.75 110.91 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.57 2.18 . . . . 0.0 111.149 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -117.38 -10.19 10.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.619 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.1 p -136.83 164.87 27.27 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.528 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.06 95.3 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.628 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -61.34 -45.13 95.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.876 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.94 -46.51 88.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.517 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -67.75 -37.58 82.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.58 -52.72 64.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.139 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.06 83.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.389 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -61.46 -51.69 67.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.006 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -62.49 -39.69 94.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -64.16 -41.49 97.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -64.07 -35.8 81.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.71 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.9 mt -54.75 -48.99 71.91 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.204 0.526 . . . . 0.0 109.845 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -59.02 -27.81 65.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.375 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -111.36 17.29 20.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.892 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -153.63 -54.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.402 HG13 HD12 ' A' ' 110' ' ' ILE . 2.8 t -100.85 -36.65 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.15 -171.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.5 130.25 3.23 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.106 -171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -35.9 45.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.85 27.83 2.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.848 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.32 161.61 15.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 111.318 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.572 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 4.6 pt-20 -122.87 121.64 36.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.643 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.7 HG21 ' HA ' ' A' ' 174' ' ' TYR . 34.3 mm -120.01 153.36 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -70.65 149.26 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 153' ' ' ALA . 73.7 mt -89.08 -1.78 58.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA2' ' HE2' ' A' ' 126' ' ' MET . . . 71.41 9.97 69.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.76 -173.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 131' ' ' ILE . 8.3 mp -94.78 127.06 40.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.747 0.419 . . . . 0.0 110.286 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -118.44 136.15 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.923 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.57 132.07 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.1 0.476 . . . . 0.0 110.693 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -123.37 -36.66 2.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.15 11.61 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 63.7 45.49 4.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.84 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -123.58 168.48 12.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.3 0.572 . . . . 0.0 111.804 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 -1.94 90.1 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 m -90.93 77.89 6.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -68.11 152.36 45.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.453 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.08 158.19 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.19 175.87 6.44 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.39 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.506 ' HE2' ' HA2' ' A' ' 113' ' ' GLY . 65.6 mtt -67.37 -20.56 65.58 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.5 p -87.25 -7.63 57.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.162 0.437 . . . . 0.0 111.117 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.55 21.16 29.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.837 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.08 164.54 11.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 0.0 110.424 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -108.02 133.63 52.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HD21 ' A' ' 114' ' ' LEU . 42.8 pt -75.96 125.92 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.279 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.34 -22.81 28.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.608 . . . . 0.0 109.727 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -92.3 120.83 33.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.534 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.534 ' HG3' ' CD1' ' A' ' 136' ' ' TRP . 55.1 tttt -144.01 119.1 10.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -156.66 113.17 3.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.534 ' CD1' ' HG3' ' A' ' 134' ' ' LYS . 42.5 m95 -124.31 140.94 52.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.44 -170.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 17.7 mm-40 -89.75 -11.86 41.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.251 174.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 8.3 t -133.33 17.13 4.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -170.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -103.6 137.76 41.21 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.392 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.45 ' HB ' ' OE1' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -94.64 161.73 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.043 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.1 p -110.79 -74.98 0.63 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.846 0.355 . . . . 0.0 111.385 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.2 90.39 3.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.398 0.618 . . . . 0.0 110.879 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.45 ' OE1' ' HB ' ' A' ' 140' ' ' ILE . 11.4 mp0 -133.19 136.29 27.1 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.977 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -15.43 23.19 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.205 1.937 . . . . 0.0 111.48 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.62 -56.34 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.532 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 54.61 23.23 27.76 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.585 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.82 53.27 4.33 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -62.9 99.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -132.76 144.32 50.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.863 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.82 108.92 11.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.688 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 3.9 p-10 -129.95 175.53 8.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.859 -165.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 35.4 m -137.97 132.42 32.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.163 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 112' ' ' LEU . . . -76.6 133.24 39.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.567 -171.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.26 164.2 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.629 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.435 ' HB2' HD22 ' A' ' 112' ' ' LEU . 55.8 tp -111.75 107.33 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.48 103.77 14.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.976 0.417 . . . . 0.0 110.601 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.7 -32.18 74.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.243 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.54 -22.89 65.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.026 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -54.15 8.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.478 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.508 ' OD1' ' HG2' ' A' ' 162' ' ' LYS . 9.6 p30 175.61 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.029 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 127.16 -11.88 6.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.534 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.508 ' HG2' ' OD1' ' A' ' 160' ' ' ASN . 31.5 mmtp -83.72 176.67 8.79 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.433 0.616 . . . . 0.0 109.981 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.482 ' HB3' HD11 ' A' ' 112' ' ' LEU . 43.1 m0 -85.86 136.85 33.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.576 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 23.6 m-85 -127.55 -168.01 1.83 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.465 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.688 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 2.8 t70 -133.86 140.88 47.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.382 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.502 ' HE2' HD22 ' A' ' 172' ' ' LEU . 9.2 ttpt -145.88 146.8 31.24 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 165.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.53 140.34 46.28 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.806 0.812 . . . . 0.0 112.538 -163.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.9 m -56.78 -25.33 55.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.59 -161.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -99.08 15.99 24.1 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.16 -176.24 6.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.529 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 31.7 tt0 -132.33 97.65 4.17 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.544 -171.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.1 pp -130.2 168.01 18.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.681 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 172' ' ' LEU . 17.1 Cg_exo -67.26 -178.98 1.61 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.188 2.592 . . . . 0.0 113.321 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.718 ' HB3' ' HZ1' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -159.05 158.72 33.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.241 -0.287 . . . . 0.0 110.368 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.428 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 58.2 mt -126.49 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.61 126.17 49.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.264 0.554 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.93 115.37 30.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.197 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -141.89 159.14 42.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.85 -59.68 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 38.8 mt -107.04 -70.89 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.306 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 70.4 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.044 0.45 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -72.9 -4.07 29.68 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.442 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.565 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 1.2 tm0? -58.1 122.15 12.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.204 0.525 . . . . 0.0 110.083 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -96.56 113.41 24.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.46 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -148.39 177.03 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -77.51 165.7 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 85.5 t80 -59.17 -38.53 79.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -59.73 -53.14 61.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.779 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -63.15 -37.8 88.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.516 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -56.95 -43.29 81.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.43 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.59 ' O ' HD13 ' A' ' 78' ' ' ILE . 19.4 m -66.93 -59.69 3.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.311 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -53.21 -44.38 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.761 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.673 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 6.3 t70 -70.36 -41.95 72.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.727 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -62.45 -31.87 72.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.362 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -58.92 -36.47 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.387 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 -14.32 28.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 21.4 mmt180 -87.61 -24.68 23.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.886 0.374 . . . . 0.0 110.968 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.68 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.29 -37.57 0.98 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.889 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -146.83 158.34 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.147 0.473 . . . . 0.0 111.942 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 85' ' ' SER . 5.7 tt -90.8 150.75 21.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.558 ' N ' HD23 ' A' ' 84' ' ' LEU . 20.9 m -60.94 109.05 0.96 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.915 0.388 . . . . 0.0 111.179 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 112' ' ' LEU . 18.0 p -113.14 106.02 55.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.484 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.31 135.23 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.232 1.955 . . . . 0.0 111.858 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 31.7 mm-40 -107.69 -26.02 11.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 110.073 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.1 m -136.15 165.84 24.78 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.903 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.19 -28.13 53.68 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.337 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 p -61.2 -50.05 74.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.635 0.255 . . . . 0.0 111.07 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.76 -39.13 73.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.034 0.445 . . . . 0.0 109.986 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -59.42 -48.37 81.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.328 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.93 -34.88 69.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.691 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.19 -31.04 72.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -45.61 93.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.769 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.696 ' CE2' ' HA2' ' A' ' 161' ' ' GLY . 78.5 m-85 -59.92 -40.78 90.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.287 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 102' ' ' GLN . 5.3 mm-40 -59.97 -44.68 94.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.294 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -75.81 -39.62 56.51 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.642 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 1.9 pp -67.99 -37.14 81.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.265 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 25.9 mtm180 -69.73 -8.63 49.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 46.7 mt-30 -119.2 17.25 13.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.598 0.237 . . . . 0.0 111.027 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -152.07 -62.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.166 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.4 t -76.76 -35.57 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 146.17 -76.92 0.27 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.146 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.457 HD21 ' HG2' ' A' ' 101' ' ' ARG . 2.7 t-20 173.8 -57.46 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.81 39.65 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.863 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.45 139.81 36.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 111.749 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HB3' HG22 ' A' ' 154' ' ' VAL . 2.9 mp0 -99.55 124.38 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.271 171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.913 HG21 ' HA ' ' A' ' 174' ' ' TYR . 5.2 mp -126.24 143.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.044 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -70.61 150.77 45.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 155' ' ' LEU . 78.7 mt -97.25 6.4 48.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 112.01 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.92 16.39 52.04 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.733 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.33 134.15 52.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.731 0.412 . . . . 0.0 111.0 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -122.39 137.26 54.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 110.441 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -118.58 129.07 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.903 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -117.09 -24.38 7.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.338 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.78 14.26 26.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 62.72 42.54 8.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.69 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.6 163.92 13.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.705 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.25 -14.17 59.22 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -89.78 79.56 6.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.53 0.681 . . . . 0.0 110.105 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.6 m95 -68.6 147.55 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.282 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.87 134.59 48.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.209 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' A' ' 127' ' ' THR . 0.0 OUTLIER -81.64 172.1 13.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.973 0.416 . . . . 0.0 110.532 -178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.3 ptp -55.8 -32.62 63.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.417 ' HG1' ' CG ' ' A' ' 125' ' ' ASP . 32.8 p -84.25 -23.13 30.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.542 -175.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.96 4.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.981 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.34 154.7 21.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.043 0.449 . . . . 0.0 110.827 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -109.01 146.45 33.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.832 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.6 HD11 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -87.46 163.32 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.514 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.88 13.78 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.377 0.608 . . . . 0.0 110.018 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 25.5 t80 -139.39 124.34 18.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.861 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 51.5 pttt -143.32 115.71 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -120.32 113.17 19.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.43 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 55.2 m95 -112.93 128.29 56.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -174.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -88.05 -47.63 8.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p -84.06 39.56 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.822 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -61.25 102.28 0.21 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.9 tt -88.33 110.04 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.401 0.62 . . . . 0.0 109.632 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.28 -24.11 18.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -127.61 127.05 43.17 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.169 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.583 ' NE2' ' HA2' ' A' ' 147' ' ' GLY . 16.6 mt-30 -82.75 106.13 6.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 89.8 Cg_endo -77.98 -27.7 5.55 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.639 2.226 . . . . 0.0 113.437 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.22 -38.42 14.26 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.281 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.24 -10.28 5.34 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.583 ' HA2' ' NE2' ' A' ' 143' ' ' GLN . . . 151.65 36.56 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.08 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -83.42 109.87 17.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.9 p -111.57 131.84 54.97 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.624 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -95.21 143.5 26.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.463 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -122.45 158.68 29.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 57.4 m 70.94 100.13 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 124.045 0.841 . . . . 0.0 110.367 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.96 145.33 38.18 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.19 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 166' ' ' LYS . 13.2 p -125.94 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.322 0.582 . . . . 0.0 110.618 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 112' ' ' LEU . 7.9 tt -91.73 123.62 35.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.2 t -108.96 121.04 44.29 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.663 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . -74.23 -53.75 6.68 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.218 -170.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.08 -1.05 52.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.734 0.302 . . . . 0.0 111.698 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.21 -35.23 66.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.743 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -177.78 -27.67 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.696 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . 92.28 29.89 10.71 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.481 -171.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 72.6 mmtt -126.49 175.9 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -85.66 138.1 32.38 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.53 171.76 10.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.751 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.9 150.1 39.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.004 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.472 ' HB2' HG13 ' A' ' 154' ' ' VAL . 34.7 tttt -153.51 -174.81 5.09 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -74.07 126.9 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 42.9 t -60.33 -22.99 63.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -99.77 17.65 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.621 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.26 137.51 36.64 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.04 99.52 12.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.284 0.564 . . . . 0.0 111.106 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 2.5 pp -128.88 164.23 40.13 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.605 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 36.8 Cg_endo -64.49 178.2 1.79 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.661 2.241 . . . . 0.0 113.191 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.913 ' HA ' HG21 ' A' ' 110' ' ' ILE . 12.1 p90 -152.69 174.2 14.29 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.554 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mp -131.51 126.89 58.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.608 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 2.4 t -102.21 149.46 24.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.794 0.331 . . . . 0.0 110.873 -172.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.53 126.93 54.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.783 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -132.17 171.0 14.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.593 ' O ' HG12 ' A' ' 180' ' ' ILE . . . 84.79 -51.59 4.58 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.189 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 179' ' ' GLY . 7.4 pt 63.15 -24.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.614 1.566 . . . . 0.0 113.998 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 179' ' ' GLY . 3.3 p . . . . . 0 C--O 1.248 0.976 0 O-C-N 122.049 -0.407 . . . . 0.0 110.44 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.502 HG21 HG12 ' A' ' 104' ' ' VAL . 1.5 m -71.53 -10.39 59.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.887 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 8.1 mm-40 -64.18 141.82 58.63 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.201 0.524 . . . . 0.0 110.258 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -95.61 147.79 23.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.177 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.56 172.29 8.25 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.078 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 80.8 p -82.43 166.52 19.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 67.3 t80 -60.89 -36.4 79.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.626 0.251 . . . . 0.0 111.52 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -59.52 -50.36 74.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.21 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -64.83 -40.74 95.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.222 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.518 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -56.48 -39.85 73.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 78' ' ' ILE . 20.3 m -64.53 -61.9 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.573 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.86 -37.29 86.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.895 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 13.3 t70 -66.84 -47.14 72.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 42.0 t -66.02 -30.35 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.378 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.468 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -59.06 -32.09 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.153 0.501 . . . . 0.0 110.179 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -83.21 -32.37 26.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.888 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.576 ' HB2' ' SG ' ' A' ' 176' ' ' CYS . 29.0 mmt180 -77.99 -26.03 48.4 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.679 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.49 -57.33 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.017 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 140.42 -23.79 2.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 p -141.23 136.45 31.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' N ' ' A' ' 85' ' ' SER . 5.1 tt -77.21 151.83 35.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.594 ' N ' HD21 ' A' ' 84' ' ' LEU . 7.5 t -67.23 108.88 2.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.102 0.477 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 125' ' ' ASP . 55.7 m -113.58 114.75 47.25 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.452 ' HB2' ' HZ2' ' A' ' 163' ' ' TRP . 11.5 Cg_exo -71.82 112.04 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.79 2.326 . . . . 0.0 111.794 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.87 -13.18 16.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.89 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.21 154.91 50.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.527 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.82 -53.09 44.29 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.337 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -56.77 -38.23 72.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.829 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.29 -42.48 93.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.131 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -70.02 -43.09 72.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.98 -39.16 93.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.396 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.84 88.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 20.9 tp -67.11 -45.64 76.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.979 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.53 -40.23 93.9 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.501 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.49 -46.08 90.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.01 -31.61 72.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.026 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.7 mt -56.89 -44.16 82.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.699 0.285 . . . . 0.0 110.658 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 36.0 mtm180 -71.9 -10.07 59.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.995 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.19 18.17 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.5 t -154.87 -58.92 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.644 HG11 HD13 ' A' ' 110' ' ' ILE . 12.2 t -96.36 -36.61 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.449 0.642 . . . . 0.0 110.086 -170.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.6 128.67 3.19 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 -55.29 -33.88 63.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.013 0.435 . . . . 0.0 110.352 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.696 ' HA ' ' HB3' ' A' ' 158' ' ' ALA . 45.9 mt-10 -93.01 26.18 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.132 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.11 160.16 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.7 124.05 40.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.296 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.772 HG21 ' HA ' ' A' ' 174' ' ' TYR . 42.5 mm -116.03 146.24 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.164 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.516 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 71.6 m95 -71.33 147.71 47.79 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' A' ' 114' ' ' LEU . 3.2 mm? -107.22 8.74 30.12 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.259 -0.276 . . . . 0.0 111.668 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.22 43.48 97.15 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.256 0.462 . . . . 0.0 114.256 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.796 HD22 ' HB1' ' A' ' 153' ' ' ALA . 1.5 pt? -139.17 155.42 47.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.14 159.27 44.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.564 0.221 . . . . 0.0 111.441 -174.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -117.25 150.65 38.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.2 ttp -126.31 -49.01 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 -176.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.49 -65.23 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.456 . . . . 0.0 111.259 -174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 147' ' ' GLY . . . -166.18 50.71 0.08 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.183 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.44 108.02 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.623 -171.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.9 -35.13 58.42 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -103.29 95.21 5.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.418 ' HB2' HD13 ' A' ' 114' ' ' LEU . 13.3 m0 -51.64 153.72 2.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.144 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 t -96.56 132.48 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.638 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.563 ' HB3' HG22 ' A' ' 86' ' ' THR . 5.1 p30 -83.1 -171.82 3.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.142 0.496 . . . . 0.0 111.3 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.4 mtt -82.16 -14.51 55.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t -98.89 0.39 44.05 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.737 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.29 24.32 16.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.431 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.65 166.42 13.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.961 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -100.6 133.22 45.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.469 HD11 ' HZ3' ' A' ' 163' ' ' TRP . 26.5 pt -58.99 124.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 0.0 111.175 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.9 12.59 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.524 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -140.67 127.88 20.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 22.5 mtmt -135.21 118.2 16.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.802 0.334 . . . . 0.0 111.722 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -131.72 111.18 11.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.806 0.812 . . . . 0.0 109.332 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.764 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 38.3 m95 -132.29 137.83 47.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 -174.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.717 ' HB2' ' HD3' ' A' ' 162' ' ' LYS . 20.3 tt0 -97.57 -18.78 18.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -104.11 24.95 10.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.843 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.764 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 8.3 tp10 -64.85 102.54 0.6 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.844 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 15.0 tt -99.56 137.34 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.1 0.476 . . . . 0.0 110.263 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.1 p -113.44 0.84 14.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.666 -175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.57 115.23 27.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.885 175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 116.06 65.94 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.0 -51.2 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.836 2.357 . . . . 0.0 111.541 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -94.1 -36.73 11.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.302 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.93 -9.64 1.0 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.343 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 119' ' ' ALA . . . 146.18 13.42 0.19 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.204 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -111.6 143.18 42.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.674 0.737 . . . . 0.0 109.733 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.434 ' HB ' HD21 ' A' ' 151' ' ' ASN . 15.5 p -132.48 121.13 22.88 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.166 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -72.17 84.34 1.03 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 109.656 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.434 HD21 ' HB ' ' A' ' 149' ' ' THR . 1.8 p30 -168.2 167.12 12.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.42 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 94.2 m -127.89 133.2 49.29 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.796 ' HB1' HD22 ' A' ' 114' ' ' LEU . . . -75.26 139.93 42.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.959 0.409 . . . . 0.0 111.466 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.632 HG13 ' HG3' ' A' ' 166' ' ' LYS . 28.2 m -129.12 159.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.157 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.75 100.18 9.7 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.4 m -87.97 101.19 13.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.693 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.83 96.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.151 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.696 ' HB3' ' HA ' ' A' ' 107' ' ' GLU . . . -63.27 -25.05 68.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 111.239 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.31 46.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.311 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 178.82 -40.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.366 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 124.41 2.36 8.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.691 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.717 ' HD3' ' HB2' ' A' ' 137' ' ' GLU . 25.8 mttt -83.62 168.45 16.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.494 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 54.6 m0 -85.17 134.62 34.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.482 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.78 177.06 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.881 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.59 153.5 23.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 0.0 111.623 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.632 ' HG3' HG13 ' A' ' 154' ' ' VAL . 37.8 mmtt -149.87 149.27 30.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.65 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -70.34 129.12 38.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 13.4 m -64.36 -1.1 1.52 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -96.32 2.65 52.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.62 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -77.17 136.37 38.58 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 68' ' ' LYS . 9.6 tt0 -98.49 90.24 4.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.279 0.562 . . . . 0.0 110.888 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.1 pp -125.87 168.83 12.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.576 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' O ' HD12 ' A' ' 172' ' ' LEU . 12.4 Cg_exo -69.31 174.64 8.82 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.79 2.327 . . . . 0.0 112.369 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.772 ' HA ' HG21 ' A' ' 110' ' ' ILE . 1.3 p90 -152.39 172.62 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.97 129.7 54.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 80' ' ' ARG . 8.2 t -102.16 136.3 42.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.043 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -96.97 110.73 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.984 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -115.09 159.71 20.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.171 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.93 -164.49 24.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.854 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.476 ' O ' HG21 ' A' ' 180' ' ' ILE . 28.3 mt 70.55 17.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.19 0.995 . . . . 0.0 109.428 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.702 179.334 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.457 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 55.7 m-85 . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.467 HG22 HG13 ' A' ' 104' ' ' VAL . 2.0 m -73.31 -6.18 44.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 12.3 mm-40 -63.91 134.1 54.52 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.531 0.681 . . . . 0.0 111.289 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -94.01 133.39 37.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.987 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.45 177.23 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.434 175.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -77.61 165.27 24.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.527 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 89.1 t80 -62.28 -37.65 86.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.211 0.529 . . . . 0.0 110.554 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -62.97 -46.51 87.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.16 -38.77 82.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -57.75 -35.92 71.39 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.444 ' O ' HD13 ' A' ' 78' ' ' ILE . 48.1 m -64.67 -58.67 5.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.383 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -57.66 -43.5 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.347 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 23.0 t70 -64.26 -59.09 4.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.98 -30.28 70.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.714 0.293 . . . . 0.0 111.406 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 74' ' ' SER . 1.2 mp -60.82 -29.82 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -98.76 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.655 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 32.4 mmt180 -80.4 -25.78 38.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.757 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.71 -50.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.15 -41.03 1.19 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.519 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -142.37 139.6 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.595 0.198 . . . . 0.0 110.867 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 85' ' ' SER . 6.6 tt -77.33 147.11 36.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.481 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.8 m -62.28 108.67 1.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.0 111.048 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 125' ' ' ASP . 15.8 p -107.63 110.53 62.74 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.378 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' HG3' HD21 ' A' ' 112' ' ' LEU . 97.5 Cg_endo -80.59 140.94 13.56 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.584 2.189 . . . . 0.0 111.509 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.518 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.4 pt20 -129.52 -10.25 4.56 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.305 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.6 p -141.9 177.39 8.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.98 68.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.952 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -61.85 -48.91 78.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.317 0.247 . . . . 0.0 111.271 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -68.84 -37.82 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.539 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.39 -39.74 88.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.15 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 36.0 t70 -68.42 -49.75 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.097 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.95 77.36 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.424 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.59 -42.81 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.6 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 2.0 t80 -61.17 -36.21 79.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 9.8 mm-40 -70.08 -46.38 65.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.0 -39.7 75.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.216 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.586 HD13 ' HB3' ' A' ' 108' ' ' ALA . 4.1 pp -65.55 -34.47 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.677 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 66.8 mtm180 -71.98 -9.58 58.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.698 0.285 . . . . 0.0 111.437 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -111.23 12.09 21.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.748 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -59.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 111.085 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.542 ' HB ' ' HB1' ' A' ' 108' ' ' ALA . 2.1 t -77.94 -33.3 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.163 0.506 . . . . 0.0 109.896 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 138.09 -73.56 0.42 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.579 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 175.29 -54.69 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.837 ' HA ' ' HB1' ' A' ' 158' ' ' ALA . 46.0 mt-10 -78.91 36.48 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.586 ' HB3' HD13 ' A' ' 100' ' ' LEU . . . -79.61 130.38 35.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.095 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.05 121.54 44.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.812 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.5 mp -126.8 141.42 46.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -70.46 148.96 47.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.534 HD12 ' HB1' ' A' ' 153' ' ' ALA . 90.1 mt -98.93 5.95 47.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.728 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.53 9.31 43.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.35 136.7 39.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.437 0.295 . . . . 0.0 111.07 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -133.13 133.34 42.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.874 0.368 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -117.38 119.21 34.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.787 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -116.96 -37.58 3.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.636 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.09 22.3 15.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.759 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 65.7 63.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.378 0.609 . . . . 0.0 111.218 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -102.52 129.13 48.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.403 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.33 -33.64 58.65 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.751 HG21 ' HB2' ' A' ' 130' ' ' ARG . 21.1 m -97.25 86.09 3.84 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -52.12 141.64 18.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.954 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.16 138.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.519 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -88.24 178.7 6.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 6.8 ptp -64.52 -32.64 74.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.408 ' HG1' ' CG ' ' A' ' 125' ' ' ASP . 31.9 p -76.56 -22.77 53.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.014 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 113.22 20.6 6.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.61 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.85 160.59 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.751 ' HB2' HG21 ' A' ' 122' ' ' THR . 0.0 OUTLIER -109.81 154.19 23.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.839 177.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.09 143.63 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.15 -18.46 20.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.153 0.501 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 20.3 t80 -119.52 120.7 37.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.644 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -144.34 131.4 20.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 111.151 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -147.99 136.09 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.413 0.625 . . . . 0.0 110.189 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -129.99 123.3 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.066 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 67.3 mm-40 -74.72 -27.05 60.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.285 0.564 . . . . 0.0 109.873 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.624 HG21 ' HD2' ' A' ' 164' ' ' PHE . 11.5 p -84.55 15.37 3.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.236 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -56.19 104.86 0.16 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.846 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 143' ' ' GLN . 10.3 tt -98.96 121.09 49.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.1 p -105.22 -25.25 12.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.117 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.63 102.05 8.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.267 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.609 ' HA ' HD12 ' A' ' 140' ' ' ILE . 25.6 mt-30 -76.42 109.34 8.28 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.139 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.517 ' HD3' HD12 ' A' ' 140' ' ' ILE . 5.5 Cg_exo -72.53 -61.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 0.0 112.67 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -67.86 -33.11 74.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.992 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.5 -25.23 1.68 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.976 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.33 18.58 0.06 OUTLIER Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.237 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.72 ' HB3' ' HZ3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -66.62 106.74 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 174.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.8 p -125.83 163.43 22.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.081 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 22.9 mm-40 -87.39 178.3 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 110.965 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 14.8 m120 -133.05 132.32 41.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.419 -173.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 151' ' ' ASN . 80.7 m 75.72 141.02 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.148 0.499 . . . . 0.0 110.999 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.534 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -91.91 139.17 30.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.878 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 p -133.41 141.43 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.681 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.487 ' HB2' HD22 ' A' ' 112' ' ' LEU . 2.4 tt -91.22 123.53 34.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -108.4 106.19 16.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.175 0.512 . . . . 0.0 110.633 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.18 1.61 84.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.11 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.837 ' HB1' ' HA ' ' A' ' 107' ' ' GLU . . . -101.27 5.38 42.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.104 0.478 . . . . 0.0 110.556 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.8 -53.17 2.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.778 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -173.38 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.296 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 111.74 -2.57 27.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.886 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 34.9 mmtp -76.31 -179.04 4.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.46 ' HZ3' HG13 ' A' ' 131' ' ' ILE . 49.9 m0 -94.39 134.02 37.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.241 0.543 . . . . 0.0 109.796 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.624 ' HD2' HG21 ' A' ' 138' ' ' THR . 91.9 m-85 -126.02 165.28 19.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.883 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.54 144.21 44.63 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.696 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 72.6 tttt -144.93 -171.89 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.696 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 1.2 mmt180 -72.54 125.54 27.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 9.4 t -69.54 -19.82 63.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.386 0.612 . . . . 0.0 110.076 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -94.73 12.31 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.233 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 20.0 t70 -80.59 136.1 36.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -93.8 93.44 7.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.229 0.538 . . . . 0.0 110.945 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.56 169.69 9.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.736 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.77 -179.1 2.27 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.995 2.464 . . . . 0.0 113.049 -176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.812 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.2 p90 -156.57 171.55 20.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.874 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.15 125.96 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 13.8 t -102.29 133.91 46.42 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -92.24 111.06 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -110.76 174.28 5.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.513 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.83 -36.64 4.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.2 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.624 HG12 ' H ' ' A' ' 181' ' ' VAL . 0.1 OUTLIER 34.8 -96.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.331 1.053 . . . . 0.0 113.286 -177.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.624 ' H ' HG12 ' A' ' 180' ' ' ILE . 3.7 p . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.994 -0.527 . . . . 0.0 110.378 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.551 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 16.8 p -77.14 -8.54 57.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 13.6 mm-40 -64.96 141.92 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.2 p -99.06 144.49 28.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.769 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.756 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.59 -179.7 3.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.34 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 74.4 p -80.3 164.97 22.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 85.3 t80 -62.34 -35.35 78.84 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -59.37 -52.14 66.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.329 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.6 mt-10 -64.25 -37.14 86.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.756 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -61.52 -43.65 98.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.9 m -65.67 -55.92 14.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.805 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -60.92 -34.27 74.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.883 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 17.1 t70 -69.95 -51.63 31.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.45 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.3 t -63.07 -34.33 77.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.502 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -56.85 -31.03 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.498 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 -37.59 20.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.59 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 31.6 mmt180 -71.8 -26.56 62.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 111.072 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.25 -48.95 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.884 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 131.82 -26.37 3.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.972 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 p -135.14 128.09 31.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.924 0.362 . . . . 0.0 111.429 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.547 HD21 ' N ' ' A' ' 85' ' ' SER . 6.1 tt -74.88 146.53 41.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.547 ' N ' HD21 ' A' ' 84' ' ' LEU . 5.0 t -65.68 108.94 2.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.155 0.502 . . . . 0.0 110.448 -172.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 125' ' ' ASP . 28.3 m -116.27 114.1 40.94 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.344 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.56 137.97 13.34 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.663 2.242 . . . . 0.0 112.076 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -114.51 -13.55 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.276 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.65 165.08 28.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.981 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.82 -42.97 94.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.755 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.6 p -55.76 -44.53 77.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -42.64 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.85 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -65.38 -45.51 83.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -38.95 91.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.53 84.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.893 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.6 tp -66.07 -43.38 87.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -59.74 -40.78 89.23 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.12 -36.88 77.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.29 -36.8 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 59.7 mt -54.39 -52.08 62.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.0 109.75 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ttm-85 -56.54 -33.35 66.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.006 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -101.4 -1.46 33.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.2 t -140.16 -50.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.768 HG11 HD12 ' A' ' 110' ' ' ILE . 7.3 t -98.02 -30.15 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.605 0.717 . . . . 0.0 110.503 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.37 125.54 3.63 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -49.89 -42.49 48.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 158' ' ' ALA . 45.6 mt-10 -94.21 47.83 1.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 111.263 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.74 145.54 41.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 10.9 mm-40 -98.52 123.82 42.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.862 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.768 HD12 HG11 ' A' ' 104' ' ' VAL . 43.0 mm -121.83 142.85 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.367 -0.133 . . . . 0.0 111.192 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 64.0 m95 -70.61 145.84 50.44 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 155' ' ' LEU . 82.2 mt -111.03 16.49 21.13 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.3 -27.67 0.83 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 123' ' ' TRP . 1.6 pt? -94.56 142.08 27.85 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.123 0.962 . . . . 0.0 110.913 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -145.06 161.66 38.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.046 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -102.86 141.98 34.75 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 53.0 ttp -127.46 -43.15 1.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.848 0.356 . . . . 0.0 111.75 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.65 -67.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.408 -174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.22 62.91 0.05 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.61 137.6 32.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.294 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.69 -53.69 1.91 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.56 105.35 17.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 169.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.516 ' HB2' HD12 ' A' ' 114' ' ' LEU . 16.9 m0 -62.3 150.03 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.205 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.47 138.19 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.72 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.643 ' OD2' HG23 ' A' ' 127' ' ' THR . 1.1 p-10 -99.89 -162.12 0.92 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.94 -33.57 51.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.375 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.643 HG23 ' OD2' ' A' ' 125' ' ' ASP . 14.4 t -83.03 -21.4 33.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.024 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.84 32.05 6.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.498 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.19 157.54 15.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 130' ' ' ARG . 0.3 OUTLIER -107.97 118.39 36.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.128 177.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 45.6 pt -64.34 125.41 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.341 0.591 . . . . 0.0 111.011 -178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.84 -20.75 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.528 0.68 . . . . 0.0 109.904 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -110.65 127.55 55.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.765 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -129.53 114.44 16.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.617 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -129.41 111.21 12.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.381 0.61 . . . . 0.0 109.772 172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.999 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 31.6 m95 -125.99 124.14 40.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . 7.4 tp10 -77.68 -25.83 49.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -103.23 25.09 9.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.588 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.999 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 40.2 tt0 -61.7 137.15 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.787 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.6 tt -123.18 119.01 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 p -75.63 -3.57 35.19 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.42 91.31 3.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.04 176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 2.7 pt20 -67.64 113.06 12.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.686 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 73.3 Cg_exo -48.99 -67.12 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.041 3.161 . . . . 0.0 114.539 -168.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -95.32 17.31 14.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.055 0.455 . . . . 0.0 111.394 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.42 -24.03 27.0 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.668 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.69 50.34 0.23 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 148' ' ' LYS . 8.6 ttpp -123.89 105.9 10.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.676 0.274 . . . . 0.0 110.534 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.9 p -136.16 157.08 47.68 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.663 0.268 . . . . 0.0 110.647 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.15 80.94 6.21 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.98 150.89 31.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.216 0.532 . . . . 0.0 110.411 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 71.6 m -125.24 136.99 54.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.14 134.82 41.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 28.7 m -120.46 156.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.497 ' HB2' HD22 ' A' ' 112' ' ' LEU . 1.5 tt -103.63 101.14 10.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.3 m -84.64 91.57 7.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.486 0.66 . . . . 0.0 110.61 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.77 -22.39 78.72 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.523 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.46 ' HA ' ' HG2' ' A' ' 107' ' ' GLU . . . -69.89 -15.83 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.136 0.493 . . . . 0.0 110.27 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.85 -65.27 0.99 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -167.19 -37.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 131.05 -4.15 5.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.364 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -77.34 174.68 10.52 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.112 0.456 . . . . 0.0 110.107 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -89.78 133.49 34.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.85 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 42.1 m-85 -119.78 166.89 12.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -104.62 144.38 31.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.272 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -146.09 150.93 36.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.911 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.12 130.35 39.08 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.485 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 6.0 m -65.14 2.96 0.67 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -95.21 -4.58 45.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.01 132.14 41.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.782 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -93.21 97.92 10.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 173' ' ' PRO . 3.2 pp -129.05 166.11 27.48 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 14.8 Cg_exo -67.08 171.13 11.77 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.721 2.281 . . . . 0.0 112.233 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.459 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 3.2 p90 -137.77 174.33 10.69 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 93.2 mt -137.8 123.55 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 10.1 t -102.08 130.51 48.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -91.46 110.58 21.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.019 0.438 . . . . 0.0 109.967 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -118.59 135.2 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.167 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -115.8 -177.52 18.4 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.1 mt 62.2 67.5 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.744 -178.652 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 74.0 m-85 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.057 0.456 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -74.38 0.28 14.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.587 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.543 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -65.98 127.56 32.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -102.29 123.95 47.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.664 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.543 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -150.07 174.73 12.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.606 -177.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 82.5 p -80.61 166.57 20.98 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.382 0.427 . . . . 0.0 110.227 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' HZ ' ' HA ' ' A' ' 115' ' ' ASN . 91.6 t80 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.556 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -60.95 -41.71 96.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.359 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -54.99 -39.96 69.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.239 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.705 ' O ' HG12 ' A' ' 78' ' ' ILE . 37.7 m -64.09 -69.64 0.27 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.55 -44.6 73.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.752 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 19.9 t70 -60.52 -58.92 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.917 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -58.57 -42.06 87.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.16 0.287 . . . . 0.0 111.215 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.705 HG12 ' O ' ' A' ' 74' ' ' SER . 42.2 mm -57.51 -41.23 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.324 0.583 . . . . 0.0 110.413 175.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 t -72.64 -24.26 61.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.702 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.752 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.1 mmp_? -74.79 -10.33 59.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.386 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.01 37.72 5.63 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.004 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.68 -170.22 27.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.189 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -130.26 146.74 51.9 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD21 ' N ' ' A' ' 85' ' ' SER . 2.6 tt -63.32 138.03 58.39 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' HD21 ' A' ' 84' ' ' LEU . 30.3 p -61.83 109.33 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.371 0.419 . . . . 0.0 111.579 -174.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.542 HG21 ' HA3' ' A' ' 113' ' ' GLY . 47.2 p -110.0 107.73 58.93 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.969 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 14.6 Cg_exo -68.5 111.33 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.085 1.857 . . . . 0.0 112.576 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' NE2' ' H ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -85.41 -27.96 25.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.6 p -129.56 173.18 10.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.61 -38.95 95.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.12 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -59.27 -43.41 92.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 87' ' ' PRO . 7.3 mm-40 -59.6 -47.81 84.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.997 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -64.14 -44.9 90.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.56 . . . . 0.0 110.203 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.02 -49.21 77.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.912 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.16 67.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.718 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.3 tp -70.64 -47.01 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -60.76 -35.55 76.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.317 0.579 . . . . 0.0 109.946 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.164 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 68.5 t80 -68.24 -27.57 66.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.513 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 22.9 mt -58.64 -54.85 42.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -58.83 -33.2 70.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.141 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 9.2 pt20 -91.62 0.98 57.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t -146.32 -59.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 -28.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.623 0.725 . . . . 0.0 110.698 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.3 119.0 4.55 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -165.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 66.9 t30 -51.54 -36.52 45.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.136 0.468 . . . . 0.0 111.749 -173.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.69 32.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.906 0.384 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.46 139.88 32.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.609 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 8.6 mm-40 -94.31 122.36 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -136.85 155.1 32.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.39 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.448 ' CE3' HG22 ' A' ' 154' ' ' VAL . 86.8 m95 -71.44 144.87 49.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.924 0.392 . . . . 0.0 110.694 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.491 HD13 HD21 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.69 -7.25 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -174.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.542 ' HA3' HG21 ' A' ' 86' ' ' THR . . . 81.11 -1.66 84.09 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.535 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.491 HD21 HD13 ' A' ' 112' ' ' LEU . 3.6 mm? -93.49 139.36 30.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.238 0.519 . . . . 0.0 110.112 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.522 ' HA ' ' HZ ' ' A' ' 70' ' ' PHE . 28.4 t-20 -91.54 154.05 19.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.081 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 6.4 p-10 -99.37 10.99 40.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.487 ' HB2' ' OD1' ' A' ' 115' ' ' ASN . 3.0 tmm? -69.77 -163.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.38 88.77 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 111.023 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -127.3 85.0 2.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.712 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.14 88.62 5.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 110.689 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.0 -45.48 3.19 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 26.8 m -95.66 103.16 15.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 119' ' ' ALA . 58.2 m95 -79.83 156.26 27.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.932 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.13 130.18 71.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.762 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' OD1' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -73.19 164.69 26.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.403 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 17.9 mmt -61.23 -33.39 73.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.55 -5.86 49.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.108 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.75 64.27 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.54 166.72 10.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.061 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -112.53 118.62 35.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.331 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.457 HD12 HD11 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -57.95 150.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.873 174.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -105.79 -5.14 20.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 109.719 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -126.79 115.33 19.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.699 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 1.6 ptmm? -144.41 114.09 7.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.314 . . . . 0.0 111.071 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -136.3 112.31 9.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.925 ' HB2' ' HG3' ' A' ' 139' ' ' GLU . 4.4 m95 -112.43 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 164' ' ' PHE . 2.8 tp10 -68.88 -27.85 66.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.07 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 13.9 p -97.63 25.38 5.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.9 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.925 ' HG3' ' HB2' ' A' ' 136' ' ' TRP . 15.2 mt-10 -65.49 102.79 0.74 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.048 0.451 . . . . 0.0 110.836 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.9 tt -107.04 124.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.665 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.8 p -106.79 4.19 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.873 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.99 148.82 48.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.9 120.86 82.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-O 121.015 0.436 . . . . 0.0 110.211 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 22.6 Cg_endo -64.84 -72.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.26 1.973 . . . . 0.0 111.418 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 148' ' ' LYS . 6.4 p-10 -103.34 -11.27 18.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.658 . . . . 0.0 109.227 172.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.44 -18.05 1.68 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.962 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.6 53.04 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.567 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.84 ' HZ1' ' HB2' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -87.45 97.07 10.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.5 p -140.07 170.09 16.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.117 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.02 148.52 36.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 5.0 m-20 -93.16 175.64 6.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.3 m 75.73 119.18 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.634 0.73 . . . . 0.0 112.029 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.568 ' HB2' ' HZ3' ' A' ' 136' ' ' TRP . . . -82.04 131.36 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.961 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.448 HG22 ' CE3' ' A' ' 111' ' ' TRP . 48.1 t -131.55 147.58 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.48 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 tt -100.98 125.22 47.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.7 t -114.27 98.5 6.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.156 0.503 . . . . 0.0 110.195 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -75.81 -22.24 75.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.294 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.36 -30.48 68.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.106 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.93 -58.68 3.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -176.94 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.384 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.74 -1.38 4.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.025 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.01 167.67 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -87.26 144.26 26.89 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 68.8 m-85 -135.99 177.12 8.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.318 0.58 . . . . 0.0 111.418 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.637 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' HB2' HG23 ' A' ' 154' ' ' VAL . 10.7 tttp -152.85 -170.39 3.62 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -80.14 122.7 27.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.35 -25.3 61.81 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.36 8.77 39.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.6 131.83 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -92.95 96.83 10.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.013 0.435 . . . . 0.0 110.755 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 110' ' ' ILE . 3.1 pp -125.89 164.37 33.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.137 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 16.8 Cg_exo -67.04 -178.38 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.164 2.576 . . . . 0.0 113.011 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -160.51 168.08 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.639 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.5 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 4.4 mp -127.53 133.68 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 69.3 m -110.06 139.21 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -93.83 111.28 22.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -117.66 134.97 54.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 111.307 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.57 -113.05 0.4 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.76 HG12 HG12 ' A' ' 181' ' ' VAL . 6.3 tt -161.61 -68.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.595 0.197 . . . . 0.0 111.067 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.76 HG12 HG12 ' A' ' 180' ' ' ILE . 8.8 p . . . . . 0 C--O 1.245 0.868 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.613 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 32.6 m-85 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 p -81.14 -0.95 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.544 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.82 122.72 17.59 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.046 0.451 . . . . 0.0 110.77 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -91.79 111.05 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.377 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.882 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -151.5 -177.14 5.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.372 -177.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.5 p -79.09 167.3 21.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -47.0 84.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.01 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -70.37 -32.64 70.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.38 -43.8 76.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.882 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.51 -38.35 69.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.842 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' HD12 ' A' ' 78' ' ' ILE . 29.5 t -64.81 -65.71 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.775 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.48 -31.38 72.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.92 -44.76 84.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.18 0.514 . . . . 0.0 109.961 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 49.5 t -65.21 -45.05 86.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.367 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.497 HD12 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -60.28 -36.82 71.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.396 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 t -78.6 -19.54 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.629 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.4 ptp180 -91.7 -3.55 56.14 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.016 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.85 45.15 4.0 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.701 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.81 -179.33 36.41 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.104 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 p -135.75 157.41 46.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD23 ' HE2' ' A' ' 126' ' ' MET . 4.0 mm? -64.27 149.45 48.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -75.05 107.02 6.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.721 HG22 ' HB2' ' A' ' 125' ' ' ASP . 23.4 m -97.61 111.46 58.74 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.488 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 112' ' ' LEU . 3.4 Cg_exo -77.67 119.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.168 2.579 . . . . 0.0 112.271 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -13.64 16.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.786 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 92' ' ' GLU . 45.1 p -130.93 170.01 15.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.317 . . . . 0.0 110.679 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.98 65.63 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.189 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.6 p -66.38 -37.94 86.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.35 0.595 . . . . 0.0 110.718 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.565 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 14.8 tt0 -69.71 -40.3 76.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.155 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -61.87 -45.36 94.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.64 -36.74 79.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.76 99.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.979 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.73 -40.59 88.42 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.479 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 88.0 t80 -57.85 -45.87 85.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 15.7 mm-40 -68.62 -38.95 80.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.235 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -66.19 -48.11 71.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 110' ' ' ILE . 0.9 OUTLIER -65.18 -34.3 78.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 47.5 ttt180 -54.62 -48.78 71.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.092 175.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 98' ' ' GLU . 27.1 pt20 -93.29 11.11 29.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.278 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -134.47 -61.41 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.642 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 175' ' ' ILE . 2.9 t -87.79 -32.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.926 0.87 . . . . 0.0 109.61 -172.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 122.26 122.95 2.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.07 -37.58 4.31 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.745 0.418 . . . . 0.0 112.088 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.28 21.63 2.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.96 161.41 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.015 0.436 . . . . 0.0 111.585 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.455 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 39.6 mt-10 -121.81 122.37 39.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.711 176.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.851 HD12 HD21 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -134.36 150.93 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.027 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.404 ' CE2' HD12 ' A' ' 172' ' ' LEU . 36.7 m95 -72.19 155.22 40.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.792 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' ALA . 55.5 mt -106.61 6.82 30.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.7 79.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.58 126.61 39.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.771 0.319 . . . . 0.0 111.109 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.14 149.4 24.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -78.65 124.81 28.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.216 0.531 . . . . 0.0 111.227 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.3 tmm? -126.27 -55.29 1.46 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.043 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.25 -22.38 9.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.759 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 68.63 -64.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.008 0.817 . . . . 0.0 111.482 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.55 95.23 2.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.527 0.679 . . . . 0.0 111.077 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.28 -70.32 0.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.841 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t -108.78 113.69 26.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.761 0.791 . . . . 0.0 112.063 -174.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.593 ' HH2' ' HA ' ' A' ' 152' ' ' CYS . 28.2 m95 -95.83 156.48 16.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.837 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -118.34 130.32 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.721 ' HB2' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.45 156.78 38.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.718 ' HE2' HD23 ' A' ' 84' ' ' LEU . 9.3 ptp -58.96 -30.25 67.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -173.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 t -106.38 6.75 30.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.239 0.542 . . . . 0.0 111.124 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.5 28.52 9.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.753 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.86 137.99 31.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.012 0.406 . . . . 0.0 110.558 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -91.63 116.14 28.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 38.4 pt -77.78 132.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.05 3.47 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.259 0.552 . . . . 0.0 110.459 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -133.67 116.8 16.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.33 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.01 100.87 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.674 0.749 . . . . 0.0 110.629 172.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -111.14 113.03 25.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.026 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.441 ' HH2' ' HB1' ' A' ' 153' ' ' ALA . 23.8 m95 -112.99 113.45 25.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.366 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.52 -23.83 53.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.62 0.724 . . . . 0.0 109.334 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.677 ' HB ' ' HD2' ' A' ' 164' ' ' PHE . 11.7 t -87.71 39.56 0.89 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.775 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -55.68 107.4 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 140' ' ' ILE . 40.3 pt -67.78 116.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.617 0.722 . . . . 0.0 110.887 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.0 p -124.12 5.79 8.55 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.497 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.46 126.65 40.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.768 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -116.19 103.36 53.21 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.202 0.525 . . . . 0.0 109.969 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.72 -62.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.024 2.483 . . . . 0.0 112.524 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.88 -40.17 69.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.25 -17.49 1.34 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.74 -26.17 1.05 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.138 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 24.4 pttt -78.01 98.99 5.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.633 0.73 . . . . 0.0 110.332 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.8 p -136.37 147.88 47.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.789 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 167' ' ' ARG . 47.4 mt-10 -79.55 100.71 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -134.09 121.24 21.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.604 0.716 . . . . 0.0 110.52 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.593 ' HA ' ' HH2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -149.07 165.92 30.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.481 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.564 ' HB2' HD11 ' A' ' 112' ' ' LEU . . . -75.52 108.81 8.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.463 HG13 ' HB2' ' A' ' 166' ' ' LYS . 12.3 p -122.07 140.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.511 ' HB2' HD22 ' A' ' 112' ' ' LEU . 31.4 tp -90.03 115.38 27.26 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.0 m -110.74 100.19 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.416 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.98 -19.41 78.76 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.596 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.62 -19.55 65.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 111.412 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.62 -56.48 2.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.44 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -171.58 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 120.13 6.53 9.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.12 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -86.96 -178.75 6.36 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.621 -0.341 . . . . 0.0 110.381 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -88.98 131.75 35.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.677 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 95.8 m-85 -125.82 171.1 10.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.552 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 5.5 p-10 -113.25 141.23 47.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.501 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 31.5 tttp -145.82 174.87 10.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.659 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 59.7 mtm180 -64.5 124.28 21.42 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.307 0.38 . . . . 0.0 110.25 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 150' ' ' GLU . 55.7 m -72.76 -21.49 61.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.69 15.16 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.676 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.659 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 3.8 t0 -87.77 166.01 14.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 68' ' ' LYS . 97.8 mt-30 -122.47 96.01 4.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.124 0.487 . . . . 0.0 111.331 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 173' ' ' PRO . 3.2 pp -126.29 172.32 6.59 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.741 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 14.7 Cg_exo -69.69 -178.63 2.41 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.563 2.175 . . . . 0.0 112.716 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.613 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -153.8 172.18 17.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 104' ' ' VAL . 95.9 mt -142.77 115.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 110.597 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.572 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 97.4 m -102.97 155.78 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -89.89 134.73 34.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -134.34 174.87 10.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.26 94.77 0.05 OUTLIER Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.479 -0.391 . . . . 0.0 112.725 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 13.4 tt -99.14 -19.47 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.151 0.501 . . . . 0.0 110.837 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.328 -178.607 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.639 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 43.3 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.901 0.382 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -71.53 -12.35 61.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.989 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG2' ' HE1' ' A' ' 174' ' ' TYR . 14.2 pt20 -72.35 135.22 45.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.501 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 p -89.71 138.38 31.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.648 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -168.95 166.04 11.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 169' ' ' ARG . 30.4 p -81.94 168.12 18.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 115' ' ' ASN . 31.4 t80 -56.22 -29.14 60.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.64 0.257 . . . . 0.0 110.571 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -60.6 -59.3 5.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.633 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 8.5 mp0 -65.43 -31.42 72.5 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.79 81.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.52 ' HB2' ' HE3' ' A' ' 126' ' ' MET . 44.5 t -72.64 -56.28 5.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.342 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 3.0 tp10 -56.39 -38.46 71.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.608 -173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -72.1 -52.82 14.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.091 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.641 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 25.2 t -66.42 -37.25 84.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.221 -174.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -62.87 -37.28 78.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 0.0 110.131 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -79.09 -27.03 42.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.738 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.641 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.9 ptp180 -83.23 6.83 18.13 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.757 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.04 43.14 27.55 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.271 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 -171.38 17.57 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 2.1 m -150.43 145.2 25.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.5 mp -58.72 135.81 57.54 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.7 p -70.37 107.52 3.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.235 0.54 . . . . 0.0 110.814 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 95.0 m -99.9 120.95 55.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.05 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 12.1 Cg_exo -70.37 111.48 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.098 1.865 . . . . 0.0 112.219 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -103.64 -18.96 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.918 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -136.05 177.77 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.213 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.93 -35.51 91.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.275 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -56.45 -43.7 79.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.557 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.2 mp0 -60.43 -58.61 7.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.7 0.286 . . . . 0.0 111.187 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -66.19 -41.33 90.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.116 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -40.07 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.551 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.42 -31.45 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.38 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 2.5 tt -60.64 -46.11 91.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 88.5 t80 -59.83 -41.84 92.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.689 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.483 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 8.3 tp10 -68.7 -37.73 79.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.103 0.478 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -62.85 -35.62 80.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.513 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 66.5 mt -56.4 -48.98 75.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.483 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 42.9 mtp180 -64.95 -17.3 64.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.951 -173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -116.18 9.94 14.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.0 m -153.58 -46.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.951 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.698 HG11 HD12 ' A' ' 110' ' ' ILE . 30.1 t -104.77 -37.44 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.532 0.682 . . . . 0.0 110.473 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.38 128.56 3.01 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -55.92 -41.9 75.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.321 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.18 154.78 18.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.207 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 156' ' ' SER . 40.2 mt-10 -122.39 122.39 38.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.984 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.698 HD12 HG11 ' A' ' 104' ' ' VAL . 2.2 mp -121.2 147.51 25.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.069 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.58 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 73.5 m95 -71.65 138.89 48.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.554 HD21 ' N ' ' A' ' 155' ' ' LEU . 2.1 mm? -100.93 12.55 37.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.44 81.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.988 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 131' ' ' ILE . 8.4 mp -94.58 125.87 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 31.9 p-10 -124.29 161.0 26.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.521 ' HB2' ' N ' ' A' ' 152' ' ' CYS . 15.2 t70 -80.1 68.63 6.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.669 0.747 . . . . 0.0 110.525 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -103.84 -44.8 4.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.34 104.84 12.19 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.062 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.69 -4.58 52.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.404 0.621 . . . . 0.0 110.272 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.5 163.21 25.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.883 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -26.86 62.93 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.095 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p -86.59 72.88 10.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.624 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.422 ' HB2' ' CD1' ' A' ' 131' ' ' ILE . 36.4 m95 -62.74 149.21 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.836 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.4 133.95 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.362 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -98.06 -165.47 1.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 0.0 111.123 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.52 ' HE3' ' HB2' ' A' ' 74' ' ' SER . 20.1 mmt -65.37 -37.57 87.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.608 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 78.2 p -82.47 -20.62 36.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.79 0.329 . . . . 0.0 111.317 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.36 28.37 13.2 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.01 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.02 165.4 12.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.05 0.452 . . . . 0.0 110.54 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -99.33 106.96 19.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.526 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 114' ' ' LEU . 44.8 pt -62.41 124.87 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.257 0.551 . . . . 0.0 110.907 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.98 -10.97 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.447 0.641 . . . . 0.0 109.872 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -104.11 116.03 31.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.204 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -135.08 99.4 4.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.915 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 135' ' ' ASN . 5.3 m120 -121.14 111.51 17.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.059 0.457 . . . . 0.0 110.309 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.881 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 36.3 m95 -122.03 124.71 44.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.837 ' HG2' HD22 ' A' ' 160' ' ' ASN . 5.1 tp10 -75.12 -29.03 60.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.644 0.735 . . . . 0.0 109.352 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.8 t -100.92 27.62 5.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.965 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 32.1 tt0 -67.64 102.11 1.13 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.673 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.452 HG12 ' H ' ' A' ' 142' ' ' ALA . 16.8 tt -110.21 122.6 65.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.721 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.7 p -95.11 8.64 42.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.243 0.544 . . . . 0.0 111.012 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.452 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -127.7 172.45 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.737 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -82.79 121.7 77.83 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.472 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.68 -46.88 6.1 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.083 1.855 . . . . 0.0 111.715 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -165.83 38.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.65 -45.75 1.26 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.25 53.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.093 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.41 99.87 10.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.757 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 46.8 p -138.03 164.65 28.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.026 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -91.3 144.16 25.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.084 0.469 . . . . 0.0 109.987 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 12.2 m120 -88.17 128.58 35.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.282 -175.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 116' ' ' ASP . 73.0 m 96.56 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.966 1.416 . . . . 0.0 111.1 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -110.83 150.35 29.27 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 166' ' ' LYS . 28.1 m -143.01 155.91 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.527 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.554 ' N ' HD21 ' A' ' 112' ' ' LEU . 50.8 tp -99.01 103.99 15.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.486 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 20.0 t -96.9 103.64 15.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 -175.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.24 -26.77 67.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.72 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.31 -19.09 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.301 0.572 . . . . 0.0 110.613 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.15 -61.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.189 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.837 HD22 ' HG2' ' A' ' 137' ' ' GLU . 15.3 p30 -174.67 -30.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.12 32.73 1.34 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.711 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 34.3 mmtp -119.66 177.73 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 49.5 m0 -78.42 124.92 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.184 0.516 . . . . 0.0 111.069 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 77.2 m-85 -127.17 178.91 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.493 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -115.92 138.57 51.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.87 0.367 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 154' ' ' VAL . 17.1 mtmt -150.02 161.15 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.649 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.512 ' O ' ' HH2' ' A' ' 111' ' ' TRP . 1.9 mtm105 -60.35 132.48 54.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.58 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -63.47 -17.41 62.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.386 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.413 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 5.7 ptp85 -103.82 29.37 5.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.984 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.3 147.31 23.02 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -91.69 85.14 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.472 . . . . 0.0 110.408 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -128.63 164.44 38.21 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.227 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.45 ' O ' HD11 ' A' ' 172' ' ' LEU . 20.1 Cg_exo -65.79 -177.1 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.48 2.787 . . . . 0.0 113.205 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.654 ' HA ' HG22 ' A' ' 110' ' ' ILE . 1.4 p90 -155.16 167.55 29.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 90.4 mt -141.23 131.0 25.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.934 0.397 . . . . 0.0 110.234 176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.449 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 74.5 m -104.54 157.93 16.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.963 177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.9 pt20 -88.56 111.32 21.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.505 0.669 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.7 113.14 16.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.193 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.13 156.5 8.45 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.988 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.58 -43.71 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.25 0.548 . . . . 0.0 109.905 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.079 179.194 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.439 ' C ' ' H ' ' A' ' 66' ' ' GLN . 77.4 m-85 . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 121.066 0.46 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 t -71.47 13.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 64' ' ' PHE . 12.8 mm100 -71.9 138.65 48.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.332 0.587 . . . . 0.0 110.515 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -93.2 137.22 32.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.578 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -171.26 -178.5 2.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 178.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 15.2 p -77.37 166.09 23.59 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.322 0.389 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.1 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -63.28 -48.19 79.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 6.1 mm-40 -67.44 -40.54 85.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.275 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -54.52 -47.48 73.07 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.061 0.458 . . . . 0.0 110.306 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' HD12 ' A' ' 78' ' ' ILE . 17.5 m -65.03 -56.66 11.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.54 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.68 -41.42 99.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.901 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.575 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 35.0 t70 -71.91 -48.51 45.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.336 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.8 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 46.8 t -64.68 -39.36 93.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -64.4 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.156 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -63.52 -31.9 73.2 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 66.9 mtt180 -66.85 -17.47 64.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 19.04 13.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.699 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -130.93 -169.42 12.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.195 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 p -139.99 161.86 36.59 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 126' ' ' MET . 9.7 mp -75.52 153.61 37.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.556 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.8 t -82.26 107.24 14.79 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 82.7 p -97.47 120.08 61.49 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 6.9 Cg_endo -84.78 113.46 1.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.458 2.105 . . . . 0.0 112.107 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 1.8 pt20 -109.44 -7.25 15.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.183 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.06 169.46 18.63 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.048 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.35 -36.64 92.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.668 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -58.32 -43.25 88.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.1 mp0 -61.25 -48.85 79.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.693 0.282 . . . . 0.0 111.281 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -64.38 -36.04 82.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.294 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.99 -48.44 76.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.645 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -33.6 76.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.158 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.408 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 52.6 mt -60.57 -62.66 1.7 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.222 173.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.729 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 48.9 t80 -53.39 -34.97 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.681 0.613 . . . . 0.0 112.005 -174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.44 -54.94 5.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.453 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 85.4 t80 -57.54 -34.43 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.831 0.824 . . . . 0.0 109.195 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.506 HD12 ' HB ' ' A' ' 104' ' ' VAL . 29.4 tp -53.83 -53.78 47.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.516 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 42.9 mtm105 -67.51 -19.06 65.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.969 -176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 3.8 pt20 -111.82 4.14 18.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.08 -44.24 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.968 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.809 HG13 HD12 ' A' ' 110' ' ' ILE . 41.3 t -102.13 -49.62 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 109.679 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.4 129.48 1.56 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.988 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.553 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 t30 -46.01 -49.11 16.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.088 0.471 . . . . 0.0 111.006 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.28 22.85 6.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.662 -174.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.39 161.31 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.002 0.429 . . . . 0.0 110.99 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 41.3 mt-10 -124.47 125.45 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.809 HD12 HG13 ' A' ' 104' ' ' VAL . 1.8 mp -123.25 144.13 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.12 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.41 ' CZ3' HG21 ' A' ' 154' ' ' VAL . 82.7 m95 -71.21 137.77 48.95 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.594 ' HB3' HD23 ' A' ' 114' ' ' LEU . 94.5 mt -83.11 -14.46 53.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . 76.51 15.76 81.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.371 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? -94.91 144.02 26.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 111.349 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -135.96 111.23 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.664 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.816 ' HA ' ' HA ' ' A' ' 123' ' ' TRP . 8.1 p-10 -72.91 104.37 4.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.746 0.784 . . . . 0.0 111.449 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -86.05 -30.68 22.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.956 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 1.022 ' HB1' ' HB ' ' A' ' 122' ' ' THR . . . -98.64 101.08 12.39 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.63 -36.38 15.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.544 -168.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 2.6 pm0 -82.69 84.31 7.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.941 0.877 . . . . 0.0 111.78 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.95 16.21 46.37 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.973 -1.012 . . . . 0.0 114.552 168.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 1.022 ' HB ' ' HB1' ' A' ' 118' ' ' ALA . 11.3 m -116.34 80.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.777 0.789 . . . . 0.0 111.386 -176.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.816 ' HA ' ' HA ' ' A' ' 116' ' ' ASP . 55.8 m95 -68.37 144.25 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.515 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -110.04 139.94 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -72.43 153.62 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 49.7 mtt -55.95 -25.06 41.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.207 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.2 t -88.51 4.1 47.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.236 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.68 37.92 9.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.341 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.39 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.768 0.284 . . . . 0.0 110.561 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -105.77 127.44 53.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 0.0 110.418 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.9 pt -69.95 151.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.409 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.09 3.11 14.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -141.13 124.29 16.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.805 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.99 130.51 31.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -133.72 111.48 10.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.609 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 18.5 m95 -121.04 128.04 52.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.37 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -72.87 -21.2 60.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 t -105.36 26.16 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 8.2 tp10 -64.38 102.56 0.55 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.8 pt -94.29 148.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 0.0 111.275 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 p -119.37 13.22 12.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.653 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.79 144.76 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.078 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 94.5 mt-30 -103.09 129.26 25.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.509 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 14.5 Cg_exo -69.03 -62.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.769 2.312 . . . . 0.0 112.543 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -97.52 -37.52 9.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.28 -19.48 1.54 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.983 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.47 32.45 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.999 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 14.0 ttpt -89.21 120.8 30.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p -122.62 125.27 45.31 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -103.16 126.19 50.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 166.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -128.71 123.63 33.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -165.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.97 97.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.789 171.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 112' ' ' LEU . . . -75.71 133.44 40.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.402 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.41 HG21 ' CZ3' ' A' ' 111' ' ' TRP . 17.3 t -126.17 141.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.473 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 63.8 tp -98.96 112.53 24.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 p -106.33 109.54 21.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.918 0.389 . . . . 0.0 111.171 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.83 -22.26 78.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.039 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.63 -25.1 67.81 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.0 -60.06 2.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.357 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.0 p30 176.91 -24.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.316 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 123.15 25.81 1.78 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.733 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -111.8 167.6 10.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.704 0.288 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -82.48 135.73 35.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.046 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -126.96 -169.03 1.96 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.071 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -143.02 139.06 30.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.0 110.687 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -139.31 164.98 28.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 167' ' ' ARG . 2.4 tpt180 -71.09 141.22 50.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.565 ' O ' ' HB ' ' A' ' 69' ' ' THR . 51.1 m -63.33 -5.9 4.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.53 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 13.7 ttp85 -112.94 20.19 16.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.9 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -90.94 145.14 24.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 mp0 -93.16 94.47 8.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 111.689 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -129.39 157.84 75.02 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.064 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 22.4 Cg_exo -64.28 179.13 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.006 2.47 . . . . 0.0 113.464 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.8 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -155.24 166.22 34.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.454 177.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.608 HG13 HG12 ' A' ' 110' ' ' ILE . 90.5 mt -124.09 130.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 55.5 m -102.45 132.18 48.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.387 0.613 . . . . 0.0 111.436 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -90.63 110.63 21.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -135.22 121.93 20.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.951 0.405 . . . . 0.0 111.581 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 60.01 2.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.898 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.3 tt -75.5 78.39 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 122.409 1.099 . . . . 0.0 109.961 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 C--O 1.247 0.924 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.062 -178.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.774 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 58.5 m-85 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 p -84.51 5.2 28.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.896 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.449 ' OE1' ' HD3' ' A' ' 68' ' ' LYS . 17.5 tm0? -77.97 123.86 27.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -97.66 115.27 27.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.606 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.719 ' HE3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -144.43 179.24 7.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.887 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.1 p -84.55 167.02 16.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.05 -20.27 62.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -72.5 -50.45 25.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.27 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 3.3 mp0 -70.42 -35.34 73.36 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.096 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.719 ' HB1' ' HE3' ' A' ' 68' ' ' LYS . . . -67.81 -18.58 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.747 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.494 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 10.3 p -91.97 -51.54 5.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.713 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.78 -29.6 65.85 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.869 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -65.66 -40.25 92.21 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.936 -175.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.705 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 33.6 m -72.28 -42.94 64.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.634 0.254 . . . . 0.0 111.211 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.72 -41.53 88.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 t -80.32 -15.8 56.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.705 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 9.9 ptp180 -91.7 4.78 51.95 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.67 38.77 31.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.432 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.74 -170.15 18.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.4 p -131.07 153.51 49.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.618 HD21 ' N ' ' A' ' 85' ' ' SER . 4.8 tt -73.4 146.41 45.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.618 ' N ' HD21 ' A' ' 84' ' ' LEU . 19.3 m -62.6 109.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.972 0.415 . . . . 0.0 111.267 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 28.5 p -107.32 119.83 49.62 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.573 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 31.3 Cg_endo -92.36 123.05 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.646 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 3.6 pt20 -127.82 0.91 6.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 92' ' ' GLU . 68.6 p -129.58 173.65 10.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.38 -36.87 89.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.5 t -64.46 -52.63 57.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.0 110.705 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.646 ' OE1' ' HG2' ' A' ' 88' ' ' GLN . 9.3 pt-20 -75.02 -24.63 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.531 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 87' ' ' PRO . 28.2 t-20 -66.59 -48.84 68.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.15 0.5 . . . . 0.0 110.284 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.35 -22.78 32.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.167 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.72 84.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.608 0.242 . . . . 0.0 110.966 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.09 -40.87 95.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.605 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 36.0 t80 -59.23 -43.69 92.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.454 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.36 -47.25 67.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.473 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.08 -38.69 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.51 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 97' ' ' TYR . 2.9 pp -68.01 -29.56 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.363 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 74.6 mtp180 -66.27 -26.31 67.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -98.83 5.84 47.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.877 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -153.67 -47.35 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 100' ' ' LEU . 4.5 t -88.25 -34.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.654 0.74 . . . . 0.0 109.349 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.28 124.2 3.78 Favored Glycine 0 N--CA 1.434 -1.433 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -50.95 -37.14 42.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.05 0.452 . . . . 0.0 111.26 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 158' ' ' ALA . 39.5 mt-10 -85.36 24.12 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.656 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.65 146.13 29.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 110.762 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 2.6 mm-40 -101.82 132.35 47.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.394 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -124.55 138.77 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 110' ' ' ILE . 83.1 m95 -71.01 148.04 48.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 112' ' ' LEU . 3.6 mm? -96.1 5.2 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.98 16.97 69.16 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.317 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.415 ' HB3' ' CE3' ' A' ' 123' ' ' TRP . 7.5 mp -94.98 126.1 40.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.648 0.261 . . . . 0.0 110.453 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.495 ' O ' HG22 ' A' ' 124' ' ' VAL . 2.6 m-20 -124.32 132.61 53.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.089 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.5 133.06 55.86 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.804 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 0.0 OUTLIER -126.77 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.047 0.451 . . . . 0.0 110.141 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 1.42 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.516 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.99 52.59 2.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.28 112.01 1.57 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.121 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.99 -13.62 29.04 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.747 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.4 p -135.3 100.44 4.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.415 ' CE3' ' HB3' ' A' ' 114' ' ' LEU . 23.5 m95 -62.05 146.59 49.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.501 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 115' ' ' ASN . 29.8 m -116.76 162.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.226 175.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.51 166.29 22.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.494 ' HE1' ' HB3' ' A' ' 74' ' ' SER . 21.0 mmt -54.5 -19.63 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.893 172.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.8 -6.98 34.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 111.434 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.45 34.69 7.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.954 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.61 166.82 10.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -100.76 143.66 30.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.656 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -104.02 148.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 173.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.19 11.57 38.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.863 0.363 . . . . 0.0 111.059 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -107.63 111.06 23.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 -176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 98.41 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.989 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.08 111.71 6.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -128.01 127.31 42.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.795 ' HG3' HD22 ' A' ' 160' ' ' ASN . 3.3 tm-20 -66.31 -52.94 42.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 9.0 t -91.67 40.31 1.03 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.549 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -51.31 107.57 0.19 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.467 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.4 pt -90.41 153.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.973 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.2 p -104.26 68.71 0.89 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.74 98.27 0.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.3 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 145' ' ' ASP . 13.3 mm100 -93.27 127.39 46.98 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.03 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.575 ' HA ' ' HG2' ' A' ' 148' ' ' LYS . 56.2 Cg_endo -71.44 37.31 0.32 Allowed 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.971 2.447 . . . . 0.0 111.022 174.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 143' ' ' GLN . 30.0 t70 -142.4 -6.26 0.93 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.201 -169.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.75 52.94 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.081 -1.056 . . . . 0.0 111.86 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.74 18.08 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.763 -1.208 . . . . 0.0 114.493 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HG2' ' HA ' ' A' ' 144' ' ' PRO . 28.5 pttt -103.79 134.07 47.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.517 0.659 . . . . 0.0 109.413 167.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 p -135.67 170.85 15.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -88.92 92.21 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.276 0.56 . . . . 0.0 110.358 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 165' ' ' ASP . 2.8 p-10 -140.27 147.63 40.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.107 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 1.2 p -117.17 167.84 10.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.783 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.82 139.69 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -170.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.59 164.61 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.433 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 tt -109.8 103.7 12.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 25.8 p -89.85 108.2 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.89 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.03 -51.42 34.09 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.002 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 107' ' ' GLU . . . -59.67 -20.12 54.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.98 -52.17 11.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.795 HD22 ' HG3' ' A' ' 137' ' ' GLU . 12.3 p30 179.94 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.016 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.42 22.67 6.33 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.137 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 56.1 mmtt -113.76 179.27 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.044 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -77.22 122.57 25.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.545 0.688 . . . . 0.0 111.627 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.525 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 10.7 m-85 -117.2 178.23 4.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.069 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.439 ' HB2' HD21 ' A' ' 151' ' ' ASN . 9.3 p-10 -130.26 144.59 51.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.105 0.478 . . . . 0.0 111.295 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.58 ' HD2' ' CD2' ' A' ' 172' ' ' LEU . 17.5 ptpt -153.24 -171.0 3.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.075 173.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 167' ' ' ARG . 40.7 ttm180 -83.34 138.28 33.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.797 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.2 m -70.82 -2.79 16.0 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -96.71 -5.42 38.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.457 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.06 133.0 48.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -92.47 97.25 10.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.649 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.58 ' CD2' ' HD2' ' A' ' 166' ' ' LYS . 3.2 pp -128.15 160.62 60.87 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.062 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.571 ' O ' HD13 ' A' ' 172' ' ' LEU . 40.7 Cg_exo -57.69 179.59 0.14 Allowed 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.461 2.774 . . . . 0.0 113.509 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.809 ' HA ' HG22 ' A' ' 110' ' ' ILE . 2.2 p90 -163.36 165.26 24.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.033 -0.417 . . . . 0.0 110.485 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.774 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.1 mt -128.46 116.56 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 5.9 t -104.24 147.36 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 0.0 110.658 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.41 117.17 29.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.484 ' HE2' ' HD3' ' A' ' 80' ' ' ARG . 1.3 t80 -112.52 116.93 31.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.534 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 132.38 -154.56 21.11 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.04 136.44 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.836 0.351 . . . . 0.0 110.254 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.197 179.278 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.484 ' HD1' ' CE2' ' A' ' 174' ' ' TYR . 54.6 m-85 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.038 0.446 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.499 HG23 HG11 ' A' ' 104' ' ' VAL . 9.1 p -72.46 -3.54 24.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.785 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 52.3 mt-30 -57.18 129.29 41.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.332 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 p -94.21 125.67 38.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.597 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.791 ' HZ3' ' HB3' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -164.22 174.27 11.39 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.225 177.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.8 p -77.75 166.08 23.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 -176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.79 -44.19 81.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.493 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.35 -45.77 91.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.084 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.765 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.23 -42.24 73.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.406 ' O ' HD12 ' A' ' 78' ' ' ILE . 36.0 m -60.22 -58.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.973 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.84 -16.79 62.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.323 . . . . 0.0 111.28 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.54 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 36.7 t70 -75.16 -50.01 17.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.033 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.549 ' HB2' HD13 ' A' ' 84' ' ' LEU . 65.7 m -67.24 -32.94 74.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.143 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -60.2 -41.63 87.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.3 p -79.26 -11.03 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.924 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 14.8 mmp_? -78.62 -14.29 59.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.77 37.77 3.36 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.299 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -177.71 -160.09 23.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.215 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 p -120.73 171.12 8.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.697 HD12 ' HE1' ' A' ' 126' ' ' MET . 9.5 mp -66.82 162.28 21.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 171.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 p -73.65 107.58 5.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 112' ' ' LEU . 35.8 p -110.46 105.81 57.43 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.145 0.498 . . . . 0.0 110.749 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.713 ' HG3' HD13 ' A' ' 96' ' ' LEU . 97.6 Cg_endo -88.03 139.24 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.466 2.111 . . . . 0.0 112.251 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.9 pt20 -135.25 9.03 3.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.748 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 p -141.53 168.64 19.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.906 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.68 98.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.8 m -59.95 -35.41 74.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.104 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -76.16 -37.01 58.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.074 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.93 -41.64 77.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.088 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.65 -36.1 81.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.173 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.03 79.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.713 HD13 ' HG3' ' A' ' 87' ' ' PRO . 22.2 mt -78.57 -4.99 51.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.626 0.25 . . . . 0.0 111.118 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -98.23 -37.66 9.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.57 -52.52 8.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.759 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 71.6 t80 -62.73 -35.27 79.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.519 0.676 . . . . 0.0 109.242 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.48 HD13 ' HB ' ' A' ' 104' ' ' VAL . 8.0 tp -57.94 -48.09 80.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.284 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.02 -19.78 64.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.702 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 17.1 pt20 -110.3 8.06 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.827 -0.546 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 -65.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.608 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 65' ' ' THR . 2.5 t -83.56 -28.69 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 151.12 -77.84 0.22 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.147 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 p-10 173.29 -40.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 6.7 pt-20 -113.39 45.76 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.785 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.03 146.93 40.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.607 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 4.6 mp0 -94.54 130.96 40.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.369 174.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 175' ' ' ILE . 3.8 mp -125.63 145.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.588 177.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.89 132.55 45.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.9 mt -90.38 10.57 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.39 30.89 56.37 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.09 141.74 47.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.146 0.973 . . . . 0.0 110.26 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HA ' ' CE3' ' A' ' 123' ' ' TRP . 25.8 p-10 -154.68 141.6 19.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 110.587 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.905 ' HB2' ' HA ' ' A' ' 123' ' ' TRP . 21.0 t0 -120.23 121.81 39.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.882 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptm -127.53 -18.35 4.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.642 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.43 -59.74 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -171.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.39 68.82 3.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.54 107.07 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.653 -165.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.22 -6.48 8.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.687 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 p -141.29 101.62 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.763 0.316 . . . . 0.0 111.207 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.905 ' HA ' ' HB2' ' A' ' 116' ' ' ASP . 25.4 m95 -64.16 137.3 57.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -107.9 139.09 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.74 ' OD2' HG23 ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.9 -179.77 4.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 0.0 110.441 -178.042 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.697 ' HE1' HD12 ' A' ' 84' ' ' LEU . 54.1 mtt -69.25 -32.32 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.74 HG23 ' OD2' ' A' ' 125' ' ' ASP . 12.4 t -81.03 -5.21 57.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.263 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.81 37.82 5.11 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.382 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.1 162.09 27.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.075 0.437 . . . . 0.0 110.834 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -99.19 126.14 44.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.64 126.18 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.407 0.623 . . . . 0.0 111.366 -174.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.72 -19.44 35.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.591 0.71 . . . . 0.0 110.02 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 41.1 t80 -120.41 115.23 23.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.305 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -144.0 120.14 10.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.997 0.427 . . . . 0.0 110.069 178.027 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -125.9 111.07 14.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.582 0.706 . . . . 0.0 110.502 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 1.008 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 3.2 m95 -111.5 118.49 35.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HG2' HD22 ' A' ' 160' ' ' ASN . 4.1 tp10 -70.0 -41.22 74.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.576 0.703 . . . . 0.0 109.77 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.17 23.11 6.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.942 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 1.008 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -71.1 102.16 2.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 140' ' ' ILE . 19.4 pt -115.87 99.98 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.756 0.788 . . . . 0.0 109.476 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.9 t -88.35 62.9 6.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.513 1.149 . . . . 0.0 110.206 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.502 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -112.81 94.31 4.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.868 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.613 ' HG3' ' HA2' ' A' ' 147' ' ' GLY . 20.7 mm-40 -100.41 104.04 27.59 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.56 -172.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 5.6 Cg_exo -76.98 -20.86 12.75 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.792 2.328 . . . . 0.0 111.758 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -84.38 -34.64 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.223 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.24 -36.75 1.1 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.237 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.613 ' HA2' ' HG3' ' A' ' 143' ' ' GLN . . . 151.72 21.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 119.992 -1.099 . . . . 0.0 114.08 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 142.89 51.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.369 0.584 . . . . 0.0 109.636 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.6 p -138.08 137.25 37.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.734 0.302 . . . . 0.0 111.086 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.41 92.32 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.566 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 3.5 p-10 -152.43 168.32 25.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 69.5 m -140.1 124.2 17.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 -176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.16 135.32 39.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.576 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.55 145.63 31.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.674 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 2.3 tm? -89.39 108.89 19.9 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 26.1 t -98.96 100.78 11.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.36 -23.9 74.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.771 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -69.67 -30.46 68.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 110.71 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.87 0.99 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.746 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.423 HD22 ' HG2' ' A' ' 137' ' ' GLU . 14.6 p30 -171.35 -27.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.055 -174.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.23 -2.25 11.5 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.839 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -82.56 174.18 11.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -83.78 126.84 33.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.307 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.54 -171.84 2.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.97 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.566 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 12.8 t70 -141.72 146.16 35.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.081 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -147.53 176.8 9.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -72.25 144.09 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 -173.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 28.7 m -68.61 -14.62 63.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.008 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -93.59 -3.21 53.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 17.6 m-20 -73.55 136.06 44.0 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -110.31 106.16 15.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.819 0.819 . . . . 0.0 111.446 -176.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.553 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 1.5 pp -129.24 171.14 9.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.346 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 14.3 Cg_endo -57.12 174.67 0.42 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.552 2.168 . . . . 0.0 113.226 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.791 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 49.1 p90 -140.91 179.59 6.63 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.041 -0.412 . . . . 0.0 110.739 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.521 HG13 HG12 ' A' ' 110' ' ' ILE . 71.6 mt -145.51 132.42 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.463 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 84.9 m -99.49 155.81 17.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 177' ' ' GLN . 6.0 tp60 -87.93 108.51 19.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.512 0.672 . . . . 0.0 110.311 -175.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -135.06 134.26 40.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 180' ' ' ILE . . . 123.95 126.67 3.12 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -172.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 179' ' ' GLY . 81.7 mt 73.27 -48.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.383 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.72 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 59.3 m-85 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -69.69 -8.11 44.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.003 -177.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.868 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 27.6 mt-30 -53.61 122.03 9.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 0.0 111.733 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 171' ' ' GLN . 17.6 p -97.02 113.53 25.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.511 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.866 ' HE3' ' HB3' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.82 -176.55 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.122 -178.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 169' ' ' ARG . 81.5 p -78.14 165.88 23.43 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.321 0.388 . . . . 0.0 110.129 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.31 -38.79 92.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.675 0.274 . . . . 0.0 110.946 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -63.33 -45.91 89.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . . . -58.88 -37.08 75.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.663 ' HA ' ' HE2' ' A' ' 126' ' ' MET . 29.1 t -63.1 -60.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.41 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 11.2 pt-20 -70.69 -15.21 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.496 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.699 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 11.7 t70 -65.06 -59.01 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.3 m -59.28 -36.8 76.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 74' ' ' SER . 28.3 mm -54.17 -44.5 64.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 p -84.39 -14.09 50.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.397 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 20.4 mmt180 -74.46 -23.69 58.93 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.98 25.59 11.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.332 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.78 -170.26 13.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.1 p -116.14 165.81 12.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 175' ' ' ILE . 19.4 tp -81.8 148.74 28.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -66.69 109.17 2.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.866 0.365 . . . . 0.0 111.219 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 4.7 t -117.51 118.5 35.27 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.905 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.498 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 2.0 Cg_endo -81.68 120.66 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.063 2.509 . . . . 0.0 112.311 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -104.28 -30.48 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.098 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.0 p -128.02 -171.0 2.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.71 -34.26 82.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.913 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -55.4 -49.81 71.37 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.834 0.454 . . . . 0.0 111.936 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.498 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 4.8 mp0 -61.66 -53.22 59.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.11 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.53 -37.75 88.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.92 -44.13 93.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.497 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.49 -32.96 58.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.562 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.7 tp -63.06 -47.66 81.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.018 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.467 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 91.4 t80 -60.08 -40.46 89.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.538 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.743 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -64.03 -33.33 75.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.617 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 155' ' ' LEU . 72.6 mt -57.14 -44.72 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.141 0.496 . . . . 0.0 109.901 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 16.5 mtp180 -69.04 -9.38 52.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.62 -172.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -127.47 15.61 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.1 t -151.32 -51.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.359 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.43 HG11 HD12 ' A' ' 110' ' ' ILE . 2.8 t -105.85 -29.05 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.649 0.737 . . . . 0.0 110.391 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.49 130.49 4.97 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -30.82 64.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.89 ' HA ' ' HB3' ' A' ' 158' ' ' ALA . 5.1 mm-40 -80.44 6.76 11.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.027 -175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.32 15.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 0.0 112.197 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.454 ' C ' HD11 ' A' ' 110' ' ' ILE . 34.0 mt-10 -121.18 123.53 42.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.078 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.601 HG12 HG13 ' A' ' 175' ' ' ILE . 2.6 mp -122.93 138.77 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 110.505 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.476 ' HB2' HD21 ' A' ' 84' ' ' LEU . 73.6 m95 -70.41 145.5 51.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 155' ' ' LEU . 95.3 mt -89.89 -2.31 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.485 ' CA ' HD22 ' A' ' 84' ' ' LEU . . . 82.73 5.81 89.08 Favored Glycine 0 C--N 1.324 -0.124 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.284 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.442 HD21 HD13 ' A' ' 131' ' ' ILE . 7.2 mp -93.27 125.47 37.89 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -93.87 145.75 24.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.758 -169.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.26 66.75 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.403 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.76 ' HE1' HG22 ' A' ' 124' ' ' VAL . 18.1 tmm? -128.33 -57.71 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.531 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.48 123.83 49.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.414 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -131.19 -1.81 4.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 88.69 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.481 0.658 . . . . 0.0 110.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.65 -70.32 2.88 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.62 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p -99.89 100.95 11.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -72.96 148.18 44.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.014 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.76 HG22 ' HE1' ' A' ' 117' ' ' MET . 16.9 m -98.11 129.22 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -83.3 164.31 20.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.771 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' A' ' 74' ' ' SER . 11.5 ptp -61.91 -43.54 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -92.56 -4.79 52.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 0.0 111.084 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.63 13.1 9.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.554 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 125' ' ' ASP . . . -77.85 128.3 33.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.039 0.447 . . . . 0.0 110.777 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -98.34 113.69 25.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.728 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.442 HD13 HD21 ' A' ' 114' ' ' LEU . 43.4 pt -62.05 135.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.977 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -112.48 8.95 19.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.537 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 135' ' ' ASN . 80.2 t80 -105.52 102.95 12.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.246 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.471 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 13.9 tptp -105.6 96.78 6.74 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 46.1 t30 -157.6 111.72 2.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.571 ' HB2' ' HB3' ' A' ' 139' ' ' GLU . 4.0 m95 -137.98 156.21 48.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.795 -173.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -97.08 -49.97 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 29.66 6.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.604 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 136' ' ' TRP . 17.1 pt-20 -67.39 151.8 46.81 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.83 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 pt -72.92 133.7 31.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.489 0.661 . . . . 0.0 111.244 -173.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.7 p -116.24 -15.21 11.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.432 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.99 50.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.62 100.3 51.21 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -22.18 8.19 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.683 2.256 . . . . 0.0 112.62 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.19 46.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.94 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.81 -36.19 3.3 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.485 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.77 34.75 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.03 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.69 100.4 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 p -138.42 129.26 26.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.916 0.389 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.91 102.73 7.41 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.5 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 5.1 p-10 -169.41 173.09 6.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.794 -173.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 94.7 m -126.9 132.12 50.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.993 0.425 . . . . 0.0 111.207 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.45 140.13 38.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.455 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.761 HG13 ' HG2' ' A' ' 166' ' ' LYS . 14.3 p -136.04 149.32 27.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 100' ' ' LEU . 1.3 tm? -98.66 101.15 12.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.0 m -99.7 109.37 21.83 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.03 -40.17 73.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.806 -175.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.89 ' HB3' ' HA ' ' A' ' 107' ' ' GLU . . . -68.78 -11.51 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 111.287 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.05 -56.46 3.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -171.69 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.864 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.23 -0.97 37.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.946 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -93.5 179.58 5.34 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.408 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 45.4 m0 -79.29 123.4 27.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 0.0 110.62 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -116.52 -168.82 1.51 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.232 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.5 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 5.6 t70 -134.4 138.21 44.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.761 ' HG2' HG13 ' A' ' 154' ' ' VAL . 12.4 mmmm -137.95 146.37 43.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -60.52 136.35 58.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.3 m -65.07 -7.1 10.66 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.51 ' HA ' HG23 ' A' ' 69' ' ' THR . 37.2 ttp180 -109.0 20.9 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.178 0.513 . . . . 0.0 110.243 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.42 141.22 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.45 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 2.0 mp0 -93.28 93.05 8.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.421 HD22 ' HZ1' ' A' ' 166' ' ' LYS . 3.9 pp -127.85 164.48 36.54 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.671 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.3 Cg_exo -63.41 -178.4 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.263 2.642 . . . . 0.0 113.745 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.868 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 6.5 p90 -154.58 176.92 11.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.15 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.601 HG13 HG12 ' A' ' 110' ' ' ILE . 74.1 mt -145.63 128.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.584 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 83.6 m -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -89.11 110.39 21.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.14 113.22 16.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.441 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.95 -85.09 1.79 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.242 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.796 ' H ' HD11 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -84.12 -31.82 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.814 0.34 . . . . 0.0 110.67 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.713 HG22 HG12 ' A' ' 180' ' ' ILE . 57.6 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.378 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 176' ' ' CYS . 29.6 m-85 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 p -84.91 17.31 2.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.194 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 44.9 tt0 -84.97 139.35 31.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.255 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 p -98.05 127.43 43.99 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.646 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -158.28 -178.88 7.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HG1' ' CD ' ' A' ' 72' ' ' GLU . 32.2 p -84.5 166.83 16.92 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.95 0.156 . . . . 0.0 110.868 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -48.26 82.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.476 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -63.32 -43.8 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.694 0.283 . . . . 0.0 110.298 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.442 ' CD ' ' HG1' ' A' ' 69' ' ' THR . 65.9 mt-10 -64.48 -43.58 93.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.54 72.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.472 ' O ' HD12 ' A' ' 78' ' ' ILE . 16.1 t -59.55 -62.57 1.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.96 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.99 -39.44 81.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.272 0.558 . . . . 0.0 110.935 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' CG ' HH12 ' A' ' 80' ' ' ARG . 12.3 t70 -64.94 -47.37 77.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.735 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 42.3 t -79.26 -36.87 39.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.003 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.472 HD12 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -57.26 -40.22 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.109 0.48 . . . . 0.0 110.457 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -76.44 -31.59 57.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.904 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' NH1' ' HH ' ' A' ' 174' ' ' TYR . 1.3 ptp85 -96.15 -18.02 20.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.053 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.16 -51.18 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.169 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.27 -46.33 0.97 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.112 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 p -145.58 155.64 43.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.608 0.242 . . . . 0.0 111.151 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -72.36 161.78 30.37 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' HD21 ' A' ' 96' ' ' LEU . 28.3 m -79.06 106.09 10.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 37.9 m -111.9 112.33 53.2 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.65 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 2.5 Cg_endo -79.85 117.22 3.57 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.936 2.424 . . . . 0.0 111.869 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.404 ' HB3' HG22 ' A' ' 131' ' ' ILE . 1.8 pt20 -115.89 -13.67 11.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.424 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.0 p -130.9 176.24 8.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.73 -26.32 66.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.745 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -56.21 -56.88 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.896 0.478 . . . . 0.0 111.521 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.663 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 9.6 mp0 -62.73 -48.61 78.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.383 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.57 -40.92 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.33 -39.66 94.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.18 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.035 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.577 HD11 ' HG3' ' A' ' 87' ' ' PRO . 22.5 mt -59.83 -46.11 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -62.19 -29.14 70.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.617 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.21 -42.7 22.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -67.68 -47.25 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.431 ' HA ' HG22 ' A' ' 104' ' ' VAL . 3.1 pp -63.58 -25.83 68.41 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 101' ' ' ARG . 9.6 ttm180 -61.04 -38.63 86.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.448 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.12 0.28 31.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.693 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.8 p -124.32 -50.2 1.78 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 100' ' ' LEU . 3.0 t -98.51 -33.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.672 0.749 . . . . 0.0 109.704 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.97 125.04 3.61 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -55.21 -26.29 38.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.046 0.423 . . . . 0.0 111.504 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.59 ' HA ' ' HB1' ' A' ' 158' ' ' ALA . 38.6 mt-10 -89.18 22.52 2.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.383 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.46 162.25 14.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.057 0.456 . . . . 0.0 110.951 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 10.5 pt-20 -128.46 130.92 48.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.825 HG21 ' HA ' ' A' ' 174' ' ' TYR . 4.0 mp -118.84 154.61 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.988 -174.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -70.08 149.65 47.41 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.903 0.382 . . . . 0.0 110.12 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.5 HD13 ' CE2' ' A' ' 163' ' ' TRP . 0.2 OUTLIER -86.73 -6.11 58.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -171.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.33 6.95 66.68 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.468 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mp -93.38 128.57 39.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.212 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.501 ' N ' HD21 ' A' ' 115' ' ' ASN . 0.9 OUTLIER -93.3 118.44 31.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 0.0 110.558 -176.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.41 96.84 6.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.031 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 53.4 ttp -126.55 -47.74 1.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -169.7 1.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.25 15.61 7.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.274 0.559 . . . . 0.0 110.741 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.76 166.72 15.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.94 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.02 -16.78 75.09 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.584 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.627 HG21 ' HG3' ' A' ' 130' ' ' ARG . 30.9 m -80.22 77.69 6.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 110.508 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.505 ' HB2' HD11 ' A' ' 131' ' ' ILE . 44.4 m95 -59.2 129.47 42.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.576 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.22 131.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HB3' ' HB1' ' A' ' 129' ' ' ALA . 5.1 t70 -73.89 161.09 30.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.468 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.447 ' SD ' HD11 ' A' ' 78' ' ' ILE . 4.4 ptp -53.61 -28.96 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.0 p -92.84 1.26 57.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.095 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.56 27.91 25.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.954 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.482 ' HB1' ' HB3' ' A' ' 125' ' ' ASP . . . -92.63 149.53 21.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.841 0.353 . . . . 0.0 111.197 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.627 ' HG3' HG21 ' A' ' 122' ' ' THR . 28.2 ttm180 -98.14 130.69 44.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.089 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.656 HG13 ' HE3' ' A' ' 134' ' ' LYS . 38.0 pt -92.33 128.46 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.065 0.46 . . . . 0.0 110.156 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.91 -19.84 24.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.243 0.544 . . . . 0.0 110.534 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -113.77 130.45 56.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.516 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.656 ' HE3' HG13 ' A' ' 131' ' ' ILE . 10.4 mptt -130.06 144.26 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.72 114.82 8.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 44.4 m95 -126.59 117.54 23.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.193 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.494 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.3 tp10 -71.08 -29.79 65.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.2 t -108.4 38.38 2.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.774 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 34.1 tt0 -56.21 121.57 9.76 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.292 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.7 pt -84.88 132.97 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.238 0.542 . . . . 0.0 110.867 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.1 p -116.66 2.2 12.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.159 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.16 161.87 28.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.355 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -100.45 111.35 62.52 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.35 -82.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.063 2.508 . . . . 0.0 114.183 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 148' ' ' LYS . 8.0 m-20 -88.68 21.12 3.12 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.78 20.07 76.83 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.93 -47.43 0.57 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.876 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 3.0 tmpt? -65.67 122.15 16.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 p -116.82 165.32 13.45 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.556 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.96 149.44 43.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.55 161.53 24.75 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -167.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 89.1 m 68.12 105.99 0.05 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.263 0.977 . . . . 0.0 112.567 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 112' ' ' LEU . . . -83.67 139.67 32.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.29 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.5 142.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.918 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 49.6 tp -100.98 101.3 12.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.429 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 17.9 m -96.44 113.53 25.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.561 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.49 -30.95 47.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.853 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.59 ' HB1' ' HA ' ' A' ' 107' ' ' GLU . . . -67.52 -24.77 65.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.89 -59.02 2.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.976 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.407 HD22 ' HG2' ' A' ' 137' ' ' GLU . 10.7 p30 -177.58 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.33 19.23 3.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.343 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.494 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 34.4 mmtp -98.73 168.46 10.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.5 ' CE2' HD13 ' A' ' 112' ' ' LEU . 49.6 m0 -84.25 132.61 34.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.248 0.547 . . . . 0.0 110.429 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.02 -179.21 4.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.33 156.64 22.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.464 ' HG2' ' N ' ' A' ' 167' ' ' ARG . 20.8 ttmm -154.35 167.65 29.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 110.518 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.464 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 33.1 mtm-85 -60.11 125.36 23.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.819 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.94 -22.56 67.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.783 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 169' ' ' ARG . 3.7 tpt180 -101.12 21.77 13.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.14 150.61 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.88 102.5 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.684 0.278 . . . . 0.0 111.23 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -130.49 167.77 19.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.0 Cg_exo -73.6 -179.24 4.32 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.966 2.444 . . . . 0.0 113.035 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.825 ' HA ' HG21 ' A' ' 110' ' ' ILE . 9.7 p90 -150.65 178.65 8.88 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.208 -0.308 . . . . 0.0 110.923 -176.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.5 ' O ' HD12 ' A' ' 84' ' ' LEU . 97.4 mt -144.39 134.73 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 45.0 m -102.79 136.88 41.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 111.984 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -104.76 115.65 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.628 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.16 158.6 43.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.26 1.34 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.995 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 60.3 mt -81.05 101.21 5.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.837 0.351 . . . . 0.0 110.653 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.691 177.794 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.557 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 49.8 m-85 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -78.08 -4.06 45.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.664 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 27.0 tt0 -66.89 136.32 55.21 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 p -104.42 134.64 47.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.889 ' HZ1' ' HB3' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -165.64 176.86 7.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 73.6 p -78.33 166.32 22.81 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.305 0.378 . . . . 0.0 110.803 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.78 -35.84 77.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.168 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -64.2 -50.79 66.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.0 mt-10 -64.79 -35.83 82.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.67 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -60.97 -42.34 98.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.577 ' O ' HG12 ' A' ' 78' ' ' ILE . 43.4 m -60.75 -54.13 48.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.082 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.13 -42.36 76.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 14.4 t70 -60.02 -52.44 65.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 0.0 110.289 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.2 m -63.11 -36.4 83.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.975 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.925 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 22.8 mm -57.29 -42.27 79.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.209 0.528 . . . . 0.0 110.683 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -77.15 -19.19 57.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.195 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 59.8 mtt-85 -107.33 15.49 24.94 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.598 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.52 -49.22 0.42 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.639 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.925 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 120.71 7.19 8.95 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.02 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.811 HG21 ' HB2' ' A' ' 126' ' ' MET . 3.0 m -153.47 138.02 16.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.981 0.42 . . . . 0.0 111.439 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.609 HD22 ' N ' ' A' ' 85' ' ' SER . 6.2 tt -85.74 158.9 19.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.609 ' N ' HD22 ' A' ' 84' ' ' LEU . 19.1 m -69.9 108.21 3.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.939 0.399 . . . . 0.0 110.912 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.2 m -110.12 112.83 57.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 66.7 Cg_endo -82.38 124.81 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.3 2.0 . . . . 0.0 111.982 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -5.87 11.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.386 -170.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.81 165.3 27.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.99 -39.02 77.87 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.029 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -54.27 -39.89 67.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.842 0.457 . . . . 0.0 112.134 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.97 -39.89 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.514 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 33.3 m-80 -66.18 -50.14 64.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.6 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.94 -35.36 80.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.8 65.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.106 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.3 tp -66.53 -44.86 81.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.727 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 110.279 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -65.3 -40.98 94.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.22 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.25 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.182 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 79.2 mt -55.96 -47.7 77.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -54.92 -37.7 66.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.543 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -96.1 -11.05 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.186 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -119.21 -64.06 1.32 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.892 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.63 -34.27 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 110.406 -171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.45 125.21 2.99 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -170.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.466 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.85 -39.86 54.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.778 0.323 . . . . 0.0 110.151 177.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.64 15.09 1.82 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.81 160.3 14.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.984 0.421 . . . . 0.0 111.258 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.57 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 40.5 mt-10 -121.42 122.64 40.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.189 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.552 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.4 mp -121.15 148.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.48 ' O ' HG21 ' A' ' 110' ' ' ILE . 87.6 m95 -70.0 151.8 45.15 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD12 ' HB1' ' A' ' 153' ' ' ALA . 72.3 mt -99.54 4.46 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.94 -27.76 1.38 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.465 ' CD1' HD12 ' A' ' 131' ' ' ILE . 1.8 pt? -94.84 155.66 16.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.652 0.726 . . . . 0.0 110.935 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.449 ' HA ' ' CE3' ' A' ' 123' ' ' TRP . 7.8 p30 -154.0 159.8 41.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.698 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -105.9 133.37 50.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -121.79 5.22 9.97 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -116.12 -68.93 0.89 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 118' ' ' ALA . . . 158.78 -15.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.24 0.963 . . . . 0.0 110.63 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.29 168.86 15.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.132 0.492 . . . . 0.0 111.66 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.67 -15.54 58.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.71 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -84.13 80.48 9.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.449 ' CE3' ' HA ' ' A' ' 115' ' ' ASN . 11.5 m0 -54.9 143.53 25.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.865 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.1 m -107.05 148.36 11.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.573 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.19 166.91 21.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.361 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.811 ' HB2' HG21 ' A' ' 83' ' ' THR . 49.0 mtt -58.67 -27.15 64.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.3 p -82.81 -12.09 57.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.738 0.304 . . . . 0.0 111.286 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.55 -0.11 53.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.819 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.17 155.57 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -109.03 149.75 28.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.465 HD12 ' CD1' ' A' ' 114' ' ' LEU . 48.6 pt -95.22 167.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.978 0.418 . . . . 0.0 111.413 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.1 5.22 3.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.888 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -118.92 119.41 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.279 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.679 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 9.7 mtpm? -138.44 98.71 3.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.996 176.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -127.68 111.52 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.53 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 32.9 m95 -125.36 123.21 38.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.69 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 4.3 mm-40 -72.97 -20.69 60.99 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.43 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 13.7 t -100.01 19.85 15.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.379 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.38 115.13 2.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.29 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.9 pt -103.36 150.4 6.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.011 0.434 . . . . 0.0 111.061 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.9 p -123.72 4.98 8.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.493 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.24 153.21 47.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.758 0.314 . . . . 0.0 111.084 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -81.75 122.81 80.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.645 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.63 -73.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.965 2.443 . . . . 0.0 112.367 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -123.04 47.83 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 110.068 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.55 23.75 27.84 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.069 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.82 -46.64 3.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.0 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 103.29 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.467 0.651 . . . . 0.0 111.152 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -140.29 149.44 42.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.512 176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 2.4 pm0 -79.27 87.15 4.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.597 0.713 . . . . 0.0 109.425 173.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -88.16 114.04 24.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.776 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.6 m -122.03 124.78 44.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.768 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.616 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.85 119.37 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 111.6 -175.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.79 140.52 47.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.998 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.494 ' HB2' HD22 ' A' ' 112' ' ' LEU . 4.1 tt -104.45 102.5 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.8 m -96.25 103.9 15.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.701 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.67 -20.55 76.35 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.461 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.43 -8.61 27.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.475 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.03 -66.43 1.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -148.67 -36.84 0.18 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.74 -0.64 36.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.073 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.1 mptm? -87.02 -179.17 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.53 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 34.0 m0 -81.36 131.7 35.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.632 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 90.6 m-85 -126.42 177.12 6.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.709 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -128.52 147.03 50.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.133 0.492 . . . . 0.0 110.665 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.748 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 34.8 ttmt -151.74 179.07 8.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.748 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 11.4 mtp180 -90.27 138.71 31.31 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -66.7 3.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -171.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 169' ' ' ARG . 69.4 mtt-85 -97.58 3.69 50.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.977 0.353 . . . . 0.0 111.743 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -84.52 140.45 31.43 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.597 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.694 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 7.7 mm100 -93.1 91.15 7.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.037 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.2 pp -125.05 167.32 16.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.811 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 32.6 Cg_exo -59.84 179.7 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.589 2.859 . . . . 0.0 114.271 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.889 ' HB3' ' HZ1' ' A' ' 68' ' ' LYS . 28.3 p90 -151.85 163.96 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.557 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.4 mt -139.02 115.43 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 74.5 m -101.9 153.28 20.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -90.39 110.12 21.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -103.43 138.31 40.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.464 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -50.52 4.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.77 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 49.8 mm 72.96 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.604 -178.063 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 175' ' ' ILE . 33.7 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -74.7 -8.77 57.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.631 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 23.5 tt0 -59.99 129.5 42.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.763 0.316 . . . . 0.0 110.245 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 p -98.74 131.04 45.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.754 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.834 ' HD3' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.37 179.87 7.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.769 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.8 p -78.77 166.0 22.95 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.46 0.475 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.24 -46.4 89.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.866 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.88 -39.67 79.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 0.0 109.658 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.466 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 87.0 tt0 -61.69 -38.13 86.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.662 176.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB1' ' HD3' ' A' ' 68' ' ' LYS . . . -65.02 -46.95 79.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.596 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.582 ' O ' HG12 ' A' ' 78' ' ' ILE . 34.0 p -58.44 -57.2 13.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.913 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -60.17 -32.49 71.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 111.31 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 13.2 t70 -63.78 -54.17 39.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.045 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 99.1 m -61.07 -38.97 88.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.702 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 74' ' ' SER . 23.6 mm -52.51 -42.74 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -80.53 -34.16 35.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.137 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 33.3 mtt-85 -91.05 -25.19 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.11 -173.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.49 -40.87 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.416 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.75 -26.36 5.68 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.322 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 p -148.71 155.75 41.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.062 0.458 . . . . 0.0 111.961 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 85' ' ' SER . 6.9 tt -96.33 154.13 17.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.582 ' N ' HD22 ' A' ' 84' ' ' LEU . 31.6 m -70.51 108.53 4.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 0.0 111.306 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.417 ' CG2' ' HB3' ' A' ' 114' ' ' LEU . 33.2 m -110.07 106.7 58.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.455 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 60.4 Cg_endo -84.01 115.95 2.08 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.484 2.123 . . . . 0.0 111.664 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 131' ' ' ILE . 3.7 pt20 -115.99 7.26 14.3 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.257 -171.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.9 p -138.06 176.21 8.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.916 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.58 -42.92 62.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.2 p -56.72 -45.7 81.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.389 . . . . 0.0 111.439 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.91 -29.0 60.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.511 -175.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.455 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 15.9 m-80 -81.11 -47.01 14.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.456 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.12 -30.87 71.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.28 62.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.832 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 31.0 tp -72.87 -44.59 61.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.484 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.88 -33.11 73.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 109.941 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.76 -44.98 69.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.558 . . . . 0.0 109.584 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.38 -32.47 72.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.147 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 74.2 mt -56.53 -41.61 77.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 110.146 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -66.57 -15.9 63.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.997 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -117.47 2.09 12.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -55.32 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 110' ' ' ILE . 3.4 t -100.35 -30.97 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.01 127.35 3.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -53.56 -35.93 61.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.929 0.395 . . . . 0.0 109.975 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.65 27.99 2.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.49 161.55 13.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.786 0.327 . . . . 0.0 111.108 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.1 mt-10 -118.65 128.05 54.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.633 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.788 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.9 mp -126.51 145.25 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.68 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.53 ' HZ3' ' HB2' ' A' ' 152' ' ' CYS . 83.1 m95 -70.66 149.9 46.53 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 155' ' ' LEU . 83.7 mt -104.39 11.73 34.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.461 ' HA2' ' HE3' ' A' ' 126' ' ' MET . . . 72.52 -25.35 0.74 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 172.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HG ' ' HE3' ' A' ' 123' ' ' TRP . 1.8 pt? -92.46 139.48 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.958 0.879 . . . . 0.0 111.869 -170.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -156.82 136.48 12.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.701 175.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 123' ' ' TRP . 24.9 t70 -112.31 135.73 52.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 171.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -126.25 16.73 7.76 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.669 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.27 -63.01 1.16 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.508 -173.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.42 -30.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.2 146.48 24.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.252 0.549 . . . . 0.0 111.466 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -4.54 78.43 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.442 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -82.08 75.04 9.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.569 ' HA ' ' HB2' ' A' ' 116' ' ' ASP . 27.5 m0 -45.88 128.42 8.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.43 155.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 0.0 111.337 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.3 165.07 25.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.461 ' HE3' ' HA2' ' A' ' 113' ' ' GLY . 66.4 mtt -55.57 -30.16 60.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.298 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.0 p -80.59 -18.88 46.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 111.148 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.71 1.92 28.91 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.401 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 150.89 45.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.633 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -99.59 159.43 15.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.003 0.43 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 46.2 pt -101.83 146.4 10.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.68 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -123.8 20.42 9.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 109.582 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -137.46 120.42 16.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.973 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.671 ' HZ2' ' HB3' ' A' ' 134' ' ' LYS . 9.5 mtpm? -135.17 97.29 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.87 110.23 17.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.601 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 46.6 m95 -129.68 135.99 49.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.263 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 61.2 mm-40 -91.9 -20.37 21.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.711 0.767 . . . . 0.0 108.948 171.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.7 t -98.56 18.7 16.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.988 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 7.9 tp10 -56.7 117.3 3.77 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.31 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.9 pt -97.57 140.55 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 111.344 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.3 p -120.8 4.95 10.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.365 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.508 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -127.49 162.55 26.13 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 -177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -92.17 102.55 6.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 4.7 Cg_exo -78.95 -72.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.087 2.524 . . . . 0.0 112.976 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 148' ' ' LYS . 30.3 t70 -100.09 46.06 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.814 0.816 . . . . 0.0 110.222 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.9 42.14 6.1 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.417 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.9 -10.68 62.03 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.049 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -135.98 159.88 40.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.5 p -138.58 143.23 39.29 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.75 81.16 5.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.015 0.912 . . . . 0.0 108.821 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.779 ' HB2' ' HB2' ' A' ' 165' ' ' ASP . 8.9 p30 -118.61 151.44 37.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.555 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . 0.53 ' HB2' ' HZ3' ' A' ' 111' ' ' TRP . 5.9 m -135.24 140.1 44.98 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.2 116.03 15.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.242 0.544 . . . . 0.0 112.003 -170.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.38 140.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.86 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 112' ' ' LEU . 3.9 tt -100.23 100.21 11.0 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 14.0 m -88.94 98.55 11.81 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.973 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.68 -29.23 73.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.879 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -68.07 -10.28 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.962 0.411 . . . . 0.0 111.101 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.65 -57.8 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.528 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.5 -33.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.187 -172.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 114.65 -5.03 22.85 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.341 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.552 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -86.5 176.93 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.601 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 39.5 m0 -80.79 131.75 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.183 0.516 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.78 172.17 9.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.632 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 151' ' ' ASN . 5.3 p-10 -124.6 143.09 50.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 27.6 ttmt -146.88 171.74 14.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.52 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 13.8 mtp85 -74.6 141.77 44.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.8 m -66.35 -7.19 17.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -96.81 13.16 29.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -89.2 137.98 31.83 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.094 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.677 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 8.7 mm100 -92.46 87.97 6.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.254 -176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -125.93 165.73 25.52 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.601 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 36.4 Cg_exo -61.44 -179.15 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.403 2.736 . . . . 0.0 113.712 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.788 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.73 169.28 24.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.447 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 76.8 mt -138.44 122.19 20.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 30.9 m -102.57 156.72 17.43 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -89.56 109.51 20.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -110.63 137.45 48.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.121 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.09 -28.8 2.85 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.081 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 45.9 mm 60.33 87.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.979 -173.225 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.49 0.662 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.66 12.97 2.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.316 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 33.8 tt0 -80.91 137.69 36.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.219 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.8 p -95.2 130.43 41.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.465 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -156.11 178.94 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 173.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.718 HG22 ' HD2' ' A' ' 169' ' ' ARG . 46.2 p -85.96 165.98 16.29 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.522 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.91 87.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.647 0.261 . . . . 0.0 111.597 -173.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -60.76 -43.69 97.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 109.966 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.563 ' CD ' ' HG1' ' A' ' 69' ' ' THR . 73.7 mt-10 -64.86 -46.67 80.86 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.277 177.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.9 -39.26 74.09 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.469 0.481 . . . . 0.0 111.396 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' HD12 ' A' ' 78' ' ' ILE . 15.5 t -58.21 -60.1 4.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.085 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.51 -32.93 74.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.02 -38.41 88.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 36.8 t -93.63 -37.03 12.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.271 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.731 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.4 mp -59.65 -36.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.065 0.459 . . . . 0.0 111.406 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -98.88 -0.51 42.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 8.8 ptm180 -105.74 -2.88 22.73 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.99 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.74 -55.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.074 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -174.2 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.741 -1.219 . . . . 0.0 112.778 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.719 HG22 HG23 ' A' ' 127' ' ' THR . 61.6 p -144.16 169.03 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.588 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.98 162.86 23.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -79.76 107.28 12.41 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.758 HG23 ' HB2' ' A' ' 125' ' ' ASP . 18.4 m -100.06 119.03 60.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 68.8 Cg_endo -84.42 121.9 2.71 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.522 2.148 . . . . 0.0 111.949 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -119.09 2.82 11.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.96 177.35 10.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.452 176.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.25 96.34 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.525 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.4 m -53.21 -47.65 68.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 2.8 mp0 -68.54 -37.98 80.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.19 -44.71 94.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.53 -45.72 74.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.35 76.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.844 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.437 HD21 ' HA ' ' A' ' 96' ' ' LEU . 23.1 mt -60.41 -52.95 63.04 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.274 -0.17 . . . . 0.0 111.076 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.4 t80 -60.5 -36.39 78.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.925 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.99 -37.53 58.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.295 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -73.98 -42.5 60.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 110' ' ' ILE . 4.2 pp -64.9 -24.23 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 0.0 110.644 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 31.9 ttm-85 -65.74 -26.22 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.373 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.16 11.4 17.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.264 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.1 p -137.83 -52.38 0.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.83 -30.73 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.723 0.773 . . . . 0.0 109.905 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 112.85 126.37 4.55 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.52 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 4.8 t30 -59.99 -20.77 59.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.936 0.398 . . . . 0.0 111.146 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.53 17.14 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.299 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.26 161.95 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.653 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.567 ' HG3' ' HB2' ' A' ' 172' ' ' LEU . 10.2 pt-20 -116.24 127.66 54.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.604 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.644 HG21 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -122.12 149.53 25.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 154' ' ' VAL . 76.1 m95 -70.05 154.71 41.6 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -88.47 -0.65 57.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 71.09 12.71 72.14 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.852 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mp -94.78 149.22 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.745 0.307 . . . . 0.0 110.61 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -96.94 111.49 23.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.573 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 16.8 t70 -76.93 98.33 4.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 110.876 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 48.6 ttp -126.37 -27.23 3.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.546 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.9 150.3 39.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.247 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.47 6.88 47.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.962 0.887 . . . . 0.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.26 169.26 10.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.802 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.36 -4.63 60.91 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.333 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m -77.24 67.57 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.393 0.616 . . . . 0.0 110.666 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -78.57 134.37 37.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.32 134.54 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.758 ' HB2' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -87.17 159.82 18.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.601 0.238 . . . . 0.0 110.527 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 6.9 ptp -66.87 -28.61 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.719 HG23 HG22 ' A' ' 83' ' ' THR . 9.2 p -76.45 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.569 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.65 6.08 19.88 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.115 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.7 132.5 47.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -94.74 113.63 25.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -71.71 138.61 21.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 111.824 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.66 -18.2 13.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.842 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -80.9 122.13 26.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.295 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -139.19 122.72 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.085 -174.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.21 113.25 13.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 1.036 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 61.4 m95 -126.03 122.99 37.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.655 ' HG2' HD22 ' A' ' 160' ' ' ASN . 19.4 tp10 -76.08 -20.63 57.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.448 0.642 . . . . 0.0 109.337 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.5 t -115.24 27.89 9.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.597 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 1.036 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 41.2 tt0 -62.64 113.95 3.29 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.366 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 pt -73.63 131.28 35.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -91.92 -23.81 19.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.516 0.674 . . . . 0.0 109.708 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.86 147.95 50.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.218 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.49 ' OE1' ' HA2' ' A' ' 147' ' ' GLY . 30.2 tt0 -76.34 110.01 10.11 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 12.4 Cg_exo -69.61 -65.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.219 2.613 . . . . 0.0 114.156 -167.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 9.0 t0 -84.97 45.28 1.15 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 0.0 111.436 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 51.05 36.75 35.44 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.991 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 143' ' ' GLN . . . 122.67 -34.84 3.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.221 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 8.0 ttpt -82.58 136.85 34.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 0.0 110.165 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.1 p -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.362 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -64.7 143.3 58.02 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.573 ' HB2' ' OD1' ' A' ' 116' ' ' ASP . 27.4 p-10 -122.65 175.8 6.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -171.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.2 m 69.12 106.93 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.258 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.18 136.97 37.93 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.606 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 166' ' ' LYS . 58.5 t -135.48 143.91 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.968 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.4 tp -98.35 105.04 17.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.83 111.25 23.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 0.0 110.787 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 -28.19 57.08 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.016 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.26 62.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.975 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.44 -60.35 1.97 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.655 HD22 ' HG2' ' A' ' 137' ' ' GLU . 11.6 p30 -173.33 -34.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.447 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 119.35 15.22 5.57 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.604 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.418 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 33.2 mmtp -93.58 173.97 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -82.93 129.54 35.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.315 0.579 . . . . 0.0 110.614 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.08 -173.25 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.744 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -124.66 143.55 50.67 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.857 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 1.5 tmmm? -152.51 138.69 18.32 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 69.8 mtm180 -60.35 135.46 57.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.557 0.694 . . . . 0.0 111.826 -169.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.601 ' O ' ' HB ' ' A' ' 69' ' ' THR . 3.0 m -59.93 -21.29 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.338 -169.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.718 ' HD2' HG22 ' A' ' 69' ' ' THR . 16.6 tpt180 -97.52 6.33 48.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.381 . . . . 0.0 111.246 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.857 ' HB3' ' HE3' ' A' ' 166' ' ' LYS . 14.1 t70 -95.27 135.94 36.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -92.85 120.47 33.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -167.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.725 HD21 ' HZ3' ' A' ' 166' ' ' LYS . 3.7 pp -131.31 165.03 38.29 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.215 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.8 Cg_exo -73.05 178.12 6.92 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.366 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.644 ' HA ' HG21 ' A' ' 110' ' ' ILE . 4.5 p90 -147.08 175.77 10.45 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.607 -0.683 . . . . 0.0 111.982 -175.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 98.5 mt -141.18 124.07 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.015 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.02 145.33 29.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 0.0 112.23 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -114.93 108.57 16.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.575 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -144.3 145.34 31.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 108.61 127.89 5.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.582 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.5 mt -98.12 101.46 12.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.913 0.387 . . . . 0.0 110.167 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.931 178.671 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.679 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -71.52 -4.59 27.61 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 3.1 tt0 -59.17 127.28 31.39 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.7 p -102.72 126.36 49.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.162 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.901 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -156.06 174.37 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 76.2 p -84.18 165.96 17.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.088 0.242 . . . . 0.0 110.611 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -55.62 -49.82 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.94 -41.7 98.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.264 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.55 -45.33 93.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.993 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.901 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -57.06 -42.38 80.46 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.799 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' HD13 ' A' ' 78' ' ' ILE . 80.6 p -63.17 -36.53 83.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.66 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -93.76 -33.93 13.4 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.288 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.7 t70 -56.99 -59.56 4.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.881 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 47.2 t -59.68 -41.04 89.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.2 mp -60.43 -42.78 92.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.157 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.6 t -68.86 -26.8 65.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.889 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 30.1 mmt180 -73.47 -10.98 60.29 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.792 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.42 43.42 2.54 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.04 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -171.15 -165.48 28.52 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.143 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -134.64 148.65 50.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.2 tt -61.46 136.37 58.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 84' ' ' LEU . 33.7 p -64.1 108.33 1.51 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.992 0.425 . . . . 0.0 111.481 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -109.84 111.12 58.93 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.475 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.34 112.0 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.242 1.962 . . . . 0.0 112.14 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.81 -13.46 24.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.186 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.67 158.6 37.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.63 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.22 95.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.08 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -58.6 -40.98 84.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.326 0.25 . . . . 0.0 111.284 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -64.61 -41.79 95.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.046 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -64.94 -43.95 91.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 109.995 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.51 -46.7 84.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.799 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.94 74.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.309 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 15.7 tp -70.11 -40.67 74.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.303 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -65.51 -40.5 93.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.09 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -67.12 -34.98 78.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.202 0.525 . . . . 0.0 110.91 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -70.76 -25.2 62.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.95 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 58.4 mt -56.09 -55.22 35.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 6.4 mmt180 -51.37 -36.89 45.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.575 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.42 15.06 27.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.99 -170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -153.95 -55.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.74 -27.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.549 0.69 . . . . 0.0 111.04 -171.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.43 127.26 5.68 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -168.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 3.8 t30 -50.61 -41.29 54.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 107' ' ' GLU . 9.4 pt-20 -94.77 36.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.206 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.58 160.68 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.666 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 22.8 mm-40 -110.31 124.89 52.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.488 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -134.21 154.45 37.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.499 ' HB2' HD11 ' A' ' 84' ' ' LEU . 77.6 m95 -70.9 145.88 49.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -91.36 2.25 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 111.795 -171.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 85.01 9.84 79.79 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.842 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 131' ' ' ILE . 4.1 mm? . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.958 0.379 . . . . 0.0 109.991 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -66.89 149.26 50.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.793 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.55 130.37 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 131' ' ' ILE . 14.2 m-20 -74.49 172.95 11.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.778 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 22.7 mmt -64.8 -24.46 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.059 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 p -82.54 -6.38 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.558 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.42 58.42 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.478 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.93 167.11 10.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.471 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -110.97 123.63 50.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.53 152.75 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 175.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -106.31 -6.1 18.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.263 0.554 . . . . 0.0 110.393 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.32 124.65 44.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.149 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 11.8 mmmm -122.32 108.67 13.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -152.24 111.69 3.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' HE1' ' HE2' ' A' ' 134' ' ' LYS . 7.7 m95 -136.66 151.11 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.632 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 8.7 tp10 -93.26 -30.68 15.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.0 p . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.604 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.8 107.37 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.483 -173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 166' ' ' LYS . 39.5 t -126.81 154.4 36.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.644 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.1 tt -111.83 122.59 48.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.0 t -109.21 98.56 7.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.151 0.501 . . . . 0.0 109.969 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -72.63 -23.85 77.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.426 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -72.47 -24.11 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 110.614 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.3 -53.23 7.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.65 -41.56 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.101 0.477 . . . . 0.0 110.415 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.68 -2.19 4.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.815 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 57.6 mttt -88.7 163.89 15.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -78.02 146.13 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.851 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.2 m-85 -135.74 -169.1 2.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.153 -172.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 6.6 p-10 -137.15 152.5 50.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.859 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.592 ' HB2' HG21 ' A' ' 154' ' ' VAL . 34.3 mttp -152.78 -167.16 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.79 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.521 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 48.2 mtm180 -86.53 131.84 34.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 68.7 m -69.06 -11.6 60.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -97.52 5.91 48.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 110.823 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.521 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 34.0 m-20 -80.76 134.89 35.89 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -92.56 90.62 7.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.22 0.533 . . . . 0.0 110.508 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -116.83 163.38 22.88 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.913 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 25.0 Cg_exo -64.04 179.92 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.122 2.548 . . . . 0.0 113.106 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.442 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -157.75 163.17 38.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.566 178.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.679 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 79.8 mt -127.29 137.74 56.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 67.6 m -121.45 146.56 46.79 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 85' ' ' SER . 16.7 mm-40 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.66 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 52.5 m-85 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.12 3.09 11.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.157 0.503 . . . . 0.0 111.168 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -75.29 137.04 40.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.631 177.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -97.21 129.41 44.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -161.63 172.45 16.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.755 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.724 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 18.3 p -82.31 167.61 18.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.37 -27.3 67.29 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -62.99 -57.29 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.568 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 5.9 mp0 -63.69 -36.32 83.47 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.37 87.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.436 . . . . 0.0 110.717 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' HD13 ' A' ' 78' ' ' ILE . 22.7 t -72.58 -56.06 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.226 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.55 -45.18 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.498 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -64.97 -52.42 56.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.127 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 12.8 t -66.82 -34.11 77.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.909 0.385 . . . . 0.0 111.209 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -68.11 -34.0 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.184 0.516 . . . . 0.0 110.331 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -28.26 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.281 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 10.7 ptp180 -80.26 0.63 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 110.612 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.99 52.16 8.26 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.032 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.51 -166.93 13.26 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -153.54 139.35 18.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.884 0.342 . . . . 0.0 110.233 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.6 mp -61.08 137.63 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -62.75 108.03 1.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.194 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 7.5 m -106.52 109.24 62.99 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.8 Cg_exo -75.51 117.28 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.749 2.299 . . . . 0.0 112.258 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.79 -5.01 20.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.134 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 173.15 12.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.438 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.82 -39.17 97.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.654 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -56.34 -48.4 76.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.582 0.229 . . . . 0.0 111.51 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.3 -51.59 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.411 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.48 -43.22 73.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.376 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.81 70.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -64.48 -48.79 73.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.24 -43.31 87.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.848 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 101' ' ' ARG . 9.9 tp10 -63.44 -43.42 97.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.344 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -63.4 -34.96 78.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.921 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 77.3 mt -54.35 -45.54 72.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 98' ' ' GLU . 52.2 mtp180 -58.5 -30.93 67.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.618 -173.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -109.43 10.4 25.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.923 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.0 m -138.78 -57.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 110' ' ' ILE . 25.1 t -103.43 -37.83 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.691 0.757 . . . . 0.0 110.55 -171.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.02 126.43 2.57 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -53.21 -37.13 61.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.698 0.285 . . . . 0.0 110.752 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -104.39 34.7 2.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.443 0.639 . . . . 0.0 111.404 -176.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.51 161.72 13.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.278 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 54.8 mt-10 -121.12 126.24 49.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 174' ' ' TYR . 2.6 mp -124.27 146.73 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 83.1 m95 -71.3 137.22 48.34 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -87.2 3.92 44.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.906 0.384 . . . . 0.0 111.393 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 83.81 9.39 82.9 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.514 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 131' ' ' ILE . 9.5 mp . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 130' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.276 0.56 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -68.61 157.36 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.399 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.35 126.7 55.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.843 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.48 163.94 27.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.951 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 9.0 mmt -64.94 -26.65 68.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.071 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -83.89 -4.9 59.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.683 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.66 56.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.846 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.4 168.12 9.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.424 ' HD3' HG22 ' A' ' 122' ' ' THR . 3.4 tmm_? -110.97 125.41 53.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HD21 ' A' ' 114' ' ' LEU . 23.1 pt -53.88 125.71 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.484 0.659 . . . . 0.0 112.343 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.95 -13.13 29.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.06 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -103.42 127.2 50.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.853 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -131.02 119.35 21.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -149.71 110.02 4.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -127.34 143.98 51.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.757 ' HG2' HD21 ' A' ' 160' ' ' ASN . 10.7 tp10 -91.13 -30.1 16.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 10.2 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.213 173.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 27.5 m . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.14 0.495 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -112.94 146.27 39.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.046 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.63 160.64 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.333 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 57.1 tp -100.34 103.07 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 23.3 t -97.17 104.8 16.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.132 0.491 . . . . 0.0 110.554 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.91 -22.15 77.33 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.721 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -73.81 -16.97 61.13 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.337 0.589 . . . . 0.0 110.594 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.141 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.757 HD21 ' HG2' ' A' ' 137' ' ' GLU . 16.7 p30 -174.51 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.692 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 126.18 15.22 2.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 32.8 mmtp -100.48 175.63 5.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -77.4 131.07 37.84 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.531 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 50.6 m-85 -127.34 176.73 7.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.838 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -113.8 137.4 51.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.537 . . . . 0.0 111.001 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 9.1 mmmm -150.61 137.01 18.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.487 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -57.68 136.65 56.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.446 0.467 . . . . 0.0 110.978 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.724 ' O ' ' HB ' ' A' ' 69' ' ' THR . 5.3 m -60.21 -14.65 18.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -96.65 13.94 26.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.532 0.206 . . . . 0.0 111.548 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.6 146.27 23.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.12 88.47 6.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 110.979 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 pp -128.09 158.08 72.06 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.62 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.6 Cg_exo -62.58 -178.5 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.367 2.711 . . . . 0.0 113.786 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 1.3 p90 -152.25 165.91 33.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 79.9 mt -139.4 130.65 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.925 0.393 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 72.0 m -108.92 143.64 37.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.019 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.494 0.664 . . . . 0.0 110.212 -179.766 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 174' ' ' TYR . 1.1 p90 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -2.87 20.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 110.766 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.716 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 34.1 tt0 -56.61 122.51 12.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.875 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -89.94 121.13 31.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.339 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.875 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.53 -175.86 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.318 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 31.7 p -78.42 166.42 22.65 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.319 0.387 . . . . 0.0 110.425 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.35 -35.39 77.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -63.58 -51.14 66.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.928 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 4.7 mm-40 -66.7 -37.98 85.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.104 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.875 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -59.74 -40.85 89.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.131 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -66.79 -56.43 10.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.292 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.39 -48.22 81.34 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 12.2 t70 -59.91 -58.95 6.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.898 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.1 t -61.3 -38.85 88.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.171 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.85 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.597 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.9 m -74.23 -9.15 58.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.999 0.428 . . . . 0.0 110.659 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -88.43 -10.09 50.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.82 56.26 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.45 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.0 179.77 17.16 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.115 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.605 0.24 . . . . 0.0 110.751 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 113' ' ' GLY . 15.8 tp -68.68 139.61 55.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 p -62.11 109.77 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 111.487 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 5.2 t -118.87 130.32 24.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 23.6 Cg_endo -93.63 144.24 2.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.364 2.709 . . . . 0.0 113.139 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -108.19 -25.65 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.896 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.695 ' HA ' ' CB ' ' A' ' 133' ' ' TYR . 11.6 t -158.9 -169.99 2.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.128 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.25 -24.93 56.52 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 112.981 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.469 ' H ' HG23 ' A' ' 89' ' ' THR . 17.3 t -56.51 -52.59 64.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.664 0.269 . . . . 0.0 110.62 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -75.99 -37.97 57.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.292 . . . . 0.0 110.332 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.441 ' C ' HD22 ' A' ' 93' ' ' ASN . 0.2 OUTLIER -56.49 -45.21 81.11 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.177 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.51 -46.89 52.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.793 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.25 94.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.098 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.12 -45.69 87.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.88 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.577 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 45.0 t80 -63.89 -34.62 78.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.623 . . . . 0.0 110.297 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -44.13 76.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.851 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.83 -34.08 64.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.394 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 3.8 pp -71.34 -32.89 69.08 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.402 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.83 -30.85 71.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.56 22.31 13.78 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.078 -0.388 . . . . 0.0 111.642 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -151.69 -64.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.008 -0.432 . . . . 0.0 111.513 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.7 t -76.25 -32.45 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.176 0.513 . . . . 0.0 109.631 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.14 -74.76 0.29 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.224 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.433 ' HB3' ' OE1' ' A' ' 107' ' ' GLU . 50.7 t-20 172.98 -62.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 106' ' ' ASN . 2.0 mp0 -86.3 37.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.13 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -98.1 149.05 22.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.04 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 35.4 mt-10 -108.58 127.33 53.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.747 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.587 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.6 mp -122.03 140.34 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 91.9 m95 -69.69 140.81 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.634 HD12 ' HB1' ' A' ' 153' ' ' ALA . 33.5 mt -80.54 0.29 34.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 86.68 -21.77 17.02 Favored Glycine 0 C--N 1.32 -0.342 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.857 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.92 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 121.228 0.537 . . . . 0.0 110.89 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.153 0.501 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.469 ' CE3' HD23 ' A' ' 114' ' ' LEU . 74.9 m95 -85.03 120.13 26.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.631 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.98 129.53 66.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.92 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 5.1 p30 -86.21 -171.47 3.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.443 0.639 . . . . 0.0 112.45 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.85 -11.18 59.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.172 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.0 p -93.96 -20.63 19.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.321 0.582 . . . . 0.0 109.95 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.29 24.84 9.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.642 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.8 154.17 18.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 110.551 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -109.26 122.0 46.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.812 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.0 pt -66.11 134.04 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.337 0.589 . . . . 0.0 111.589 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -113.64 17.29 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.61 0.719 . . . . 0.0 109.875 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 60.0 t80 -136.71 117.36 13.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.861 -177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.92 107.54 12.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 0.0 111.009 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.61 ' OD1' ' HG3' ' A' ' 162' ' ' LYS . 29.4 t-20 -133.31 110.22 9.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -123.26 147.04 47.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.993 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.7 tm-20 -89.87 -42.38 11.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 164' ' ' PHE . 9.0 t . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.262 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 92.7 m . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.652 0.739 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -84.22 143.55 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.464 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 11.5 t -125.15 146.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.821 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.495 ' HB2' HD21 ' A' ' 112' ' ' LEU . 69.0 tp -98.8 100.81 12.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.4 m -93.44 98.51 11.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.383 0.611 . . . . 0.0 110.405 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.13 -13.04 76.3 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.439 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . . . -67.78 -18.22 64.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.826 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.75 -63.99 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.062 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -177.72 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.499 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.23 3.59 14.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.256 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.61 ' HG3' ' OD1' ' A' ' 135' ' ' ASN . 0.7 OUTLIER -81.26 154.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -75.35 137.71 41.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.137 0.494 . . . . 0.0 111.301 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.578 ' HA ' HG22 ' A' ' 138' ' ' THR . 21.9 m-85 -121.68 -179.24 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.608 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -135.41 138.74 43.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.145 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.8 162.89 40.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 168.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.4 ' HA ' ' HD2' ' A' ' 167' ' ' ARG . 8.1 tpt180 -62.7 144.7 56.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.819 0.342 . . . . 0.0 110.758 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.579 ' O ' ' HB ' ' A' ' 69' ' ' THR . 12.3 m -59.99 -11.74 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -100.74 8.97 42.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 172' ' ' LEU . 29.4 t70 -74.76 139.04 43.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.706 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 66.9 mm-40 -92.6 83.05 4.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.817 -174.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.545 HD23 ' OD2' ' A' ' 170' ' ' ASP . 3.7 pp -125.13 161.69 48.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 172' ' ' LEU . 24.3 Cg_exo -63.11 -177.92 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.594 2.863 . . . . 0.0 113.713 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.716 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 7.4 p90 -155.04 178.03 10.66 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.036 -0.415 . . . . 0.0 110.352 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 96.6 mt -145.23 135.27 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 93.9 m -108.52 147.08 32.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.577 0.703 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.607 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 13.5 t -74.99 -0.29 18.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.202 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 13.5 mp0 -64.6 124.93 23.14 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.426 0.631 . . . . 0.0 111.416 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -91.01 122.29 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.291 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.742 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.81 -175.4 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.106 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -81.74 166.89 19.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -62.45 -31.31 72.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.05 -52.37 43.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.93 -38.6 89.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.922 0.392 . . . . 0.0 110.366 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -60.61 -30.41 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.087 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 30.6 m -74.48 -63.6 1.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.305 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.5 -42.61 99.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.332 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.73 -25.03 61.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -174.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 34.9 t -87.16 -43.12 12.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.61 -43.58 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.274 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -71.4 -13.66 61.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.901 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -92.22 11.01 27.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.45 35.21 81.21 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.222 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.74 175.87 21.52 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -142.41 138.87 31.42 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.128 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -58.86 127.3 31.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.42 ' OG ' HD21 ' A' ' 96' ' ' LEU . 23.0 t -55.04 122.49 11.05 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.393 0.433 . . . . 0.0 110.953 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.585 ' HB ' ' OD1' ' A' ' 125' ' ' ASP . 52.3 p -108.94 108.9 60.97 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.213 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 93' ' ' ASN . 70.8 Cg_endo -84.87 110.75 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.378 2.052 . . . . 0.0 112.529 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -101.96 -16.19 16.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.732 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.3 p -129.89 167.99 17.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.226 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.59 91.61 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.271 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.9 m -64.34 -28.75 69.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.11 -34.14 43.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -71.25 -55.85 7.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.002 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -68.02 -17.42 64.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.9 78.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.447 . . . . 0.0 110.309 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.42 HD21 ' OG ' ' A' ' 85' ' ' SER . 64.8 mt -66.98 -38.92 86.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.204 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.556 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 89.9 t80 -59.17 -35.87 74.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.32 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -71.11 -46.89 60.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.91 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -67.18 -43.76 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.488 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HD11 ' A' ' 175' ' ' ILE . 2.9 pp -63.0 -31.0 72.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.579 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 32.5 ttp-105 -65.32 -36.33 83.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.031 177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.58 13.56 25.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 m -149.42 -46.66 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 110' ' ' ILE . 3.5 p -106.65 -23.92 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.28 0.562 . . . . 0.0 110.539 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.45 126.26 4.05 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 8.7 t30 -59.37 -34.03 71.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.424 0.612 . . . . 0.0 111.042 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -88.8 24.06 2.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.385 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -98.11 161.48 13.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.985 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.3 mt-10 -118.38 126.51 52.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.683 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.801 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -120.2 152.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.548 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 76.3 m95 -70.62 146.53 49.98 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.65 HD12 ' HB1' ' A' ' 153' ' ' ALA . 40.2 mt -80.88 -2.5 47.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 74.66 6.3 76.75 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.882 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.326 -0.432 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.398 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 130' ' ' ARG . 1.5 p . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.4 157.38 34.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.755 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.6 125.18 54.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.056 0.455 . . . . 0.0 110.651 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.585 ' OD1' ' HB ' ' A' ' 86' ' ' THR . 12.8 m-20 -72.32 162.2 29.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.237 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 18.5 mmt -55.52 -30.73 61.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.884 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -85.23 0.16 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.067 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.33 44.58 9.48 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.583 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.55 165.12 20.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.734 0.302 . . . . 0.0 110.954 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 6.8 mtp85 -112.49 120.07 40.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.106 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.652 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -70.68 141.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 111.578 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.2 -21.22 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.832 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -88.4 115.97 26.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -137.96 107.39 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.686 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -137.8 112.92 9.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -119.38 114.49 22.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.809 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 28.7 tt0 -70.97 -37.0 72.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.823 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 164' ' ' PHE . 6.8 t . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 166' ' ' LYS . 5.4 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -111.82 106.86 15.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.48 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 166' ' ' LYS . 45.9 t -131.96 140.3 48.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.127 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.55 HD23 HD21 ' A' ' 112' ' ' LEU . 1.5 tm? -106.4 100.91 10.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.1 m -98.43 112.03 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.327 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.64 -23.03 68.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.968 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.39 -28.82 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 111.26 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.95 -62.67 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -169.68 -25.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.017 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.87 20.23 7.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.67 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 162' ' ' LYS . 10.4 mmpt? -93.12 -179.18 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' CH2' HG13 ' A' ' 131' ' ' ILE . 40.3 m0 -82.25 123.91 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.433 . . . . 0.0 111.215 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 87.3 m-85 -126.05 -179.29 4.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -130.1 154.57 47.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.525 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.4 tttp -153.69 -152.68 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -100.21 121.9 42.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.548 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 14.2 m -65.33 -2.48 3.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -112.19 -0.47 15.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.788 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.15 149.68 21.35 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.19 107.7 19.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.9 pp -129.41 167.46 19.94 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.426 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 19.3 Cg_exo -67.01 -177.68 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.133 2.555 . . . . 0.0 113.445 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.801 ' HA ' HG23 ' A' ' 110' ' ' ILE . 34.9 p90 -143.87 179.67 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.304 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 100' ' ' LEU . 76.3 mt -143.1 116.96 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.1 m -112.57 133.73 54.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.146 0.498 . . . . 0.0 112.17 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.177 175.359 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 56.1 m-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.001 0.429 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -68.34 -13.89 62.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.852 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 15.7 mm100 -60.25 132.65 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 111.029 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.553 ' HB ' ' HG2' ' A' ' 171' ' ' GLN . 41.3 p -101.48 143.22 31.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.668 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.73 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.01 -179.2 5.06 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.229 0.331 . . . . 0.0 110.114 178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 71.8 p -84.93 166.47 16.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.49 0.186 . . . . 0.0 110.524 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.18 -49.69 76.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -70.79 -26.44 63.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 109.636 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 68' ' ' LYS . 36.2 tt0 -76.67 -32.49 57.96 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.704 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -66.38 -43.17 86.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.5 p -63.6 -54.21 39.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.651 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.62 -39.56 84.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -64.7 -59.22 4.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.375 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.657 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 22.6 t -61.08 -36.52 79.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 0.0 110.483 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 74' ' ' SER . 1.5 mp -65.82 -34.62 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 -29.13 44.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.657 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 16.3 ptm180 -88.29 1.26 54.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.688 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.68 66.26 1.51 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.493 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.17 167.23 38.77 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.667 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -114.16 133.0 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 85' ' ' SER . 5.5 tt -60.46 134.13 56.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.482 ' N ' HD23 ' A' ' 84' ' ' LEU . 39.6 m -54.09 109.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.805 0.691 . . . . 0.0 112.156 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t -108.23 118.65 51.93 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.52 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.1 Cg_exo -75.75 110.91 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.57 2.18 . . . . 0.0 111.149 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 2.9 pt20 -117.38 -10.19 10.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.619 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.1 p -136.83 164.87 27.27 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.528 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.06 95.3 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.628 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -61.34 -45.13 95.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.876 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.94 -46.51 88.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.517 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -67.75 -37.58 82.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.58 -52.72 64.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.139 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.06 83.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.389 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -61.46 -51.69 67.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.006 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -62.49 -39.69 94.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -64.16 -41.49 97.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -64.07 -35.8 81.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.71 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.9 mt -54.75 -48.99 71.91 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.204 0.526 . . . . 0.0 109.845 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -59.02 -27.81 65.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.375 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -111.36 17.29 20.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.892 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -153.63 -54.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -100.85 -36.65 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.15 -171.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.5 130.25 3.23 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.106 -171.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -35.9 45.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.85 27.83 2.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.848 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.32 161.61 15.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 111.318 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.571 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 4.6 pt-20 -122.87 121.64 36.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.643 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.709 HG23 ' HA ' ' A' ' 174' ' ' TYR . 34.3 mm -120.01 153.36 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.404 ' CE3' HG12 ' A' ' 154' ' ' VAL . 83.2 m95 -70.65 149.26 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.85 HD12 ' HB1' ' A' ' 153' ' ' ALA . 73.7 mt -89.08 -1.78 58.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.41 9.97 69.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.76 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.461 HD21 HD13 ' A' ' 131' ' ' ILE . 8.3 mp . . . . . 0 C--N 1.326 -0.427 0 C-N-CA 122.747 0.419 . . . . 0.0 110.286 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -68.11 152.36 45.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.453 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.08 158.19 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.19 175.87 6.44 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.39 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.37 -20.56 65.58 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.5 p -87.25 -7.63 57.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.162 0.437 . . . . 0.0 111.117 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.55 21.16 29.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.837 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.08 164.54 11.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 0.0 110.424 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -108.02 133.63 52.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 HD21 ' A' ' 114' ' ' LEU . 42.8 pt -75.96 125.92 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.279 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.34 -22.81 28.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.608 . . . . 0.0 109.727 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -92.3 120.83 33.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.534 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 136' ' ' TRP . 55.1 tttt -144.01 119.1 10.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -156.66 113.17 3.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.55 ' CD1' ' HG3' ' A' ' 134' ' ' LYS . 42.5 m95 -124.31 140.94 52.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.44 -170.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 17.7 mm-40 -89.75 -11.86 41.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.251 174.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 8.3 t . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.85 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.6 133.24 39.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.567 -171.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CE3' ' A' ' 111' ' ' TRP . 27.3 m -128.26 164.2 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.629 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 112' ' ' LEU . 55.8 tp -111.75 107.33 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.48 103.77 14.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.976 0.417 . . . . 0.0 110.601 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.7 -32.18 74.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.243 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.54 -22.89 65.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.026 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -54.15 8.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.478 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 162' ' ' LYS . 9.6 p30 175.61 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.029 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 127.16 -11.88 6.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.534 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.515 ' HG2' ' OD1' ' A' ' 160' ' ' ASN . 31.5 mmtp -83.72 176.67 8.79 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.433 0.616 . . . . 0.0 109.981 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.472 ' HB3' HD11 ' A' ' 112' ' ' LEU . 43.1 m0 -85.86 136.85 33.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 23.6 m-85 -127.55 -168.01 1.83 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.465 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -133.86 140.88 47.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HE2' HD23 ' A' ' 172' ' ' LEU . 9.2 ttpt -145.88 146.8 31.24 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 165.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.53 140.34 46.28 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.806 0.812 . . . . 0.0 112.538 -163.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.9 m -56.78 -25.33 55.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.59 -161.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -99.08 15.99 24.1 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.16 -176.24 6.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.553 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 31.7 tt0 -132.33 97.65 4.17 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.544 -171.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.1 pp -130.2 168.01 18.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.681 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.597 ' O ' HD12 ' A' ' 172' ' ' LEU . 17.1 Cg_exo -67.26 -178.98 1.61 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.188 2.592 . . . . 0.0 113.321 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.709 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -159.05 158.72 33.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.241 -0.287 . . . . 0.0 110.368 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.432 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 58.2 mt -126.49 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.61 126.17 49.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.264 0.554 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.197 178.488 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.767 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 70.4 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.044 0.45 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -72.9 -4.07 29.68 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.442 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 1.2 tm0? -58.1 122.15 12.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.204 0.525 . . . . 0.0 110.083 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -96.56 113.41 24.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.46 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.673 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -148.39 177.03 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -77.51 165.7 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.474 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 85.5 t80 -59.17 -38.53 79.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -59.73 -53.14 61.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.779 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -63.15 -37.8 88.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.516 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.673 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -56.95 -43.29 81.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.43 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.575 ' O ' HD13 ' A' ' 78' ' ' ILE . 19.4 m -66.93 -59.69 3.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.311 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -53.21 -44.38 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.761 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.683 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 6.3 t70 -70.36 -41.95 72.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.727 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -62.45 -31.87 72.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.362 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -58.92 -36.47 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.387 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 -14.32 28.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 21.4 mmt180 -87.61 -24.68 23.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.886 0.374 . . . . 0.0 110.968 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.68 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.29 -37.57 0.98 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.889 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -146.83 158.34 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.147 0.473 . . . . 0.0 111.942 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 85' ' ' SER . 5.7 tt -90.8 150.75 21.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 20.9 m -60.94 109.05 0.96 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.915 0.388 . . . . 0.0 111.179 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 112' ' ' LEU . 18.0 p -113.14 106.02 55.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.484 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.31 135.23 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.232 1.955 . . . . 0.0 111.858 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 14.1 mm100 -107.69 -26.02 11.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 110.073 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.1 m -136.15 165.84 24.78 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.903 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.19 -28.13 53.68 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.337 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 p -61.2 -50.05 74.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.635 0.255 . . . . 0.0 111.07 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.76 -39.13 73.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.034 0.445 . . . . 0.0 109.986 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -59.42 -48.37 81.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.328 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.93 -34.88 69.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.691 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.19 -31.04 72.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -45.61 93.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.769 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.702 ' CE2' ' HA2' ' A' ' 161' ' ' GLY . 78.5 m-85 -59.92 -40.78 90.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.287 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 5.3 mm-40 -59.97 -44.68 94.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.294 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -75.81 -39.62 56.51 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.642 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HA ' HG23 ' A' ' 104' ' ' VAL . 1.9 pp -67.99 -37.14 81.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.265 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 25.9 mtm180 -69.73 -8.63 49.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 46.7 mt-30 -119.2 17.25 13.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.598 0.237 . . . . 0.0 111.027 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -152.07 -62.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.166 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.4 t -76.76 -35.57 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 146.17 -76.92 0.27 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.146 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 50.6 t30 173.8 -57.46 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.81 39.65 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.863 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.45 139.81 36.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 111.749 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HB3' HG21 ' A' ' 154' ' ' VAL . 2.9 mp0 -99.55 124.38 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.271 171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 174' ' ' TYR . 5.2 mp -126.24 143.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.044 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -70.61 150.77 45.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.7 mt -97.25 6.4 48.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 112.01 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.92 16.39 52.04 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.733 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 123' ' ' TRP . 5.0 mp . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 122.731 0.412 . . . . 0.0 111.0 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.53 0.681 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.424 ' HB2' HD23 ' A' ' 114' ' ' LEU . 26.6 m95 -68.6 147.55 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.282 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.87 134.59 48.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.209 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 172.1 13.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.973 0.416 . . . . 0.0 110.532 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.3 ptp -55.8 -32.62 63.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.8 p -84.25 -23.13 30.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.542 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.96 4.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.981 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.34 154.7 21.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.043 0.449 . . . . 0.0 110.827 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -109.01 146.45 33.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.832 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.685 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -87.46 163.32 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.514 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.88 13.78 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.377 0.608 . . . . 0.0 110.018 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 25.5 t80 -139.39 124.34 18.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.861 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 51.5 pttt -143.32 115.71 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -120.32 113.17 19.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.477 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 55.2 m95 -112.93 128.29 56.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -88.05 -47.63 8.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.822 -177.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.334 0.588 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.96 145.33 38.18 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.19 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 166' ' ' LYS . 13.2 p -125.94 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.322 0.582 . . . . 0.0 110.618 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 7.9 tt -91.73 123.62 35.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.2 t -108.96 121.04 44.29 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.67 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . -74.23 -53.75 6.68 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.218 -170.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.08 -1.05 52.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.734 0.302 . . . . 0.0 111.698 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.21 -35.23 66.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.743 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -177.78 -27.67 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.702 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . 92.28 29.89 10.71 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.481 -171.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 72.6 mmtt -126.49 175.9 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -85.66 138.1 32.38 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.53 171.76 10.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.751 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.9 150.1 39.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.004 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HB2' HG11 ' A' ' 154' ' ' VAL . 34.7 tttt -153.51 -174.81 5.09 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -74.07 126.9 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 42.9 t -60.33 -22.99 63.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -99.77 17.65 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.621 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.26 137.51 36.64 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.04 99.52 12.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.284 0.564 . . . . 0.0 111.106 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 2.5 pp -128.88 164.23 40.13 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.605 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 36.8 Cg_endo -64.49 178.2 1.79 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.661 2.241 . . . . 0.0 113.191 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.933 ' HA ' HG23 ' A' ' 110' ' ' ILE . 12.1 p90 -152.69 174.2 14.29 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.554 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mp -131.51 126.89 58.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.599 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 2.4 t -102.21 149.46 24.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.794 0.331 . . . . 0.0 110.873 -172.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.783 -179.104 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.51 HG23 HG13 ' A' ' 104' ' ' VAL . 1.5 m -71.53 -10.39 59.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.887 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 8.1 mm-40 -64.18 141.82 58.63 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.201 0.524 . . . . 0.0 110.258 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -95.61 147.79 23.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.177 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.56 172.29 8.25 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.078 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 80.8 p -82.43 166.52 19.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 67.3 t80 -60.89 -36.4 79.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.626 0.251 . . . . 0.0 111.52 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -59.52 -50.36 74.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.21 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -64.83 -40.74 95.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.222 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.48 -39.85 73.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.3 m -64.53 -61.9 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.573 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.86 -37.29 86.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.895 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 13.3 t70 -66.84 -47.14 72.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 42.0 t -66.02 -30.35 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.378 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -59.06 -32.09 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.153 0.501 . . . . 0.0 110.179 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -83.21 -32.37 26.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.888 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.589 ' HB2' ' SG ' ' A' ' 176' ' ' CYS . 29.0 mmt180 -77.99 -26.03 48.4 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.679 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.49 -57.33 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.017 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 140.42 -23.79 2.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 p -141.23 136.45 31.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 85' ' ' SER . 5.1 tt -77.21 151.83 35.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.607 ' N ' HD23 ' A' ' 84' ' ' LEU . 7.5 t -67.23 108.88 2.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.102 0.477 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 125' ' ' ASP . 55.7 m -113.58 114.75 47.25 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 163' ' ' TRP . 11.5 Cg_exo -71.82 112.04 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.79 2.326 . . . . 0.0 111.794 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.87 -13.18 16.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.89 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.21 154.91 50.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.527 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.82 -53.09 44.29 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.337 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -56.77 -38.23 72.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.829 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.29 -42.48 93.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.131 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -70.02 -43.09 72.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.98 -39.16 93.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.396 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.84 88.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 20.9 tp -67.11 -45.64 76.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.979 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.53 -40.23 93.9 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.501 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.49 -46.08 90.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.01 -31.61 72.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.026 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.7 mt -56.89 -44.16 82.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.699 0.285 . . . . 0.0 110.658 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 36.0 mtm180 -71.9 -10.07 59.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.995 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -122.19 18.17 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.5 t -154.87 -58.92 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 110' ' ' ILE . 12.2 t -96.36 -36.61 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.449 0.642 . . . . 0.0 110.086 -170.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.6 128.67 3.19 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 54.2 t30 -55.29 -33.88 63.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.013 0.435 . . . . 0.0 110.352 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.688 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 45.9 mt-10 -93.01 26.18 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.132 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.11 160.16 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.7 124.05 40.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.296 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 174' ' ' TYR . 42.5 mm -116.03 146.24 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.164 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.541 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 71.6 m95 -71.33 147.71 47.79 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.574 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.2 mm? -107.22 8.74 30.12 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.259 -0.276 . . . . 0.0 111.668 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.22 43.48 97.15 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.256 0.462 . . . . 0.0 114.256 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 153' ' ' ALA . 1.5 pt? . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.449 ' HB2' HD12 ' A' ' 114' ' ' LEU . 13.3 m0 -51.64 153.72 2.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.144 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.418 HG22 ' HD2' ' A' ' 130' ' ' ARG . 31.6 t -96.56 132.48 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.638 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' HB3' HG21 ' A' ' 86' ' ' THR . 5.1 p30 -83.1 -171.82 3.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.142 0.496 . . . . 0.0 111.3 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.4 mtt -82.16 -14.51 55.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t -98.89 0.39 44.05 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.737 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.29 24.32 16.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.431 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.65 166.42 13.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.961 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' HG22 ' A' ' 124' ' ' VAL . 2.1 mpp_? -100.6 133.22 45.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.479 HD12 ' HZ3' ' A' ' 163' ' ' TRP . 26.5 pt -58.99 124.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 0.0 111.175 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.9 12.59 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.524 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -140.67 127.88 20.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 22.5 mtmt -135.21 118.2 16.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.802 0.334 . . . . 0.0 111.722 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -131.72 111.18 11.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.806 0.812 . . . . 0.0 109.332 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 38.3 m95 -132.29 137.83 47.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 -174.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.731 ' HB2' ' HD3' ' A' ' 162' ' ' LYS . 20.3 tt0 -97.57 -18.78 18.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.843 177.461 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 94.2 m . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.818 ' HB3' HD21 ' A' ' 114' ' ' LEU . . . -75.26 139.93 42.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.959 0.409 . . . . 0.0 111.466 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.634 HG11 ' HG3' ' A' ' 166' ' ' LYS . 28.2 m -129.12 159.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.157 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -106.75 100.18 9.7 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.4 m -87.97 101.19 13.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.693 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.83 96.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.151 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -63.27 -25.05 68.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 111.239 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.31 46.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.311 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 160' ' ' ASN . 0.2 OUTLIER 178.82 -40.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 124.41 2.36 8.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.691 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.731 ' HD3' ' HB2' ' A' ' 137' ' ' GLU . 25.8 mttt -83.62 168.45 16.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.488 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 54.6 m0 -85.17 134.62 34.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.482 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.78 177.06 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.881 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.59 153.5 23.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 0.0 111.623 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.634 ' HG3' HG11 ' A' ' 154' ' ' VAL . 37.8 mmtt -149.87 149.27 30.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.65 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -70.34 129.12 38.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 13.4 m -64.36 -1.1 1.52 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -96.32 2.65 52.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.62 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -77.17 136.37 38.58 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 68' ' ' LYS . 9.6 tt0 -98.49 90.24 4.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.279 0.562 . . . . 0.0 110.888 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.1 pp -125.87 168.83 12.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.576 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.429 ' O ' HD12 ' A' ' 172' ' ' LEU . 12.4 Cg_exo -69.31 174.64 8.82 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.79 2.327 . . . . 0.0 112.369 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.3 p90 -152.39 172.62 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.97 129.7 54.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 80' ' ' ARG . 8.2 t -102.16 136.3 42.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.043 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.984 -176.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 55.7 m-85 . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.458 HG23 HG13 ' A' ' 104' ' ' VAL . 2.0 m -73.31 -6.18 44.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 12.3 mm-40 -63.91 134.1 54.52 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.531 0.681 . . . . 0.0 111.289 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -94.01 133.39 37.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.987 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.45 177.23 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.434 175.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -77.61 165.27 24.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.533 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 89.1 t80 -62.28 -37.65 86.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.211 0.529 . . . . 0.0 110.554 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -62.97 -46.51 87.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.16 -38.77 82.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -57.75 -35.92 71.39 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 78' ' ' ILE . 48.1 m -64.67 -58.67 5.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.383 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -57.66 -43.5 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.347 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 23.0 t70 -64.26 -59.09 4.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.98 -30.28 70.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.714 0.293 . . . . 0.0 111.406 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 74' ' ' SER . 1.2 mp -60.82 -29.82 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -98.76 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 32.4 mmt180 -80.4 -25.78 38.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.757 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.71 -50.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.15 -41.03 1.19 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.519 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -142.37 139.6 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.595 0.198 . . . . 0.0 110.867 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 85' ' ' SER . 6.6 tt -77.33 147.11 36.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.8 m -62.28 108.67 1.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.0 111.048 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 125' ' ' ASP . 15.8 p -107.63 110.53 62.74 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.378 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' A' ' 112' ' ' LEU . 97.5 Cg_endo -80.59 140.94 13.56 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.584 2.189 . . . . 0.0 111.509 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.4 pt20 -129.52 -10.25 4.56 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.305 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.6 p -141.9 177.39 8.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.98 68.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.952 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -61.85 -48.91 78.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.317 0.247 . . . . 0.0 111.271 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -68.84 -37.82 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.539 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.39 -39.74 88.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.15 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 36.0 t70 -68.42 -49.75 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.097 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.95 77.36 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.424 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.59 -42.81 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.6 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.521 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 2.0 t80 -61.17 -36.21 79.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 9.8 mm-40 -70.08 -46.38 65.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.0 -39.7 75.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.216 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 108' ' ' ALA . 4.1 pp -65.55 -34.47 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.677 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.578 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 66.8 mtm180 -71.98 -9.58 58.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.698 0.285 . . . . 0.0 111.437 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -111.23 12.09 21.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.748 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -59.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 111.085 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' ALA . 2.1 t -77.94 -33.3 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.163 0.506 . . . . 0.0 109.896 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 138.09 -73.56 0.42 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.579 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.578 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 39.2 t30 175.29 -54.69 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.842 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 46.0 mt-10 -78.91 36.48 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 100' ' ' LEU . . . -79.61 130.38 35.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.095 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.05 121.54 44.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.828 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.5 mp -126.8 141.42 46.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -70.46 148.96 47.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 153' ' ' ALA . 90.1 mt -98.93 5.95 47.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.728 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.53 9.31 43.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 122.437 0.295 . . . . 0.0 111.07 -176.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.788 HG22 ' HB2' ' A' ' 130' ' ' ARG . 21.1 m . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -52.12 141.64 18.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.954 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.16 138.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.519 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -88.24 178.7 6.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 126' ' ' MET . 6.8 ptp -64.52 -32.64 74.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.9 p -76.56 -22.77 53.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.014 -175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 113.22 20.6 6.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.61 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.85 160.59 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.788 ' HB2' HG22 ' A' ' 122' ' ' THR . 0.0 OUTLIER -109.81 154.19 23.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.839 177.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.09 143.63 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.15 -18.46 20.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.153 0.501 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 20.3 t80 -119.52 120.7 37.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.644 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -144.34 131.4 20.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 111.151 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.99 136.09 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.413 0.625 . . . . 0.0 110.189 171.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -129.99 123.3 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.066 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 164' ' ' PHE . 67.3 mm-40 -74.72 -27.05 60.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.285 0.564 . . . . 0.0 109.873 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.662 HG23 ' HD2' ' A' ' 164' ' ' PHE . 11.5 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.236 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.7 m . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 121.148 0.499 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.618 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -91.91 139.17 30.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.878 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 p -133.41 141.43 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.681 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.616 ' HB2' HD21 ' A' ' 112' ' ' LEU . 2.4 tt -91.22 123.53 34.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -108.4 106.19 16.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.175 0.512 . . . . 0.0 110.633 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.18 1.61 84.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.11 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.842 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -101.27 5.38 42.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.104 0.478 . . . . 0.0 110.556 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.8 -53.17 2.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.778 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -173.38 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.296 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 111.74 -2.57 27.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.886 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 34.9 mmtp -76.31 -179.04 4.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HZ3' HG13 ' A' ' 131' ' ' ILE . 49.9 m0 -94.39 134.02 37.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.241 0.543 . . . . 0.0 109.796 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.662 ' HD2' HG23 ' A' ' 138' ' ' THR . 91.9 m-85 -126.02 165.28 19.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.883 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.54 144.21 44.63 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.698 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 72.6 tttt -144.93 -171.89 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.698 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 1.2 mmt180 -72.54 125.54 27.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 9.4 t -69.54 -19.82 63.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.386 0.612 . . . . 0.0 110.076 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -94.73 12.31 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.233 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 20.0 t70 -80.59 136.1 36.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -93.8 93.44 7.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.229 0.538 . . . . 0.0 110.945 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.56 169.69 9.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.736 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 16.6 Cg_exo -68.77 -179.1 2.27 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.995 2.464 . . . . 0.0 113.049 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.828 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.2 p90 -156.57 171.55 20.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.874 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.15 125.96 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 13.8 t -102.29 133.91 46.42 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.634 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 16.8 p -77.14 -8.54 57.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 13.6 mm-40 -64.96 141.92 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.2 p -99.06 144.49 28.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.769 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.781 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.59 -179.7 3.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.34 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 74.4 p -80.3 164.97 22.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 85.3 t80 -62.34 -35.35 78.84 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -59.37 -52.14 66.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.329 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.6 mt-10 -64.25 -37.14 86.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.781 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -61.52 -43.65 98.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.9 m -65.67 -55.92 14.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.805 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -60.92 -34.27 74.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.883 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 17.1 t70 -69.95 -51.63 31.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.45 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.3 t -63.07 -34.33 77.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -56.85 -31.03 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.498 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 -37.59 20.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.59 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 31.6 mmt180 -71.8 -26.56 62.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 111.072 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.25 -48.95 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.884 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 131.82 -26.37 3.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.972 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 p -135.14 128.09 31.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.924 0.362 . . . . 0.0 111.429 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 85' ' ' SER . 6.1 tt -74.88 146.53 41.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.555 ' N ' HD23 ' A' ' 84' ' ' LEU . 5.0 t -65.68 108.94 2.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.155 0.502 . . . . 0.0 110.448 -172.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.538 HG21 ' HB3' ' A' ' 125' ' ' ASP . 28.3 m -116.27 114.1 40.94 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.344 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 2.1 Cg_endo -79.56 137.97 13.34 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.663 2.242 . . . . 0.0 112.076 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -114.51 -13.55 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.276 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.65 165.08 28.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.981 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.82 -42.97 94.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.755 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.6 p -55.76 -44.53 77.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -42.64 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.85 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -65.38 -45.51 83.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -38.95 91.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.53 84.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.893 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.6 tp -66.07 -43.38 87.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -59.74 -40.78 89.23 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.12 -36.88 77.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.29 -36.8 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 59.7 mt -54.39 -52.08 62.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.0 109.75 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ttm-85 -56.54 -33.35 66.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.006 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -101.4 -1.46 33.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.2 t -140.16 -50.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.797 HG11 HD11 ' A' ' 110' ' ' ILE . 7.3 t -98.02 -30.15 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.605 0.717 . . . . 0.0 110.503 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.37 125.54 3.63 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -49.89 -42.49 48.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 158' ' ' ALA . 45.6 mt-10 -94.21 47.83 1.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 111.263 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.74 145.54 41.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 10.9 mm-40 -98.52 123.82 42.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.862 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.797 HD11 HG11 ' A' ' 104' ' ' VAL . 43.0 mm -121.83 142.85 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.367 -0.133 . . . . 0.0 111.192 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 64.0 m95 -70.61 145.84 50.44 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 82.2 mt -111.03 16.49 21.13 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.3 -27.67 0.83 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.562 HD12 ' HB2' ' A' ' 123' ' ' TRP . 1.6 pt? . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 118.123 0.962 . . . . 0.0 110.913 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.562 ' HB2' HD12 ' A' ' 114' ' ' LEU . 16.9 m0 -62.3 150.03 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.205 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.47 138.19 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.72 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.66 ' OD2' HG22 ' A' ' 127' ' ' THR . 1.1 p-10 -99.89 -162.12 0.92 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.94 -33.57 51.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.375 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.66 HG22 ' OD2' ' A' ' 125' ' ' ASP . 14.4 t -83.03 -21.4 33.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.024 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.84 32.05 6.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.498 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.19 157.54 15.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 130' ' ' ARG . 0.3 OUTLIER -107.97 118.39 36.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.128 177.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.6 pt -64.34 125.41 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.341 0.591 . . . . 0.0 111.011 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.84 -20.75 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.528 0.68 . . . . 0.0 109.904 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -110.65 127.55 55.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.765 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -129.53 114.44 16.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.617 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -129.41 111.21 12.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.381 0.61 . . . . 0.0 109.772 172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -125.99 124.14 40.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . 7.4 tp10 -77.68 -25.83 49.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.588 175.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 71.6 m . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.14 134.82 41.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 28.7 m -120.46 156.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -103.63 101.14 10.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.3 m -84.64 91.57 7.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.486 0.66 . . . . 0.0 110.61 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.77 -22.39 78.72 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.523 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.473 ' HA ' ' HG2' ' A' ' 107' ' ' GLU . . . -69.89 -15.83 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.136 0.493 . . . . 0.0 110.27 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.85 -65.27 0.99 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -167.19 -37.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 131.05 -4.15 5.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.364 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -77.34 174.68 10.52 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.112 0.456 . . . . 0.0 110.107 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -89.78 133.49 34.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.85 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 42.1 m-85 -119.78 166.89 12.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -104.62 144.38 31.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.272 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.412 ' HD2' HG11 ' A' ' 154' ' ' VAL . 52.1 mttt -146.09 150.93 36.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.911 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.12 130.35 39.08 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.504 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 6.0 m -65.14 2.96 0.67 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -95.21 -4.58 45.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.01 132.14 41.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.782 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -93.21 97.92 10.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.2 pp -129.05 166.11 27.48 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.588 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 14.8 Cg_exo -67.08 171.13 11.77 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.721 2.281 . . . . 0.0 112.233 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -137.77 174.33 10.69 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.498 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 93.2 mt -137.8 123.55 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 10.1 t -102.08 130.51 48.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.019 0.438 . . . . 0.0 109.967 -178.084 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.497 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 74.0 m-85 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.057 0.456 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 2.4 m -74.38 0.28 14.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.587 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.55 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -65.98 127.56 32.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -102.29 123.95 47.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.664 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -150.07 174.73 12.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.606 -177.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 82.5 p -80.61 166.57 20.98 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.382 0.427 . . . . 0.0 110.227 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.556 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -60.95 -41.71 96.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.359 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -54.99 -39.96 69.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.239 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.725 ' O ' HG12 ' A' ' 78' ' ' ILE . 37.7 m -64.09 -69.64 0.27 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.55 -44.6 73.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 19.9 t70 -60.52 -58.92 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.917 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -58.57 -42.06 87.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.16 0.287 . . . . 0.0 111.215 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 74' ' ' SER . 42.2 mm -57.51 -41.23 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.324 0.583 . . . . 0.0 110.413 175.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 t -72.64 -24.26 61.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.702 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.1 mmp_? -74.79 -10.33 59.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.386 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.01 37.72 5.63 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.004 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.68 -170.22 27.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.189 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -130.26 146.74 51.9 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.6 tt -63.32 138.03 58.39 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 84' ' ' LEU . 30.3 p -61.83 109.33 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.371 0.419 . . . . 0.0 111.579 -174.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.541 HG22 ' HA3' ' A' ' 113' ' ' GLY . 47.2 p -110.0 107.73 58.93 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.969 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 14.6 Cg_exo -68.5 111.33 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.085 1.857 . . . . 0.0 112.576 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' NE2' ' H ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -85.41 -27.96 25.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.6 p -129.56 173.18 10.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.61 -38.95 95.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.12 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -59.27 -43.41 92.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 87' ' ' PRO . 7.3 mm-40 -59.6 -47.81 84.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.997 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -64.14 -44.9 90.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.56 . . . . 0.0 110.203 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.02 -49.21 77.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.912 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.16 67.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.718 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.3 tp -70.64 -47.01 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -60.76 -35.55 76.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.317 0.579 . . . . 0.0 109.946 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.164 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 68.5 t80 -68.24 -27.57 66.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.513 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 22.9 mt -58.64 -54.85 42.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -58.83 -33.2 70.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.141 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 9.2 pt20 -91.62 0.98 57.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t -146.32 -59.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 -28.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.623 0.725 . . . . 0.0 110.698 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.3 119.0 4.55 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -165.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 66.9 t30 -51.54 -36.52 45.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.136 0.468 . . . . 0.0 111.749 -173.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.69 32.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.906 0.384 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.46 139.88 32.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 8.6 mm-40 -94.31 122.36 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -136.85 155.1 32.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.39 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.512 ' HB2' HD11 ' A' ' 84' ' ' LEU . 86.8 m95 -71.44 144.87 49.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.924 0.392 . . . . 0.0 110.694 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.69 -7.25 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -174.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.541 ' HA3' HG22 ' A' ' 86' ' ' THR . . . 81.11 -1.66 84.09 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.535 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 112' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 117.238 0.519 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -79.83 156.26 27.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.932 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.13 130.18 71.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.762 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.448 ' OD1' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -73.19 164.69 26.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.403 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 17.9 mmt -61.23 -33.39 73.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.55 -5.86 49.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.108 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.75 64.27 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.54 166.72 10.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.061 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -112.53 118.62 35.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.331 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -57.95 150.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.873 174.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -105.79 -5.14 20.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 109.719 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -126.79 115.33 19.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.699 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 1.6 ptmm? -144.41 114.09 7.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.314 . . . . 0.0 111.071 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -136.3 112.31 9.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.588 ' HE1' ' HE2' ' A' ' 134' ' ' LYS . 4.4 m95 -112.43 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 164' ' ' PHE . 2.8 tp10 -68.88 -27.85 66.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.07 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.9 179.342 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.634 0.73 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.504 ' HB1' ' HZ3' ' A' ' 136' ' ' TRP . . . -82.04 131.36 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.961 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 166' ' ' LYS . 48.1 t -131.55 147.58 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.482 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 tt -100.98 125.22 47.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.7 t -114.27 98.5 6.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.156 0.503 . . . . 0.0 110.195 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -75.81 -22.24 75.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.294 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.36 -30.48 68.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.106 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.93 -58.68 3.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -176.94 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.384 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.74 -1.38 4.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.025 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.01 167.67 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.407 ' CZ3' ' HA ' ' A' ' 134' ' ' LYS . 46.7 m0 -87.26 144.26 26.89 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 68.8 m-85 -135.99 177.12 8.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.318 0.58 . . . . 0.0 111.418 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.637 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.516 ' HB2' HG21 ' A' ' 154' ' ' VAL . 10.7 tttp -152.85 -170.39 3.62 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -80.14 122.7 27.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.35 -25.3 61.81 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.36 8.77 39.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.6 131.83 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -92.95 96.83 10.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.013 0.435 . . . . 0.0 110.755 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 110' ' ' ILE . 3.1 pp -125.89 164.37 33.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.137 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 16.8 Cg_exo -67.04 -178.38 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.164 2.576 . . . . 0.0 113.011 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -160.51 168.08 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.639 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.497 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 4.4 mp -127.53 133.68 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 69.3 m -110.06 139.21 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.117 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 32.6 m-85 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 p -81.14 -0.95 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.544 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.82 122.72 17.59 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.046 0.451 . . . . 0.0 110.77 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -91.79 111.05 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.377 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.923 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -151.5 -177.14 5.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.372 -177.926 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.5 p -79.09 167.3 21.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -47.0 84.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.01 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -70.37 -32.64 70.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.38 -43.8 76.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.923 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.51 -38.35 69.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.842 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 78' ' ' ILE . 29.5 t -64.81 -65.71 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.775 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.48 -31.38 72.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.92 -44.76 84.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.18 0.514 . . . . 0.0 109.961 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.524 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 49.5 t -65.21 -45.05 86.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.367 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -60.28 -36.82 71.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.396 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 t -78.6 -19.54 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.629 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.4 ptp180 -91.7 -3.55 56.14 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.016 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.85 45.15 4.0 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.701 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.81 -179.33 36.41 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.104 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 p -135.75 157.41 46.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 ' HE3' ' A' ' 126' ' ' MET . 4.0 mm? -64.27 149.45 48.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -75.05 107.02 6.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.737 HG21 ' HB2' ' A' ' 125' ' ' ASP . 23.4 m -97.61 111.46 58.74 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.488 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HG2' HD22 ' A' ' 112' ' ' LEU . 3.4 Cg_exo -77.67 119.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.168 2.579 . . . . 0.0 112.271 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -13.64 16.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.786 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 92' ' ' GLU . 45.1 p -130.93 170.01 15.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.317 . . . . 0.0 110.679 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.98 65.63 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.189 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.6 p -66.38 -37.94 86.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.35 0.595 . . . . 0.0 110.718 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.584 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 14.8 tt0 -69.71 -40.3 76.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.155 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -61.87 -45.36 94.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.64 -36.74 79.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.76 99.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.979 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.73 -40.59 88.42 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 88.0 t80 -57.85 -45.87 85.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 15.7 mm-40 -68.62 -38.95 80.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.235 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -66.19 -48.11 71.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.875 HD22 HD11 ' A' ' 110' ' ' ILE . 0.9 OUTLIER -65.18 -34.3 78.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 47.5 ttt180 -54.62 -48.78 71.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.092 175.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 98' ' ' GLU . 4.9 pt20 -93.29 11.11 29.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.278 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -134.47 -61.41 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.642 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.526 HG21 HD11 ' A' ' 175' ' ' ILE . 2.9 t -87.79 -32.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.926 0.87 . . . . 0.0 109.61 -172.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 122.26 122.95 2.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.07 -37.58 4.31 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.745 0.418 . . . . 0.0 112.088 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.28 21.63 2.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.96 161.41 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.015 0.436 . . . . 0.0 111.585 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 39.6 mt-10 -121.81 122.37 39.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.711 176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.875 HD11 HD22 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -134.36 150.93 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.027 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -72.19 155.22 40.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.792 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 153' ' ' ALA . 55.5 mt -106.61 6.82 30.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.7 79.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 120.771 0.319 . . . . 0.0 111.109 -179.031 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.761 0.791 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.603 ' HH2' ' HA ' ' A' ' 152' ' ' CYS . 28.2 m95 -95.83 156.48 16.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.837 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -118.34 130.32 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.737 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.45 156.78 38.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.761 ' HE3' HD23 ' A' ' 84' ' ' LEU . 9.3 ptp -58.96 -30.25 67.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -173.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 t -106.38 6.75 30.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.239 0.542 . . . . 0.0 111.124 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.5 28.52 9.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.753 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.86 137.99 31.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.012 0.406 . . . . 0.0 110.558 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -91.63 116.14 28.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 38.4 pt -77.78 132.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.05 3.47 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.259 0.552 . . . . 0.0 110.459 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -133.67 116.8 16.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.33 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.01 100.87 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.674 0.749 . . . . 0.0 110.629 172.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -111.14 113.03 25.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.026 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HH2' ' HB2' ' A' ' 153' ' ' ALA . 23.8 m95 -112.99 113.45 25.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.366 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 162' ' ' LYS . 4.9 mm-40 -76.52 -23.83 53.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.62 0.724 . . . . 0.0 109.334 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' A' ' 164' ' ' PHE . 11.7 t . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.775 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.603 ' HA ' ' HH2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.52 108.81 8.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 166' ' ' LYS . 12.3 p -122.07 140.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.643 ' HB2' HD21 ' A' ' 112' ' ' LEU . 31.4 tp -90.03 115.38 27.26 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.0 m -110.74 100.19 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.416 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.98 -19.41 78.76 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.596 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.62 -19.55 65.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 111.412 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.62 -56.48 2.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.44 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -171.58 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 120.13 6.53 9.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.12 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 137' ' ' GLU . 2.2 mptm? -86.96 -178.75 6.36 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.621 -0.341 . . . . 0.0 110.381 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -88.98 131.75 35.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.683 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 95.8 m-85 -125.82 171.1 10.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.552 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 5.5 p-10 -113.25 141.23 47.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB2' HG11 ' A' ' 154' ' ' VAL . 31.5 tttp -145.82 174.87 10.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.669 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 59.7 mtm180 -64.5 124.28 21.42 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.307 0.38 . . . . 0.0 110.25 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.76 -21.49 61.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.69 15.16 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.676 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 3.8 t0 -87.77 166.01 14.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 68' ' ' LYS . 97.8 mt-30 -122.47 96.01 4.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.124 0.487 . . . . 0.0 111.331 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HB2' ' CD ' ' A' ' 173' ' ' PRO . 3.2 pp -126.29 172.32 6.59 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.741 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 14.7 Cg_exo -69.69 -178.63 2.41 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.563 2.175 . . . . 0.0 112.716 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -153.8 172.18 17.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 104' ' ' VAL . 95.9 mt -142.77 115.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 110.597 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 97.4 m -102.97 155.78 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.13 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 43.3 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.901 0.382 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -71.53 -12.35 61.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.989 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG2' ' HE1' ' A' ' 174' ' ' TYR . 14.2 pt20 -72.35 135.22 45.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.501 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 p -89.71 138.38 31.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -168.95 166.04 11.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 169' ' ' ARG . 30.4 p -81.94 168.12 18.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.22 -29.14 60.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.64 0.257 . . . . 0.0 110.571 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -60.6 -59.3 5.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.633 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 8.5 mp0 -65.43 -31.42 72.5 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.79 81.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.418 ' O ' HD13 ' A' ' 78' ' ' ILE . 44.5 t -72.64 -56.28 5.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.342 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 3.0 tp10 -56.39 -38.46 71.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.608 -173.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -72.1 -52.82 14.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.091 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 25.2 t -66.42 -37.25 84.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.221 -174.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -62.87 -37.28 78.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 0.0 110.131 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -79.09 -27.03 42.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.738 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.66 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.9 ptp180 -83.23 6.83 18.13 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.757 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.04 43.14 27.55 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.271 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 -171.38 17.57 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 2.1 m -150.43 145.2 25.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.526 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.5 mp -58.72 135.81 57.54 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.7 p -70.37 107.52 3.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.235 0.54 . . . . 0.0 110.814 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 95.0 m -99.9 120.95 55.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.05 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 12.1 Cg_exo -70.37 111.48 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.098 1.865 . . . . 0.0 112.219 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -103.64 -18.96 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.918 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -136.05 177.77 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.213 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.93 -35.51 91.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.275 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -56.45 -43.7 79.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.2 mp0 -60.43 -58.61 7.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.7 0.286 . . . . 0.0 111.187 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -66.19 -41.33 90.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.116 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -40.07 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.551 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.42 -31.45 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.38 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 2.5 tt -60.64 -46.11 91.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 88.5 t80 -59.83 -41.84 92.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.689 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 8.3 tp10 -68.7 -37.73 79.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.103 0.478 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 78.2 t80 -62.85 -35.62 80.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.513 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 66.5 mt -56.4 -48.98 75.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.487 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 42.9 mtp180 -64.95 -17.3 64.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.951 -173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 11.0 pt20 -116.18 9.94 14.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.0 m -153.58 -46.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.951 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 110' ' ' ILE . 30.1 t -104.77 -37.44 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.532 0.682 . . . . 0.0 110.473 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.38 128.56 3.01 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.509 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -55.92 -41.9 75.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.321 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.18 154.78 18.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.207 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 156' ' ' SER . 40.2 mt-10 -122.39 122.39 38.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.984 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 HG11 ' A' ' 104' ' ' VAL . 2.2 mp -121.2 147.51 25.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.069 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 73.5 m95 -71.65 138.89 48.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 155' ' ' LEU . 2.1 mm? -100.93 12.55 37.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.44 81.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.988 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 131' ' ' ILE . 8.4 mp . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.432 ' HB2' ' CD1' ' A' ' 131' ' ' ILE . 36.4 m95 -62.74 149.21 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.836 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.4 133.95 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.362 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' CB ' HG21 ' A' ' 86' ' ' THR . 4.1 p-10 -98.06 -165.47 1.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 0.0 111.123 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' A' ' 84' ' ' LEU . 20.1 mmt -65.37 -37.57 87.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.608 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 78.2 p -82.47 -20.62 36.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.79 0.329 . . . . 0.0 111.317 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.36 28.37 13.2 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.01 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.02 165.4 12.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.05 0.452 . . . . 0.0 110.54 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.409 ' HB2' ' HE ' ' A' ' 130' ' ' ARG . 15.5 ttm180 -99.33 106.96 19.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.526 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 114' ' ' LEU . 44.8 pt -62.41 124.87 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.257 0.551 . . . . 0.0 110.907 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.98 -10.97 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.447 0.641 . . . . 0.0 109.872 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -104.11 116.03 31.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.204 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -135.08 99.4 4.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.915 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.433 ' HA ' HD22 ' A' ' 135' ' ' ASN . 5.3 m120 -121.14 111.51 17.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.059 0.457 . . . . 0.0 110.309 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -122.03 124.71 44.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.883 ' HG2' HD21 ' A' ' 160' ' ' ASN . 5.1 tp10 -75.12 -29.03 60.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.644 0.735 . . . . 0.0 109.352 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.965 178.624 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.918 0.389 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -110.83 150.35 29.27 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.586 HG21 ' HG3' ' A' ' 166' ' ' LYS . 28.1 m -143.01 155.91 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.527 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.557 ' N ' HD21 ' A' ' 112' ' ' LEU . 50.8 tp -99.01 103.99 15.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 20.0 t -96.9 103.64 15.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 -175.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.24 -26.77 67.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.72 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.31 -19.09 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.301 0.572 . . . . 0.0 110.613 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.15 -61.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.189 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.883 HD21 ' HG2' ' A' ' 137' ' ' GLU . 15.3 p30 -174.67 -30.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.12 32.73 1.34 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.711 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 34.3 mmtp -119.66 177.73 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.437 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 49.5 m0 -78.42 124.92 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.184 0.516 . . . . 0.0 111.069 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 77.2 m-85 -127.17 178.91 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.493 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -115.92 138.57 51.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.87 0.367 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.586 ' HG3' HG21 ' A' ' 154' ' ' VAL . 17.1 mtmt -150.02 161.15 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.649 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.514 ' O ' ' HH2' ' A' ' 111' ' ' TRP . 1.9 mtm105 -60.35 132.48 54.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.595 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -63.47 -17.41 62.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.386 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.416 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 5.7 ptp85 -103.82 29.37 5.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.984 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.3 147.31 23.02 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -91.69 85.14 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.472 . . . . 0.0 110.408 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -128.63 164.44 38.21 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.227 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.1 Cg_exo -65.79 -177.1 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.48 2.787 . . . . 0.0 113.205 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.667 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.4 p90 -155.16 167.55 29.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 90.4 mt -141.23 131.0 25.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.934 0.397 . . . . 0.0 110.234 176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.446 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 74.5 m -104.54 157.93 16.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.963 177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.9 pt20 . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 121.505 0.669 . . . . 0.0 109.64 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 121.066 0.46 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 t -71.47 13.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.9 138.65 48.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.332 0.587 . . . . 0.0 110.515 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -93.2 137.22 32.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.578 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.713 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -171.26 -178.5 2.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 178.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 15.2 p -77.37 166.09 23.59 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.322 0.389 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.1 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -63.28 -48.19 79.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 6.1 mm-40 -67.44 -40.54 85.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.275 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -54.52 -47.48 73.07 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.061 0.458 . . . . 0.0 110.306 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' HD13 ' A' ' 78' ' ' ILE . 17.5 m -65.03 -56.66 11.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.54 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.68 -41.42 99.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.901 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 35.0 t70 -71.91 -48.51 45.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.336 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.812 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 46.8 t -64.68 -39.36 93.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -64.4 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.156 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -63.52 -31.9 73.2 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 66.9 mtt180 -66.85 -17.47 64.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 19.04 13.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.699 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -130.93 -169.42 12.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.195 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 p -139.99 161.86 36.59 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 126' ' ' MET . 9.7 mp -75.52 153.61 37.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.556 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.8 t -82.26 107.24 14.79 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 82.7 p -97.47 120.08 61.49 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 6.9 Cg_endo -84.78 113.46 1.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.458 2.105 . . . . 0.0 112.107 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -109.44 -7.25 15.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.183 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.06 169.46 18.63 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.048 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.35 -36.64 92.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.668 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -58.32 -43.25 88.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.25 -48.85 79.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.693 0.282 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -64.38 -36.04 82.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.294 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.99 -48.44 76.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.645 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -33.6 76.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.158 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 52.6 mt -60.57 -62.66 1.7 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.222 173.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.739 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 48.9 t80 -53.39 -34.97 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.681 0.613 . . . . 0.0 112.005 -174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.44 -54.94 5.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 85.4 t80 -57.54 -34.43 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.831 0.824 . . . . 0.0 109.195 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.522 HD12 ' HB ' ' A' ' 104' ' ' VAL . 29.4 tp -53.83 -53.78 47.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.516 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.739 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 42.9 mtm105 -67.51 -19.06 65.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.969 -176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 13.8 pt20 -111.82 4.14 18.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.08 -44.24 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.968 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 110' ' ' ILE . 41.3 t -102.13 -49.62 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 109.679 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.4 129.48 1.56 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.988 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 t30 -46.01 -49.11 16.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.088 0.471 . . . . 0.0 111.006 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.9 OUTLIER -95.28 22.85 6.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.662 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.39 161.31 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.002 0.429 . . . . 0.0 110.99 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 41.3 mt-10 -124.47 125.45 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.834 HD11 HG11 ' A' ' 104' ' ' VAL . 1.8 mp -123.25 144.13 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.12 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CZ3' HG22 ' A' ' 154' ' ' VAL . 82.7 m95 -71.21 137.77 48.95 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' HD23 ' A' ' 114' ' ' LEU . 94.5 mt -83.11 -14.46 53.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . 76.51 15.76 81.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.371 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 111.349 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.568 0.699 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 55.8 m95 -68.37 144.25 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.515 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -110.04 139.94 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -72.43 153.62 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 49.7 mtt -55.95 -25.06 41.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.207 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.2 t -88.51 4.1 47.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.236 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.68 37.92 9.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.341 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.39 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.768 0.284 . . . . 0.0 110.561 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -105.77 127.44 53.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 0.0 110.418 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.9 pt -69.95 151.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.409 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.09 3.11 14.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -141.13 124.29 16.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.805 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 20.4 pttp -136.99 130.51 31.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -133.72 111.48 10.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.415 ' HE1' ' HB2' ' A' ' 134' ' ' LYS . 18.5 m95 -121.04 128.04 52.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.37 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -72.87 -21.2 60.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.446 179.483 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.71 133.44 40.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.402 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 17.3 t -126.17 141.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.473 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.584 ' HB2' HD21 ' A' ' 112' ' ' LEU . 63.8 tp -98.96 112.53 24.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 p -106.33 109.54 21.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.918 0.389 . . . . 0.0 111.171 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.83 -22.26 78.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.039 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -64.63 -25.1 67.81 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.0 -60.06 2.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.357 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.0 p30 176.91 -24.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.316 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 123.15 25.81 1.78 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.733 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -111.8 167.6 10.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.704 0.288 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -82.48 135.73 35.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.046 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -126.96 -169.03 1.96 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.071 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -143.02 139.06 30.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.0 110.687 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -139.31 164.98 28.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 167' ' ' ARG . 2.4 tpt180 -71.09 141.22 50.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 69' ' ' THR . 51.1 m -63.33 -5.9 4.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 13.7 ttp85 -112.94 20.19 16.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.9 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -90.94 145.14 24.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 17.8 mp0 -93.16 94.47 8.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 111.689 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -129.39 157.84 75.02 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.064 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 22.4 Cg_exo -64.28 179.13 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.006 2.47 . . . . 0.0 113.464 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.812 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -155.24 166.22 34.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.454 177.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 110' ' ' ILE . 90.5 mt -124.09 130.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 55.5 m -102.45 132.18 48.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.387 0.613 . . . . 0.0 111.436 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.317 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.616 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.785 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 58.5 m-85 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 p -84.51 5.2 28.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.896 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' OE1' ' HD3' ' A' ' 68' ' ' LYS . 17.5 tm0? -77.97 123.86 27.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -97.66 115.27 27.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.606 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -144.43 179.24 7.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.887 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.1 p -84.55 167.02 16.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.05 -20.27 62.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -72.5 -50.45 25.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.27 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 3.3 mp0 -70.42 -35.34 73.36 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.096 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.764 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -67.81 -18.58 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.747 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.578 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 10.3 p -91.97 -51.54 5.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.713 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.78 -29.6 65.85 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.869 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -65.66 -40.25 92.21 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.936 -175.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.715 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 33.6 m -72.28 -42.94 64.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.634 0.254 . . . . 0.0 111.211 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.72 -41.53 88.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 t -80.32 -15.8 56.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 9.9 ptp180 -91.7 4.78 51.95 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.67 38.77 31.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.432 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.74 -170.15 18.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.4 p -131.07 153.51 49.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 85' ' ' SER . 4.8 tt -73.4 146.41 45.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.622 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.3 m -62.6 109.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.972 0.415 . . . . 0.0 111.267 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 28.5 p -107.32 119.83 49.62 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.573 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 31.3 Cg_endo -92.36 123.05 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.659 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 3.6 pt20 -127.82 0.91 6.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 92' ' ' GLU . 68.6 p -129.58 173.65 10.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.38 -36.87 89.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.5 t -64.46 -52.63 57.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.0 110.705 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' OE1' ' HG2' ' A' ' 88' ' ' GLN . 9.3 pt-20 -75.02 -24.63 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.531 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' ' CB ' ' A' ' 87' ' ' PRO . 28.2 t-20 -66.59 -48.84 68.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.15 0.5 . . . . 0.0 110.284 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.35 -22.78 32.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.167 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.72 84.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.608 0.242 . . . . 0.0 110.966 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.09 -40.87 95.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 36.0 t80 -59.23 -43.69 92.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.454 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.36 -47.25 67.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.473 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.08 -38.69 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.51 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 110' ' ' ILE . 2.9 pp -68.01 -29.56 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.363 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 74.6 mtp180 -66.27 -26.31 67.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -98.83 5.84 47.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.877 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -153.67 -47.35 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 100' ' ' LEU . 4.5 t -88.25 -34.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.654 0.74 . . . . 0.0 109.349 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.28 124.2 3.78 Favored Glycine 0 N--CA 1.434 -1.433 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -50.95 -37.14 42.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.05 0.452 . . . . 0.0 111.26 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 158' ' ' ALA . 39.5 mt-10 -85.36 24.12 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.656 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.65 146.13 29.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 110.762 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 2.6 mm-40 -101.82 132.35 47.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.394 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.82 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -124.55 138.77 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 110' ' ' ILE . 83.1 m95 -71.01 148.04 48.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.6 mm? -96.1 5.2 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.98 16.97 69.16 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.317 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.428 ' HB3' ' CE3' ' A' ' 123' ' ' TRP . 7.5 mp . . . . . 0 C--N 1.326 -0.43 0 CA-C-O 120.648 0.261 . . . . 0.0 110.453 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 114' ' ' LEU . 23.5 m95 -62.05 146.59 49.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.501 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.76 162.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.226 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.51 166.29 22.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.578 ' HE1' ' HB3' ' A' ' 74' ' ' SER . 21.0 mmt -54.5 -19.63 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.893 172.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.8 -6.98 34.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 111.434 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.45 34.69 7.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.954 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.61 166.82 10.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -100.76 143.66 30.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.656 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -104.02 148.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 173.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.19 11.57 38.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.863 0.363 . . . . 0.0 111.059 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 48.3 t80 -107.63 111.06 23.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 -176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 98.41 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.989 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.08 111.71 6.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -128.01 127.31 42.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.814 ' HG3' HD21 ' A' ' 160' ' ' ASN . 3.3 tm-20 -66.31 -52.94 42.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.541 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 9.0 t . . . . . 0 C--N 1.315 -0.904 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.549 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.611 0.243 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.82 139.69 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -170.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.59 164.61 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.433 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 tt -109.8 103.7 12.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 25.8 p -89.85 108.2 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.89 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.03 -51.42 34.09 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.002 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . . . -59.67 -20.12 54.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.98 -52.17 11.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.814 HD21 ' HG3' ' A' ' 137' ' ' GLU . 12.3 p30 179.94 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.016 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.42 22.67 6.33 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.137 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 56.1 mmtt -113.76 179.27 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.044 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -77.22 122.57 25.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.545 0.688 . . . . 0.0 111.627 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.541 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 10.7 m-85 -117.2 178.23 4.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.069 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.26 144.59 51.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.105 0.478 . . . . 0.0 111.295 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.6 ' HD2' ' CD2' ' A' ' 172' ' ' LEU . 17.5 ptpt -153.24 -171.0 3.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.075 173.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 167' ' ' ARG . 40.7 ttm180 -83.34 138.28 33.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.797 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.2 m -70.82 -2.79 16.0 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -96.71 -5.42 38.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.457 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.06 133.0 48.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -92.47 97.25 10.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.649 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.6 ' CD2' ' HD2' ' A' ' 166' ' ' LYS . 3.2 pp -128.15 160.62 60.87 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.062 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 172' ' ' LEU . 40.7 Cg_exo -57.69 179.59 0.14 Allowed 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.461 2.774 . . . . 0.0 113.509 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.82 ' HA ' HG23 ' A' ' 110' ' ' ILE . 2.2 p90 -163.36 165.26 24.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.033 -0.417 . . . . 0.0 110.485 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.785 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.1 mt -128.46 116.56 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 5.9 t -104.24 147.36 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 0.0 110.658 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.482 ' HD1' ' CE2' ' A' ' 174' ' ' TYR . 54.6 m-85 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.038 0.446 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.547 HG22 HG13 ' A' ' 104' ' ' VAL . 9.1 p -72.46 -3.54 24.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.787 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 52.3 mt-30 -57.18 129.29 41.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.332 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 p -94.21 125.67 38.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.597 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.829 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -164.22 174.27 11.39 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.225 177.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 69.8 p -77.75 166.08 23.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 -176.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.79 -44.19 81.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.493 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.35 -45.77 91.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.084 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.23 -42.24 73.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.421 ' O ' HD13 ' A' ' 78' ' ' ILE . 36.0 m -60.22 -58.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.973 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.84 -16.79 62.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.323 . . . . 0.0 111.28 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 36.7 t70 -75.16 -50.01 17.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.033 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.544 ' HB2' HD12 ' A' ' 84' ' ' LEU . 65.7 m -67.24 -32.94 74.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.143 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -60.2 -41.63 87.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.3 p -79.26 -11.03 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.924 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 14.8 mmp_? -78.62 -14.29 59.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.77 37.77 3.36 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.299 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -177.71 -160.09 23.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.215 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 p -120.73 171.12 8.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 77' ' ' CYS . 9.5 mp -66.82 162.28 21.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 171.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 p -73.65 107.58 5.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 112' ' ' LEU . 35.8 p -110.46 105.81 57.43 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.145 0.498 . . . . 0.0 110.749 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.72 ' HG3' HD12 ' A' ' 96' ' ' LEU . 97.6 Cg_endo -88.03 139.24 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.466 2.111 . . . . 0.0 112.251 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.9 pt20 -135.25 9.03 3.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.748 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 p -141.53 168.64 19.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.906 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.68 98.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.8 m -59.95 -35.41 74.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.104 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -76.16 -37.01 58.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.074 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.93 -41.64 77.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.088 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.65 -36.1 81.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.173 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.03 79.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.72 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.2 mt -78.57 -4.99 51.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.626 0.25 . . . . 0.0 111.118 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -98.23 -37.66 9.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.57 -52.52 8.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.759 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 71.6 t80 -62.73 -35.27 79.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.519 0.676 . . . . 0.0 109.242 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 104' ' ' VAL . 8.0 tp -57.94 -48.09 80.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.284 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.543 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.02 -19.78 64.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.702 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 17.1 pt20 -110.3 8.06 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.827 -0.546 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 -65.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.608 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 65' ' ' THR . 2.5 t -83.56 -28.69 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 151.12 -77.84 0.22 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.147 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.411 ' CB ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 p-10 173.29 -40.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 6.7 pt-20 -113.39 45.76 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.785 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 100' ' ' LEU . . . -115.03 146.93 40.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.607 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 4.6 mp0 -94.54 130.96 40.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.369 174.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 175' ' ' ILE . 3.8 mp -125.63 145.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.588 177.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.89 132.55 45.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.9 mt -90.38 10.57 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.39 30.89 56.37 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 118.146 0.973 . . . . 0.0 110.26 176.631 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.763 0.316 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -64.16 137.3 57.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -107.9 139.09 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.745 ' OD2' HG22 ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.9 -179.77 4.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 0.0 110.441 -178.042 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.1 mtt -69.25 -32.32 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.745 HG22 ' OD2' ' A' ' 125' ' ' ASP . 12.4 t -81.03 -5.21 57.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.263 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.81 37.82 5.11 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.382 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.1 162.09 27.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.075 0.437 . . . . 0.0 110.834 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -99.19 126.14 44.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.495 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.64 126.18 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.407 0.623 . . . . 0.0 111.366 -174.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.72 -19.44 35.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.591 0.71 . . . . 0.0 110.02 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 41.1 t80 -120.41 115.23 23.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.305 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.0 120.14 10.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.997 0.427 . . . . 0.0 110.069 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -125.9 111.07 14.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.582 0.706 . . . . 0.0 110.502 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -111.5 118.49 35.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' HD21 ' A' ' 160' ' ' ASN . 4.1 tp10 -70.0 -41.22 74.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.576 0.703 . . . . 0.0 109.77 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.942 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.16 135.32 39.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.576 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.55 145.63 31.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.674 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 2.3 tm? -89.39 108.89 19.9 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 26.1 t -98.96 100.78 11.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.36 -23.9 74.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.771 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -69.67 -30.46 68.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 110.71 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.87 0.99 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.746 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.459 HD21 ' HG2' ' A' ' 137' ' ' GLU . 14.6 p30 -171.35 -27.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.055 -174.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.23 -2.25 11.5 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.839 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 1.1 mptm? -82.56 174.18 11.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -83.78 126.84 33.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.307 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.54 -171.84 2.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.97 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.72 146.16 35.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.081 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -147.53 176.8 9.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -72.25 144.09 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 -173.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -68.61 -14.62 63.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.008 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -93.59 -3.21 53.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 17.6 m-20 -73.55 136.06 44.0 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -110.31 106.16 15.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.819 0.819 . . . . 0.0 111.446 -176.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 1.5 pp -129.24 171.14 9.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.346 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 14.3 Cg_endo -57.12 174.67 0.42 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.552 2.168 . . . . 0.0 113.226 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.787 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 49.1 p90 -140.91 179.59 6.63 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.041 -0.412 . . . . 0.0 110.739 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.54 HG13 HG12 ' A' ' 110' ' ' ILE . 71.6 mt -145.51 132.42 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.461 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 84.9 m -99.49 155.81 17.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 6.0 tp60 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 121.512 0.672 . . . . 0.0 110.311 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.733 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 59.3 m-85 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -69.69 -8.11 44.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.003 -177.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.87 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 27.6 mt-30 -53.61 122.03 9.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 0.0 111.733 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 171' ' ' GLN . 17.6 p -97.02 113.53 25.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.511 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.885 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.82 -176.55 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.122 -178.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 169' ' ' ARG . 81.5 p -78.14 165.88 23.43 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.321 0.388 . . . . 0.0 110.129 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.31 -38.79 92.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.675 0.274 . . . . 0.0 110.946 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -63.33 -45.91 89.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -58.88 -37.08 75.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 78' ' ' ILE . 29.1 t -63.1 -60.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.41 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 11.2 pt-20 -70.69 -15.21 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.496 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.703 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 11.7 t70 -65.06 -59.01 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.3 m -59.28 -36.8 76.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 74' ' ' SER . 28.3 mm -54.17 -44.5 64.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 p -84.39 -14.09 50.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.397 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 20.4 mmt180 -74.46 -23.69 58.93 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.98 25.59 11.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.332 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.78 -170.26 13.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.1 p -116.14 165.81 12.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.535 HD23 ' HA2' ' A' ' 113' ' ' GLY . 19.4 tp -81.8 148.74 28.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -66.69 109.17 2.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.866 0.365 . . . . 0.0 111.219 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 4.7 t -117.51 118.5 35.27 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.905 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 2.0 Cg_endo -81.68 120.66 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.063 2.509 . . . . 0.0 112.311 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -104.28 -30.48 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.098 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.0 p -128.02 -171.0 2.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.71 -34.26 82.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.913 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -55.4 -49.81 71.37 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.834 0.454 . . . . 0.0 111.936 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 4.8 mp0 -61.66 -53.22 59.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.11 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.53 -37.75 88.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.92 -44.13 93.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.497 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.49 -32.96 58.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.7 tp -63.06 -47.66 81.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.018 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 91.4 t80 -60.08 -40.46 89.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.538 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.743 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -64.03 -33.33 75.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.617 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD11 HD12 ' A' ' 155' ' ' LEU . 72.6 mt -57.14 -44.72 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.141 0.496 . . . . 0.0 109.901 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 16.5 mtp180 -69.04 -9.38 52.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.62 -172.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -127.47 15.61 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.1 t -151.32 -51.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.359 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -105.85 -29.05 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.649 0.737 . . . . 0.0 110.391 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.49 130.49 4.97 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -30.82 64.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.893 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 5.1 mm-40 -80.44 6.76 11.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.027 -175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.32 15.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 0.0 112.197 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.463 ' C ' HD12 ' A' ' 110' ' ' ILE . 34.0 mt-10 -121.18 123.53 42.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.078 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 175' ' ' ILE . 2.6 mp -122.93 138.77 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 110.505 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 73.6 m95 -70.41 145.5 51.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 155' ' ' LEU . 95.3 mt -89.89 -2.31 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 82.73 5.81 89.08 Favored Glycine 0 C--N 1.324 -0.124 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.284 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 131' ' ' ILE . 7.2 mp . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.4 ' H ' HD11 ' A' ' 131' ' ' ILE . 14.1 m95 -72.96 148.18 44.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.014 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.11 129.22 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -83.3 164.31 20.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.771 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.552 ' HE1' ' HA ' ' A' ' 74' ' ' SER . 11.5 ptp -61.91 -43.54 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -92.56 -4.79 52.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 0.0 111.084 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.63 13.1 9.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.554 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 125' ' ' ASP . . . -77.85 128.3 33.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.039 0.447 . . . . 0.0 110.777 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -98.34 113.69 25.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.728 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 114' ' ' LEU . 43.4 pt -62.05 135.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.977 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -112.48 8.95 19.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.537 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 135' ' ' ASN . 80.2 t80 -105.52 102.95 12.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.246 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.505 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 13.9 tptp -105.6 96.78 6.74 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 46.1 t30 -157.6 111.72 2.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.505 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 4.0 m95 -137.98 156.21 48.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.795 -173.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 2.4 tm-20 -97.08 -49.97 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.604 -173.359 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.45 140.13 38.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.455 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.756 HG11 ' HG2' ' A' ' 166' ' ' LYS . 14.3 p -136.04 149.32 27.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.592 HD12 HD11 ' A' ' 100' ' ' LEU . 1.3 tm? -98.66 101.15 12.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.0 m -99.7 109.37 21.83 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.03 -40.17 73.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.806 -175.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.893 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -68.78 -11.51 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 111.287 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.05 -56.46 3.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -171.69 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.864 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.23 -0.97 37.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.946 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 66.9 mmtt -93.5 179.58 5.34 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 45.4 m0 -79.29 123.4 27.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 0.0 110.62 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -116.52 -168.82 1.51 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.232 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.4 138.21 44.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.756 ' HG2' HG11 ' A' ' 154' ' ' VAL . 12.4 mmmm -137.95 146.37 43.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -60.52 136.35 58.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.3 m -65.07 -7.1 10.66 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.548 ' HA ' HG22 ' A' ' 69' ' ' THR . 37.2 ttp180 -109.0 20.9 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.178 0.513 . . . . 0.0 110.243 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.42 141.22 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 2.0 mp0 -93.28 93.05 8.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 111' ' ' TRP . 3.9 pp -127.85 164.48 36.54 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.671 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 24.3 Cg_exo -63.41 -178.4 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.263 2.642 . . . . 0.0 113.745 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.87 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 6.5 p90 -154.58 176.92 11.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.15 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 110' ' ' ILE . 74.1 mt -145.63 128.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.583 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 83.6 m -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.555 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 176' ' ' CYS . 29.6 m-85 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 p -84.91 17.31 2.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.194 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 44.9 tt0 -84.97 139.35 31.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.255 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 p -98.05 127.43 43.99 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.646 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -158.28 -178.88 7.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.2 p -84.5 166.83 16.92 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.95 0.156 . . . . 0.0 110.868 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -48.26 82.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.476 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -63.32 -43.8 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.694 0.283 . . . . 0.0 110.298 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -64.48 -43.58 93.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.54 72.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' ILE . 16.1 t -59.55 -62.57 1.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.96 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.99 -39.44 81.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.272 0.558 . . . . 0.0 110.935 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' CG ' HH12 ' A' ' 80' ' ' ARG . 12.3 t70 -64.94 -47.37 77.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.735 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 42.3 t -79.26 -36.87 39.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.003 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 126' ' ' MET . 1.4 mp -57.26 -40.22 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.109 0.48 . . . . 0.0 110.457 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -76.44 -31.59 57.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.904 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.553 HH12 ' CG ' ' A' ' 76' ' ' ASP . 1.3 ptp85 -96.15 -18.02 20.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.053 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.16 -51.18 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.169 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.27 -46.33 0.97 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.112 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 p -145.58 155.64 43.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.608 0.242 . . . . 0.0 111.151 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -72.36 161.78 30.37 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.045 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB3' HD21 ' A' ' 96' ' ' LEU . 28.3 m -79.06 106.09 10.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 37.9 m -111.9 112.33 53.2 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.65 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 2.5 Cg_endo -79.85 117.22 3.57 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.936 2.424 . . . . 0.0 111.869 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB3' HG22 ' A' ' 131' ' ' ILE . 1.8 pt20 -115.89 -13.67 11.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.424 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.0 p -130.9 176.24 8.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.73 -26.32 66.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.745 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -56.21 -56.88 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.896 0.478 . . . . 0.0 111.521 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 9.6 mp0 -62.73 -48.61 78.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.383 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.57 -40.92 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.33 -39.66 94.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.18 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.035 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.5 mt -59.83 -46.11 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -62.19 -29.14 70.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.617 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.21 -42.7 22.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -67.68 -47.25 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' HG23 ' A' ' 104' ' ' VAL . 3.1 pp -63.58 -25.83 68.41 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 101' ' ' ARG . 9.6 ttm180 -61.04 -38.63 86.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.448 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.12 0.28 31.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.693 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.8 p -124.32 -50.2 1.78 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 100' ' ' LEU . 3.0 t -98.51 -33.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.672 0.749 . . . . 0.0 109.704 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.97 125.04 3.61 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -55.21 -26.29 38.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.046 0.423 . . . . 0.0 111.504 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 38.6 mt-10 -89.18 22.52 2.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.383 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.46 162.25 14.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.057 0.456 . . . . 0.0 110.951 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 10.5 pt-20 -128.46 130.92 48.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.835 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.0 mp -118.84 154.61 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.988 -174.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -70.08 149.65 47.41 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.903 0.382 . . . . 0.0 110.12 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 163' ' ' TRP . 0.2 OUTLIER -86.73 -6.11 58.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -171.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.33 6.95 66.68 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.468 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.212 -176.355 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 130' ' ' ARG . 30.9 m . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 131' ' ' ILE . 44.4 m95 -59.2 129.47 42.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.576 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.22 131.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . 5.1 t70 -73.89 161.09 30.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.468 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.464 ' SD ' HD11 ' A' ' 78' ' ' ILE . 4.4 ptp -53.61 -28.96 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.0 p -92.84 1.26 57.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.095 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.56 27.91 25.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.954 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 125' ' ' ASP . . . -92.63 149.53 21.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.841 0.353 . . . . 0.0 111.197 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 122' ' ' THR . 28.2 ttm180 -98.14 130.69 44.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.089 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.669 HG13 ' HE3' ' A' ' 134' ' ' LYS . 38.0 pt -92.33 128.46 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.065 0.46 . . . . 0.0 110.156 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.91 -19.84 24.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.243 0.544 . . . . 0.0 110.534 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -113.77 130.45 56.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.516 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.669 ' HE3' HG13 ' A' ' 131' ' ' ILE . 10.4 mptt -130.06 144.26 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.72 114.82 8.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' NE1' ' HB3' ' A' ' 134' ' ' LYS . 44.4 m95 -126.59 117.54 23.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.193 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.3 tp10 -71.08 -29.79 65.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.774 177.024 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 121.642 0.734 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 112' ' ' LEU . . . -83.67 139.67 32.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.29 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 166' ' ' LYS . 21.3 t -133.5 142.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.918 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 49.6 tp -100.98 101.3 12.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 17.9 m -96.44 113.53 25.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.561 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.49 -30.95 47.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.853 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -67.52 -24.77 65.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.89 -59.02 2.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.976 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.447 HD21 ' HG2' ' A' ' 137' ' ' GLU . 10.7 p30 -177.58 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.33 19.23 3.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.343 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 34.4 mmtp -98.73 168.46 10.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CE2' HD11 ' A' ' 112' ' ' LEU . 49.6 m0 -84.25 132.61 34.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.248 0.547 . . . . 0.0 110.429 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.02 -179.21 4.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.33 156.64 22.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 167' ' ' ARG . 20.8 ttmm -154.35 167.65 29.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 110.518 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 33.1 mtm-85 -60.11 125.36 23.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.819 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.94 -22.56 67.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.783 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 169' ' ' ARG . 3.7 tpt180 -101.12 21.77 13.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.14 150.61 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.88 102.5 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.684 0.278 . . . . 0.0 111.23 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -130.49 167.77 19.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.0 Cg_exo -73.6 -179.24 4.32 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.966 2.444 . . . . 0.0 113.035 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.835 ' HA ' HG23 ' A' ' 110' ' ' ILE . 9.7 p90 -150.65 178.65 8.88 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.208 -0.308 . . . . 0.0 110.923 -176.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 84' ' ' LEU . 97.4 mt -144.39 134.73 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 45.0 m -102.79 136.88 41.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 111.984 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.628 178.427 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 49.8 m-85 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -78.08 -4.06 45.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.668 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 27.0 tt0 -66.89 136.32 55.21 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 p -104.42 134.64 47.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -165.64 176.86 7.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 73.6 p -78.33 166.32 22.81 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.305 0.378 . . . . 0.0 110.803 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.78 -35.84 77.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.168 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -64.2 -50.79 66.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.0 mt-10 -64.79 -35.83 82.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -60.97 -42.34 98.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.595 ' O ' HG12 ' A' ' 78' ' ' ILE . 43.4 m -60.75 -54.13 48.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.082 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.13 -42.36 76.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 14.4 t70 -60.02 -52.44 65.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 0.0 110.289 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.2 m -63.11 -36.4 83.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.975 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.925 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 22.8 mm -57.29 -42.27 79.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.209 0.528 . . . . 0.0 110.683 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -77.15 -19.19 57.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.195 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 59.8 mtt-85 -107.33 15.49 24.94 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.598 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.52 -49.22 0.42 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.639 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.925 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 120.71 7.19 8.95 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.02 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.824 HG23 ' HB2' ' A' ' 126' ' ' MET . 3.0 m -153.47 138.02 16.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.981 0.42 . . . . 0.0 111.439 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 85' ' ' SER . 6.2 tt -85.74 158.9 19.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.623 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.1 m -69.9 108.21 3.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.939 0.399 . . . . 0.0 110.912 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.2 m -110.12 112.83 57.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 66.7 Cg_endo -82.38 124.81 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.3 2.0 . . . . 0.0 111.982 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -5.87 11.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.386 -170.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.81 165.3 27.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.99 -39.02 77.87 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.029 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -54.27 -39.89 67.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.842 0.457 . . . . 0.0 112.134 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.97 -39.89 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.514 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 33.3 m-80 -66.18 -50.14 64.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.6 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.94 -35.36 80.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.8 65.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.106 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.3 tp -66.53 -44.86 81.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.727 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 110.279 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -65.3 -40.98 94.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.22 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.25 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.182 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 79.2 mt -55.96 -47.7 77.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -54.92 -37.7 66.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.543 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -96.1 -11.05 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.186 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -119.21 -64.06 1.32 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.892 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 110' ' ' ILE . 4.3 t -94.63 -34.27 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 110.406 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.45 125.21 2.99 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -170.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.85 -39.86 54.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.778 0.323 . . . . 0.0 110.151 177.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.64 15.09 1.82 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.81 160.3 14.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.984 0.421 . . . . 0.0 111.258 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 40.5 mt-10 -121.42 122.64 40.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.189 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.4 mp -121.15 148.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.491 ' O ' HG22 ' A' ' 110' ' ' ILE . 87.6 m95 -70.0 151.8 45.15 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.647 HD12 ' HB1' ' A' ' 153' ' ' ALA . 72.3 mt -99.54 4.46 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.94 -27.76 1.38 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' CD1' HD13 ' A' ' 131' ' ' ILE . 1.8 pt? . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.652 0.726 . . . . 0.0 110.935 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.417 ' CZ3' ' HB2' ' A' ' 153' ' ' ALA . 11.5 m0 -54.9 143.53 25.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.865 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.1 m -107.05 148.36 11.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.573 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.19 166.91 21.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.361 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.824 ' HB2' HG23 ' A' ' 83' ' ' THR . 49.0 mtt -58.67 -27.15 64.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.3 p -82.81 -12.09 57.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.738 0.304 . . . . 0.0 111.286 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.55 -0.11 53.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.819 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.17 155.57 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -109.03 149.75 28.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.477 HD13 ' CD1' ' A' ' 114' ' ' LEU . 48.6 pt -95.22 167.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.978 0.418 . . . . 0.0 111.413 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.1 5.22 3.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.888 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -118.92 119.41 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.279 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -138.44 98.71 3.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.996 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -127.68 111.52 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.526 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 32.9 m95 -125.36 123.21 38.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 4.3 mm-40 -72.97 -20.69 60.99 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 13.7 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.379 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.647 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.85 119.37 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 111.6 -175.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.79 140.52 47.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.998 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.1 tt -104.45 102.5 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.8 m -96.25 103.9 15.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.701 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.67 -20.55 76.35 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.461 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.43 -8.61 27.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.475 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.03 -66.43 1.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -148.67 -36.84 0.18 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.74 -0.64 36.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.073 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.724 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.1 mptm? -87.02 -179.17 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 34.0 m0 -81.36 131.7 35.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.632 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 90.6 m-85 -126.42 177.12 6.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.709 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -128.52 147.03 50.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.133 0.492 . . . . 0.0 110.665 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.74 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 34.8 ttmt -151.74 179.07 8.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.74 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 11.4 mtp180 -90.27 138.71 31.31 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -66.7 3.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -171.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 169' ' ' ARG . 69.4 mtt-85 -97.58 3.69 50.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.977 0.353 . . . . 0.0 111.743 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -84.52 140.45 31.43 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.597 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 48.4 mm-40 -93.1 91.15 7.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.037 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 4.2 pp -125.05 167.32 16.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.811 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 32.6 Cg_exo -59.84 179.7 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.589 2.859 . . . . 0.0 114.271 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.668 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 28.3 p90 -151.85 163.96 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.569 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.4 mt -139.02 115.43 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 74.5 m -101.9 153.28 20.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.194 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' ILE . 33.7 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -74.7 -8.77 57.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.631 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 23.5 tt0 -59.99 129.5 42.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.763 0.316 . . . . 0.0 110.245 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 p -98.74 131.04 45.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.754 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.884 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.37 179.87 7.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.769 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.456 HG23 ' NE2' ' A' ' 171' ' ' GLN . 67.8 p -78.77 166.0 22.95 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.46 0.475 . . . . 0.0 111.238 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.24 -46.4 89.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.866 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.88 -39.67 79.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 0.0 109.658 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 87.0 tt0 -61.69 -38.13 86.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.662 176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.884 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -65.02 -46.95 79.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.596 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 78' ' ' ILE . 34.0 p -58.44 -57.2 13.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.913 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -60.17 -32.49 71.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 111.31 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 13.2 t70 -63.78 -54.17 39.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.045 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 99.1 m -61.07 -38.97 88.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.702 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 74' ' ' SER . 23.6 mm -52.51 -42.74 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -80.53 -34.16 35.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.137 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 33.3 mtt-85 -91.05 -25.19 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.11 -173.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.49 -40.87 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.416 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.75 -26.36 5.68 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.322 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 127' ' ' THR . 1.2 p -148.71 155.75 41.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.062 0.458 . . . . 0.0 111.961 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 85' ' ' SER . 6.9 tt -96.33 154.13 17.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.587 ' N ' HD23 ' A' ' 84' ' ' LEU . 31.6 m -70.51 108.53 4.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 0.0 111.306 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 114' ' ' LEU . 33.2 m -110.07 106.7 58.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 60.4 Cg_endo -84.01 115.95 2.08 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.484 2.123 . . . . 0.0 111.664 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 131' ' ' ILE . 3.7 pt20 -115.99 7.26 14.3 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.257 -171.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.9 p -138.06 176.21 8.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.916 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.58 -42.92 62.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.2 p -56.72 -45.7 81.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.389 . . . . 0.0 111.439 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.91 -29.0 60.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.511 -175.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 15.9 m-80 -81.11 -47.01 14.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.456 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.12 -30.87 71.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.28 62.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.832 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 31.0 tp -72.87 -44.59 61.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.484 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.88 -33.11 73.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 109.941 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.76 -44.98 69.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.558 . . . . 0.0 109.584 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.38 -32.47 72.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.147 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 74.2 mt -56.53 -41.61 77.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 110.146 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -66.57 -15.9 63.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.997 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -117.47 2.09 12.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -55.32 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 110' ' ' ILE . 3.4 t -100.35 -30.97 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.01 127.35 3.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -53.56 -35.93 61.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.929 0.395 . . . . 0.0 109.975 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.65 27.99 2.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.49 161.55 13.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.786 0.327 . . . . 0.0 111.108 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.1 mt-10 -118.65 128.05 54.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.633 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.814 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.9 mp -126.51 145.25 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.68 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 152' ' ' CYS . 83.1 m95 -70.66 149.9 46.53 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 83.7 mt -104.39 11.73 34.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.52 -25.35 0.74 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.472 ' HG ' ' HE3' ' A' ' 123' ' ' TRP . 1.8 pt? . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 117.958 0.879 . . . . 0.0 111.869 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.444 -0.742 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.472 ' HE3' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m0 -45.88 128.42 8.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.43 155.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 0.0 111.337 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.3 165.07 25.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -55.57 -30.16 60.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.298 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.412 HG23 HG21 ' A' ' 83' ' ' THR . 76.0 p -80.59 -18.88 46.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 111.148 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.71 1.92 28.91 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.401 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 150.89 45.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.633 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -99.59 159.43 15.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.003 0.43 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 46.2 pt -101.83 146.4 10.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.68 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -123.8 20.42 9.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 109.582 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -137.46 120.42 16.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.973 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 134' ' ' LYS . 9.5 mtpm? -135.17 97.29 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.87 110.23 17.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 46.6 m95 -129.68 135.99 49.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.263 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 61.2 mm-40 -91.9 -20.37 21.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.711 0.767 . . . . 0.0 108.948 171.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.988 179.305 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 152' ' ' CYS . . . . . 0.554 ' HB2' ' HZ3' ' A' ' 111' ' ' TRP . 5.9 m . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.2 116.03 15.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.242 0.544 . . . . 0.0 112.003 -170.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.38 140.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.86 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 3.9 tt -100.23 100.21 11.0 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 14.0 m -88.94 98.55 11.81 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.973 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.68 -29.23 73.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.879 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -68.07 -10.28 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.962 0.411 . . . . 0.0 111.101 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.65 -57.8 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.528 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.5 -33.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.187 -172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 114.65 -5.03 22.85 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.341 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.586 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -86.5 176.93 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.595 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 39.5 m0 -80.79 131.75 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.183 0.516 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.78 172.17 9.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.632 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -124.6 143.09 50.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.492 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 27.6 ttmt -146.88 171.74 14.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 13.8 mtp85 -74.6 141.77 44.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.8 m -66.35 -7.19 17.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -96.81 13.16 29.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -89.2 137.98 31.83 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.094 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.531 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 55.1 mm-40 -92.46 87.97 6.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.254 -176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -125.93 165.73 25.52 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.601 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 36.4 Cg_exo -61.44 -179.15 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.403 2.736 . . . . 0.0 113.712 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.814 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.73 169.28 24.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.451 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 76.8 mt -138.44 122.19 20.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 30.9 m -102.57 156.72 17.43 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.218 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.49 0.662 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.66 12.97 2.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.316 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 33.8 tt0 -80.91 137.69 36.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.219 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.8 p -95.2 130.43 41.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -156.11 178.94 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 173.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 ' HD2' ' A' ' 169' ' ' ARG . 46.2 p -85.96 165.98 16.29 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.522 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.91 87.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.647 0.261 . . . . 0.0 111.597 -173.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -60.76 -43.69 97.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 109.966 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.86 -46.67 80.86 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.277 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.9 -39.26 74.09 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.469 0.481 . . . . 0.0 111.396 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' HD13 ' A' ' 78' ' ' ILE . 15.5 t -58.21 -60.1 4.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.085 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.51 -32.93 74.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.02 -38.41 88.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.602 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 36.8 t -93.63 -37.03 12.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.271 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.4 mp -59.65 -36.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.065 0.459 . . . . 0.0 111.406 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -98.88 -0.51 42.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 8.8 ptm180 -105.74 -2.88 22.73 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.99 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.74 -55.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.074 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -174.2 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.741 -1.219 . . . . 0.0 112.778 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.728 HG21 HG22 ' A' ' 127' ' ' THR . 61.6 p -144.16 169.03 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.588 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD23 ' HE1' ' A' ' 126' ' ' MET . 2.9 mm? -67.98 162.86 23.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 96' ' ' LEU . 23.6 m -79.76 107.28 12.41 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 125' ' ' ASP . 18.4 m -100.06 119.03 60.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 68.8 Cg_endo -84.42 121.9 2.71 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.522 2.148 . . . . 0.0 111.949 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -119.09 2.82 11.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.96 177.35 10.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.452 176.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.25 96.34 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.525 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.4 m -53.21 -47.65 68.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 2.8 mp0 -68.54 -37.98 80.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.19 -44.71 94.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.53 -45.72 74.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.35 76.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.844 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 85' ' ' SER . 23.1 mt -60.41 -52.95 63.04 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.274 -0.17 . . . . 0.0 111.076 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.4 t80 -60.5 -36.39 78.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.925 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.99 -37.53 58.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.295 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -73.98 -42.5 60.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -64.9 -24.23 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 0.0 110.644 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 31.9 ttm-85 -65.74 -26.22 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.373 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.16 11.4 17.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.264 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.1 p -137.83 -52.38 0.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.83 -30.73 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.723 0.773 . . . . 0.0 109.905 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 112.85 126.37 4.55 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 4.8 t30 -59.99 -20.77 59.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.936 0.398 . . . . 0.0 111.146 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.53 17.14 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.299 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.26 161.95 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.653 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 172' ' ' LEU . 10.2 pt-20 -116.24 127.66 54.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.604 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.672 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -122.12 149.53 25.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.478 ' CE3' HG22 ' A' ' 154' ' ' VAL . 76.1 m95 -70.05 154.71 41.6 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -88.47 -0.65 57.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 71.09 12.71 72.14 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.852 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.745 0.307 . . . . 0.0 110.61 -177.508 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.393 0.616 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -78.57 134.37 37.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.32 134.54 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.76 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -87.17 159.82 18.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.601 0.238 . . . . 0.0 110.527 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.492 ' HE1' HD23 ' A' ' 84' ' ' LEU . 6.9 ptp -66.87 -28.61 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.728 HG22 HG21 ' A' ' 83' ' ' THR . 9.2 p -76.45 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.569 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.65 6.08 19.88 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.115 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.7 132.5 47.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -94.74 113.63 25.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -71.71 138.61 21.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 111.824 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.66 -18.2 13.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.842 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -80.9 122.13 26.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.295 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 88.7 mttt -139.19 122.72 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.085 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.21 113.25 13.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 134' ' ' LYS . 61.4 m95 -126.03 122.99 37.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HG2' HD21 ' A' ' 160' ' ' ASN . 19.4 tp10 -76.08 -20.63 57.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.448 0.642 . . . . 0.0 109.337 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.597 178.871 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.18 136.97 37.93 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.606 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 166' ' ' LYS . 58.5 t -135.48 143.91 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.968 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.4 tp -98.35 105.04 17.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.83 111.25 23.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 0.0 110.787 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 -28.19 57.08 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.016 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.26 62.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.975 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.44 -60.35 1.97 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.697 HD21 ' HG2' ' A' ' 137' ' ' GLU . 11.6 p30 -173.33 -34.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.447 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 119.35 15.22 5.57 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.604 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.435 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 33.2 mmtp -93.58 173.97 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -82.93 129.54 35.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.315 0.579 . . . . 0.0 110.614 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.08 -173.25 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.744 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -124.66 143.55 50.67 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.845 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 1.5 tmmm? -152.51 138.69 18.32 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 69.8 mtm180 -60.35 135.46 57.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.557 0.694 . . . . 0.0 111.826 -169.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.613 ' O ' ' HB ' ' A' ' 69' ' ' THR . 3.0 m -59.93 -21.29 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.338 -169.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.74 ' HD2' HG21 ' A' ' 69' ' ' THR . 16.6 tpt180 -97.52 6.33 48.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.381 . . . . 0.0 111.246 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.845 ' HB3' ' HE3' ' A' ' 166' ' ' LYS . 14.1 t70 -95.27 135.94 36.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -92.85 120.47 33.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -167.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.693 HD23 ' HZ1' ' A' ' 166' ' ' LYS . 3.7 pp -131.31 165.03 38.29 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.215 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.8 Cg_exo -73.05 178.12 6.92 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.366 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.672 ' HA ' HG23 ' A' ' 110' ' ' ILE . 4.5 p90 -147.08 175.77 10.45 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.607 -0.683 . . . . 0.0 111.982 -175.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 98.5 mt -141.18 124.07 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.015 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.02 145.33 29.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 0.0 112.23 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.575 176.338 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.679 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -71.52 -4.59 27.61 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 3.1 tt0 -59.17 127.28 31.39 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.7 p -102.72 126.36 49.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.162 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.901 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -156.06 174.37 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 76.2 p -84.18 165.96 17.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.088 0.242 . . . . 0.0 110.611 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' HZ ' ' HA ' ' A' ' 115' ' ' ASN . 85.9 t80 -55.62 -49.82 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.94 -41.7 98.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.264 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.55 -45.33 93.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.993 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.901 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -57.06 -42.38 80.46 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.799 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' HD13 ' A' ' 78' ' ' ILE . 80.6 p -63.17 -36.53 83.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.66 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -93.76 -33.93 13.4 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.288 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.7 t70 -56.99 -59.56 4.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.881 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 47.2 t -59.68 -41.04 89.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.2 mp -60.43 -42.78 92.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.157 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.6 t -68.86 -26.8 65.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.889 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 30.1 mmt180 -73.47 -10.98 60.29 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.792 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.42 43.42 2.54 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.04 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -171.15 -165.48 28.52 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.143 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -134.64 148.65 50.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.2 tt -61.46 136.37 58.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 84' ' ' LEU . 33.7 p -64.1 108.33 1.51 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.992 0.425 . . . . 0.0 111.481 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -109.84 111.12 58.93 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.475 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.34 112.0 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.242 1.962 . . . . 0.0 112.14 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.81 -13.46 24.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.186 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.67 158.6 37.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.63 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.22 95.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.08 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -58.6 -40.98 84.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.326 0.25 . . . . 0.0 111.284 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -64.61 -41.79 95.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.046 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -64.94 -43.95 91.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 109.995 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.51 -46.7 84.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.799 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.94 74.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.309 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 15.7 tp -70.11 -40.67 74.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.303 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -65.51 -40.5 93.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.09 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -67.12 -34.98 78.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.202 0.525 . . . . 0.0 110.91 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -70.76 -25.2 62.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.95 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 58.4 mt -56.09 -55.22 35.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 6.4 mmt180 -51.37 -36.89 45.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.575 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.42 15.06 27.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.99 -170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -153.95 -55.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.74 -27.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.549 0.69 . . . . 0.0 111.04 -171.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.43 127.26 5.68 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -168.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 3.8 t30 -50.61 -41.29 54.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 107' ' ' GLU . 9.4 pt-20 -94.77 36.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.206 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.58 160.68 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.666 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 22.8 mm-40 -110.31 124.89 52.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.488 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -134.21 154.45 37.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.499 ' HB2' HD11 ' A' ' 84' ' ' LEU . 77.6 m95 -70.9 145.88 49.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -91.36 2.25 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 111.795 -171.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 85.01 9.84 79.79 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.842 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 131' ' ' ILE . 4.1 mm? -95.16 159.0 15.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.958 0.379 . . . . 0.0 109.991 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.494 ' HA ' ' HZ ' ' A' ' 70' ' ' PHE . 15.8 t-20 -98.87 100.24 11.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.494 ' HB3' ' HZ3' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -87.52 39.54 0.88 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.928 -172.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -77.95 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.82 -0.55 . . . . 0.0 111.162 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.85 79.28 3.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.857 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.65 126.17 30.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.03 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.91 -70.71 2.98 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.318 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -98.99 106.05 18.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.494 ' HZ3' ' HB3' ' A' ' 116' ' ' ASP . 52.8 m95 -66.89 149.26 50.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.793 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.55 130.37 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 131' ' ' ILE . 14.2 m-20 -74.49 172.95 11.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.778 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 22.7 mmt -64.8 -24.46 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.059 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 p -82.54 -6.38 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.558 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.42 58.42 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.478 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.93 167.11 10.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.471 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -110.97 123.63 50.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.53 152.75 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 175.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -106.31 -6.1 18.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.263 0.554 . . . . 0.0 110.393 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.32 124.65 44.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.149 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 11.8 mmmm -122.32 108.67 13.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -152.24 111.69 3.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 7.7 m95 -136.66 151.11 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.632 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 8.7 tp10 -93.26 -30.68 15.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.0 p -109.47 24.83 12.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 40.6 tt0 -71.13 102.74 2.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.866 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.88 137.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.296 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.0 p -105.51 -22.84 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.178 0.514 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.07 101.93 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.736 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -70.39 127.85 91.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.501 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.21 -65.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.772 2.315 . . . . 0.0 113.311 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -102.49 -34.87 8.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.75 5.14 3.66 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.504 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.77 34.29 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.89 -1.148 . . . . 0.0 113.872 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -77.5 99.57 5.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.9 p -92.7 108.35 19.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -168.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -126.23 84.64 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -135.63 126.79 28.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.042 -168.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -158.12 129.43 6.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.8 107.37 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.483 -173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 166' ' ' LYS . 39.5 t -126.81 154.4 36.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.644 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.1 tt -111.83 122.59 48.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.0 t -109.21 98.56 7.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.151 0.501 . . . . 0.0 109.969 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -72.63 -23.85 77.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.426 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -72.47 -24.11 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 110.614 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.3 -53.23 7.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.65 -41.56 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.101 0.477 . . . . 0.0 110.415 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.68 -2.19 4.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.815 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 57.6 mttt -88.7 163.89 15.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -78.02 146.13 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.851 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.2 m-85 -135.74 -169.1 2.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.153 -172.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 6.6 p-10 -137.15 152.5 50.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.859 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.592 ' HB2' HG21 ' A' ' 154' ' ' VAL . 34.3 mttp -152.78 -167.16 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.79 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.521 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 48.2 mtm180 -86.53 131.84 34.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 68.7 m -69.06 -11.6 60.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -97.52 5.91 48.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 110.823 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.521 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 34.0 m-20 -80.76 134.89 35.89 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -92.56 90.62 7.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.22 0.533 . . . . 0.0 110.508 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -116.83 163.38 22.88 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.913 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 25.0 Cg_exo -64.04 179.92 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.122 2.548 . . . . 0.0 113.106 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.442 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -157.75 163.17 38.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.566 178.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.679 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 79.8 mt -127.29 137.74 56.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 67.6 m -121.45 146.56 46.79 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 85' ' ' SER . 16.7 mm-40 -97.98 110.54 23.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -104.81 150.66 24.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.393 0.616 . . . . 0.0 112.11 -171.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.45 -122.16 0.6 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 181' ' ' VAL . 13.4 tt -145.09 -49.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.014 0.407 . . . . 0.0 110.503 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 180' ' ' ILE . 14.2 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.33 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.66 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 52.5 m-85 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.12 3.09 11.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.157 0.503 . . . . 0.0 111.168 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -75.29 137.04 40.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.631 177.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -97.21 129.41 44.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -161.63 172.45 16.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.755 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.724 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 18.3 p -82.31 167.61 18.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.37 -27.3 67.29 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -62.99 -57.29 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.568 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 5.9 mp0 -63.69 -36.32 83.47 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.37 87.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.436 . . . . 0.0 110.717 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' HD13 ' A' ' 78' ' ' ILE . 22.7 t -72.58 -56.06 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.226 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.55 -45.18 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.498 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -64.97 -52.42 56.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.127 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 12.8 t -66.82 -34.11 77.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.909 0.385 . . . . 0.0 111.209 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -68.11 -34.0 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.184 0.516 . . . . 0.0 110.331 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -28.26 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.281 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 10.7 ptp180 -80.26 0.63 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 110.612 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.99 52.16 8.26 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.032 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.51 -166.93 13.26 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -153.54 139.35 18.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.884 0.342 . . . . 0.0 110.233 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.6 mp -61.08 137.63 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -62.75 108.03 1.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.194 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 7.5 m -106.52 109.24 62.99 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.8 Cg_exo -75.51 117.28 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.749 2.299 . . . . 0.0 112.258 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.79 -5.01 20.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.134 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 173.15 12.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.438 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.82 -39.17 97.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.654 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -56.34 -48.4 76.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.582 0.229 . . . . 0.0 111.51 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.3 -51.59 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.411 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.48 -43.22 73.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.376 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.81 70.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -64.48 -48.79 73.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.24 -43.31 87.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.848 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 101' ' ' ARG . 9.9 tp10 -63.44 -43.42 97.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.344 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -63.4 -34.96 78.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.921 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 77.3 mt -54.35 -45.54 72.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 98' ' ' GLU . 52.2 mtp180 -58.5 -30.93 67.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.618 -173.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -109.43 10.4 25.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.923 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.0 m -138.78 -57.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 110' ' ' ILE . 25.1 t -103.43 -37.83 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.691 0.757 . . . . 0.0 110.55 -171.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.02 126.43 2.57 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -53.21 -37.13 61.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.698 0.285 . . . . 0.0 110.752 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -104.39 34.7 2.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.443 0.639 . . . . 0.0 111.404 -176.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.51 161.72 13.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.278 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 54.8 mt-10 -121.12 126.24 49.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 174' ' ' TYR . 2.6 mp -124.27 146.73 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 83.1 m95 -71.3 137.22 48.34 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -87.2 3.92 44.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.906 0.384 . . . . 0.0 111.393 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 83.81 9.39 82.9 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.514 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 131' ' ' ILE . 9.5 mp -94.85 126.25 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -94.34 142.37 27.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.838 0.352 . . . . 0.0 110.652 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -87.86 84.63 7.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 0.0 109.898 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 51.5 ttp -119.01 -35.09 3.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.94 116.99 28.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.082 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.36 -4.2 46.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.5 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.95 168.64 17.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.02 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.8 -7.88 50.55 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.614 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 130' ' ' ARG . 0.8 OUTLIER -90.31 67.06 6.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.276 0.56 . . . . 0.0 111.053 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -68.61 157.36 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.399 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.35 126.7 55.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.843 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.48 163.94 27.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.951 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 9.0 mmt -64.94 -26.65 68.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.071 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -83.89 -4.9 59.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.683 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.66 56.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.846 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.4 168.12 9.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.424 ' HD3' HG22 ' A' ' 122' ' ' THR . 3.4 tmm_? -110.97 125.41 53.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HD21 ' A' ' 114' ' ' LEU . 23.1 pt -53.88 125.71 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.484 0.659 . . . . 0.0 112.343 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.95 -13.13 29.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.06 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -103.42 127.2 50.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.853 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -131.02 119.35 21.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -149.71 110.02 4.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 139' ' ' GLU . 21.1 m95 -127.34 143.98 51.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -175.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.757 ' HG2' HD21 ' A' ' 160' ' ' ASN . 10.7 tp10 -91.13 -30.1 16.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 10.2 t -94.25 34.6 1.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.213 173.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 136' ' ' TRP . 15.0 tt0 -63.63 101.85 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.83 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tt -76.6 98.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.866 0.841 . . . . 0.0 111.547 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.6 p -121.31 -15.22 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.958 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.65 156.61 42.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.493 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -105.92 108.55 61.85 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.337 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.8 -64.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.905 2.404 . . . . 0.0 111.913 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -131.62 48.34 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.753 0.787 . . . . 0.0 108.977 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.03 -39.83 2.72 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.16 53.13 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.753 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 4.0 pttt -67.41 98.91 0.68 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.463 0.649 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.7 p -139.45 143.78 37.72 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.747 -174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -87.33 148.19 25.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.89 146.42 26.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 27.5 m 83.37 143.9 0.07 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.689 1.243 . . . . 0.0 111.165 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -112.94 146.27 39.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.046 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.63 160.64 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.333 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 57.1 tp -100.34 103.07 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 23.3 t -97.17 104.8 16.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.132 0.491 . . . . 0.0 110.554 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.91 -22.15 77.33 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.721 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -73.81 -16.97 61.13 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.337 0.589 . . . . 0.0 110.594 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.141 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.757 HD21 ' HG2' ' A' ' 137' ' ' GLU . 16.7 p30 -174.51 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.692 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 126.18 15.22 2.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 32.8 mmtp -100.48 175.63 5.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -77.4 131.07 37.84 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.531 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 50.6 m-85 -127.34 176.73 7.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.838 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -113.8 137.4 51.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.537 . . . . 0.0 111.001 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 9.1 mmmm -150.61 137.01 18.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.487 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -57.68 136.65 56.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.446 0.467 . . . . 0.0 110.978 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.724 ' O ' ' HB ' ' A' ' 69' ' ' THR . 5.3 m -60.21 -14.65 18.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -96.65 13.94 26.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.532 0.206 . . . . 0.0 111.548 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.6 146.27 23.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.12 88.47 6.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 110.979 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 pp -128.09 158.08 72.06 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.62 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.6 Cg_exo -62.58 -178.5 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.367 2.711 . . . . 0.0 113.786 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 1.3 p90 -152.25 165.91 33.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 79.9 mt -139.4 130.65 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.925 0.393 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 72.0 m -108.92 143.64 37.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.019 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -89.54 111.0 21.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.494 0.664 . . . . 0.0 110.212 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -124.48 129.68 51.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.428 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.95 -168.49 22.42 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.858 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.07 -52.3 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 0.0 110.252 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.218 179.223 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 174' ' ' TYR . 1.1 p90 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -2.87 20.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 110.766 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.716 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 34.1 tt0 -56.61 122.51 12.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.875 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -89.94 121.13 31.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.339 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.875 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.53 -175.86 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.318 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 31.7 p -78.42 166.42 22.65 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.319 0.387 . . . . 0.0 110.425 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.35 -35.39 77.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -63.58 -51.14 66.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.928 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 4.7 mm-40 -66.7 -37.98 85.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.104 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.875 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -59.74 -40.85 89.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.131 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -66.79 -56.43 10.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.292 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.39 -48.22 81.34 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 12.2 t70 -59.91 -58.95 6.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.898 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.1 t -61.3 -38.85 88.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.171 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.85 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.597 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.9 m -74.23 -9.15 58.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.999 0.428 . . . . 0.0 110.659 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -88.43 -10.09 50.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.82 56.26 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.45 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.0 179.77 17.16 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.115 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.605 0.24 . . . . 0.0 110.751 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 113' ' ' GLY . 15.8 tp -68.68 139.61 55.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 p -62.11 109.77 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 111.487 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 5.2 t -118.87 130.32 24.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 23.6 Cg_endo -93.63 144.24 2.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.364 2.709 . . . . 0.0 113.139 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -108.19 -25.65 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.896 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.695 ' HA ' ' CB ' ' A' ' 133' ' ' TYR . 11.6 t -158.9 -169.99 2.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.128 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.25 -24.93 56.52 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 112.981 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.469 ' H ' HG23 ' A' ' 89' ' ' THR . 17.3 t -56.51 -52.59 64.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.664 0.269 . . . . 0.0 110.62 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -75.99 -37.97 57.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.292 . . . . 0.0 110.332 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.441 ' C ' HD22 ' A' ' 93' ' ' ASN . 0.2 OUTLIER -56.49 -45.21 81.11 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.177 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.51 -46.89 52.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.793 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.25 94.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.098 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.12 -45.69 87.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.88 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.577 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 45.0 t80 -63.89 -34.62 78.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.623 . . . . 0.0 110.297 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -44.13 76.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.851 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.83 -34.08 64.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.394 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 3.8 pp -71.34 -32.89 69.08 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.402 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.83 -30.85 71.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.56 22.31 13.78 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.078 -0.388 . . . . 0.0 111.642 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -151.69 -64.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.008 -0.432 . . . . 0.0 111.513 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.7 t -76.25 -32.45 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.176 0.513 . . . . 0.0 109.631 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.14 -74.76 0.29 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.224 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.433 ' HB3' ' OE1' ' A' ' 107' ' ' GLU . 50.7 t-20 172.98 -62.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 106' ' ' ASN . 2.0 mp0 -86.3 37.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.13 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -98.1 149.05 22.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.04 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 35.4 mt-10 -108.58 127.33 53.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.747 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.587 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.6 mp -122.03 140.34 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 91.9 m95 -69.69 140.81 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.634 HD12 ' HB1' ' A' ' 153' ' ' ALA . 33.5 mt -80.54 0.29 34.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 86.68 -21.77 17.02 Favored Glycine 0 C--N 1.32 -0.342 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.857 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.92 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -94.05 151.97 19.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.228 0.537 . . . . 0.0 110.89 178.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -117.07 132.57 56.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.488 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 123' ' ' TRP . 6.1 p-10 -79.08 126.97 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.288 0.565 . . . . 0.0 110.036 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -162.1 1.11 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.58 62.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.586 ' HB1' ' HB ' ' A' ' 122' ' ' THR . . . -70.49 85.25 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -62.47 108.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.2 -14.3 56.98 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.219 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.586 ' HB ' ' HB1' ' A' ' 119' ' ' ALA . 25.6 m -106.36 104.27 13.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.153 0.501 . . . . 0.0 110.307 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.469 ' CE3' HD23 ' A' ' 114' ' ' LEU . 74.9 m95 -85.03 120.13 26.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.631 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.98 129.53 66.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.92 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 5.1 p30 -86.21 -171.47 3.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.443 0.639 . . . . 0.0 112.45 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.85 -11.18 59.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.172 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.0 p -93.96 -20.63 19.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.321 0.582 . . . . 0.0 109.95 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.29 24.84 9.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.642 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.8 154.17 18.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 110.551 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -109.26 122.0 46.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.812 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.0 pt -66.11 134.04 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.337 0.589 . . . . 0.0 111.589 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -113.64 17.29 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.61 0.719 . . . . 0.0 109.875 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 60.0 t80 -136.71 117.36 13.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.861 -177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.92 107.54 12.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 0.0 111.009 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.61 ' OD1' ' HG3' ' A' ' 162' ' ' LYS . 29.4 t-20 -133.31 110.22 9.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 139' ' ' GLU . 53.4 m95 -123.26 147.04 47.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.993 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.7 tm-20 -89.87 -42.38 11.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 164' ' ' PHE . 9.0 t -117.15 34.86 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.262 -172.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 136' ' ' TRP . 41.8 tt0 -69.22 106.13 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.686 -0.634 . . . . 0.0 109.776 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.621 HG12 ' H ' ' A' ' 142' ' ' ALA . 12.8 tt -116.16 134.9 58.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.986 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 p -102.51 0.84 34.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.0 111.236 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.621 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -106.69 160.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.906 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -107.1 100.99 35.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.194 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.98 -29.26 5.36 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.927 2.418 . . . . 0.0 113.288 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.404 ' CG ' ' HB3' ' A' ' 148' ' ' LYS . 10.3 t70 -64.78 -49.64 69.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 111.355 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.58 41.7 2.88 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.508 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.47 -42.31 0.72 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 145' ' ' ASP . 21.1 ttpp -95.97 126.81 41.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.119 0.485 . . . . 0.0 111.88 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.79 125.58 47.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 168.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.694 ' HG2' ' HD3' ' A' ' 167' ' ' ARG . 43.8 mt-10 -95.76 146.58 24.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.324 0.583 . . . . 0.0 111.691 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 22.2 p-10 -126.02 176.94 6.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.351 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 151' ' ' ASN . 92.7 m 78.79 110.8 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.163 0.914 . . . . 0.0 111.033 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -84.22 143.55 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.464 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 11.5 t -125.15 146.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.821 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.495 ' HB2' HD21 ' A' ' 112' ' ' LEU . 69.0 tp -98.8 100.81 12.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.4 m -93.44 98.51 11.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.383 0.611 . . . . 0.0 110.405 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.13 -13.04 76.3 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.439 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . . . -67.78 -18.22 64.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.826 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.75 -63.99 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.062 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -177.72 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.499 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.23 3.59 14.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.256 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.61 ' HG3' ' OD1' ' A' ' 135' ' ' ASN . 0.7 OUTLIER -81.26 154.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -75.35 137.71 41.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.137 0.494 . . . . 0.0 111.301 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.578 ' HA ' HG22 ' A' ' 138' ' ' THR . 21.9 m-85 -121.68 -179.24 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.608 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -135.41 138.74 43.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.145 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.8 162.89 40.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 168.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.694 ' HD3' ' HG2' ' A' ' 150' ' ' GLU . 8.1 tpt180 -62.7 144.7 56.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.819 0.342 . . . . 0.0 110.758 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.579 ' O ' ' HB ' ' A' ' 69' ' ' THR . 12.3 m -59.99 -11.74 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -100.74 8.97 42.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 172' ' ' LEU . 29.4 t70 -74.76 139.04 43.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.706 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 66.9 mm-40 -92.6 83.05 4.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.817 -174.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.545 HD23 ' OD2' ' A' ' 170' ' ' ASP . 3.7 pp -125.13 161.69 48.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 172' ' ' LEU . 24.3 Cg_exo -63.11 -177.92 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.594 2.863 . . . . 0.0 113.713 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.716 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 7.4 p90 -155.04 178.03 10.66 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.036 -0.415 . . . . 0.0 110.352 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 96.6 mt -145.23 135.27 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 93.9 m -108.52 147.08 32.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 111.34 22.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.577 0.703 . . . . 0.0 109.589 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.73 119.4 36.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.478 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -170.14 174.03 44.21 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.36 118.13 55.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.686 179.316 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.594 ' HZ ' ' HE1' ' A' ' 178' ' ' PHE . 45.4 m-85 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.607 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 13.5 t -74.99 -0.29 18.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.202 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 13.5 mp0 -64.6 124.93 23.14 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.426 0.631 . . . . 0.0 111.416 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -91.01 122.29 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.291 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.742 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.81 -175.4 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.106 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -81.74 166.89 19.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 115' ' ' ASN . 81.8 t80 -62.45 -31.31 72.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.05 -52.37 43.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.93 -38.6 89.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.922 0.392 . . . . 0.0 110.366 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -60.61 -30.41 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.087 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 30.6 m -74.48 -63.6 1.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.305 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.5 -42.61 99.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.332 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.73 -25.03 61.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -174.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 34.9 t -87.16 -43.12 12.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.61 -43.58 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.274 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -71.4 -13.66 61.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.901 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -92.22 11.01 27.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.45 35.21 81.21 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.222 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.74 175.87 21.52 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -142.41 138.87 31.42 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.128 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -58.86 127.3 31.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.42 ' OG ' HD21 ' A' ' 96' ' ' LEU . 23.0 t -55.04 122.49 11.05 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.393 0.433 . . . . 0.0 110.953 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.585 ' HB ' ' OD1' ' A' ' 125' ' ' ASP . 52.3 p -108.94 108.9 60.97 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.213 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 93' ' ' ASN . 70.8 Cg_endo -84.87 110.75 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.378 2.052 . . . . 0.0 112.529 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -101.96 -16.19 16.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.732 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.3 p -129.89 167.99 17.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.226 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.59 91.61 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.271 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.9 m -64.34 -28.75 69.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.11 -34.14 43.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -71.25 -55.85 7.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.002 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -68.02 -17.42 64.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.9 78.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.447 . . . . 0.0 110.309 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.42 HD21 ' OG ' ' A' ' 85' ' ' SER . 64.8 mt -66.98 -38.92 86.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.204 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.556 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 89.9 t80 -59.17 -35.87 74.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.32 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -71.11 -46.89 60.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.91 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -67.18 -43.76 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.488 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HD11 ' A' ' 175' ' ' ILE . 2.9 pp -63.0 -31.0 72.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.579 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 32.5 ttp-105 -65.32 -36.33 83.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.031 177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.58 13.56 25.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 m -149.42 -46.66 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 110' ' ' ILE . 3.5 p -106.65 -23.92 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.28 0.562 . . . . 0.0 110.539 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.45 126.26 4.05 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 8.7 t30 -59.37 -34.03 71.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.424 0.612 . . . . 0.0 111.042 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -88.8 24.06 2.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.385 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -98.11 161.48 13.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.985 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.3 mt-10 -118.38 126.51 52.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.683 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.801 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -120.2 152.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.548 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 76.3 m95 -70.62 146.53 49.98 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.65 HD12 ' HB1' ' A' ' 153' ' ' ALA . 40.2 mt -80.88 -2.5 47.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 74.66 6.3 76.75 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.882 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.43 126.91 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 70' ' ' PHE . 39.6 t30 -93.34 130.13 39.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.09 -176.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.61 80.58 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.716 0.77 . . . . 0.0 110.866 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -108.82 -59.34 1.89 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.86 54.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.151 168.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.36 3.05 8.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.42 87.67 6.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.241 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 134' ' ' LYS . . . 81.38 -70.83 3.03 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.787 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 130' ' ' ARG . 1.5 p -99.42 100.82 11.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 -176.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.4 157.38 34.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.755 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.6 125.18 54.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.056 0.455 . . . . 0.0 110.651 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.585 ' OD1' ' HB ' ' A' ' 86' ' ' THR . 12.8 m-20 -72.32 162.2 29.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.237 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 18.5 mmt -55.52 -30.73 61.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.884 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -85.23 0.16 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.067 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.33 44.58 9.48 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.583 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.55 165.12 20.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.734 0.302 . . . . 0.0 110.954 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 6.8 mtp85 -112.49 120.07 40.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.106 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.652 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -70.68 141.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 111.578 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.2 -21.22 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.832 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -88.4 115.97 26.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 121' ' ' GLY . 7.8 mtmp? -137.96 107.39 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.686 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -137.8 112.92 9.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.933 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 5.5 m95 -119.38 114.49 22.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.809 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 28.7 tt0 -70.97 -37.0 72.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.823 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 164' ' ' PHE . 6.8 t -97.09 22.91 7.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 -176.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.933 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 43.2 tt0 -58.5 114.1 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.097 0.475 . . . . 0.0 111.034 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 tt -99.95 104.24 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 121.79 0.805 . . . . 0.0 109.676 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.447 HG23 ' HG2' ' A' ' 139' ' ' GLU . 1.6 p -105.59 12.98 30.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.955 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.77 150.32 20.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.857 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.476 ' OE1' ' HA2' ' A' ' 146' ' ' GLY . 7.2 tt0 -88.33 113.15 53.98 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.63 -62.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.356 2.038 . . . . 0.0 113.599 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 148' ' ' LYS . 34.6 t70 -129.53 48.17 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.168 0.508 . . . . 0.0 112.081 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.476 ' HA2' ' OE1' ' A' ' 143' ' ' GLN . . . 78.29 12.05 84.71 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.784 170.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.71 -42.47 0.71 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.453 -1.355 . . . . 0.0 113.69 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' A' ' 145' ' ' ASP . 19.2 ptpt -60.09 136.17 57.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.38 0.59 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.8 p -131.8 121.62 24.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.345 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -78.41 105.11 9.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -137.83 148.04 45.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.333 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 166' ' ' LYS . 5.4 t -172.29 165.94 5.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -111.82 106.86 15.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.48 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 166' ' ' LYS . 45.9 t -131.96 140.3 48.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.127 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.55 HD23 HD21 ' A' ' 112' ' ' LEU . 1.5 tm? -106.4 100.91 10.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.1 m -98.43 112.03 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.327 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.64 -23.03 68.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.968 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.39 -28.82 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 111.26 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.95 -62.67 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -169.68 -25.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.017 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.87 20.23 7.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.67 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 162' ' ' LYS . 10.4 mmpt? -93.12 -179.18 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' CH2' HG13 ' A' ' 131' ' ' ILE . 40.3 m0 -82.25 123.91 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.433 . . . . 0.0 111.215 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 87.3 m-85 -126.05 -179.29 4.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -130.1 154.57 47.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.525 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.4 tttp -153.69 -152.68 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -100.21 121.9 42.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.548 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 14.2 m -65.33 -2.48 3.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -112.19 -0.47 15.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.788 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.15 149.68 21.35 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.19 107.7 19.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.9 pp -129.41 167.46 19.94 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.426 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 19.3 Cg_exo -67.01 -177.68 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.133 2.555 . . . . 0.0 113.445 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.801 ' HA ' HG23 ' A' ' 110' ' ' ILE . 34.9 p90 -143.87 179.67 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.304 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 100' ' ' LEU . 76.3 mt -143.1 116.96 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.1 m -112.57 133.73 54.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.146 0.498 . . . . 0.0 112.17 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -94.01 122.02 36.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.177 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.594 ' HE1' ' HZ ' ' A' ' 64' ' ' PHE . 45.9 p90 -135.11 151.85 51.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 120.54 -142.6 15.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.657 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.5 tp -164.82 111.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.196 0.522 . . . . 0.0 110.457 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.466 177.393 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 56.1 m-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.001 0.429 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -68.34 -13.89 62.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.852 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 15.7 mm100 -60.25 132.65 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 111.029 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.553 ' HB ' ' HG2' ' A' ' 171' ' ' GLN . 41.3 p -101.48 143.22 31.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.668 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.73 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.01 -179.2 5.06 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.229 0.331 . . . . 0.0 110.114 178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 71.8 p -84.93 166.47 16.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.49 0.186 . . . . 0.0 110.524 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.18 -49.69 76.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -70.79 -26.44 63.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 109.636 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 68' ' ' LYS . 36.2 tt0 -76.67 -32.49 57.96 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.704 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -66.38 -43.17 86.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.5 p -63.6 -54.21 39.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.651 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.62 -39.56 84.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -64.7 -59.22 4.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.375 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.657 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 22.6 t -61.08 -36.52 79.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 0.0 110.483 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 74' ' ' SER . 1.5 mp -65.82 -34.62 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 -29.13 44.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.657 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 16.3 ptm180 -88.29 1.26 54.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.688 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.68 66.26 1.51 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.493 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.17 167.23 38.77 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.667 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -114.16 133.0 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 85' ' ' SER . 5.5 tt -60.46 134.13 56.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.482 ' N ' HD23 ' A' ' 84' ' ' LEU . 39.6 m -54.09 109.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.805 0.691 . . . . 0.0 112.156 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t -108.23 118.65 51.93 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.52 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.1 Cg_exo -75.75 110.91 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.57 2.18 . . . . 0.0 111.149 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 2.9 pt20 -117.38 -10.19 10.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.619 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.1 p -136.83 164.87 27.27 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.528 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.06 95.3 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.628 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -61.34 -45.13 95.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.876 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.94 -46.51 88.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.517 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -67.75 -37.58 82.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.58 -52.72 64.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.139 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.06 83.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.389 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -61.46 -51.69 67.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.006 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -62.49 -39.69 94.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -64.16 -41.49 97.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -64.07 -35.8 81.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.71 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.9 mt -54.75 -48.99 71.91 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.204 0.526 . . . . 0.0 109.845 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -59.02 -27.81 65.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.375 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -111.36 17.29 20.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.892 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -153.63 -54.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -100.85 -36.65 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.15 -171.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.5 130.25 3.23 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.106 -171.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -35.9 45.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.85 27.83 2.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.848 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.32 161.61 15.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 111.318 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.571 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 4.6 pt-20 -122.87 121.64 36.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.643 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.709 HG23 ' HA ' ' A' ' 174' ' ' TYR . 34.3 mm -120.01 153.36 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.404 ' CE3' HG12 ' A' ' 154' ' ' VAL . 83.2 m95 -70.65 149.26 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.85 HD12 ' HB1' ' A' ' 153' ' ' ALA . 73.7 mt -89.08 -1.78 58.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.41 9.97 69.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.76 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.461 HD21 HD13 ' A' ' 131' ' ' ILE . 8.3 mp -94.78 127.06 40.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.747 0.419 . . . . 0.0 110.286 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -118.44 136.15 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.923 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.57 132.07 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.1 0.476 . . . . 0.0 110.693 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -123.37 -36.66 2.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.15 11.61 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 63.7 45.49 4.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.84 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -123.58 168.48 12.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.3 0.572 . . . . 0.0 111.804 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 -1.94 90.1 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 m -90.93 77.89 6.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -68.11 152.36 45.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.453 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.08 158.19 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.19 175.87 6.44 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.39 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.37 -20.56 65.58 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.5 p -87.25 -7.63 57.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.162 0.437 . . . . 0.0 111.117 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.55 21.16 29.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.837 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.08 164.54 11.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 0.0 110.424 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -108.02 133.63 52.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 HD21 ' A' ' 114' ' ' LEU . 42.8 pt -75.96 125.92 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.279 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.34 -22.81 28.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.608 . . . . 0.0 109.727 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -92.3 120.83 33.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.534 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 136' ' ' TRP . 55.1 tttt -144.01 119.1 10.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -156.66 113.17 3.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.55 ' CD1' ' HG3' ' A' ' 134' ' ' LYS . 42.5 m95 -124.31 140.94 52.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.44 -170.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 17.7 mm-40 -89.75 -11.86 41.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.251 174.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 8.3 t -133.33 17.13 4.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -170.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -103.6 137.76 41.21 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.392 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.476 ' HB ' ' OE1' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -94.64 161.73 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.043 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.1 p -110.79 -74.98 0.63 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.846 0.355 . . . . 0.0 111.385 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.2 90.39 3.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.398 0.618 . . . . 0.0 110.879 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.476 ' OE1' ' HB ' ' A' ' 140' ' ' ILE . 11.4 mp0 -133.19 136.29 27.1 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.977 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -15.43 23.19 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.205 1.937 . . . . 0.0 111.48 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.62 -56.34 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.532 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 54.61 23.23 27.76 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.585 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.82 53.27 4.33 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -62.9 99.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -132.76 144.32 50.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.863 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.82 108.92 11.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.685 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 3.9 p-10 -129.95 175.53 8.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.859 -165.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 35.4 m -137.97 132.42 32.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.163 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.85 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.6 133.24 39.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.567 -171.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CE3' ' A' ' 111' ' ' TRP . 27.3 m -128.26 164.2 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.629 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 112' ' ' LEU . 55.8 tp -111.75 107.33 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.48 103.77 14.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.976 0.417 . . . . 0.0 110.601 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.7 -32.18 74.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.243 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.54 -22.89 65.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.026 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -54.15 8.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.478 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 162' ' ' LYS . 9.6 p30 175.61 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.029 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 127.16 -11.88 6.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.534 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.515 ' HG2' ' OD1' ' A' ' 160' ' ' ASN . 31.5 mmtp -83.72 176.67 8.79 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.433 0.616 . . . . 0.0 109.981 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.472 ' HB3' HD11 ' A' ' 112' ' ' LEU . 43.1 m0 -85.86 136.85 33.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 23.6 m-85 -127.55 -168.01 1.83 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.465 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.685 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 2.8 t70 -133.86 140.88 47.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.382 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HE2' HD23 ' A' ' 172' ' ' LEU . 9.2 ttpt -145.88 146.8 31.24 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 165.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.53 140.34 46.28 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.806 0.812 . . . . 0.0 112.538 -163.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.9 m -56.78 -25.33 55.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.59 -161.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -99.08 15.99 24.1 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.16 -176.24 6.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.553 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 31.7 tt0 -132.33 97.65 4.17 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.544 -171.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.1 pp -130.2 168.01 18.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.681 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.597 ' O ' HD12 ' A' ' 172' ' ' LEU . 17.1 Cg_exo -67.26 -178.98 1.61 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.188 2.592 . . . . 0.0 113.321 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.709 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -159.05 158.72 33.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.241 -0.287 . . . . 0.0 110.368 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.432 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 58.2 mt -126.49 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.61 126.17 49.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.264 0.554 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.93 115.37 30.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.197 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -141.89 159.14 42.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.85 -59.68 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 38.8 mt -107.04 -70.89 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.306 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.767 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 70.4 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.044 0.45 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -72.9 -4.07 29.68 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.442 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 1.2 tm0? -58.1 122.15 12.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.204 0.525 . . . . 0.0 110.083 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -96.56 113.41 24.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.46 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.673 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -148.39 177.03 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -77.51 165.7 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.474 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 85.5 t80 -59.17 -38.53 79.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -59.73 -53.14 61.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.779 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -63.15 -37.8 88.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.516 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.673 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -56.95 -43.29 81.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.43 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.575 ' O ' HD13 ' A' ' 78' ' ' ILE . 19.4 m -66.93 -59.69 3.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.311 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -53.21 -44.38 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.761 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.683 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 6.3 t70 -70.36 -41.95 72.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.727 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -62.45 -31.87 72.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.362 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -58.92 -36.47 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.387 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 -14.32 28.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 21.4 mmt180 -87.61 -24.68 23.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.886 0.374 . . . . 0.0 110.968 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.68 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.29 -37.57 0.98 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.889 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -146.83 158.34 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.147 0.473 . . . . 0.0 111.942 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 85' ' ' SER . 5.7 tt -90.8 150.75 21.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 20.9 m -60.94 109.05 0.96 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.915 0.388 . . . . 0.0 111.179 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 112' ' ' LEU . 18.0 p -113.14 106.02 55.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.484 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.31 135.23 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.232 1.955 . . . . 0.0 111.858 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 14.1 mm100 -107.69 -26.02 11.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 110.073 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.1 m -136.15 165.84 24.78 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.903 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.19 -28.13 53.68 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.337 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 p -61.2 -50.05 74.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.635 0.255 . . . . 0.0 111.07 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.76 -39.13 73.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.034 0.445 . . . . 0.0 109.986 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -59.42 -48.37 81.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.328 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.93 -34.88 69.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.691 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.19 -31.04 72.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -45.61 93.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.769 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.702 ' CE2' ' HA2' ' A' ' 161' ' ' GLY . 78.5 m-85 -59.92 -40.78 90.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.287 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 5.3 mm-40 -59.97 -44.68 94.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.294 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -75.81 -39.62 56.51 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.642 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HA ' HG23 ' A' ' 104' ' ' VAL . 1.9 pp -67.99 -37.14 81.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.265 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 25.9 mtm180 -69.73 -8.63 49.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 46.7 mt-30 -119.2 17.25 13.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.598 0.237 . . . . 0.0 111.027 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -152.07 -62.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.166 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.4 t -76.76 -35.57 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 146.17 -76.92 0.27 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.146 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 50.6 t30 173.8 -57.46 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.81 39.65 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.863 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.45 139.81 36.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 111.749 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HB3' HG21 ' A' ' 154' ' ' VAL . 2.9 mp0 -99.55 124.38 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.271 171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 174' ' ' TYR . 5.2 mp -126.24 143.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.044 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -70.61 150.77 45.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.7 mt -97.25 6.4 48.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 112.01 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.92 16.39 52.04 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.733 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 123' ' ' TRP . 5.0 mp -109.33 134.15 52.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.731 0.412 . . . . 0.0 111.0 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -122.39 137.26 54.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 110.441 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -118.58 129.07 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.903 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -117.09 -24.38 7.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.338 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.78 14.26 26.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 62.72 42.54 8.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.69 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.6 163.92 13.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.705 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.25 -14.17 59.22 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -89.78 79.56 6.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.53 0.681 . . . . 0.0 110.105 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.424 ' HB2' HD23 ' A' ' 114' ' ' LEU . 26.6 m95 -68.6 147.55 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.282 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.87 134.59 48.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.209 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 172.1 13.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.973 0.416 . . . . 0.0 110.532 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.3 ptp -55.8 -32.62 63.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.8 p -84.25 -23.13 30.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.542 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.96 4.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.981 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.34 154.7 21.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.043 0.449 . . . . 0.0 110.827 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -109.01 146.45 33.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.832 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.685 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -87.46 163.32 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.514 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.88 13.78 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.377 0.608 . . . . 0.0 110.018 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 25.5 t80 -139.39 124.34 18.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.861 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 51.5 pttt -143.32 115.71 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -120.32 113.17 19.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.477 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 55.2 m95 -112.93 128.29 56.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -88.05 -47.63 8.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p -84.06 39.56 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.822 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -61.25 102.28 0.21 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.9 tt -88.33 110.04 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.401 0.62 . . . . 0.0 109.632 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.28 -24.11 18.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -127.61 127.05 43.17 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.169 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' OE1' ' HA2' ' A' ' 147' ' ' GLY . 63.3 mt-30 -82.75 106.13 6.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 89.8 Cg_endo -77.98 -27.7 5.55 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.639 2.226 . . . . 0.0 113.437 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.22 -38.42 14.26 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.281 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.24 -10.28 5.34 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.443 ' HA2' ' OE1' ' A' ' 143' ' ' GLN . . . 151.65 36.56 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.08 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -83.42 109.87 17.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.9 p -111.57 131.84 54.97 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.624 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -95.21 143.5 26.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.463 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -122.45 158.68 29.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 57.4 m 70.94 100.13 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 124.045 0.841 . . . . 0.0 110.367 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.96 145.33 38.18 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.19 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 166' ' ' LYS . 13.2 p -125.94 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.322 0.582 . . . . 0.0 110.618 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 7.9 tt -91.73 123.62 35.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.2 t -108.96 121.04 44.29 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.67 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . -74.23 -53.75 6.68 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.218 -170.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.08 -1.05 52.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.734 0.302 . . . . 0.0 111.698 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.21 -35.23 66.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.743 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -177.78 -27.67 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.702 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . 92.28 29.89 10.71 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.481 -171.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 72.6 mmtt -126.49 175.9 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -85.66 138.1 32.38 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.53 171.76 10.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.751 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.9 150.1 39.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.004 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HB2' HG11 ' A' ' 154' ' ' VAL . 34.7 tttt -153.51 -174.81 5.09 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -74.07 126.9 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 42.9 t -60.33 -22.99 63.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -99.77 17.65 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.621 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.26 137.51 36.64 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.04 99.52 12.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.284 0.564 . . . . 0.0 111.106 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 2.5 pp -128.88 164.23 40.13 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.605 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 36.8 Cg_endo -64.49 178.2 1.79 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.661 2.241 . . . . 0.0 113.191 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.933 ' HA ' HG23 ' A' ' 110' ' ' ILE . 12.1 p90 -152.69 174.2 14.29 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.554 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mp -131.51 126.89 58.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.599 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 2.4 t -102.21 149.46 24.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.794 0.331 . . . . 0.0 110.873 -172.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.53 126.93 54.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.783 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -132.17 171.0 14.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.616 ' O ' HG12 ' A' ' 180' ' ' ILE . . . 84.79 -51.59 4.58 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.189 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 179' ' ' GLY . 7.4 pt 63.15 -24.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.614 1.566 . . . . 0.0 113.998 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 179' ' ' GLY . 3.3 p . . . . . 0 C--O 1.248 0.976 0 O-C-N 122.049 -0.407 . . . . 0.0 110.44 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.51 HG23 HG13 ' A' ' 104' ' ' VAL . 1.5 m -71.53 -10.39 59.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.887 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 8.1 mm-40 -64.18 141.82 58.63 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.201 0.524 . . . . 0.0 110.258 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -95.61 147.79 23.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.177 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.56 172.29 8.25 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.078 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 80.8 p -82.43 166.52 19.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 67.3 t80 -60.89 -36.4 79.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.626 0.251 . . . . 0.0 111.52 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -59.52 -50.36 74.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.21 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -64.83 -40.74 95.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.222 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.48 -39.85 73.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.3 m -64.53 -61.9 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.573 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.86 -37.29 86.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.895 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 13.3 t70 -66.84 -47.14 72.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 42.0 t -66.02 -30.35 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.378 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -59.06 -32.09 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.153 0.501 . . . . 0.0 110.179 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -83.21 -32.37 26.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.888 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.589 ' HB2' ' SG ' ' A' ' 176' ' ' CYS . 29.0 mmt180 -77.99 -26.03 48.4 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.679 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.49 -57.33 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.017 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 140.42 -23.79 2.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 p -141.23 136.45 31.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 85' ' ' SER . 5.1 tt -77.21 151.83 35.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.607 ' N ' HD23 ' A' ' 84' ' ' LEU . 7.5 t -67.23 108.88 2.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.102 0.477 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 125' ' ' ASP . 55.7 m -113.58 114.75 47.25 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 163' ' ' TRP . 11.5 Cg_exo -71.82 112.04 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.79 2.326 . . . . 0.0 111.794 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.87 -13.18 16.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.89 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.21 154.91 50.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.527 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.82 -53.09 44.29 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.337 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -56.77 -38.23 72.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.829 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.29 -42.48 93.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.131 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -70.02 -43.09 72.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.98 -39.16 93.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.396 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.84 88.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 20.9 tp -67.11 -45.64 76.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.979 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.53 -40.23 93.9 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.501 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.49 -46.08 90.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.01 -31.61 72.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.026 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.7 mt -56.89 -44.16 82.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.699 0.285 . . . . 0.0 110.658 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 36.0 mtm180 -71.9 -10.07 59.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.995 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -122.19 18.17 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.5 t -154.87 -58.92 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 110' ' ' ILE . 12.2 t -96.36 -36.61 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.449 0.642 . . . . 0.0 110.086 -170.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.6 128.67 3.19 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 54.2 t30 -55.29 -33.88 63.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.013 0.435 . . . . 0.0 110.352 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.688 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 45.9 mt-10 -93.01 26.18 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.132 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.11 160.16 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.7 124.05 40.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.296 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 174' ' ' TYR . 42.5 mm -116.03 146.24 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.164 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.541 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 71.6 m95 -71.33 147.71 47.79 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.574 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.2 mm? -107.22 8.74 30.12 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.259 -0.276 . . . . 0.0 111.668 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.22 43.48 97.15 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.256 0.462 . . . . 0.0 114.256 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 153' ' ' ALA . 1.5 pt? -139.17 155.42 47.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.14 159.27 44.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.564 0.221 . . . . 0.0 111.441 -174.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -117.25 150.65 38.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.2 ttp -126.31 -49.01 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 -176.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.49 -65.23 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.456 . . . . 0.0 111.259 -174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 147' ' ' GLY . . . -166.18 50.71 0.08 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.183 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.44 108.02 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.623 -171.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.9 -35.13 58.42 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -103.29 95.21 5.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.449 ' HB2' HD12 ' A' ' 114' ' ' LEU . 13.3 m0 -51.64 153.72 2.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.144 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.418 HG22 ' HD2' ' A' ' 130' ' ' ARG . 31.6 t -96.56 132.48 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.638 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' HB3' HG21 ' A' ' 86' ' ' THR . 5.1 p30 -83.1 -171.82 3.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.142 0.496 . . . . 0.0 111.3 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.4 mtt -82.16 -14.51 55.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t -98.89 0.39 44.05 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.737 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.29 24.32 16.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.431 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.65 166.42 13.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.961 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' HG22 ' A' ' 124' ' ' VAL . 2.1 mpp_? -100.6 133.22 45.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.479 HD12 ' HZ3' ' A' ' 163' ' ' TRP . 26.5 pt -58.99 124.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 0.0 111.175 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.9 12.59 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.524 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -140.67 127.88 20.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 22.5 mtmt -135.21 118.2 16.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.802 0.334 . . . . 0.0 111.722 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -131.72 111.18 11.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.806 0.812 . . . . 0.0 109.332 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.794 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 38.3 m95 -132.29 137.83 47.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 -174.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.731 ' HB2' ' HD3' ' A' ' 162' ' ' LYS . 20.3 tt0 -97.57 -18.78 18.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -104.11 24.95 10.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.843 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.794 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 8.3 tp10 -64.85 102.54 0.6 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.844 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 15.0 tt -99.56 137.34 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.1 0.476 . . . . 0.0 110.263 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.1 p -113.44 0.84 14.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.666 -175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.57 115.23 27.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.885 175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.44 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -93.6 116.06 65.94 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 -177.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 5.7 Cg_exo -75.0 -51.2 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.836 2.357 . . . . 0.0 111.541 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -94.1 -36.73 11.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.302 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.93 -9.64 1.0 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.343 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 119' ' ' ALA . . . 146.18 13.42 0.19 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.204 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -111.6 143.18 42.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.674 0.737 . . . . 0.0 109.733 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.5 p -132.48 121.13 22.88 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.166 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -72.17 84.34 1.03 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 109.656 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.2 167.12 12.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.42 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 94.2 m -127.89 133.2 49.29 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.818 ' HB3' HD21 ' A' ' 114' ' ' LEU . . . -75.26 139.93 42.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.959 0.409 . . . . 0.0 111.466 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.634 HG11 ' HG3' ' A' ' 166' ' ' LYS . 28.2 m -129.12 159.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.157 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -106.75 100.18 9.7 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.4 m -87.97 101.19 13.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.693 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.83 96.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.151 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -63.27 -25.05 68.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 111.239 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.31 46.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.311 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 160' ' ' ASN . 0.2 OUTLIER 178.82 -40.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 124.41 2.36 8.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.691 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.731 ' HD3' ' HB2' ' A' ' 137' ' ' GLU . 25.8 mttt -83.62 168.45 16.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.488 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 54.6 m0 -85.17 134.62 34.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.482 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.78 177.06 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.881 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.59 153.5 23.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 0.0 111.623 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.634 ' HG3' HG11 ' A' ' 154' ' ' VAL . 37.8 mmtt -149.87 149.27 30.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.65 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -70.34 129.12 38.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 13.4 m -64.36 -1.1 1.52 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -96.32 2.65 52.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.62 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -77.17 136.37 38.58 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 68' ' ' LYS . 9.6 tt0 -98.49 90.24 4.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.279 0.562 . . . . 0.0 110.888 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.1 pp -125.87 168.83 12.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.576 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.429 ' O ' HD12 ' A' ' 172' ' ' LEU . 12.4 Cg_exo -69.31 174.64 8.82 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.79 2.327 . . . . 0.0 112.369 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.3 p90 -152.39 172.62 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.97 129.7 54.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 80' ' ' ARG . 8.2 t -102.16 136.3 42.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.043 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -96.97 110.73 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.984 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -115.09 159.71 20.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.171 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.93 -164.49 24.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.854 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 180' ' ' ILE . 28.3 mt 70.55 17.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.19 0.995 . . . . 0.0 109.428 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.702 179.334 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 55.7 m-85 . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.458 HG23 HG13 ' A' ' 104' ' ' VAL . 2.0 m -73.31 -6.18 44.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 12.3 mm-40 -63.91 134.1 54.52 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.531 0.681 . . . . 0.0 111.289 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -94.01 133.39 37.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.987 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.45 177.23 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.434 175.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -77.61 165.27 24.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.533 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 89.1 t80 -62.28 -37.65 86.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.211 0.529 . . . . 0.0 110.554 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -62.97 -46.51 87.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.16 -38.77 82.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -57.75 -35.92 71.39 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 78' ' ' ILE . 48.1 m -64.67 -58.67 5.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.383 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -57.66 -43.5 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.347 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 23.0 t70 -64.26 -59.09 4.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.98 -30.28 70.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.714 0.293 . . . . 0.0 111.406 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 74' ' ' SER . 1.2 mp -60.82 -29.82 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -98.76 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 32.4 mmt180 -80.4 -25.78 38.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.757 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.71 -50.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.15 -41.03 1.19 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.519 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -142.37 139.6 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.595 0.198 . . . . 0.0 110.867 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 85' ' ' SER . 6.6 tt -77.33 147.11 36.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.8 m -62.28 108.67 1.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.0 111.048 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 125' ' ' ASP . 15.8 p -107.63 110.53 62.74 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.378 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' A' ' 112' ' ' LEU . 97.5 Cg_endo -80.59 140.94 13.56 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.584 2.189 . . . . 0.0 111.509 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.4 pt20 -129.52 -10.25 4.56 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.305 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.6 p -141.9 177.39 8.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.98 68.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.952 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -61.85 -48.91 78.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.317 0.247 . . . . 0.0 111.271 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -68.84 -37.82 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.539 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.39 -39.74 88.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.15 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 36.0 t70 -68.42 -49.75 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.097 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.95 77.36 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.424 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.59 -42.81 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.6 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.521 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 2.0 t80 -61.17 -36.21 79.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 9.8 mm-40 -70.08 -46.38 65.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.0 -39.7 75.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.216 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 108' ' ' ALA . 4.1 pp -65.55 -34.47 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.677 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 66.8 mtm180 -71.98 -9.58 58.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.698 0.285 . . . . 0.0 111.437 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -111.23 12.09 21.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.748 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -59.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 111.085 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' ALA . 2.1 t -77.94 -33.3 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.163 0.506 . . . . 0.0 109.896 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 138.09 -73.56 0.42 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.579 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 39.2 t30 175.29 -54.69 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.842 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 46.0 mt-10 -78.91 36.48 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 100' ' ' LEU . . . -79.61 130.38 35.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.095 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.05 121.54 44.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.828 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.5 mp -126.8 141.42 46.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -70.46 148.96 47.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 153' ' ' ALA . 90.1 mt -98.93 5.95 47.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.728 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.53 9.31 43.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.35 136.7 39.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.437 0.295 . . . . 0.0 111.07 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -133.13 133.34 42.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.874 0.368 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -117.38 119.21 34.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.787 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -116.96 -37.58 3.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.636 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.09 22.3 15.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.759 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 65.7 63.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.378 0.609 . . . . 0.0 111.218 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -102.52 129.13 48.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.403 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.33 -33.64 58.65 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.788 HG22 ' HB2' ' A' ' 130' ' ' ARG . 21.1 m -97.25 86.09 3.84 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -52.12 141.64 18.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.954 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.16 138.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.519 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -88.24 178.7 6.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 126' ' ' MET . 6.8 ptp -64.52 -32.64 74.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.9 p -76.56 -22.77 53.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.014 -175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 113.22 20.6 6.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.61 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.85 160.59 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.788 ' HB2' HG22 ' A' ' 122' ' ' THR . 0.0 OUTLIER -109.81 154.19 23.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.839 177.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.09 143.63 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.15 -18.46 20.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.153 0.501 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 20.3 t80 -119.52 120.7 37.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.644 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -144.34 131.4 20.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 111.151 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.99 136.09 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.413 0.625 . . . . 0.0 110.189 171.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -129.99 123.3 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.066 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 164' ' ' PHE . 67.3 mm-40 -74.72 -27.05 60.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.285 0.564 . . . . 0.0 109.873 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.662 HG23 ' HD2' ' A' ' 164' ' ' PHE . 11.5 p -84.55 15.37 3.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.236 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -56.19 104.86 0.16 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.846 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 143' ' ' GLN . 10.3 tt -98.96 121.09 49.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.1 p -105.22 -25.25 12.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.117 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.63 102.05 8.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.267 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.638 ' HA ' HD11 ' A' ' 140' ' ' ILE . 71.0 mt-30 -76.42 109.34 8.28 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.139 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.534 ' HD3' HD11 ' A' ' 140' ' ' ILE . 5.5 Cg_exo -72.53 -61.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 0.0 112.67 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -67.86 -33.11 74.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.992 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.5 -25.23 1.68 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.976 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.33 18.58 0.06 OUTLIER Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.237 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -66.62 106.74 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 174.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.8 p -125.83 163.43 22.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.081 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 22.9 mm-40 -87.39 178.3 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 110.965 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 84.1 m-20 -133.05 132.32 41.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.419 -173.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 151' ' ' ASN . 80.7 m 75.72 141.02 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.148 0.499 . . . . 0.0 110.999 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.618 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -91.91 139.17 30.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.878 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 p -133.41 141.43 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.681 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.616 ' HB2' HD21 ' A' ' 112' ' ' LEU . 2.4 tt -91.22 123.53 34.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -108.4 106.19 16.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.175 0.512 . . . . 0.0 110.633 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.18 1.61 84.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.11 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.842 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -101.27 5.38 42.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.104 0.478 . . . . 0.0 110.556 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.8 -53.17 2.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.778 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -173.38 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.296 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 111.74 -2.57 27.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.886 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 34.9 mmtp -76.31 -179.04 4.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HZ3' HG13 ' A' ' 131' ' ' ILE . 49.9 m0 -94.39 134.02 37.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.241 0.543 . . . . 0.0 109.796 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.662 ' HD2' HG23 ' A' ' 138' ' ' THR . 91.9 m-85 -126.02 165.28 19.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.883 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.54 144.21 44.63 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.698 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 72.6 tttt -144.93 -171.89 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.698 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 1.2 mmt180 -72.54 125.54 27.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 9.4 t -69.54 -19.82 63.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.386 0.612 . . . . 0.0 110.076 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -94.73 12.31 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.233 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 20.0 t70 -80.59 136.1 36.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -93.8 93.44 7.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.229 0.538 . . . . 0.0 110.945 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.56 169.69 9.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.736 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 16.6 Cg_exo -68.77 -179.1 2.27 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.995 2.464 . . . . 0.0 113.049 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.828 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.2 p90 -156.57 171.55 20.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.874 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.15 125.96 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 13.8 t -102.29 133.91 46.42 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -92.24 111.06 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -110.76 174.28 5.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.513 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.83 -36.64 4.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.2 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.614 HG12 ' H ' ' A' ' 181' ' ' VAL . 0.1 OUTLIER 34.8 -96.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.331 1.053 . . . . 0.0 113.286 -177.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.614 ' H ' HG12 ' A' ' 180' ' ' ILE . 3.7 p . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.994 -0.527 . . . . 0.0 110.378 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 16.8 p -77.14 -8.54 57.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 13.6 mm-40 -64.96 141.92 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.2 p -99.06 144.49 28.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.769 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.781 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.59 -179.7 3.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.34 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 74.4 p -80.3 164.97 22.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 85.3 t80 -62.34 -35.35 78.84 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -59.37 -52.14 66.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.329 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.6 mt-10 -64.25 -37.14 86.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.781 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -61.52 -43.65 98.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.9 m -65.67 -55.92 14.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.805 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -60.92 -34.27 74.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.883 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 17.1 t70 -69.95 -51.63 31.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.45 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.3 t -63.07 -34.33 77.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -56.85 -31.03 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.498 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 -37.59 20.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.59 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 31.6 mmt180 -71.8 -26.56 62.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 111.072 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.25 -48.95 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.884 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 131.82 -26.37 3.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.972 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 p -135.14 128.09 31.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.924 0.362 . . . . 0.0 111.429 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 85' ' ' SER . 6.1 tt -74.88 146.53 41.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.555 ' N ' HD23 ' A' ' 84' ' ' LEU . 5.0 t -65.68 108.94 2.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.155 0.502 . . . . 0.0 110.448 -172.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.538 HG21 ' HB3' ' A' ' 125' ' ' ASP . 28.3 m -116.27 114.1 40.94 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.344 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 2.1 Cg_endo -79.56 137.97 13.34 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.663 2.242 . . . . 0.0 112.076 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -114.51 -13.55 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.276 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.65 165.08 28.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.981 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.82 -42.97 94.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.755 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.6 p -55.76 -44.53 77.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -42.64 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.85 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -65.38 -45.51 83.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -38.95 91.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.53 84.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.893 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.6 tp -66.07 -43.38 87.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -59.74 -40.78 89.23 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.12 -36.88 77.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.29 -36.8 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 59.7 mt -54.39 -52.08 62.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.0 109.75 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ttm-85 -56.54 -33.35 66.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.006 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -101.4 -1.46 33.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.2 t -140.16 -50.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.797 HG11 HD11 ' A' ' 110' ' ' ILE . 7.3 t -98.02 -30.15 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.605 0.717 . . . . 0.0 110.503 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.37 125.54 3.63 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -49.89 -42.49 48.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 158' ' ' ALA . 45.6 mt-10 -94.21 47.83 1.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 111.263 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.74 145.54 41.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 10.9 mm-40 -98.52 123.82 42.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.862 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.797 HD11 HG11 ' A' ' 104' ' ' VAL . 43.0 mm -121.83 142.85 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.367 -0.133 . . . . 0.0 111.192 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 64.0 m95 -70.61 145.84 50.44 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 82.2 mt -111.03 16.49 21.13 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.3 -27.67 0.83 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.562 HD12 ' HB2' ' A' ' 123' ' ' TRP . 1.6 pt? -94.56 142.08 27.85 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.123 0.962 . . . . 0.0 110.913 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -145.06 161.66 38.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.046 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -102.86 141.98 34.75 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 53.0 ttp -127.46 -43.15 1.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.848 0.356 . . . . 0.0 111.75 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.65 -67.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.408 -174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.22 62.91 0.05 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.61 137.6 32.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.294 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.69 -53.69 1.91 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.56 105.35 17.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 169.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.562 ' HB2' HD12 ' A' ' 114' ' ' LEU . 16.9 m0 -62.3 150.03 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.205 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.47 138.19 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.72 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.66 ' OD2' HG22 ' A' ' 127' ' ' THR . 1.1 p-10 -99.89 -162.12 0.92 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.94 -33.57 51.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.375 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.66 HG22 ' OD2' ' A' ' 125' ' ' ASP . 14.4 t -83.03 -21.4 33.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.024 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.84 32.05 6.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.498 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.19 157.54 15.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 130' ' ' ARG . 0.3 OUTLIER -107.97 118.39 36.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.128 177.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.6 pt -64.34 125.41 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.341 0.591 . . . . 0.0 111.011 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.84 -20.75 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.528 0.68 . . . . 0.0 109.904 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -110.65 127.55 55.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.765 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -129.53 114.44 16.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.617 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -129.41 111.21 12.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.381 0.61 . . . . 0.0 109.772 172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.994 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 31.6 m95 -125.99 124.14 40.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . 7.4 tp10 -77.68 -25.83 49.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -103.23 25.09 9.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.588 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.994 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 40.2 tt0 -61.7 137.15 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.787 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 142' ' ' ALA . 12.6 tt -123.18 119.01 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 p -75.63 -3.57 35.19 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -127.42 91.31 3.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.04 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 2.7 pt20 -67.64 113.06 12.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.686 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 73.3 Cg_exo -48.99 -67.12 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.041 3.161 . . . . 0.0 114.539 -168.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -95.32 17.31 14.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.055 0.455 . . . . 0.0 111.394 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.42 -24.03 27.0 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.668 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.69 50.34 0.23 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 148' ' ' LYS . 8.6 ttpp -123.89 105.9 10.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.676 0.274 . . . . 0.0 110.534 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.9 p -136.16 157.08 47.68 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.663 0.268 . . . . 0.0 110.647 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.15 80.94 6.21 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.98 150.89 31.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.216 0.532 . . . . 0.0 110.411 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 71.6 m -125.24 136.99 54.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.14 134.82 41.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 28.7 m -120.46 156.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -103.63 101.14 10.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.3 m -84.64 91.57 7.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.486 0.66 . . . . 0.0 110.61 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.77 -22.39 78.72 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.523 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.473 ' HA ' ' HG2' ' A' ' 107' ' ' GLU . . . -69.89 -15.83 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.136 0.493 . . . . 0.0 110.27 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.85 -65.27 0.99 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -167.19 -37.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 131.05 -4.15 5.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.364 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -77.34 174.68 10.52 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.112 0.456 . . . . 0.0 110.107 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -89.78 133.49 34.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.85 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 42.1 m-85 -119.78 166.89 12.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -104.62 144.38 31.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.272 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.412 ' HD2' HG11 ' A' ' 154' ' ' VAL . 52.1 mttt -146.09 150.93 36.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.911 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.12 130.35 39.08 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.504 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 6.0 m -65.14 2.96 0.67 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -95.21 -4.58 45.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.01 132.14 41.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.782 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -93.21 97.92 10.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.2 pp -129.05 166.11 27.48 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.588 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 14.8 Cg_exo -67.08 171.13 11.77 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.721 2.281 . . . . 0.0 112.233 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -137.77 174.33 10.69 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.498 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 93.2 mt -137.8 123.55 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 10.1 t -102.08 130.51 48.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -91.46 110.58 21.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.019 0.438 . . . . 0.0 109.967 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -118.59 135.2 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.167 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -115.8 -177.52 18.4 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.1 mt 62.2 67.5 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.744 -178.652 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 74.0 m-85 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.057 0.456 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 2.4 m -74.38 0.28 14.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.587 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.55 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -65.98 127.56 32.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -102.29 123.95 47.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.664 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -150.07 174.73 12.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.606 -177.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 82.5 p -80.61 166.57 20.98 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.382 0.427 . . . . 0.0 110.227 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' HZ ' ' HA ' ' A' ' 115' ' ' ASN . 91.6 t80 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.556 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -60.95 -41.71 96.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.359 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -54.99 -39.96 69.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.239 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.725 ' O ' HG12 ' A' ' 78' ' ' ILE . 37.7 m -64.09 -69.64 0.27 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.55 -44.6 73.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 19.9 t70 -60.52 -58.92 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.917 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -58.57 -42.06 87.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.16 0.287 . . . . 0.0 111.215 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 74' ' ' SER . 42.2 mm -57.51 -41.23 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.324 0.583 . . . . 0.0 110.413 175.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 t -72.64 -24.26 61.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.702 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.1 mmp_? -74.79 -10.33 59.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.386 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.01 37.72 5.63 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.004 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.68 -170.22 27.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.189 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -130.26 146.74 51.9 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.6 tt -63.32 138.03 58.39 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 84' ' ' LEU . 30.3 p -61.83 109.33 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.371 0.419 . . . . 0.0 111.579 -174.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.541 HG22 ' HA3' ' A' ' 113' ' ' GLY . 47.2 p -110.0 107.73 58.93 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.969 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 14.6 Cg_exo -68.5 111.33 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.085 1.857 . . . . 0.0 112.576 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' NE2' ' H ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -85.41 -27.96 25.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.6 p -129.56 173.18 10.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.61 -38.95 95.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.12 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -59.27 -43.41 92.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 87' ' ' PRO . 7.3 mm-40 -59.6 -47.81 84.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.997 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -64.14 -44.9 90.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.56 . . . . 0.0 110.203 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.02 -49.21 77.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.912 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.16 67.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.718 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.3 tp -70.64 -47.01 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -60.76 -35.55 76.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.317 0.579 . . . . 0.0 109.946 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.164 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 68.5 t80 -68.24 -27.57 66.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.513 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 22.9 mt -58.64 -54.85 42.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -58.83 -33.2 70.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.141 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 9.2 pt20 -91.62 0.98 57.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t -146.32 -59.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 -28.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.623 0.725 . . . . 0.0 110.698 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.3 119.0 4.55 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -165.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 66.9 t30 -51.54 -36.52 45.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.136 0.468 . . . . 0.0 111.749 -173.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.69 32.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.906 0.384 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.46 139.88 32.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 8.6 mm-40 -94.31 122.36 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -136.85 155.1 32.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.39 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.512 ' HB2' HD11 ' A' ' 84' ' ' LEU . 86.8 m95 -71.44 144.87 49.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.924 0.392 . . . . 0.0 110.694 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.69 -7.25 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -174.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.541 ' HA3' HG22 ' A' ' 86' ' ' THR . . . 81.11 -1.66 84.09 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.535 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 112' ' ' LEU . 3.6 mm? -93.49 139.36 30.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.238 0.519 . . . . 0.0 110.112 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.516 ' HA ' ' HZ ' ' A' ' 70' ' ' PHE . 28.4 t-20 -91.54 154.05 19.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.081 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 6.4 p-10 -99.37 10.99 40.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.503 ' HB2' ' OD1' ' A' ' 115' ' ' ASN . 3.0 tmm? -69.77 -163.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.38 88.77 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 111.023 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 123' ' ' TRP . . . -127.3 85.0 2.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.712 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.14 88.62 5.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 110.689 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.0 -45.48 3.19 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.4 ' O ' ' HB1' ' A' ' 119' ' ' ALA . 26.8 m -95.66 103.16 15.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.416 ' HA ' ' HB1' ' A' ' 119' ' ' ALA . 58.2 m95 -79.83 156.26 27.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.932 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.13 130.18 71.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.762 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.448 ' OD1' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -73.19 164.69 26.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.403 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 17.9 mmt -61.23 -33.39 73.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.55 -5.86 49.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.108 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.75 64.27 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.54 166.72 10.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.061 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -112.53 118.62 35.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.331 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -57.95 150.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.873 174.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -105.79 -5.14 20.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 109.719 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -126.79 115.33 19.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.699 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 1.6 ptmm? -144.41 114.09 7.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.314 . . . . 0.0 111.071 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -136.3 112.31 9.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.93 ' HB2' ' HG3' ' A' ' 139' ' ' GLU . 4.4 m95 -112.43 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 164' ' ' PHE . 2.8 tp10 -68.88 -27.85 66.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.07 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 13.9 p -97.63 25.38 5.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.9 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.93 ' HG3' ' HB2' ' A' ' 136' ' ' TRP . 15.2 mt-10 -65.49 102.79 0.74 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.048 0.451 . . . . 0.0 110.836 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.9 tt -107.04 124.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.665 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.8 p -106.79 4.19 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.873 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.99 148.82 48.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.9 120.86 82.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-O 121.015 0.436 . . . . 0.0 110.211 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.542 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 22.6 Cg_endo -64.84 -72.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.26 1.973 . . . . 0.0 111.418 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 148' ' ' LYS . 6.4 p-10 -103.34 -11.27 18.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.658 . . . . 0.0 109.227 172.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.44 -18.05 1.68 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.962 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.6 53.04 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.567 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.542 ' H ' ' HG2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -87.45 97.07 10.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.5 p -140.07 170.09 16.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.117 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.02 148.52 36.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 5.0 m-20 -93.16 175.64 6.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.3 m 75.73 119.18 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.634 0.73 . . . . 0.0 112.029 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.504 ' HB1' ' HZ3' ' A' ' 136' ' ' TRP . . . -82.04 131.36 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.961 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 166' ' ' LYS . 48.1 t -131.55 147.58 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.482 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 tt -100.98 125.22 47.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.7 t -114.27 98.5 6.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.156 0.503 . . . . 0.0 110.195 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -75.81 -22.24 75.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.294 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.36 -30.48 68.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.106 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.93 -58.68 3.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -176.94 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.384 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.74 -1.38 4.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.025 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.01 167.67 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.407 ' CZ3' ' HA ' ' A' ' 134' ' ' LYS . 46.7 m0 -87.26 144.26 26.89 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 68.8 m-85 -135.99 177.12 8.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.318 0.58 . . . . 0.0 111.418 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.637 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.516 ' HB2' HG21 ' A' ' 154' ' ' VAL . 10.7 tttp -152.85 -170.39 3.62 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -80.14 122.7 27.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.35 -25.3 61.81 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.36 8.77 39.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.6 131.83 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -92.95 96.83 10.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.013 0.435 . . . . 0.0 110.755 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 110' ' ' ILE . 3.1 pp -125.89 164.37 33.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.137 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 16.8 Cg_exo -67.04 -178.38 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.164 2.576 . . . . 0.0 113.011 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -160.51 168.08 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.639 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.497 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 4.4 mp -127.53 133.68 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 69.3 m -110.06 139.21 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -93.83 111.28 22.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -117.66 134.97 54.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 111.307 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.57 -113.05 0.4 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.787 HG12 HG12 ' A' ' 181' ' ' VAL . 6.3 tt -161.61 -68.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.595 0.197 . . . . 0.0 111.067 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.787 HG12 HG12 ' A' ' 180' ' ' ILE . 8.8 p . . . . . 0 C--O 1.245 0.868 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 32.6 m-85 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 p -81.14 -0.95 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.544 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.82 122.72 17.59 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.046 0.451 . . . . 0.0 110.77 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -91.79 111.05 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.377 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.923 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -151.5 -177.14 5.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.372 -177.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.5 p -79.09 167.3 21.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -47.0 84.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.01 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -70.37 -32.64 70.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.38 -43.8 76.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.923 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.51 -38.35 69.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.842 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 78' ' ' ILE . 29.5 t -64.81 -65.71 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.775 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.48 -31.38 72.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.92 -44.76 84.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.18 0.514 . . . . 0.0 109.961 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.524 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 49.5 t -65.21 -45.05 86.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.367 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -60.28 -36.82 71.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.396 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 t -78.6 -19.54 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.629 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.4 ptp180 -91.7 -3.55 56.14 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.016 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.85 45.15 4.0 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.701 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.81 -179.33 36.41 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.104 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 p -135.75 157.41 46.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 ' HE3' ' A' ' 126' ' ' MET . 4.0 mm? -64.27 149.45 48.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -75.05 107.02 6.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.737 HG21 ' HB2' ' A' ' 125' ' ' ASP . 23.4 m -97.61 111.46 58.74 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.488 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HG2' HD22 ' A' ' 112' ' ' LEU . 3.4 Cg_exo -77.67 119.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.168 2.579 . . . . 0.0 112.271 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -13.64 16.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.786 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 92' ' ' GLU . 45.1 p -130.93 170.01 15.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.317 . . . . 0.0 110.679 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.98 65.63 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.189 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.6 p -66.38 -37.94 86.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.35 0.595 . . . . 0.0 110.718 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.584 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 14.8 tt0 -69.71 -40.3 76.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.155 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -61.87 -45.36 94.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.64 -36.74 79.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.76 99.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.979 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.73 -40.59 88.42 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 88.0 t80 -57.85 -45.87 85.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 15.7 mm-40 -68.62 -38.95 80.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.235 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -66.19 -48.11 71.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.875 HD22 HD11 ' A' ' 110' ' ' ILE . 0.9 OUTLIER -65.18 -34.3 78.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 47.5 ttt180 -54.62 -48.78 71.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.092 175.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 98' ' ' GLU . 4.9 pt20 -93.29 11.11 29.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.278 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -134.47 -61.41 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.642 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.526 HG21 HD11 ' A' ' 175' ' ' ILE . 2.9 t -87.79 -32.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.926 0.87 . . . . 0.0 109.61 -172.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 122.26 122.95 2.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.07 -37.58 4.31 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.745 0.418 . . . . 0.0 112.088 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.28 21.63 2.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.96 161.41 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.015 0.436 . . . . 0.0 111.585 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 39.6 mt-10 -121.81 122.37 39.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.711 176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.875 HD11 HD22 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -134.36 150.93 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.027 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -72.19 155.22 40.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.792 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 153' ' ' ALA . 55.5 mt -106.61 6.82 30.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.7 79.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.58 126.61 39.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.771 0.319 . . . . 0.0 111.109 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.14 149.4 24.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -78.65 124.81 28.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.216 0.531 . . . . 0.0 111.227 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.3 tmm? -126.27 -55.29 1.46 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.043 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.25 -22.38 9.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.759 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 68.63 -64.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.008 0.817 . . . . 0.0 111.482 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 120' ' ' GLU . 10.1 pt-20 -74.55 95.23 2.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.527 0.679 . . . . 0.0 111.077 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.28 -70.32 0.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.841 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t -108.78 113.69 26.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.761 0.791 . . . . 0.0 112.063 -174.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.603 ' HH2' ' HA ' ' A' ' 152' ' ' CYS . 28.2 m95 -95.83 156.48 16.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.837 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -118.34 130.32 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.737 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.45 156.78 38.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.761 ' HE3' HD23 ' A' ' 84' ' ' LEU . 9.3 ptp -58.96 -30.25 67.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -173.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 t -106.38 6.75 30.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.239 0.542 . . . . 0.0 111.124 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.5 28.52 9.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.753 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.86 137.99 31.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.012 0.406 . . . . 0.0 110.558 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -91.63 116.14 28.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 38.4 pt -77.78 132.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.05 3.47 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.259 0.552 . . . . 0.0 110.459 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -133.67 116.8 16.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.33 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.01 100.87 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.674 0.749 . . . . 0.0 110.629 172.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -111.14 113.03 25.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.026 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HH2' ' HB2' ' A' ' 153' ' ' ALA . 23.8 m95 -112.99 113.45 25.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.366 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 162' ' ' LYS . 4.9 mm-40 -76.52 -23.83 53.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.62 0.724 . . . . 0.0 109.334 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' A' ' 164' ' ' PHE . 11.7 t -87.71 39.56 0.89 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.775 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -55.68 107.4 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 140' ' ' ILE . 40.3 pt -67.78 116.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.617 0.722 . . . . 0.0 110.887 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.0 p -124.12 5.79 8.55 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.497 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.46 126.65 40.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.768 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -116.19 103.36 53.21 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.202 0.525 . . . . 0.0 109.969 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.72 -62.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.024 2.483 . . . . 0.0 112.524 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.88 -40.17 69.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.25 -17.49 1.34 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.74 -26.17 1.05 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.138 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 24.4 pttt -78.01 98.99 5.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.633 0.73 . . . . 0.0 110.332 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.8 p -136.37 147.88 47.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.789 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 167' ' ' ARG . 47.4 mt-10 -79.55 100.71 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 165' ' ' ASP . 8.5 p30 -134.09 121.24 21.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.604 0.716 . . . . 0.0 110.52 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.603 ' HA ' ' HH2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -149.07 165.92 30.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.481 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.52 108.81 8.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 166' ' ' LYS . 12.3 p -122.07 140.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.643 ' HB2' HD21 ' A' ' 112' ' ' LEU . 31.4 tp -90.03 115.38 27.26 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.0 m -110.74 100.19 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.416 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.98 -19.41 78.76 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.596 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.62 -19.55 65.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 111.412 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.62 -56.48 2.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.44 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -171.58 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 120.13 6.53 9.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.12 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 137' ' ' GLU . 2.2 mptm? -86.96 -178.75 6.36 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.621 -0.341 . . . . 0.0 110.381 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -88.98 131.75 35.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.683 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 95.8 m-85 -125.82 171.1 10.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.552 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 5.5 p-10 -113.25 141.23 47.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB2' HG11 ' A' ' 154' ' ' VAL . 31.5 tttp -145.82 174.87 10.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.669 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 59.7 mtm180 -64.5 124.28 21.42 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.307 0.38 . . . . 0.0 110.25 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 150' ' ' GLU . 55.7 m -72.76 -21.49 61.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.69 15.16 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.676 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 3.8 t0 -87.77 166.01 14.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 68' ' ' LYS . 97.8 mt-30 -122.47 96.01 4.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.124 0.487 . . . . 0.0 111.331 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HB2' ' CD ' ' A' ' 173' ' ' PRO . 3.2 pp -126.29 172.32 6.59 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.741 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 14.7 Cg_exo -69.69 -178.63 2.41 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.563 2.175 . . . . 0.0 112.716 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -153.8 172.18 17.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 104' ' ' VAL . 95.9 mt -142.77 115.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 110.597 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 97.4 m -102.97 155.78 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -89.89 134.73 34.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -134.34 174.87 10.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.26 94.77 0.05 OUTLIER Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.479 -0.391 . . . . 0.0 112.725 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 13.4 tt -99.14 -19.47 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.151 0.501 . . . . 0.0 110.837 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.328 -178.607 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 43.3 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.901 0.382 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -71.53 -12.35 61.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.989 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG2' ' HE1' ' A' ' 174' ' ' TYR . 14.2 pt20 -72.35 135.22 45.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.501 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 p -89.71 138.38 31.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -168.95 166.04 11.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 169' ' ' ARG . 30.4 p -81.94 168.12 18.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 115' ' ' ASN . 31.4 t80 -56.22 -29.14 60.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.64 0.257 . . . . 0.0 110.571 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -60.6 -59.3 5.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.633 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 8.5 mp0 -65.43 -31.42 72.5 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.79 81.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.418 ' O ' HD13 ' A' ' 78' ' ' ILE . 44.5 t -72.64 -56.28 5.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.342 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 3.0 tp10 -56.39 -38.46 71.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.608 -173.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -72.1 -52.82 14.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.091 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 25.2 t -66.42 -37.25 84.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.221 -174.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -62.87 -37.28 78.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 0.0 110.131 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -79.09 -27.03 42.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.738 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.66 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.9 ptp180 -83.23 6.83 18.13 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.757 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.04 43.14 27.55 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.271 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 -171.38 17.57 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 2.1 m -150.43 145.2 25.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.526 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.5 mp -58.72 135.81 57.54 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.7 p -70.37 107.52 3.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.235 0.54 . . . . 0.0 110.814 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 95.0 m -99.9 120.95 55.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.05 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 12.1 Cg_exo -70.37 111.48 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.098 1.865 . . . . 0.0 112.219 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -103.64 -18.96 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.918 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -136.05 177.77 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.213 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.93 -35.51 91.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.275 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -56.45 -43.7 79.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.2 mp0 -60.43 -58.61 7.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.7 0.286 . . . . 0.0 111.187 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -66.19 -41.33 90.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.116 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -40.07 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.551 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.42 -31.45 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.38 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 2.5 tt -60.64 -46.11 91.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 88.5 t80 -59.83 -41.84 92.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.689 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 8.3 tp10 -68.7 -37.73 79.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.103 0.478 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 78.2 t80 -62.85 -35.62 80.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.513 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 66.5 mt -56.4 -48.98 75.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.487 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 42.9 mtp180 -64.95 -17.3 64.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.951 -173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 11.0 pt20 -116.18 9.94 14.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.0 m -153.58 -46.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.951 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 110' ' ' ILE . 30.1 t -104.77 -37.44 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.532 0.682 . . . . 0.0 110.473 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.38 128.56 3.01 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.509 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -55.92 -41.9 75.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.321 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.18 154.78 18.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.207 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 156' ' ' SER . 40.2 mt-10 -122.39 122.39 38.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.984 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 HG11 ' A' ' 104' ' ' VAL . 2.2 mp -121.2 147.51 25.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.069 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 73.5 m95 -71.65 138.89 48.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 155' ' ' LEU . 2.1 mm? -100.93 12.55 37.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.44 81.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.988 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 131' ' ' ILE . 8.4 mp -94.58 125.87 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 31.9 p-10 -124.29 161.0 26.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.539 ' HB2' ' N ' ' A' ' 152' ' ' CYS . 15.2 t70 -80.1 68.63 6.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.669 0.747 . . . . 0.0 110.525 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -103.84 -44.8 4.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.34 104.84 12.19 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.062 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.69 -4.58 52.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.404 0.621 . . . . 0.0 110.272 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.5 163.21 25.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.883 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -26.86 62.93 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.095 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p -86.59 72.88 10.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.624 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.432 ' HB2' ' CD1' ' A' ' 131' ' ' ILE . 36.4 m95 -62.74 149.21 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.836 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.4 133.95 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.362 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' CB ' HG21 ' A' ' 86' ' ' THR . 4.1 p-10 -98.06 -165.47 1.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 0.0 111.123 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' A' ' 84' ' ' LEU . 20.1 mmt -65.37 -37.57 87.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.608 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 78.2 p -82.47 -20.62 36.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.79 0.329 . . . . 0.0 111.317 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.36 28.37 13.2 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.01 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.02 165.4 12.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.05 0.452 . . . . 0.0 110.54 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.409 ' HB2' ' HE ' ' A' ' 130' ' ' ARG . 15.5 ttm180 -99.33 106.96 19.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.526 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 114' ' ' LEU . 44.8 pt -62.41 124.87 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.257 0.551 . . . . 0.0 110.907 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.98 -10.97 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.447 0.641 . . . . 0.0 109.872 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -104.11 116.03 31.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.204 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -135.08 99.4 4.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.915 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.433 ' HA ' HD22 ' A' ' 135' ' ' ASN . 5.3 m120 -121.14 111.51 17.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.059 0.457 . . . . 0.0 110.309 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.898 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 36.3 m95 -122.03 124.71 44.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.883 ' HG2' HD21 ' A' ' 160' ' ' ASN . 5.1 tp10 -75.12 -29.03 60.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.644 0.735 . . . . 0.0 109.352 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.8 t -100.92 27.62 5.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.965 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.898 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 32.1 tt0 -67.64 102.11 1.13 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.673 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.523 HG12 ' H ' ' A' ' 142' ' ' ALA . 16.8 tt -110.21 122.6 65.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.721 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.7 p -95.11 8.64 42.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.243 0.544 . . . . 0.0 111.012 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -127.7 172.45 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.737 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -82.79 121.7 77.83 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.472 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.68 -46.88 6.1 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.083 1.855 . . . . 0.0 111.715 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -165.83 38.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.65 -45.75 1.26 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.25 53.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.093 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.41 99.87 10.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.757 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 46.8 p -138.03 164.65 28.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.026 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -91.3 144.16 25.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.084 0.469 . . . . 0.0 109.987 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 12.2 m120 -88.17 128.58 35.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.282 -175.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 116' ' ' ASP . 73.0 m 96.56 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.966 1.416 . . . . 0.0 111.1 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -110.83 150.35 29.27 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.586 HG21 ' HG3' ' A' ' 166' ' ' LYS . 28.1 m -143.01 155.91 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.527 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.557 ' N ' HD21 ' A' ' 112' ' ' LEU . 50.8 tp -99.01 103.99 15.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 20.0 t -96.9 103.64 15.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 -175.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.24 -26.77 67.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.72 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.31 -19.09 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.301 0.572 . . . . 0.0 110.613 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.15 -61.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.189 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.883 HD21 ' HG2' ' A' ' 137' ' ' GLU . 15.3 p30 -174.67 -30.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.12 32.73 1.34 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.711 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 34.3 mmtp -119.66 177.73 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.437 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 49.5 m0 -78.42 124.92 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.184 0.516 . . . . 0.0 111.069 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 77.2 m-85 -127.17 178.91 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.493 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -115.92 138.57 51.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.87 0.367 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.586 ' HG3' HG21 ' A' ' 154' ' ' VAL . 17.1 mtmt -150.02 161.15 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.649 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.514 ' O ' ' HH2' ' A' ' 111' ' ' TRP . 1.9 mtm105 -60.35 132.48 54.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.595 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -63.47 -17.41 62.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.386 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.416 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 5.7 ptp85 -103.82 29.37 5.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.984 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.3 147.31 23.02 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -91.69 85.14 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.472 . . . . 0.0 110.408 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -128.63 164.44 38.21 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.227 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.1 Cg_exo -65.79 -177.1 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.48 2.787 . . . . 0.0 113.205 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.667 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.4 p90 -155.16 167.55 29.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 90.4 mt -141.23 131.0 25.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.934 0.397 . . . . 0.0 110.234 176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.446 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 74.5 m -104.54 157.93 16.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.963 177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.9 pt20 -88.56 111.32 21.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.505 0.669 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.7 113.14 16.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.193 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.13 156.5 8.45 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.988 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.58 -43.71 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.25 0.548 . . . . 0.0 109.905 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.079 179.194 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 121.066 0.46 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 t -71.47 13.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.9 138.65 48.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.332 0.587 . . . . 0.0 110.515 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -93.2 137.22 32.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.578 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.713 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -171.26 -178.5 2.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 178.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 15.2 p -77.37 166.09 23.59 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.322 0.389 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.1 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -63.28 -48.19 79.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 6.1 mm-40 -67.44 -40.54 85.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.275 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -54.52 -47.48 73.07 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.061 0.458 . . . . 0.0 110.306 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' HD13 ' A' ' 78' ' ' ILE . 17.5 m -65.03 -56.66 11.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.54 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.68 -41.42 99.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.901 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 35.0 t70 -71.91 -48.51 45.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.336 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.812 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 46.8 t -64.68 -39.36 93.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -64.4 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.156 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -63.52 -31.9 73.2 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 66.9 mtt180 -66.85 -17.47 64.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 19.04 13.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.699 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -130.93 -169.42 12.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.195 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 p -139.99 161.86 36.59 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 126' ' ' MET . 9.7 mp -75.52 153.61 37.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.556 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.8 t -82.26 107.24 14.79 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 82.7 p -97.47 120.08 61.49 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 6.9 Cg_endo -84.78 113.46 1.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.458 2.105 . . . . 0.0 112.107 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -109.44 -7.25 15.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.183 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.06 169.46 18.63 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.048 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.35 -36.64 92.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.668 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -58.32 -43.25 88.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.25 -48.85 79.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.693 0.282 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -64.38 -36.04 82.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.294 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.99 -48.44 76.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.645 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -33.6 76.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.158 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 52.6 mt -60.57 -62.66 1.7 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.222 173.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.739 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 48.9 t80 -53.39 -34.97 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.681 0.613 . . . . 0.0 112.005 -174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.44 -54.94 5.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 85.4 t80 -57.54 -34.43 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.831 0.824 . . . . 0.0 109.195 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.522 HD12 ' HB ' ' A' ' 104' ' ' VAL . 29.4 tp -53.83 -53.78 47.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.516 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.739 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 42.9 mtm105 -67.51 -19.06 65.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.969 -176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 13.8 pt20 -111.82 4.14 18.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.08 -44.24 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.968 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 110' ' ' ILE . 41.3 t -102.13 -49.62 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 109.679 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.4 129.48 1.56 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.988 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 t30 -46.01 -49.11 16.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.088 0.471 . . . . 0.0 111.006 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.9 OUTLIER -95.28 22.85 6.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.662 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.39 161.31 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.002 0.429 . . . . 0.0 110.99 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 41.3 mt-10 -124.47 125.45 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.834 HD11 HG11 ' A' ' 104' ' ' VAL . 1.8 mp -123.25 144.13 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.12 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CZ3' HG22 ' A' ' 154' ' ' VAL . 82.7 m95 -71.21 137.77 48.95 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' HD23 ' A' ' 114' ' ' LEU . 94.5 mt -83.11 -14.46 53.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . 76.51 15.76 81.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.371 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? -94.91 144.02 26.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 111.349 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -135.96 111.23 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.664 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 123' ' ' TRP . 8.1 p-10 -72.91 104.37 4.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.746 0.784 . . . . 0.0 111.449 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -86.05 -30.68 22.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.956 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.014 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -98.64 101.08 12.39 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.63 -36.38 15.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.544 -168.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 2.6 pm0 -82.69 84.31 7.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.941 0.877 . . . . 0.0 111.78 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.95 16.21 46.37 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.973 -1.012 . . . . 0.0 114.552 168.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 1.014 ' HB ' ' HB3' ' A' ' 118' ' ' ALA . 11.3 m -116.34 80.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.777 0.789 . . . . 0.0 111.386 -176.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 116' ' ' ASP . 55.8 m95 -68.37 144.25 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.515 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -110.04 139.94 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -72.43 153.62 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 49.7 mtt -55.95 -25.06 41.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.207 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.2 t -88.51 4.1 47.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.236 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.68 37.92 9.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.341 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.39 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.768 0.284 . . . . 0.0 110.561 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -105.77 127.44 53.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 0.0 110.418 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.9 pt -69.95 151.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.409 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.09 3.11 14.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -141.13 124.29 16.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.805 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 20.4 pttp -136.99 130.51 31.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -133.72 111.48 10.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.621 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 18.5 m95 -121.04 128.04 52.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.37 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -72.87 -21.2 60.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 t -105.36 26.16 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 8.2 tp10 -64.38 102.56 0.55 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.8 pt -94.29 148.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 0.0 111.275 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 p -119.37 13.22 12.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.653 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.79 144.76 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.078 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 94.5 mt-30 -103.09 129.26 25.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.509 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 14.5 Cg_exo -69.03 -62.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.769 2.312 . . . . 0.0 112.543 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -97.52 -37.52 9.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.28 -19.48 1.54 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.983 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.47 32.45 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.999 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -89.21 120.8 30.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p -122.62 125.27 45.31 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 150' ' ' GLU . 5.6 pt-20 -103.16 126.19 50.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -128.71 123.63 33.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -165.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.97 97.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.789 171.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.71 133.44 40.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.402 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 17.3 t -126.17 141.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.473 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.584 ' HB2' HD21 ' A' ' 112' ' ' LEU . 63.8 tp -98.96 112.53 24.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 p -106.33 109.54 21.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.918 0.389 . . . . 0.0 111.171 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.83 -22.26 78.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.039 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -64.63 -25.1 67.81 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.0 -60.06 2.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.357 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.0 p30 176.91 -24.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.316 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 123.15 25.81 1.78 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.733 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -111.8 167.6 10.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.704 0.288 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -82.48 135.73 35.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.046 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -126.96 -169.03 1.96 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.071 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -143.02 139.06 30.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.0 110.687 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -139.31 164.98 28.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 167' ' ' ARG . 2.4 tpt180 -71.09 141.22 50.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 69' ' ' THR . 51.1 m -63.33 -5.9 4.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 13.7 ttp85 -112.94 20.19 16.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.9 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -90.94 145.14 24.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 17.8 mp0 -93.16 94.47 8.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 111.689 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -129.39 157.84 75.02 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.064 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 22.4 Cg_exo -64.28 179.13 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.006 2.47 . . . . 0.0 113.464 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.812 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -155.24 166.22 34.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.454 177.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 110' ' ' ILE . 90.5 mt -124.09 130.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 55.5 m -102.45 132.18 48.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.387 0.613 . . . . 0.0 111.436 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -90.63 110.63 21.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -135.22 121.93 20.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.951 0.405 . . . . 0.0 111.581 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 60.01 2.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.898 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.3 tt -75.5 78.39 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 122.409 1.099 . . . . 0.0 109.961 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 C--O 1.247 0.924 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.062 -178.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.785 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 58.5 m-85 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 p -84.51 5.2 28.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.896 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' OE1' ' HD3' ' A' ' 68' ' ' LYS . 17.5 tm0? -77.97 123.86 27.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -97.66 115.27 27.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.606 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -144.43 179.24 7.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.887 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.1 p -84.55 167.02 16.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.05 -20.27 62.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -72.5 -50.45 25.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.27 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 3.3 mp0 -70.42 -35.34 73.36 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.096 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.764 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -67.81 -18.58 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.747 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.578 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 10.3 p -91.97 -51.54 5.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.713 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.78 -29.6 65.85 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.869 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -65.66 -40.25 92.21 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.936 -175.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.715 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 33.6 m -72.28 -42.94 64.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.634 0.254 . . . . 0.0 111.211 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.72 -41.53 88.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 t -80.32 -15.8 56.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 9.9 ptp180 -91.7 4.78 51.95 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.67 38.77 31.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.432 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.74 -170.15 18.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.4 p -131.07 153.51 49.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 85' ' ' SER . 4.8 tt -73.4 146.41 45.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.622 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.3 m -62.6 109.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.972 0.415 . . . . 0.0 111.267 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 28.5 p -107.32 119.83 49.62 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.573 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 31.3 Cg_endo -92.36 123.05 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.659 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 3.6 pt20 -127.82 0.91 6.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 92' ' ' GLU . 68.6 p -129.58 173.65 10.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.38 -36.87 89.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.5 t -64.46 -52.63 57.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.0 110.705 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' OE1' ' HG2' ' A' ' 88' ' ' GLN . 9.3 pt-20 -75.02 -24.63 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.531 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' ' CB ' ' A' ' 87' ' ' PRO . 28.2 t-20 -66.59 -48.84 68.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.15 0.5 . . . . 0.0 110.284 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.35 -22.78 32.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.167 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.72 84.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.608 0.242 . . . . 0.0 110.966 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.09 -40.87 95.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 36.0 t80 -59.23 -43.69 92.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.454 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.36 -47.25 67.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.473 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.08 -38.69 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.51 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 110' ' ' ILE . 2.9 pp -68.01 -29.56 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.363 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 74.6 mtp180 -66.27 -26.31 67.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -98.83 5.84 47.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.877 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -153.67 -47.35 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 100' ' ' LEU . 4.5 t -88.25 -34.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.654 0.74 . . . . 0.0 109.349 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.28 124.2 3.78 Favored Glycine 0 N--CA 1.434 -1.433 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -50.95 -37.14 42.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.05 0.452 . . . . 0.0 111.26 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 158' ' ' ALA . 39.5 mt-10 -85.36 24.12 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.656 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.65 146.13 29.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 110.762 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 2.6 mm-40 -101.82 132.35 47.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.394 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.82 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -124.55 138.77 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 110' ' ' ILE . 83.1 m95 -71.01 148.04 48.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.6 mm? -96.1 5.2 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.98 16.97 69.16 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.317 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.428 ' HB3' ' CE3' ' A' ' 123' ' ' TRP . 7.5 mp -94.98 126.1 40.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.648 0.261 . . . . 0.0 110.453 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.497 ' O ' HG22 ' A' ' 124' ' ' VAL . 2.6 m-20 -124.32 132.61 53.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.089 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.5 133.06 55.86 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.556 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -126.77 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.047 0.451 . . . . 0.0 110.141 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 1.42 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.516 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.99 52.59 2.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.28 112.01 1.57 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.121 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.99 -13.62 29.04 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.747 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.4 p -135.3 100.44 4.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 114' ' ' LEU . 23.5 m95 -62.05 146.59 49.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.501 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 115' ' ' ASN . 29.8 m -116.76 162.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.226 175.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.51 166.29 22.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.578 ' HE1' ' HB3' ' A' ' 74' ' ' SER . 21.0 mmt -54.5 -19.63 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.893 172.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.8 -6.98 34.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 111.434 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.45 34.69 7.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.954 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.61 166.82 10.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -100.76 143.66 30.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.656 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -104.02 148.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 173.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.19 11.57 38.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.863 0.363 . . . . 0.0 111.059 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 48.3 t80 -107.63 111.06 23.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 -176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 98.41 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.989 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.08 111.71 6.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -128.01 127.31 42.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.814 ' HG3' HD21 ' A' ' 160' ' ' ASN . 3.3 tm-20 -66.31 -52.94 42.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.541 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 9.0 t -91.67 40.31 1.03 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.549 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -51.31 107.57 0.19 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.467 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.4 pt -90.41 153.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.973 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.2 p -104.26 68.71 0.89 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.74 98.27 0.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.3 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 145' ' ' ASP . 13.3 mm100 -93.27 127.39 46.98 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.03 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 148' ' ' LYS . 56.2 Cg_endo -71.44 37.31 0.32 Allowed 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.971 2.447 . . . . 0.0 111.022 174.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 143' ' ' GLN . 30.0 t70 -142.4 -6.26 0.93 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.201 -169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.75 52.94 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.081 -1.056 . . . . 0.0 111.86 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.74 18.08 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.763 -1.208 . . . . 0.0 114.493 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 144' ' ' PRO . 28.5 pttt -103.79 134.07 47.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.517 0.659 . . . . 0.0 109.413 167.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 p -135.67 170.85 15.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -88.92 92.21 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.276 0.56 . . . . 0.0 110.358 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 165' ' ' ASP . 2.8 p-10 -140.27 147.63 40.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.107 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 1.2 p -117.17 167.84 10.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.783 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.82 139.69 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -170.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.59 164.61 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.433 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 tt -109.8 103.7 12.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 25.8 p -89.85 108.2 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.89 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.03 -51.42 34.09 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.002 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . . . -59.67 -20.12 54.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.98 -52.17 11.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.814 HD21 ' HG3' ' A' ' 137' ' ' GLU . 12.3 p30 179.94 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.016 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.42 22.67 6.33 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.137 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 56.1 mmtt -113.76 179.27 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.044 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -77.22 122.57 25.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.545 0.688 . . . . 0.0 111.627 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.541 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 10.7 m-85 -117.2 178.23 4.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.069 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.484 ' HB2' HD22 ' A' ' 151' ' ' ASN . 9.3 p-10 -130.26 144.59 51.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.105 0.478 . . . . 0.0 111.295 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.6 ' HD2' ' CD2' ' A' ' 172' ' ' LEU . 17.5 ptpt -153.24 -171.0 3.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.075 173.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 167' ' ' ARG . 40.7 ttm180 -83.34 138.28 33.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.797 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.2 m -70.82 -2.79 16.0 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -96.71 -5.42 38.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.457 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.06 133.0 48.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -92.47 97.25 10.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.649 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.6 ' CD2' ' HD2' ' A' ' 166' ' ' LYS . 3.2 pp -128.15 160.62 60.87 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.062 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 172' ' ' LEU . 40.7 Cg_exo -57.69 179.59 0.14 Allowed 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.461 2.774 . . . . 0.0 113.509 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.82 ' HA ' HG23 ' A' ' 110' ' ' ILE . 2.2 p90 -163.36 165.26 24.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.033 -0.417 . . . . 0.0 110.485 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.785 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.1 mt -128.46 116.56 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 5.9 t -104.24 147.36 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 0.0 110.658 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.41 117.17 29.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.487 ' HE2' ' HD3' ' A' ' 80' ' ' ARG . 1.3 t80 -112.52 116.93 31.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.534 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 132.38 -154.56 21.11 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.04 136.44 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.836 0.351 . . . . 0.0 110.254 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.197 179.278 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' HD1' ' CE2' ' A' ' 174' ' ' TYR . 54.6 m-85 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.038 0.446 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.547 HG22 HG13 ' A' ' 104' ' ' VAL . 9.1 p -72.46 -3.54 24.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.787 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 52.3 mt-30 -57.18 129.29 41.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.332 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 p -94.21 125.67 38.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.597 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.829 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -164.22 174.27 11.39 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.225 177.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 69.8 p -77.75 166.08 23.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 -176.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.79 -44.19 81.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.493 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.35 -45.77 91.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.084 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.23 -42.24 73.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.421 ' O ' HD13 ' A' ' 78' ' ' ILE . 36.0 m -60.22 -58.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.973 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.84 -16.79 62.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.323 . . . . 0.0 111.28 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 36.7 t70 -75.16 -50.01 17.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.033 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.544 ' HB2' HD12 ' A' ' 84' ' ' LEU . 65.7 m -67.24 -32.94 74.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.143 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -60.2 -41.63 87.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.3 p -79.26 -11.03 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.924 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 14.8 mmp_? -78.62 -14.29 59.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.77 37.77 3.36 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.299 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -177.71 -160.09 23.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.215 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 p -120.73 171.12 8.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 77' ' ' CYS . 9.5 mp -66.82 162.28 21.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 171.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 p -73.65 107.58 5.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 112' ' ' LEU . 35.8 p -110.46 105.81 57.43 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.145 0.498 . . . . 0.0 110.749 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.72 ' HG3' HD12 ' A' ' 96' ' ' LEU . 97.6 Cg_endo -88.03 139.24 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.466 2.111 . . . . 0.0 112.251 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.9 pt20 -135.25 9.03 3.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.748 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 p -141.53 168.64 19.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.906 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.68 98.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.8 m -59.95 -35.41 74.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.104 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -76.16 -37.01 58.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.074 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.93 -41.64 77.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.088 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.65 -36.1 81.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.173 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.03 79.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.72 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.2 mt -78.57 -4.99 51.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.626 0.25 . . . . 0.0 111.118 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -98.23 -37.66 9.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.57 -52.52 8.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.759 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 71.6 t80 -62.73 -35.27 79.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.519 0.676 . . . . 0.0 109.242 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 104' ' ' VAL . 8.0 tp -57.94 -48.09 80.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.284 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.543 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.02 -19.78 64.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.702 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 17.1 pt20 -110.3 8.06 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.827 -0.546 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 -65.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.608 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 65' ' ' THR . 2.5 t -83.56 -28.69 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 151.12 -77.84 0.22 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.147 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.411 ' CB ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 p-10 173.29 -40.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 6.7 pt-20 -113.39 45.76 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.785 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 100' ' ' LEU . . . -115.03 146.93 40.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.607 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 4.6 mp0 -94.54 130.96 40.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.369 174.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 175' ' ' ILE . 3.8 mp -125.63 145.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.588 177.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.89 132.55 45.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.9 mt -90.38 10.57 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.39 30.89 56.37 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.09 141.74 47.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.146 0.973 . . . . 0.0 110.26 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HA ' ' CE3' ' A' ' 123' ' ' TRP . 25.8 p-10 -154.68 141.6 19.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 110.587 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.928 ' HB2' ' HA ' ' A' ' 123' ' ' TRP . 21.0 t0 -120.23 121.81 39.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.882 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptm -127.53 -18.35 4.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.642 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.43 -59.74 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -171.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.39 68.82 3.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.54 107.07 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.653 -165.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.22 -6.48 8.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.687 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 p -141.29 101.62 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.763 0.316 . . . . 0.0 111.207 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.928 ' HA ' ' HB2' ' A' ' 116' ' ' ASP . 25.4 m95 -64.16 137.3 57.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -107.9 139.09 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.745 ' OD2' HG22 ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.9 -179.77 4.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 0.0 110.441 -178.042 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.1 mtt -69.25 -32.32 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.745 HG22 ' OD2' ' A' ' 125' ' ' ASP . 12.4 t -81.03 -5.21 57.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.263 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.81 37.82 5.11 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.382 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.1 162.09 27.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.075 0.437 . . . . 0.0 110.834 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -99.19 126.14 44.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.495 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.64 126.18 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.407 0.623 . . . . 0.0 111.366 -174.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.72 -19.44 35.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.591 0.71 . . . . 0.0 110.02 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 41.1 t80 -120.41 115.23 23.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.305 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.0 120.14 10.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.997 0.427 . . . . 0.0 110.069 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -125.9 111.07 14.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.582 0.706 . . . . 0.0 110.502 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 1.033 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 3.2 m95 -111.5 118.49 35.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' HD21 ' A' ' 160' ' ' ASN . 4.1 tp10 -70.0 -41.22 74.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.576 0.703 . . . . 0.0 109.77 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.17 23.11 6.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.942 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 1.033 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -71.1 102.16 2.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 140' ' ' ILE . 19.4 pt -115.87 99.98 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.756 0.788 . . . . 0.0 109.476 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.9 t -88.35 62.9 6.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.513 1.149 . . . . 0.0 110.206 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -112.81 94.31 4.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.868 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HG3' ' HA2' ' A' ' 147' ' ' GLY . 20.7 mm-40 -100.41 104.04 27.59 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.56 -172.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 5.6 Cg_exo -76.98 -20.86 12.75 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.792 2.328 . . . . 0.0 111.758 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -84.38 -34.64 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.223 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.24 -36.75 1.1 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.237 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.612 ' HA2' ' HG3' ' A' ' 143' ' ' GLN . . . 151.72 21.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 119.992 -1.099 . . . . 0.0 114.08 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 142.89 51.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.369 0.584 . . . . 0.0 109.636 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.6 p -138.08 137.25 37.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.734 0.302 . . . . 0.0 111.086 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.41 92.32 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.562 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 3.5 p-10 -152.43 168.32 25.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 69.5 m -140.1 124.2 17.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 -176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.16 135.32 39.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.576 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.55 145.63 31.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.674 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 2.3 tm? -89.39 108.89 19.9 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 26.1 t -98.96 100.78 11.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.36 -23.9 74.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.771 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -69.67 -30.46 68.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 110.71 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.87 0.99 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.746 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.459 HD21 ' HG2' ' A' ' 137' ' ' GLU . 14.6 p30 -171.35 -27.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.055 -174.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.23 -2.25 11.5 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.839 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 1.1 mptm? -82.56 174.18 11.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -83.78 126.84 33.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.307 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.54 -171.84 2.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.97 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.562 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 12.8 t70 -141.72 146.16 35.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.081 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -147.53 176.8 9.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -72.25 144.09 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 -173.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -68.61 -14.62 63.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.008 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -93.59 -3.21 53.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 17.6 m-20 -73.55 136.06 44.0 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -110.31 106.16 15.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.819 0.819 . . . . 0.0 111.446 -176.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 1.5 pp -129.24 171.14 9.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.346 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 14.3 Cg_endo -57.12 174.67 0.42 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.552 2.168 . . . . 0.0 113.226 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.787 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 49.1 p90 -140.91 179.59 6.63 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.041 -0.412 . . . . 0.0 110.739 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.54 HG13 HG12 ' A' ' 110' ' ' ILE . 71.6 mt -145.51 132.42 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.461 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 84.9 m -99.49 155.81 17.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 6.0 tp60 -87.93 108.51 19.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.512 0.672 . . . . 0.0 110.311 -175.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -135.06 134.26 40.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 180' ' ' ILE . . . 123.95 126.67 3.12 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -172.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 179' ' ' GLY . 81.7 mt 73.27 -48.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.383 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.733 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 59.3 m-85 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -69.69 -8.11 44.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.003 -177.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.87 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 27.6 mt-30 -53.61 122.03 9.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 0.0 111.733 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 171' ' ' GLN . 17.6 p -97.02 113.53 25.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.511 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.885 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.82 -176.55 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.122 -178.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 169' ' ' ARG . 81.5 p -78.14 165.88 23.43 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.321 0.388 . . . . 0.0 110.129 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.31 -38.79 92.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.675 0.274 . . . . 0.0 110.946 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -63.33 -45.91 89.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -58.88 -37.08 75.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 78' ' ' ILE . 29.1 t -63.1 -60.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.41 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 11.2 pt-20 -70.69 -15.21 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.496 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.703 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 11.7 t70 -65.06 -59.01 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.3 m -59.28 -36.8 76.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 74' ' ' SER . 28.3 mm -54.17 -44.5 64.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 p -84.39 -14.09 50.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.397 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 20.4 mmt180 -74.46 -23.69 58.93 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.98 25.59 11.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.332 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.78 -170.26 13.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.1 p -116.14 165.81 12.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.535 HD23 ' HA2' ' A' ' 113' ' ' GLY . 19.4 tp -81.8 148.74 28.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -66.69 109.17 2.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.866 0.365 . . . . 0.0 111.219 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 4.7 t -117.51 118.5 35.27 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.905 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 2.0 Cg_endo -81.68 120.66 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.063 2.509 . . . . 0.0 112.311 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -104.28 -30.48 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.098 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.0 p -128.02 -171.0 2.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.71 -34.26 82.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.913 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -55.4 -49.81 71.37 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.834 0.454 . . . . 0.0 111.936 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 4.8 mp0 -61.66 -53.22 59.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.11 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.53 -37.75 88.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.92 -44.13 93.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.497 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.49 -32.96 58.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.7 tp -63.06 -47.66 81.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.018 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 91.4 t80 -60.08 -40.46 89.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.538 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.743 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -64.03 -33.33 75.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.617 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD11 HD12 ' A' ' 155' ' ' LEU . 72.6 mt -57.14 -44.72 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.141 0.496 . . . . 0.0 109.901 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 16.5 mtp180 -69.04 -9.38 52.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.62 -172.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -127.47 15.61 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.1 t -151.32 -51.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.359 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -105.85 -29.05 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.649 0.737 . . . . 0.0 110.391 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.49 130.49 4.97 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -30.82 64.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.893 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 5.1 mm-40 -80.44 6.76 11.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.027 -175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.32 15.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 0.0 112.197 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.463 ' C ' HD12 ' A' ' 110' ' ' ILE . 34.0 mt-10 -121.18 123.53 42.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.078 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 175' ' ' ILE . 2.6 mp -122.93 138.77 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 110.505 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 73.6 m95 -70.41 145.5 51.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 155' ' ' LEU . 95.3 mt -89.89 -2.31 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 82.73 5.81 89.08 Favored Glycine 0 C--N 1.324 -0.124 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.284 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 131' ' ' ILE . 7.2 mp -93.27 125.47 37.89 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.87 145.75 24.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.758 -169.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.26 66.75 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.403 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -128.33 -57.71 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.531 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.48 123.83 49.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.414 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -131.19 -1.81 4.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 88.69 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.481 0.658 . . . . 0.0 110.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.65 -70.32 2.88 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.62 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p -99.89 100.95 11.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.4 ' H ' HD11 ' A' ' 131' ' ' ILE . 14.1 m95 -72.96 148.18 44.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.014 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.11 129.22 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -83.3 164.31 20.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.771 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.552 ' HE1' ' HA ' ' A' ' 74' ' ' SER . 11.5 ptp -61.91 -43.54 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -92.56 -4.79 52.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 0.0 111.084 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.63 13.1 9.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.554 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 125' ' ' ASP . . . -77.85 128.3 33.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.039 0.447 . . . . 0.0 110.777 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -98.34 113.69 25.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.728 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 114' ' ' LEU . 43.4 pt -62.05 135.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.977 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -112.48 8.95 19.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.537 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 135' ' ' ASN . 80.2 t80 -105.52 102.95 12.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.246 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.505 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 13.9 tptp -105.6 96.78 6.74 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 46.1 t30 -157.6 111.72 2.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 139' ' ' GLU . 4.0 m95 -137.98 156.21 48.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.795 -173.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 2.4 tm-20 -97.08 -49.97 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 29.66 6.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.604 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 136' ' ' TRP . 17.1 pt-20 -67.39 151.8 46.81 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.83 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 pt -72.92 133.7 31.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.489 0.661 . . . . 0.0 111.244 -173.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.7 p -116.24 -15.21 11.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.432 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.99 50.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.62 100.3 51.21 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -22.18 8.19 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.683 2.256 . . . . 0.0 112.62 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.19 46.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.94 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.81 -36.19 3.3 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.485 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.77 34.75 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.03 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.69 100.4 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 p -138.42 129.26 26.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.916 0.389 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.91 102.73 7.41 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.498 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 5.1 p-10 -169.41 173.09 6.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.794 -173.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 94.7 m -126.9 132.12 50.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.993 0.425 . . . . 0.0 111.207 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.45 140.13 38.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.455 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.756 HG11 ' HG2' ' A' ' 166' ' ' LYS . 14.3 p -136.04 149.32 27.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.592 HD12 HD11 ' A' ' 100' ' ' LEU . 1.3 tm? -98.66 101.15 12.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.0 m -99.7 109.37 21.83 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.03 -40.17 73.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.806 -175.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.893 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -68.78 -11.51 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 111.287 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.05 -56.46 3.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -171.69 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.864 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.23 -0.97 37.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.946 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 66.9 mmtt -93.5 179.58 5.34 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 45.4 m0 -79.29 123.4 27.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 0.0 110.62 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -116.52 -168.82 1.51 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.232 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 5.6 t70 -134.4 138.21 44.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.756 ' HG2' HG11 ' A' ' 154' ' ' VAL . 12.4 mmmm -137.95 146.37 43.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -60.52 136.35 58.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.3 m -65.07 -7.1 10.66 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.548 ' HA ' HG22 ' A' ' 69' ' ' THR . 37.2 ttp180 -109.0 20.9 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.178 0.513 . . . . 0.0 110.243 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.42 141.22 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 2.0 mp0 -93.28 93.05 8.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 111' ' ' TRP . 3.9 pp -127.85 164.48 36.54 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.671 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 24.3 Cg_exo -63.41 -178.4 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.263 2.642 . . . . 0.0 113.745 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.87 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 6.5 p90 -154.58 176.92 11.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.15 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 110' ' ' ILE . 74.1 mt -145.63 128.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.583 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 83.6 m -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -89.11 110.39 21.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.14 113.22 16.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.441 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.95 -85.09 1.79 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.242 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.825 ' H ' HD13 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -84.12 -31.82 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.814 0.34 . . . . 0.0 110.67 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 180' ' ' ILE . 57.6 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.378 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 176' ' ' CYS . 29.6 m-85 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 p -84.91 17.31 2.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.194 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 44.9 tt0 -84.97 139.35 31.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.255 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 p -98.05 127.43 43.99 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.646 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -158.28 -178.88 7.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.2 p -84.5 166.83 16.92 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.95 0.156 . . . . 0.0 110.868 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -48.26 82.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.476 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -63.32 -43.8 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.694 0.283 . . . . 0.0 110.298 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -64.48 -43.58 93.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.54 72.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' ILE . 16.1 t -59.55 -62.57 1.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.96 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.99 -39.44 81.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.272 0.558 . . . . 0.0 110.935 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' CG ' HH12 ' A' ' 80' ' ' ARG . 12.3 t70 -64.94 -47.37 77.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.735 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 42.3 t -79.26 -36.87 39.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.003 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 126' ' ' MET . 1.4 mp -57.26 -40.22 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.109 0.48 . . . . 0.0 110.457 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -76.44 -31.59 57.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.904 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.553 HH12 ' CG ' ' A' ' 76' ' ' ASP . 1.3 ptp85 -96.15 -18.02 20.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.053 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.16 -51.18 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.169 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.27 -46.33 0.97 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.112 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 p -145.58 155.64 43.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.608 0.242 . . . . 0.0 111.151 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -72.36 161.78 30.37 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.045 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB3' HD21 ' A' ' 96' ' ' LEU . 28.3 m -79.06 106.09 10.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 37.9 m -111.9 112.33 53.2 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.65 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 2.5 Cg_endo -79.85 117.22 3.57 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.936 2.424 . . . . 0.0 111.869 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB3' HG22 ' A' ' 131' ' ' ILE . 1.8 pt20 -115.89 -13.67 11.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.424 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.0 p -130.9 176.24 8.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.73 -26.32 66.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.745 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -56.21 -56.88 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.896 0.478 . . . . 0.0 111.521 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 9.6 mp0 -62.73 -48.61 78.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.383 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.57 -40.92 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.33 -39.66 94.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.18 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.035 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.5 mt -59.83 -46.11 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -62.19 -29.14 70.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.617 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.21 -42.7 22.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -67.68 -47.25 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' HG23 ' A' ' 104' ' ' VAL . 3.1 pp -63.58 -25.83 68.41 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 101' ' ' ARG . 9.6 ttm180 -61.04 -38.63 86.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.448 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.12 0.28 31.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.693 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.8 p -124.32 -50.2 1.78 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 100' ' ' LEU . 3.0 t -98.51 -33.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.672 0.749 . . . . 0.0 109.704 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.97 125.04 3.61 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -55.21 -26.29 38.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.046 0.423 . . . . 0.0 111.504 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 38.6 mt-10 -89.18 22.52 2.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.383 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.46 162.25 14.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.057 0.456 . . . . 0.0 110.951 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 10.5 pt-20 -128.46 130.92 48.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.835 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.0 mp -118.84 154.61 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.988 -174.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -70.08 149.65 47.41 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.903 0.382 . . . . 0.0 110.12 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 163' ' ' TRP . 0.2 OUTLIER -86.73 -6.11 58.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -171.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.33 6.95 66.68 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.468 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mp -93.38 128.57 39.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.212 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -93.3 118.44 31.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 0.0 110.558 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.41 96.84 6.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.031 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 53.4 ttp -126.55 -47.74 1.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -169.7 1.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.25 15.61 7.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.274 0.559 . . . . 0.0 110.741 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.76 166.72 15.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.94 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.02 -16.78 75.09 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.584 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 130' ' ' ARG . 30.9 m -80.22 77.69 6.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 110.508 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 131' ' ' ILE . 44.4 m95 -59.2 129.47 42.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.576 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.22 131.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . 5.1 t70 -73.89 161.09 30.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.468 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.464 ' SD ' HD11 ' A' ' 78' ' ' ILE . 4.4 ptp -53.61 -28.96 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.0 p -92.84 1.26 57.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.095 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.56 27.91 25.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.954 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 125' ' ' ASP . . . -92.63 149.53 21.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.841 0.353 . . . . 0.0 111.197 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 122' ' ' THR . 28.2 ttm180 -98.14 130.69 44.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.089 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.669 HG13 ' HE3' ' A' ' 134' ' ' LYS . 38.0 pt -92.33 128.46 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.065 0.46 . . . . 0.0 110.156 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.91 -19.84 24.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.243 0.544 . . . . 0.0 110.534 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -113.77 130.45 56.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.516 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.669 ' HE3' HG13 ' A' ' 131' ' ' ILE . 10.4 mptt -130.06 144.26 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.72 114.82 8.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.564 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 44.4 m95 -126.59 117.54 23.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.193 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.3 tp10 -71.08 -29.79 65.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.2 t -108.4 38.38 2.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.774 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 34.1 tt0 -56.21 121.57 9.76 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.292 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.7 pt -84.88 132.97 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.238 0.542 . . . . 0.0 110.867 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.1 p -116.66 2.2 12.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.159 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.16 161.87 28.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.355 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -100.45 111.35 62.52 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.35 -82.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.063 2.508 . . . . 0.0 114.183 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 148' ' ' LYS . 8.0 m-20 -88.68 21.12 3.12 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.78 20.07 76.83 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.93 -47.43 0.57 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.876 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 3.0 tmpt? -65.67 122.15 16.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 p -116.82 165.32 13.45 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.556 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.96 149.44 43.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -123.55 161.53 24.75 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -167.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 89.1 m 68.12 105.99 0.05 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.263 0.977 . . . . 0.0 112.567 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 112' ' ' LEU . . . -83.67 139.67 32.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.29 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 166' ' ' LYS . 21.3 t -133.5 142.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.918 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 49.6 tp -100.98 101.3 12.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 17.9 m -96.44 113.53 25.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.561 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.49 -30.95 47.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.853 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -67.52 -24.77 65.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.89 -59.02 2.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.976 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.447 HD21 ' HG2' ' A' ' 137' ' ' GLU . 10.7 p30 -177.58 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.33 19.23 3.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.343 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 34.4 mmtp -98.73 168.46 10.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CE2' HD11 ' A' ' 112' ' ' LEU . 49.6 m0 -84.25 132.61 34.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.248 0.547 . . . . 0.0 110.429 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.02 -179.21 4.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.33 156.64 22.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 167' ' ' ARG . 20.8 ttmm -154.35 167.65 29.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 110.518 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 33.1 mtm-85 -60.11 125.36 23.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.819 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.94 -22.56 67.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.783 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 169' ' ' ARG . 3.7 tpt180 -101.12 21.77 13.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.14 150.61 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.88 102.5 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.684 0.278 . . . . 0.0 111.23 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -130.49 167.77 19.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.0 Cg_exo -73.6 -179.24 4.32 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.966 2.444 . . . . 0.0 113.035 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.835 ' HA ' HG23 ' A' ' 110' ' ' ILE . 9.7 p90 -150.65 178.65 8.88 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.208 -0.308 . . . . 0.0 110.923 -176.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 84' ' ' LEU . 97.4 mt -144.39 134.73 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 45.0 m -102.79 136.88 41.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 111.984 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -104.76 115.65 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.628 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.16 158.6 43.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.26 1.34 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.995 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 60.3 mt -81.05 101.21 5.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.837 0.351 . . . . 0.0 110.653 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.691 177.794 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 49.8 m-85 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -78.08 -4.06 45.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.668 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 27.0 tt0 -66.89 136.32 55.21 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 p -104.42 134.64 47.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -165.64 176.86 7.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 73.6 p -78.33 166.32 22.81 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.305 0.378 . . . . 0.0 110.803 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.78 -35.84 77.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.168 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -64.2 -50.79 66.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.0 mt-10 -64.79 -35.83 82.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -60.97 -42.34 98.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.595 ' O ' HG12 ' A' ' 78' ' ' ILE . 43.4 m -60.75 -54.13 48.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.082 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.13 -42.36 76.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 14.4 t70 -60.02 -52.44 65.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 0.0 110.289 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.2 m -63.11 -36.4 83.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.975 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.925 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 22.8 mm -57.29 -42.27 79.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.209 0.528 . . . . 0.0 110.683 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -77.15 -19.19 57.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.195 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 59.8 mtt-85 -107.33 15.49 24.94 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.598 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.52 -49.22 0.42 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.639 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.925 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 120.71 7.19 8.95 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.02 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.824 HG23 ' HB2' ' A' ' 126' ' ' MET . 3.0 m -153.47 138.02 16.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.981 0.42 . . . . 0.0 111.439 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 85' ' ' SER . 6.2 tt -85.74 158.9 19.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.623 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.1 m -69.9 108.21 3.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.939 0.399 . . . . 0.0 110.912 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.2 m -110.12 112.83 57.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 66.7 Cg_endo -82.38 124.81 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.3 2.0 . . . . 0.0 111.982 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -5.87 11.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.386 -170.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.81 165.3 27.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.99 -39.02 77.87 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.029 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -54.27 -39.89 67.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.842 0.457 . . . . 0.0 112.134 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.97 -39.89 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.514 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 33.3 m-80 -66.18 -50.14 64.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.6 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.94 -35.36 80.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.8 65.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.106 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.3 tp -66.53 -44.86 81.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.727 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 110.279 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -65.3 -40.98 94.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.22 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.25 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.182 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 79.2 mt -55.96 -47.7 77.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -54.92 -37.7 66.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.543 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -96.1 -11.05 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.186 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -119.21 -64.06 1.32 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.892 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 110' ' ' ILE . 4.3 t -94.63 -34.27 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 110.406 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.45 125.21 2.99 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -170.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.85 -39.86 54.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.778 0.323 . . . . 0.0 110.151 177.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.64 15.09 1.82 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.81 160.3 14.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.984 0.421 . . . . 0.0 111.258 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 40.5 mt-10 -121.42 122.64 40.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.189 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.4 mp -121.15 148.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.491 ' O ' HG22 ' A' ' 110' ' ' ILE . 87.6 m95 -70.0 151.8 45.15 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.647 HD12 ' HB1' ' A' ' 153' ' ' ALA . 72.3 mt -99.54 4.46 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.94 -27.76 1.38 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' CD1' HD13 ' A' ' 131' ' ' ILE . 1.8 pt? -94.84 155.66 16.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.652 0.726 . . . . 0.0 110.935 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.457 ' HA ' ' CE3' ' A' ' 123' ' ' TRP . 7.8 p30 -154.0 159.8 41.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.698 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -105.9 133.37 50.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -121.79 5.22 9.97 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 119' ' ' ALA . . . -116.12 -68.93 0.89 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 118' ' ' ALA . . . 158.78 -15.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.24 0.963 . . . . 0.0 110.63 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.29 168.86 15.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.132 0.492 . . . . 0.0 111.66 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.67 -15.54 58.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.71 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -84.13 80.48 9.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.457 ' CE3' ' HA ' ' A' ' 115' ' ' ASN . 11.5 m0 -54.9 143.53 25.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.865 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.1 m -107.05 148.36 11.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.573 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.19 166.91 21.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.361 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.824 ' HB2' HG23 ' A' ' 83' ' ' THR . 49.0 mtt -58.67 -27.15 64.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.3 p -82.81 -12.09 57.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.738 0.304 . . . . 0.0 111.286 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.55 -0.11 53.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.819 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.17 155.57 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -109.03 149.75 28.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.477 HD13 ' CD1' ' A' ' 114' ' ' LEU . 48.6 pt -95.22 167.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.978 0.418 . . . . 0.0 111.413 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.1 5.22 3.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.888 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -118.92 119.41 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.279 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -138.44 98.71 3.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.996 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -127.68 111.52 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.526 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 32.9 m95 -125.36 123.21 38.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 4.3 mm-40 -72.97 -20.69 60.99 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 13.7 t -100.01 19.85 15.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.379 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.38 115.13 2.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.29 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.9 pt -103.36 150.4 6.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.011 0.434 . . . . 0.0 111.061 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.9 p -123.72 4.98 8.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.493 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.24 153.21 47.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.758 0.314 . . . . 0.0 111.084 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 42.9 mt-30 -81.75 122.81 80.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.645 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 17.0 Cg_exo -67.63 -73.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.965 2.443 . . . . 0.0 112.367 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -123.04 47.83 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 110.068 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.55 23.75 27.84 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.069 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.82 -46.64 3.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.0 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 103.29 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.467 0.651 . . . . 0.0 111.152 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -140.29 149.44 42.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.512 176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 2.4 pm0 -79.27 87.15 4.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.597 0.713 . . . . 0.0 109.425 173.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -88.16 114.04 24.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.776 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.6 m -122.03 124.78 44.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.768 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.647 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.85 119.37 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 111.6 -175.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.79 140.52 47.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.998 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.1 tt -104.45 102.5 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.8 m -96.25 103.9 15.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.701 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.67 -20.55 76.35 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.461 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.43 -8.61 27.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.475 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.03 -66.43 1.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -148.67 -36.84 0.18 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.74 -0.64 36.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.073 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.724 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.1 mptm? -87.02 -179.17 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 34.0 m0 -81.36 131.7 35.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.632 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 90.6 m-85 -126.42 177.12 6.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.709 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -128.52 147.03 50.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.133 0.492 . . . . 0.0 110.665 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.74 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 34.8 ttmt -151.74 179.07 8.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.74 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 11.4 mtp180 -90.27 138.71 31.31 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -66.7 3.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -171.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 169' ' ' ARG . 69.4 mtt-85 -97.58 3.69 50.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.977 0.353 . . . . 0.0 111.743 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -84.52 140.45 31.43 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.597 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.557 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 48.4 mm-40 -93.1 91.15 7.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.037 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 4.2 pp -125.05 167.32 16.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.811 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 32.6 Cg_exo -59.84 179.7 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.589 2.859 . . . . 0.0 114.271 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.668 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 28.3 p90 -151.85 163.96 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.569 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.4 mt -139.02 115.43 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 74.5 m -101.9 153.28 20.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -90.39 110.12 21.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 8.4 t80 -103.43 138.31 40.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.464 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -50.52 4.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.77 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 49.8 mm 72.96 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.604 -178.063 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' ILE . 33.7 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -74.7 -8.77 57.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.631 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 23.5 tt0 -59.99 129.5 42.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.763 0.316 . . . . 0.0 110.245 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 p -98.74 131.04 45.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.754 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.884 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.37 179.87 7.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.769 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.456 HG23 ' NE2' ' A' ' 171' ' ' GLN . 67.8 p -78.77 166.0 22.95 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.46 0.475 . . . . 0.0 111.238 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.24 -46.4 89.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.866 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.88 -39.67 79.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 0.0 109.658 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 87.0 tt0 -61.69 -38.13 86.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.662 176.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.884 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -65.02 -46.95 79.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.596 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 78' ' ' ILE . 34.0 p -58.44 -57.2 13.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.913 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -60.17 -32.49 71.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 111.31 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 13.2 t70 -63.78 -54.17 39.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.045 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 99.1 m -61.07 -38.97 88.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.702 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 74' ' ' SER . 23.6 mm -52.51 -42.74 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -80.53 -34.16 35.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.137 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 33.3 mtt-85 -91.05 -25.19 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.11 -173.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.49 -40.87 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.416 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.75 -26.36 5.68 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.322 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 127' ' ' THR . 1.2 p -148.71 155.75 41.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.062 0.458 . . . . 0.0 111.961 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 85' ' ' SER . 6.9 tt -96.33 154.13 17.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.587 ' N ' HD23 ' A' ' 84' ' ' LEU . 31.6 m -70.51 108.53 4.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 0.0 111.306 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 114' ' ' LEU . 33.2 m -110.07 106.7 58.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 60.4 Cg_endo -84.01 115.95 2.08 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.484 2.123 . . . . 0.0 111.664 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 131' ' ' ILE . 3.7 pt20 -115.99 7.26 14.3 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.257 -171.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.9 p -138.06 176.21 8.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.916 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.58 -42.92 62.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.2 p -56.72 -45.7 81.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.389 . . . . 0.0 111.439 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.91 -29.0 60.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.511 -175.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 15.9 m-80 -81.11 -47.01 14.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.456 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.12 -30.87 71.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.28 62.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.832 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 31.0 tp -72.87 -44.59 61.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.484 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.88 -33.11 73.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 109.941 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.76 -44.98 69.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.558 . . . . 0.0 109.584 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.38 -32.47 72.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.147 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 74.2 mt -56.53 -41.61 77.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 110.146 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -66.57 -15.9 63.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.997 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -117.47 2.09 12.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -55.32 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 110' ' ' ILE . 3.4 t -100.35 -30.97 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.01 127.35 3.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -53.56 -35.93 61.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.929 0.395 . . . . 0.0 109.975 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.65 27.99 2.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.49 161.55 13.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.786 0.327 . . . . 0.0 111.108 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.1 mt-10 -118.65 128.05 54.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.633 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.814 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.9 mp -126.51 145.25 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.68 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 152' ' ' CYS . 83.1 m95 -70.66 149.9 46.53 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 83.7 mt -104.39 11.73 34.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.52 -25.35 0.74 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.472 ' HG ' ' HE3' ' A' ' 123' ' ' TRP . 1.8 pt? -92.46 139.48 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.958 0.879 . . . . 0.0 111.869 -170.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -156.82 136.48 12.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.701 175.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.603 ' HB2' ' HA ' ' A' ' 123' ' ' TRP . 24.9 t70 -112.31 135.73 52.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 171.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -126.25 16.73 7.76 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.669 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.27 -63.01 1.16 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.508 -173.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.42 -30.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.2 146.48 24.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.252 0.549 . . . . 0.0 111.466 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -4.54 78.43 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.442 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -82.08 75.04 9.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.603 ' HA ' ' HB2' ' A' ' 116' ' ' ASP . 27.5 m0 -45.88 128.42 8.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.43 155.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 0.0 111.337 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.3 165.07 25.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -55.57 -30.16 60.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.298 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.412 HG23 HG21 ' A' ' 83' ' ' THR . 76.0 p -80.59 -18.88 46.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 111.148 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.71 1.92 28.91 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.401 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 150.89 45.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.633 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -99.59 159.43 15.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.003 0.43 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 46.2 pt -101.83 146.4 10.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.68 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -123.8 20.42 9.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 109.582 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -137.46 120.42 16.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.973 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 134' ' ' LYS . 9.5 mtpm? -135.17 97.29 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.87 110.23 17.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 46.6 m95 -129.68 135.99 49.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.263 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 61.2 mm-40 -91.9 -20.37 21.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.711 0.767 . . . . 0.0 108.948 171.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.7 t -98.56 18.7 16.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.988 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 7.9 tp10 -56.7 117.3 3.77 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.31 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.9 pt -97.57 140.55 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 111.344 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.3 p -120.8 4.95 10.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.365 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -127.49 162.55 26.13 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 -177.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -92.17 102.55 6.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 4.7 Cg_exo -78.95 -72.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.087 2.524 . . . . 0.0 112.976 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 148' ' ' LYS . 30.3 t70 -100.09 46.06 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.814 0.816 . . . . 0.0 110.222 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.9 42.14 6.1 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.417 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.9 -10.68 62.03 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.049 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -135.98 159.88 40.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.5 p -138.58 143.23 39.29 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.75 81.16 5.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.015 0.912 . . . . 0.0 108.821 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.786 ' HB2' ' HB2' ' A' ' 165' ' ' ASP . 8.9 p30 -118.61 151.44 37.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.555 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' CYS . . . . . 0.554 ' HB2' ' HZ3' ' A' ' 111' ' ' TRP . 5.9 m -135.24 140.1 44.98 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.2 116.03 15.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.242 0.544 . . . . 0.0 112.003 -170.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.38 140.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.86 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 3.9 tt -100.23 100.21 11.0 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 14.0 m -88.94 98.55 11.81 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.973 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.68 -29.23 73.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.879 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -68.07 -10.28 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.962 0.411 . . . . 0.0 111.101 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.65 -57.8 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.528 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.5 -33.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.187 -172.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 114.65 -5.03 22.85 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.341 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.586 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -86.5 176.93 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.595 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 39.5 m0 -80.79 131.75 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.183 0.516 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.78 172.17 9.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.632 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.786 ' HB2' ' HB2' ' A' ' 151' ' ' ASN . 5.3 p-10 -124.6 143.09 50.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.492 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 27.6 ttmt -146.88 171.74 14.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 13.8 mtp85 -74.6 141.77 44.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.8 m -66.35 -7.19 17.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -96.81 13.16 29.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -89.2 137.98 31.83 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.094 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.531 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 55.1 mm-40 -92.46 87.97 6.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.254 -176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -125.93 165.73 25.52 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.601 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 36.4 Cg_exo -61.44 -179.15 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.403 2.736 . . . . 0.0 113.712 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.814 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.73 169.28 24.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.451 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 76.8 mt -138.44 122.19 20.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 30.9 m -102.57 156.72 17.43 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -89.56 109.51 20.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -110.63 137.45 48.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.121 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.09 -28.8 2.85 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.081 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 45.9 mm 60.33 87.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.979 -173.225 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.49 0.662 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.66 12.97 2.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.316 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 33.8 tt0 -80.91 137.69 36.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.219 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.8 p -95.2 130.43 41.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -156.11 178.94 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 173.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 ' HD2' ' A' ' 169' ' ' ARG . 46.2 p -85.96 165.98 16.29 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.522 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.91 87.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.647 0.261 . . . . 0.0 111.597 -173.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -60.76 -43.69 97.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 109.966 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.86 -46.67 80.86 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.277 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.9 -39.26 74.09 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.469 0.481 . . . . 0.0 111.396 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' HD13 ' A' ' 78' ' ' ILE . 15.5 t -58.21 -60.1 4.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.085 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.51 -32.93 74.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.02 -38.41 88.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.602 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 36.8 t -93.63 -37.03 12.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.271 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.4 mp -59.65 -36.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.065 0.459 . . . . 0.0 111.406 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -98.88 -0.51 42.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 8.8 ptm180 -105.74 -2.88 22.73 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.99 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.74 -55.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.074 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -174.2 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.741 -1.219 . . . . 0.0 112.778 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.728 HG21 HG22 ' A' ' 127' ' ' THR . 61.6 p -144.16 169.03 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.588 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD23 ' HE1' ' A' ' 126' ' ' MET . 2.9 mm? -67.98 162.86 23.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 96' ' ' LEU . 23.6 m -79.76 107.28 12.41 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 125' ' ' ASP . 18.4 m -100.06 119.03 60.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 68.8 Cg_endo -84.42 121.9 2.71 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.522 2.148 . . . . 0.0 111.949 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -119.09 2.82 11.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.96 177.35 10.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.452 176.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.25 96.34 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.525 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.4 m -53.21 -47.65 68.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 2.8 mp0 -68.54 -37.98 80.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.19 -44.71 94.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.53 -45.72 74.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.35 76.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.844 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 85' ' ' SER . 23.1 mt -60.41 -52.95 63.04 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.274 -0.17 . . . . 0.0 111.076 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.4 t80 -60.5 -36.39 78.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.925 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.99 -37.53 58.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.295 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -73.98 -42.5 60.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -64.9 -24.23 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 0.0 110.644 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 31.9 ttm-85 -65.74 -26.22 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.373 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.16 11.4 17.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.264 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.1 p -137.83 -52.38 0.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.83 -30.73 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.723 0.773 . . . . 0.0 109.905 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 112.85 126.37 4.55 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 4.8 t30 -59.99 -20.77 59.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.936 0.398 . . . . 0.0 111.146 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.53 17.14 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.299 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.26 161.95 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.653 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 172' ' ' LEU . 10.2 pt-20 -116.24 127.66 54.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.604 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.672 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -122.12 149.53 25.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.478 ' CE3' HG22 ' A' ' 154' ' ' VAL . 76.1 m95 -70.05 154.71 41.6 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -88.47 -0.65 57.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 71.09 12.71 72.14 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.852 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mp -94.78 149.22 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.745 0.307 . . . . 0.0 110.61 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -96.94 111.49 23.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 16.8 t70 -76.93 98.33 4.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 110.876 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 48.6 ttp -126.37 -27.23 3.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.546 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.9 150.3 39.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.247 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.47 6.88 47.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.962 0.887 . . . . 0.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.26 169.26 10.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.802 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.36 -4.63 60.91 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.333 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m -77.24 67.57 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.393 0.616 . . . . 0.0 110.666 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -78.57 134.37 37.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.32 134.54 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.76 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -87.17 159.82 18.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.601 0.238 . . . . 0.0 110.527 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.492 ' HE1' HD23 ' A' ' 84' ' ' LEU . 6.9 ptp -66.87 -28.61 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.728 HG22 HG21 ' A' ' 83' ' ' THR . 9.2 p -76.45 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.569 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.65 6.08 19.88 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.115 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.7 132.5 47.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -94.74 113.63 25.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -71.71 138.61 21.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 111.824 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.66 -18.2 13.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.842 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -80.9 122.13 26.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.295 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 88.7 mttt -139.19 122.72 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.085 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.21 113.25 13.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 1.071 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 61.4 m95 -126.03 122.99 37.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HG2' HD21 ' A' ' 160' ' ' ASN . 19.4 tp10 -76.08 -20.63 57.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.448 0.642 . . . . 0.0 109.337 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.5 t -115.24 27.89 9.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.597 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 1.071 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 41.2 tt0 -62.64 113.95 3.29 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.366 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 pt -73.63 131.28 35.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -91.92 -23.81 19.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.516 0.674 . . . . 0.0 109.708 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.86 147.95 50.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.218 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.494 ' OE1' ' HA2' ' A' ' 147' ' ' GLY . 30.2 tt0 -76.34 110.01 10.11 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 12.4 Cg_exo -69.61 -65.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.219 2.613 . . . . 0.0 114.156 -167.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 9.0 t0 -84.97 45.28 1.15 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 0.0 111.436 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 51.05 36.75 35.44 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.991 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' HA2' ' OE1' ' A' ' 143' ' ' GLN . . . 122.67 -34.84 3.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.221 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 8.0 ttpt -82.58 136.85 34.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 0.0 110.165 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.1 p -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.362 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -64.7 143.3 58.02 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.577 ' HB2' ' OD1' ' A' ' 116' ' ' ASP . 27.4 p-10 -122.65 175.8 6.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -171.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.2 m 69.12 106.93 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.258 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.18 136.97 37.93 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.606 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 166' ' ' LYS . 58.5 t -135.48 143.91 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.968 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.4 tp -98.35 105.04 17.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.83 111.25 23.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 0.0 110.787 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 -28.19 57.08 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.016 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.26 62.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.975 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.44 -60.35 1.97 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.697 HD21 ' HG2' ' A' ' 137' ' ' GLU . 11.6 p30 -173.33 -34.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.447 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 119.35 15.22 5.57 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.604 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.435 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 33.2 mmtp -93.58 173.97 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -82.93 129.54 35.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.315 0.579 . . . . 0.0 110.614 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.08 -173.25 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.744 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -124.66 143.55 50.67 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.845 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 1.5 tmmm? -152.51 138.69 18.32 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 69.8 mtm180 -60.35 135.46 57.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.557 0.694 . . . . 0.0 111.826 -169.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.613 ' O ' ' HB ' ' A' ' 69' ' ' THR . 3.0 m -59.93 -21.29 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.338 -169.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.74 ' HD2' HG21 ' A' ' 69' ' ' THR . 16.6 tpt180 -97.52 6.33 48.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.381 . . . . 0.0 111.246 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.845 ' HB3' ' HE3' ' A' ' 166' ' ' LYS . 14.1 t70 -95.27 135.94 36.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -92.85 120.47 33.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -167.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.693 HD23 ' HZ1' ' A' ' 166' ' ' LYS . 3.7 pp -131.31 165.03 38.29 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.215 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.8 Cg_exo -73.05 178.12 6.92 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.366 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.672 ' HA ' HG23 ' A' ' 110' ' ' ILE . 4.5 p90 -147.08 175.77 10.45 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.607 -0.683 . . . . 0.0 111.982 -175.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 98.5 mt -141.18 124.07 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.015 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.02 145.33 29.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 0.0 112.23 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -114.93 108.57 16.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.575 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -144.3 145.34 31.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 108.61 127.89 5.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.582 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.5 mt -98.12 101.46 12.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.913 0.387 . . . . 0.0 110.167 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.931 178.671 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.679 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -71.52 -4.59 27.61 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 3.1 tt0 -59.17 127.28 31.39 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.7 p -102.72 126.36 49.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.162 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.901 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -156.06 174.37 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 76.2 p -84.18 165.96 17.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.088 0.242 . . . . 0.0 110.611 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -55.62 -49.82 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.94 -41.7 98.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.264 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.55 -45.33 93.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.993 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.901 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -57.06 -42.38 80.46 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.799 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' HD13 ' A' ' 78' ' ' ILE . 80.6 p -63.17 -36.53 83.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.66 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -93.76 -33.93 13.4 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.288 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.7 t70 -56.99 -59.56 4.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.881 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 47.2 t -59.68 -41.04 89.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.2 mp -60.43 -42.78 92.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.157 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.6 t -68.86 -26.8 65.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.889 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 30.1 mmt180 -73.47 -10.98 60.29 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.792 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.42 43.42 2.54 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.04 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -171.15 -165.48 28.52 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.143 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -134.64 148.65 50.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.2 tt -61.46 136.37 58.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 84' ' ' LEU . 33.7 p -64.1 108.33 1.51 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.992 0.425 . . . . 0.0 111.481 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -109.84 111.12 58.93 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.475 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.34 112.0 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.242 1.962 . . . . 0.0 112.14 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.81 -13.46 24.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.186 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.67 158.6 37.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.63 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.22 95.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.08 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -58.6 -40.98 84.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.326 0.25 . . . . 0.0 111.284 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -64.61 -41.79 95.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.046 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -64.94 -43.95 91.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 109.995 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.51 -46.7 84.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.799 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.94 74.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.309 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 15.7 tp -70.11 -40.67 74.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.303 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -65.51 -40.5 93.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.09 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -67.12 -34.98 78.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.202 0.525 . . . . 0.0 110.91 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -70.76 -25.2 62.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.95 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 58.4 mt -56.09 -55.22 35.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 6.4 mmt180 -51.37 -36.89 45.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.575 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.42 15.06 27.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.99 -170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -153.95 -55.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.74 -27.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.549 0.69 . . . . 0.0 111.04 -171.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.43 127.26 5.68 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -168.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 3.8 t30 -50.61 -41.29 54.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 107' ' ' GLU . 9.4 pt-20 -94.77 36.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.206 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.58 160.68 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.666 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 22.8 mm-40 -110.31 124.89 52.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.488 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -134.21 154.45 37.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.499 ' HB2' HD11 ' A' ' 84' ' ' LEU . 77.6 m95 -70.9 145.88 49.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -91.36 2.25 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 111.795 -171.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 85.01 9.84 79.79 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.842 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 131' ' ' ILE . 4.1 mm? . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.958 0.379 . . . . 0.0 109.991 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -66.89 149.26 50.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.793 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.55 130.37 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 131' ' ' ILE . 14.2 m-20 -74.49 172.95 11.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.778 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 22.7 mmt -64.8 -24.46 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.059 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 p -82.54 -6.38 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.558 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.42 58.42 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.478 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.93 167.11 10.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.471 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -110.97 123.63 50.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.53 152.75 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 175.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -106.31 -6.1 18.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.263 0.554 . . . . 0.0 110.393 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.32 124.65 44.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.149 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 11.8 mmmm -122.32 108.67 13.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -152.24 111.69 3.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' HE1' ' HE2' ' A' ' 134' ' ' LYS . 7.7 m95 -136.66 151.11 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.632 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 8.7 tp10 -93.26 -30.68 15.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.0 p . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.604 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.8 107.37 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.483 -173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 166' ' ' LYS . 39.5 t -126.81 154.4 36.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.644 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.1 tt -111.83 122.59 48.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.0 t -109.21 98.56 7.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.151 0.501 . . . . 0.0 109.969 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -72.63 -23.85 77.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.426 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -72.47 -24.11 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 110.614 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.3 -53.23 7.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.65 -41.56 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.101 0.477 . . . . 0.0 110.415 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.68 -2.19 4.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.815 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 57.6 mttt -88.7 163.89 15.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -78.02 146.13 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.851 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.2 m-85 -135.74 -169.1 2.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.153 -172.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 6.6 p-10 -137.15 152.5 50.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.859 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.592 ' HB2' HG21 ' A' ' 154' ' ' VAL . 34.3 mttp -152.78 -167.16 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.79 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.521 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 48.2 mtm180 -86.53 131.84 34.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 68.7 m -69.06 -11.6 60.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -97.52 5.91 48.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 110.823 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.521 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 34.0 m-20 -80.76 134.89 35.89 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -92.56 90.62 7.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.22 0.533 . . . . 0.0 110.508 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -116.83 163.38 22.88 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.913 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 25.0 Cg_exo -64.04 179.92 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.122 2.548 . . . . 0.0 113.106 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.442 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -157.75 163.17 38.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.566 178.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.679 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 79.8 mt -127.29 137.74 56.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 67.6 m -121.45 146.56 46.79 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 85' ' ' SER . 16.7 mm-40 . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.66 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 52.5 m-85 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.12 3.09 11.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.157 0.503 . . . . 0.0 111.168 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -75.29 137.04 40.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.631 177.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -97.21 129.41 44.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -161.63 172.45 16.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.755 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.724 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 18.3 p -82.31 167.61 18.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.37 -27.3 67.29 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -62.99 -57.29 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.568 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 5.9 mp0 -63.69 -36.32 83.47 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.37 87.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.436 . . . . 0.0 110.717 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' HD13 ' A' ' 78' ' ' ILE . 22.7 t -72.58 -56.06 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.226 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.55 -45.18 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.498 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -64.97 -52.42 56.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.127 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 12.8 t -66.82 -34.11 77.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.909 0.385 . . . . 0.0 111.209 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -68.11 -34.0 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.184 0.516 . . . . 0.0 110.331 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -28.26 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.281 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 10.7 ptp180 -80.26 0.63 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 110.612 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.99 52.16 8.26 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.032 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.51 -166.93 13.26 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -153.54 139.35 18.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.884 0.342 . . . . 0.0 110.233 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.6 mp -61.08 137.63 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -62.75 108.03 1.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.194 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 7.5 m -106.52 109.24 62.99 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.8 Cg_exo -75.51 117.28 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.749 2.299 . . . . 0.0 112.258 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.79 -5.01 20.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.134 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 173.15 12.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.438 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.82 -39.17 97.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.654 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -56.34 -48.4 76.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.582 0.229 . . . . 0.0 111.51 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.3 -51.59 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.411 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.48 -43.22 73.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.376 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.81 70.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -64.48 -48.79 73.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.24 -43.31 87.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.848 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 101' ' ' ARG . 9.9 tp10 -63.44 -43.42 97.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.344 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -63.4 -34.96 78.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.921 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 77.3 mt -54.35 -45.54 72.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 98' ' ' GLU . 52.2 mtp180 -58.5 -30.93 67.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.618 -173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -109.43 10.4 25.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.923 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.0 m -138.78 -57.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 110' ' ' ILE . 25.1 t -103.43 -37.83 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.691 0.757 . . . . 0.0 110.55 -171.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.02 126.43 2.57 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -53.21 -37.13 61.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.698 0.285 . . . . 0.0 110.752 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -104.39 34.7 2.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.443 0.639 . . . . 0.0 111.404 -176.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.51 161.72 13.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.278 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 54.8 mt-10 -121.12 126.24 49.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 174' ' ' TYR . 2.6 mp -124.27 146.73 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 83.1 m95 -71.3 137.22 48.34 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -87.2 3.92 44.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.906 0.384 . . . . 0.0 111.393 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 83.81 9.39 82.9 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.514 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 131' ' ' ILE . 9.5 mp . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 130' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 121.276 0.56 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -68.61 157.36 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.399 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 42.7 t -101.35 126.7 55.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.843 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.48 163.94 27.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.951 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 9.0 mmt -64.94 -26.65 68.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.071 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -83.89 -4.9 59.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.683 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.66 56.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.846 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.4 168.12 9.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.424 ' HD3' HG22 ' A' ' 122' ' ' THR . 3.4 tmm_? -110.97 125.41 53.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HD21 ' A' ' 114' ' ' LEU . 23.1 pt -53.88 125.71 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.484 0.659 . . . . 0.0 112.343 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.95 -13.13 29.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.06 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -103.42 127.2 50.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.853 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -131.02 119.35 21.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -149.71 110.02 4.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -127.34 143.98 51.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.757 ' HG2' HD21 ' A' ' 160' ' ' ASN . 10.7 tp10 -91.13 -30.1 16.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 10.2 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.213 173.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 27.5 m . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 121.14 0.495 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -112.94 146.27 39.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.046 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.63 160.64 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.333 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 57.1 tp -100.34 103.07 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 23.3 t -97.17 104.8 16.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.132 0.491 . . . . 0.0 110.554 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.91 -22.15 77.33 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.721 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -73.81 -16.97 61.13 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.337 0.589 . . . . 0.0 110.594 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.141 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.757 HD21 ' HG2' ' A' ' 137' ' ' GLU . 16.7 p30 -174.51 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.692 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 126.18 15.22 2.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 32.8 mmtp -100.48 175.63 5.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -77.4 131.07 37.84 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.531 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 50.6 m-85 -127.34 176.73 7.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.838 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -113.8 137.4 51.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.537 . . . . 0.0 111.001 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 9.1 mmmm -150.61 137.01 18.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.487 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -57.68 136.65 56.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.446 0.467 . . . . 0.0 110.978 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.724 ' O ' ' HB ' ' A' ' 69' ' ' THR . 5.3 m -60.21 -14.65 18.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -96.65 13.94 26.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.532 0.206 . . . . 0.0 111.548 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.6 146.27 23.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.12 88.47 6.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 110.979 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 pp -128.09 158.08 72.06 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.62 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.6 Cg_exo -62.58 -178.5 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.367 2.711 . . . . 0.0 113.786 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 1.3 p90 -152.25 165.91 33.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 79.9 mt -139.4 130.65 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.925 0.393 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 72.0 m -108.92 143.64 37.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.019 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 121.494 0.664 . . . . 0.0 110.212 -179.766 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 174' ' ' TYR . 1.1 p90 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -2.87 20.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 110.766 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.716 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 34.1 tt0 -56.61 122.51 12.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.875 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -89.94 121.13 31.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.339 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.875 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.53 -175.86 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.318 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 31.7 p -78.42 166.42 22.65 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.319 0.387 . . . . 0.0 110.425 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.35 -35.39 77.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -63.58 -51.14 66.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.928 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 4.7 mm-40 -66.7 -37.98 85.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.104 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.875 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -59.74 -40.85 89.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.131 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -66.79 -56.43 10.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.292 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.39 -48.22 81.34 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 12.2 t70 -59.91 -58.95 6.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.898 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.1 t -61.3 -38.85 88.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.171 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.85 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.597 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.9 m -74.23 -9.15 58.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.999 0.428 . . . . 0.0 110.659 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -88.43 -10.09 50.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.82 56.26 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.45 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.0 179.77 17.16 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.115 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.605 0.24 . . . . 0.0 110.751 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 113' ' ' GLY . 15.8 tp -68.68 139.61 55.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 p -62.11 109.77 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 111.487 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 5.2 t -118.87 130.32 24.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 23.6 Cg_endo -93.63 144.24 2.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.364 2.709 . . . . 0.0 113.139 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -108.19 -25.65 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.896 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.695 ' HA ' ' CB ' ' A' ' 133' ' ' TYR . 11.6 t -158.9 -169.99 2.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.128 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.25 -24.93 56.52 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 112.981 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.469 ' H ' HG23 ' A' ' 89' ' ' THR . 17.3 t -56.51 -52.59 64.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.664 0.269 . . . . 0.0 110.62 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -75.99 -37.97 57.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.292 . . . . 0.0 110.332 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.441 ' C ' HD22 ' A' ' 93' ' ' ASN . 0.2 OUTLIER -56.49 -45.21 81.11 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.177 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.51 -46.89 52.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.793 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.25 94.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.098 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.12 -45.69 87.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.88 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.577 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 45.0 t80 -63.89 -34.62 78.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.623 . . . . 0.0 110.297 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -44.13 76.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.851 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.83 -34.08 64.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.394 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 3.8 pp -71.34 -32.89 69.08 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.402 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.83 -30.85 71.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.56 22.31 13.78 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.078 -0.388 . . . . 0.0 111.642 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -151.69 -64.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.008 -0.432 . . . . 0.0 111.513 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.7 t -76.25 -32.45 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.176 0.513 . . . . 0.0 109.631 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.14 -74.76 0.29 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.224 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.515 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER 172.98 -62.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -175.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 106' ' ' ASN . 2.0 mp0 -86.3 37.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.13 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -98.1 149.05 22.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.04 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 35.4 mt-10 -108.58 127.33 53.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.747 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.587 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.6 mp -122.03 140.34 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 91.9 m95 -69.69 140.81 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.634 HD12 ' HB1' ' A' ' 153' ' ' ALA . 33.5 mt -80.54 0.29 34.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 86.68 -21.77 17.02 Favored Glycine 0 C--N 1.32 -0.342 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.857 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.92 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 121.228 0.537 . . . . 0.0 110.89 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.153 0.501 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.469 ' CE3' HD23 ' A' ' 114' ' ' LEU . 74.9 m95 -85.03 120.13 26.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.631 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.98 129.53 66.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.92 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 5.1 p30 -86.21 -171.47 3.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.443 0.639 . . . . 0.0 112.45 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.85 -11.18 59.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.172 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.0 p -93.96 -20.63 19.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.321 0.582 . . . . 0.0 109.95 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.29 24.84 9.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.642 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.8 154.17 18.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 110.551 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -109.26 122.0 46.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.812 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.0 pt -66.11 134.04 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.337 0.589 . . . . 0.0 111.589 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -113.64 17.29 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.61 0.719 . . . . 0.0 109.875 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 60.0 t80 -136.71 117.36 13.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.861 -177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.92 107.54 12.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 0.0 111.009 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.61 ' OD1' ' HG3' ' A' ' 162' ' ' LYS . 29.4 t-20 -133.31 110.22 9.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -123.26 147.04 47.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.993 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.7 tm-20 -89.87 -42.38 11.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 164' ' ' PHE . 9.0 t . . . . . 0 CA--C 1.54 0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.262 -172.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 92.7 m . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 121.652 0.739 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -84.22 143.55 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.464 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 11.5 t -125.15 146.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.821 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.495 ' HB2' HD21 ' A' ' 112' ' ' LEU . 69.0 tp -98.8 100.81 12.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.4 m -93.44 98.51 11.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.383 0.611 . . . . 0.0 110.405 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.13 -13.04 76.3 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.439 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . . . -67.78 -18.22 64.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.826 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.75 -63.99 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.062 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -177.72 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.499 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.23 3.59 14.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.256 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.61 ' HG3' ' OD1' ' A' ' 135' ' ' ASN . 0.7 OUTLIER -81.26 154.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -75.35 137.71 41.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.137 0.494 . . . . 0.0 111.301 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.578 ' HA ' HG22 ' A' ' 138' ' ' THR . 21.9 m-85 -121.68 -179.24 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.608 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -135.41 138.74 43.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.145 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.8 162.89 40.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 168.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.4 ' HA ' ' HD2' ' A' ' 167' ' ' ARG . 8.1 tpt180 -62.7 144.7 56.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.819 0.342 . . . . 0.0 110.758 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.579 ' O ' ' HB ' ' A' ' 69' ' ' THR . 12.3 m -59.99 -11.74 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -100.74 8.97 42.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 172' ' ' LEU . 29.4 t70 -74.76 139.04 43.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.706 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 66.9 mm-40 -92.6 83.05 4.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.817 -174.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.545 HD23 ' OD2' ' A' ' 170' ' ' ASP . 3.7 pp -125.13 161.69 48.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 172' ' ' LEU . 24.3 Cg_exo -63.11 -177.92 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.594 2.863 . . . . 0.0 113.713 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.716 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 7.4 p90 -155.04 178.03 10.66 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.036 -0.415 . . . . 0.0 110.352 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 96.6 mt -145.23 135.27 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 93.9 m -108.52 147.08 32.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.577 0.703 . . . . 0.0 109.589 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.607 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 13.5 t -74.99 -0.29 18.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.202 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 13.5 mp0 -64.6 124.93 23.14 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.426 0.631 . . . . 0.0 111.416 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -91.01 122.29 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.291 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.742 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.81 -175.4 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -81.74 166.89 19.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -62.45 -31.31 72.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.05 -52.37 43.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.93 -38.6 89.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.922 0.392 . . . . 0.0 110.366 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -60.61 -30.41 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.087 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 30.6 m -74.48 -63.6 1.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.305 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.5 -42.61 99.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.332 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.73 -25.03 61.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -174.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 34.9 t -87.16 -43.12 12.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.61 -43.58 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.274 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -71.4 -13.66 61.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.901 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -92.22 11.01 27.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.45 35.21 81.21 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.222 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.74 175.87 21.52 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -142.41 138.87 31.42 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.128 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -58.86 127.3 31.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.42 ' OG ' HD21 ' A' ' 96' ' ' LEU . 23.0 t -55.04 122.49 11.05 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.393 0.433 . . . . 0.0 110.953 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.585 ' HB ' ' OD1' ' A' ' 125' ' ' ASP . 52.3 p -108.94 108.9 60.97 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.213 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 93' ' ' ASN . 70.8 Cg_endo -84.87 110.75 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.378 2.052 . . . . 0.0 112.529 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -101.96 -16.19 16.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.732 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.3 p -129.89 167.99 17.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.226 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.59 91.61 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.271 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.9 m -64.34 -28.75 69.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.11 -34.14 43.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -71.25 -55.85 7.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.002 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -68.02 -17.42 64.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.9 78.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.447 . . . . 0.0 110.309 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.42 HD21 ' OG ' ' A' ' 85' ' ' SER . 64.8 mt -66.98 -38.92 86.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.204 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.556 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 89.9 t80 -59.17 -35.87 74.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.32 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -71.11 -46.89 60.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.91 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -67.18 -43.76 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.488 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HD11 ' A' ' 175' ' ' ILE . 2.9 pp -63.0 -31.0 72.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.579 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 32.5 ttp-105 -65.32 -36.33 83.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.031 177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.58 13.56 25.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 m -149.42 -46.66 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 110' ' ' ILE . 3.5 p -106.65 -23.92 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.28 0.562 . . . . 0.0 110.539 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.45 126.26 4.05 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 8.7 t30 -59.37 -34.03 71.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.424 0.612 . . . . 0.0 111.042 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -88.8 24.06 2.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.385 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -98.11 161.48 13.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.985 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.3 mt-10 -118.38 126.51 52.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.683 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.801 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -120.2 152.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.548 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 76.3 m95 -70.62 146.53 49.98 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.65 HD12 ' HB1' ' A' ' 153' ' ' ALA . 40.2 mt -80.88 -2.5 47.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 74.66 6.3 76.75 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.882 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.326 -0.432 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.398 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 130' ' ' ARG . 1.5 p . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.4 157.38 34.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.755 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.6 125.18 54.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.056 0.455 . . . . 0.0 110.651 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.585 ' OD1' ' HB ' ' A' ' 86' ' ' THR . 12.8 m-20 -72.32 162.2 29.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.237 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 18.5 mmt -55.52 -30.73 61.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.884 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -85.23 0.16 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.067 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.33 44.58 9.48 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.583 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.55 165.12 20.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.734 0.302 . . . . 0.0 110.954 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 6.8 mtp85 -112.49 120.07 40.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.106 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.652 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -70.68 141.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 111.578 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.2 -21.22 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.832 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -88.4 115.97 26.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -137.96 107.39 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.686 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -137.8 112.92 9.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -119.38 114.49 22.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.809 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 28.7 tt0 -70.97 -37.0 72.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.823 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 164' ' ' PHE . 6.8 t . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 166' ' ' LYS . 5.4 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -111.82 106.86 15.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.48 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 166' ' ' LYS . 45.9 t -131.96 140.3 48.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.127 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.55 HD23 HD21 ' A' ' 112' ' ' LEU . 1.5 tm? -106.4 100.91 10.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.1 m -98.43 112.03 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.327 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.64 -23.03 68.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.968 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.39 -28.82 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 111.26 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.95 -62.67 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -169.68 -25.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.017 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.87 20.23 7.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.67 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 162' ' ' LYS . 10.4 mmpt? -93.12 -179.18 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.552 ' CH2' HG13 ' A' ' 131' ' ' ILE . 40.3 m0 -82.25 123.91 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.433 . . . . 0.0 111.215 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 87.3 m-85 -126.05 -179.29 4.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -130.1 154.57 47.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.525 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.4 tttp -153.69 -152.68 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -100.21 121.9 42.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.548 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 14.2 m -65.33 -2.48 3.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -112.19 -0.47 15.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.788 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.15 149.68 21.35 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.19 107.7 19.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.9 pp -129.41 167.46 19.94 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.426 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 19.3 Cg_exo -67.01 -177.68 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.133 2.555 . . . . 0.0 113.445 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.801 ' HA ' HG23 ' A' ' 110' ' ' ILE . 34.9 p90 -143.87 179.67 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.304 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 100' ' ' LEU . 76.3 mt -143.1 116.96 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.1 m -112.57 133.73 54.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.146 0.498 . . . . 0.0 112.17 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 . . . . . 0 N--CA 1.447 -0.598 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.177 175.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 56.1 m-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.001 0.429 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -68.34 -13.89 62.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.852 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 15.7 mm100 -60.25 132.65 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 111.029 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.553 ' HB ' ' HG2' ' A' ' 171' ' ' GLN . 41.3 p -101.48 143.22 31.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.668 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.73 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.01 -179.2 5.06 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.229 0.331 . . . . 0.0 110.114 178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 71.8 p -84.93 166.47 16.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.49 0.186 . . . . 0.0 110.524 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.18 -49.69 76.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -70.79 -26.44 63.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 109.636 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 68' ' ' LYS . 36.2 tt0 -76.67 -32.49 57.96 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.704 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -66.38 -43.17 86.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.5 p -63.6 -54.21 39.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.651 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.62 -39.56 84.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -64.7 -59.22 4.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.375 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.657 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 22.6 t -61.08 -36.52 79.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 0.0 110.483 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 74' ' ' SER . 1.5 mp -65.82 -34.62 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 -29.13 44.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.657 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 16.3 ptm180 -88.29 1.26 54.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.688 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.68 66.26 1.51 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.493 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.17 167.23 38.77 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.667 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -114.16 133.0 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 85' ' ' SER . 5.5 tt -60.46 134.13 56.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.482 ' N ' HD23 ' A' ' 84' ' ' LEU . 39.6 m -54.09 109.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.805 0.691 . . . . 0.0 112.156 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t -108.23 118.65 51.93 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.52 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.1 Cg_exo -75.75 110.91 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.57 2.18 . . . . 0.0 111.149 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 2.9 pt20 -117.38 -10.19 10.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.619 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.1 p -136.83 164.87 27.27 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.528 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.06 95.3 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.628 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -61.34 -45.13 95.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.876 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.94 -46.51 88.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.517 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -67.75 -37.58 82.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.58 -52.72 64.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.139 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.06 83.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.389 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -61.46 -51.69 67.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.006 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -62.49 -39.69 94.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -64.16 -41.49 97.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -64.07 -35.8 81.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.71 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.9 mt -54.75 -48.99 71.91 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.204 0.526 . . . . 0.0 109.845 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -59.02 -27.81 65.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.375 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -111.36 17.29 20.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.892 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -153.63 -54.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -100.85 -36.65 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.15 -171.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.5 130.25 3.23 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.106 -171.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -35.9 45.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.85 27.83 2.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.848 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.32 161.61 15.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 111.318 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.571 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 4.6 pt-20 -122.87 121.64 36.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.643 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.709 HG23 ' HA ' ' A' ' 174' ' ' TYR . 34.3 mm -120.01 153.36 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.404 ' CE3' HG12 ' A' ' 154' ' ' VAL . 83.2 m95 -70.65 149.26 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.85 HD12 ' HB1' ' A' ' 153' ' ' ALA . 73.7 mt -89.08 -1.78 58.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.41 9.97 69.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.76 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.461 HD21 HD13 ' A' ' 131' ' ' ILE . 8.3 mp . . . . . 0 C--N 1.326 -0.427 0 C-N-CA 122.747 0.419 . . . . 0.0 110.286 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -68.11 152.36 45.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.453 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.08 158.19 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.19 175.87 6.44 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.39 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.37 -20.56 65.58 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.5 p -87.25 -7.63 57.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.162 0.437 . . . . 0.0 111.117 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.55 21.16 29.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.837 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.08 164.54 11.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 0.0 110.424 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -108.02 133.63 52.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 HD21 ' A' ' 114' ' ' LEU . 42.8 pt -75.96 125.92 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.279 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.34 -22.81 28.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.608 . . . . 0.0 109.727 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -92.3 120.83 33.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.534 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 136' ' ' TRP . 55.1 tttt -144.01 119.1 10.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -156.66 113.17 3.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.55 ' CD1' ' HG3' ' A' ' 134' ' ' LYS . 42.5 m95 -124.31 140.94 52.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.44 -170.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 17.7 mm-40 -89.75 -11.86 41.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.251 174.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 8.3 t . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.53 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.85 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.6 133.24 39.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.567 -171.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CE3' ' A' ' 111' ' ' TRP . 27.3 m -128.26 164.2 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.629 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 112' ' ' LEU . 55.8 tp -111.75 107.33 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.48 103.77 14.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.976 0.417 . . . . 0.0 110.601 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.7 -32.18 74.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.243 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.54 -22.89 65.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.026 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -54.15 8.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.478 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 162' ' ' LYS . 9.6 p30 175.61 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.029 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 127.16 -11.88 6.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.534 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.515 ' HG2' ' OD1' ' A' ' 160' ' ' ASN . 31.5 mmtp -83.72 176.67 8.79 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.433 0.616 . . . . 0.0 109.981 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.472 ' HB3' HD11 ' A' ' 112' ' ' LEU . 43.1 m0 -85.86 136.85 33.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 23.6 m-85 -127.55 -168.01 1.83 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.465 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -133.86 140.88 47.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HE2' HD23 ' A' ' 172' ' ' LEU . 9.2 ttpt -145.88 146.8 31.24 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 165.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.53 140.34 46.28 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.806 0.812 . . . . 0.0 112.538 -163.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.9 m -56.78 -25.33 55.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.59 -161.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -99.08 15.99 24.1 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.16 -176.24 6.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.553 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 31.7 tt0 -132.33 97.65 4.17 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.544 -171.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.1 pp -130.2 168.01 18.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.681 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.597 ' O ' HD12 ' A' ' 172' ' ' LEU . 17.1 Cg_exo -67.26 -178.98 1.61 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.188 2.592 . . . . 0.0 113.321 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.709 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -159.05 158.72 33.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.241 -0.287 . . . . 0.0 110.368 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.432 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 58.2 mt -126.49 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.61 126.17 49.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.264 0.554 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.197 178.488 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.767 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 70.4 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.044 0.45 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -72.9 -4.07 29.68 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.442 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 1.2 tm0? -58.1 122.15 12.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.204 0.525 . . . . 0.0 110.083 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -96.56 113.41 24.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.46 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.673 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -148.39 177.03 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -77.51 165.7 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.474 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 85.5 t80 -59.17 -38.53 79.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -59.73 -53.14 61.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.779 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -63.15 -37.8 88.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.516 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.673 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -56.95 -43.29 81.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.43 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.575 ' O ' HD13 ' A' ' 78' ' ' ILE . 19.4 m -66.93 -59.69 3.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.311 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -53.21 -44.38 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.761 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.683 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 6.3 t70 -70.36 -41.95 72.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.727 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -62.45 -31.87 72.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.362 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -58.92 -36.47 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.387 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 -14.32 28.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 21.4 mmt180 -87.61 -24.68 23.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.886 0.374 . . . . 0.0 110.968 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.68 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.29 -37.57 0.98 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.889 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -146.83 158.34 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.147 0.473 . . . . 0.0 111.942 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 85' ' ' SER . 5.7 tt -90.8 150.75 21.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 20.9 m -60.94 109.05 0.96 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.915 0.388 . . . . 0.0 111.179 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 112' ' ' LEU . 18.0 p -113.14 106.02 55.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.484 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.31 135.23 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.232 1.955 . . . . 0.0 111.858 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 31.7 mm-40 -107.69 -26.02 11.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 110.073 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.1 m -136.15 165.84 24.78 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.903 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.19 -28.13 53.68 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.337 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 p -61.2 -50.05 74.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.635 0.255 . . . . 0.0 111.07 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.76 -39.13 73.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.034 0.445 . . . . 0.0 109.986 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -59.42 -48.37 81.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.328 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.93 -34.88 69.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.691 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.19 -31.04 72.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -45.61 93.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.769 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.702 ' CE2' ' HA2' ' A' ' 161' ' ' GLY . 78.5 m-85 -59.92 -40.78 90.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.287 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 5.3 mm-40 -59.97 -44.68 94.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.294 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -75.81 -39.62 56.51 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.642 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HA ' HG23 ' A' ' 104' ' ' VAL . 1.9 pp -67.99 -37.14 81.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.265 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 25.9 mtm180 -69.73 -8.63 49.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 46.7 mt-30 -119.2 17.25 13.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.598 0.237 . . . . 0.0 111.027 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -152.07 -62.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.166 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.4 t -76.76 -35.57 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 146.17 -76.92 0.27 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.146 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.493 HD22 ' HG2' ' A' ' 101' ' ' ARG . 2.7 t-20 173.8 -57.46 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.81 39.65 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.863 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.45 139.81 36.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 111.749 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HB3' HG21 ' A' ' 154' ' ' VAL . 2.9 mp0 -99.55 124.38 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.271 171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 174' ' ' TYR . 5.2 mp -126.24 143.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.044 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -70.61 150.77 45.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.7 mt -97.25 6.4 48.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 112.01 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.92 16.39 52.04 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.733 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 123' ' ' TRP . 5.0 mp . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 122.731 0.412 . . . . 0.0 111.0 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.53 0.681 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.424 ' HB2' HD23 ' A' ' 114' ' ' LEU . 26.6 m95 -68.6 147.55 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.282 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.87 134.59 48.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.209 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 172.1 13.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.973 0.416 . . . . 0.0 110.532 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.3 ptp -55.8 -32.62 63.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.8 p -84.25 -23.13 30.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.542 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.96 4.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.981 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.34 154.7 21.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.043 0.449 . . . . 0.0 110.827 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -109.01 146.45 33.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.832 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.685 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -87.46 163.32 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.514 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.88 13.78 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.377 0.608 . . . . 0.0 110.018 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 25.5 t80 -139.39 124.34 18.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.861 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.477 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 51.5 pttt -143.32 115.71 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -120.32 113.17 19.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.477 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 55.2 m95 -112.93 128.29 56.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -88.05 -47.63 8.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.822 -177.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.334 0.588 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.96 145.33 38.18 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.19 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 166' ' ' LYS . 13.2 p -125.94 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.322 0.582 . . . . 0.0 110.618 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 7.9 tt -91.73 123.62 35.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.2 t -108.96 121.04 44.29 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.67 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . -74.23 -53.75 6.68 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.218 -170.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.08 -1.05 52.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.734 0.302 . . . . 0.0 111.698 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.21 -35.23 66.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.743 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -177.78 -27.67 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.702 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . 92.28 29.89 10.71 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.481 -171.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 72.6 mmtt -126.49 175.9 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -85.66 138.1 32.38 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.53 171.76 10.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.751 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.9 150.1 39.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.004 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HB2' HG11 ' A' ' 154' ' ' VAL . 34.7 tttt -153.51 -174.81 5.09 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -74.07 126.9 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 42.9 t -60.33 -22.99 63.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -99.77 17.65 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.621 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.26 137.51 36.64 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.04 99.52 12.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.284 0.564 . . . . 0.0 111.106 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 2.5 pp -128.88 164.23 40.13 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.605 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 36.8 Cg_endo -64.49 178.2 1.79 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.661 2.241 . . . . 0.0 113.191 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.933 ' HA ' HG23 ' A' ' 110' ' ' ILE . 12.1 p90 -152.69 174.2 14.29 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.554 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mp -131.51 126.89 58.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.599 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 2.4 t -102.21 149.46 24.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.794 0.331 . . . . 0.0 110.873 -172.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.783 -179.104 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.51 HG23 HG13 ' A' ' 104' ' ' VAL . 1.5 m -71.53 -10.39 59.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.887 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 8.1 mm-40 -64.18 141.82 58.63 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.201 0.524 . . . . 0.0 110.258 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -95.61 147.79 23.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.177 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.56 172.29 8.25 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.078 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 80.8 p -82.43 166.52 19.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 67.3 t80 -60.89 -36.4 79.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.626 0.251 . . . . 0.0 111.52 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -59.52 -50.36 74.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.21 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -64.83 -40.74 95.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.222 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.48 -39.85 73.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.3 m -64.53 -61.9 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.573 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.86 -37.29 86.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.895 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 13.3 t70 -66.84 -47.14 72.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 42.0 t -66.02 -30.35 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.378 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -59.06 -32.09 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.153 0.501 . . . . 0.0 110.179 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -83.21 -32.37 26.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.888 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.589 ' HB2' ' SG ' ' A' ' 176' ' ' CYS . 29.0 mmt180 -77.99 -26.03 48.4 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.679 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.49 -57.33 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.017 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 140.42 -23.79 2.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 p -141.23 136.45 31.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 85' ' ' SER . 5.1 tt -77.21 151.83 35.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.607 ' N ' HD23 ' A' ' 84' ' ' LEU . 7.5 t -67.23 108.88 2.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.102 0.477 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 125' ' ' ASP . 55.7 m -113.58 114.75 47.25 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 163' ' ' TRP . 11.5 Cg_exo -71.82 112.04 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.79 2.326 . . . . 0.0 111.794 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.87 -13.18 16.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.89 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.21 154.91 50.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.527 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.82 -53.09 44.29 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.337 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -56.77 -38.23 72.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.829 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.29 -42.48 93.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.131 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -70.02 -43.09 72.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.98 -39.16 93.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.396 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.84 88.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 20.9 tp -67.11 -45.64 76.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.979 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.53 -40.23 93.9 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.501 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.49 -46.08 90.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.01 -31.61 72.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.026 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.7 mt -56.89 -44.16 82.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.699 0.285 . . . . 0.0 110.658 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 36.0 mtm180 -71.9 -10.07 59.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.995 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.19 18.17 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.5 t -154.87 -58.92 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 110' ' ' ILE . 12.2 t -96.36 -36.61 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.449 0.642 . . . . 0.0 110.086 -170.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.6 128.67 3.19 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 -55.29 -33.88 63.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.013 0.435 . . . . 0.0 110.352 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.688 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 45.9 mt-10 -93.01 26.18 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.132 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.11 160.16 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.7 124.05 40.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.296 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 174' ' ' TYR . 42.5 mm -116.03 146.24 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.164 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.541 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 71.6 m95 -71.33 147.71 47.79 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.574 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.2 mm? -107.22 8.74 30.12 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.259 -0.276 . . . . 0.0 111.668 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.22 43.48 97.15 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.256 0.462 . . . . 0.0 114.256 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 153' ' ' ALA . 1.5 pt? . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.449 ' HB2' HD12 ' A' ' 114' ' ' LEU . 13.3 m0 -51.64 153.72 2.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.144 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.418 HG22 ' HD2' ' A' ' 130' ' ' ARG . 31.6 t -96.56 132.48 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.638 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' HB3' HG21 ' A' ' 86' ' ' THR . 5.1 p30 -83.1 -171.82 3.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.142 0.496 . . . . 0.0 111.3 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.4 mtt -82.16 -14.51 55.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t -98.89 0.39 44.05 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.737 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.29 24.32 16.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.431 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.65 166.42 13.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.961 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' HG22 ' A' ' 124' ' ' VAL . 2.1 mpp_? -100.6 133.22 45.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.479 HD12 ' HZ3' ' A' ' 163' ' ' TRP . 26.5 pt -58.99 124.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 0.0 111.175 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.9 12.59 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.524 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -140.67 127.88 20.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 22.5 mtmt -135.21 118.2 16.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.802 0.334 . . . . 0.0 111.722 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -131.72 111.18 11.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.806 0.812 . . . . 0.0 109.332 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 38.3 m95 -132.29 137.83 47.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 -174.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.731 ' HB2' ' HD3' ' A' ' 162' ' ' LYS . 20.3 tt0 -97.57 -18.78 18.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.843 177.461 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 94.2 m . . . . . 0 N--CA 1.441 -0.915 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.818 ' HB3' HD21 ' A' ' 114' ' ' LEU . . . -75.26 139.93 42.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.959 0.409 . . . . 0.0 111.466 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.634 HG11 ' HG3' ' A' ' 166' ' ' LYS . 28.2 m -129.12 159.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.157 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -106.75 100.18 9.7 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.4 m -87.97 101.19 13.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.693 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.83 96.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.151 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -63.27 -25.05 68.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 111.239 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.31 46.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.311 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 160' ' ' ASN . 0.2 OUTLIER 178.82 -40.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 124.41 2.36 8.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.691 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.731 ' HD3' ' HB2' ' A' ' 137' ' ' GLU . 25.8 mttt -83.62 168.45 16.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.488 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 54.6 m0 -85.17 134.62 34.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.482 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.78 177.06 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.881 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.59 153.5 23.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 0.0 111.623 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.634 ' HG3' HG11 ' A' ' 154' ' ' VAL . 37.8 mmtt -149.87 149.27 30.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.65 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -70.34 129.12 38.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 13.4 m -64.36 -1.1 1.52 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -96.32 2.65 52.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.62 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -77.17 136.37 38.58 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 68' ' ' LYS . 9.6 tt0 -98.49 90.24 4.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.279 0.562 . . . . 0.0 110.888 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.1 pp -125.87 168.83 12.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.576 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.429 ' O ' HD12 ' A' ' 172' ' ' LEU . 12.4 Cg_exo -69.31 174.64 8.82 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.79 2.327 . . . . 0.0 112.369 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.3 p90 -152.39 172.62 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.97 129.7 54.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 80' ' ' ARG . 8.2 t -102.16 136.3 42.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.043 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.984 -176.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 55.7 m-85 . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.458 HG23 HG13 ' A' ' 104' ' ' VAL . 2.0 m -73.31 -6.18 44.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 12.3 mm-40 -63.91 134.1 54.52 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.531 0.681 . . . . 0.0 111.289 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -94.01 133.39 37.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.987 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.45 177.23 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.434 175.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -77.61 165.27 24.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.533 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 89.1 t80 -62.28 -37.65 86.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.211 0.529 . . . . 0.0 110.554 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -62.97 -46.51 87.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.16 -38.77 82.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -57.75 -35.92 71.39 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 78' ' ' ILE . 48.1 m -64.67 -58.67 5.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.383 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -57.66 -43.5 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.347 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 23.0 t70 -64.26 -59.09 4.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.98 -30.28 70.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.714 0.293 . . . . 0.0 111.406 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 74' ' ' SER . 1.2 mp -60.82 -29.82 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -98.76 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 32.4 mmt180 -80.4 -25.78 38.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.757 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.71 -50.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.15 -41.03 1.19 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.519 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -142.37 139.6 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.595 0.198 . . . . 0.0 110.867 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 85' ' ' SER . 6.6 tt -77.33 147.11 36.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.8 m -62.28 108.67 1.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.0 111.048 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 125' ' ' ASP . 15.8 p -107.63 110.53 62.74 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.378 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' A' ' 112' ' ' LEU . 97.5 Cg_endo -80.59 140.94 13.56 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.584 2.189 . . . . 0.0 111.509 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.4 pt20 -129.52 -10.25 4.56 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.305 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.6 p -141.9 177.39 8.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.98 68.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.952 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -61.85 -48.91 78.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.317 0.247 . . . . 0.0 111.271 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -68.84 -37.82 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.539 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.39 -39.74 88.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.15 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 36.0 t70 -68.42 -49.75 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.097 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.95 77.36 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.424 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.59 -42.81 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.6 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.521 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 2.0 t80 -61.17 -36.21 79.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 9.8 mm-40 -70.08 -46.38 65.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.0 -39.7 75.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.216 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 108' ' ' ALA . 4.1 pp -65.55 -34.47 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.677 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.578 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 66.8 mtm180 -71.98 -9.58 58.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.698 0.285 . . . . 0.0 111.437 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -111.23 12.09 21.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.748 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -59.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 111.085 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' ALA . 2.1 t -77.94 -33.3 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.163 0.506 . . . . 0.0 109.896 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 138.09 -73.56 0.42 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.579 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.578 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 175.29 -54.69 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.842 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 46.0 mt-10 -78.91 36.48 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 100' ' ' LEU . . . -79.61 130.38 35.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.095 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.05 121.54 44.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.828 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.5 mp -126.8 141.42 46.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -70.46 148.96 47.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 153' ' ' ALA . 90.1 mt -98.93 5.95 47.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.728 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.53 9.31 43.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 122.437 0.295 . . . . 0.0 111.07 -176.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.788 HG22 ' HB2' ' A' ' 130' ' ' ARG . 21.1 m . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -52.12 141.64 18.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.954 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.16 138.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.519 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -88.24 178.7 6.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 126' ' ' MET . 6.8 ptp -64.52 -32.64 74.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.9 p -76.56 -22.77 53.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.014 -175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 113.22 20.6 6.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.61 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.85 160.59 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.788 ' HB2' HG22 ' A' ' 122' ' ' THR . 0.0 OUTLIER -109.81 154.19 23.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.839 177.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.09 143.63 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.15 -18.46 20.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.153 0.501 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 20.3 t80 -119.52 120.7 37.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.644 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -144.34 131.4 20.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 111.151 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -147.99 136.09 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.413 0.625 . . . . 0.0 110.189 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -129.99 123.3 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.066 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 164' ' ' PHE . 67.3 mm-40 -74.72 -27.05 60.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.285 0.564 . . . . 0.0 109.873 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.662 HG23 ' HD2' ' A' ' 164' ' ' PHE . 11.5 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.236 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 80.7 m . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 121.148 0.499 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.618 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -91.91 139.17 30.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.878 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 p -133.41 141.43 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.681 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.616 ' HB2' HD21 ' A' ' 112' ' ' LEU . 2.4 tt -91.22 123.53 34.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -108.4 106.19 16.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.175 0.512 . . . . 0.0 110.633 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.18 1.61 84.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.11 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.842 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -101.27 5.38 42.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.104 0.478 . . . . 0.0 110.556 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.8 -53.17 2.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.778 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -173.38 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.296 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 111.74 -2.57 27.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.886 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 34.9 mmtp -76.31 -179.04 4.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HZ3' HG13 ' A' ' 131' ' ' ILE . 49.9 m0 -94.39 134.02 37.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.241 0.543 . . . . 0.0 109.796 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.662 ' HD2' HG23 ' A' ' 138' ' ' THR . 91.9 m-85 -126.02 165.28 19.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.883 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.54 144.21 44.63 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.698 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 72.6 tttt -144.93 -171.89 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.698 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 1.2 mmt180 -72.54 125.54 27.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 9.4 t -69.54 -19.82 63.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.386 0.612 . . . . 0.0 110.076 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -94.73 12.31 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.233 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 20.0 t70 -80.59 136.1 36.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -93.8 93.44 7.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.229 0.538 . . . . 0.0 110.945 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.56 169.69 9.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.736 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 16.6 Cg_exo -68.77 -179.1 2.27 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.995 2.464 . . . . 0.0 113.049 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.828 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.2 p90 -156.57 171.55 20.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.874 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.15 125.96 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 13.8 t -102.29 133.91 46.42 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.634 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 16.8 p -77.14 -8.54 57.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 13.6 mm-40 -64.96 141.92 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.2 p -99.06 144.49 28.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.769 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.781 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.59 -179.7 3.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.34 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 74.4 p -80.3 164.97 22.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 85.3 t80 -62.34 -35.35 78.84 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -59.37 -52.14 66.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.329 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.6 mt-10 -64.25 -37.14 86.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.781 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -61.52 -43.65 98.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.9 m -65.67 -55.92 14.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.805 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -60.92 -34.27 74.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.883 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 17.1 t70 -69.95 -51.63 31.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.45 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.3 t -63.07 -34.33 77.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -56.85 -31.03 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.498 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 -37.59 20.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.59 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 31.6 mmt180 -71.8 -26.56 62.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 111.072 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.25 -48.95 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.884 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 131.82 -26.37 3.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.972 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 p -135.14 128.09 31.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.924 0.362 . . . . 0.0 111.429 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 85' ' ' SER . 6.1 tt -74.88 146.53 41.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.555 ' N ' HD23 ' A' ' 84' ' ' LEU . 5.0 t -65.68 108.94 2.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.155 0.502 . . . . 0.0 110.448 -172.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.538 HG21 ' HB3' ' A' ' 125' ' ' ASP . 28.3 m -116.27 114.1 40.94 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.344 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 2.1 Cg_endo -79.56 137.97 13.34 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.663 2.242 . . . . 0.0 112.076 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -114.51 -13.55 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.276 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.65 165.08 28.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.981 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.82 -42.97 94.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.755 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.6 p -55.76 -44.53 77.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -42.64 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.85 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -65.38 -45.51 83.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -38.95 91.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.53 84.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.893 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.6 tp -66.07 -43.38 87.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -59.74 -40.78 89.23 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.12 -36.88 77.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.29 -36.8 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 59.7 mt -54.39 -52.08 62.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.0 109.75 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ttm-85 -56.54 -33.35 66.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.006 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -101.4 -1.46 33.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.2 t -140.16 -50.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.797 HG11 HD11 ' A' ' 110' ' ' ILE . 7.3 t -98.02 -30.15 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.605 0.717 . . . . 0.0 110.503 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.37 125.54 3.63 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -49.89 -42.49 48.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 158' ' ' ALA . 45.6 mt-10 -94.21 47.83 1.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 111.263 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.74 145.54 41.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 10.9 mm-40 -98.52 123.82 42.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.862 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.797 HD11 HG11 ' A' ' 104' ' ' VAL . 43.0 mm -121.83 142.85 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.367 -0.133 . . . . 0.0 111.192 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 64.0 m95 -70.61 145.84 50.44 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 82.2 mt -111.03 16.49 21.13 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.3 -27.67 0.83 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.562 HD12 ' HB2' ' A' ' 123' ' ' TRP . 1.6 pt? . . . . . 0 N--CA 1.467 0.421 0 CA-C-N 118.123 0.962 . . . . 0.0 110.913 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.562 ' HB2' HD12 ' A' ' 114' ' ' LEU . 16.9 m0 -62.3 150.03 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.205 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.47 138.19 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.72 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.66 ' OD2' HG22 ' A' ' 127' ' ' THR . 1.1 p-10 -99.89 -162.12 0.92 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.94 -33.57 51.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.375 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.66 HG22 ' OD2' ' A' ' 125' ' ' ASP . 14.4 t -83.03 -21.4 33.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.024 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.84 32.05 6.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.498 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.19 157.54 15.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 130' ' ' ARG . 0.3 OUTLIER -107.97 118.39 36.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.128 177.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.6 pt -64.34 125.41 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.341 0.591 . . . . 0.0 111.011 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.84 -20.75 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.528 0.68 . . . . 0.0 109.904 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -110.65 127.55 55.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.765 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -129.53 114.44 16.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.617 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -129.41 111.21 12.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.381 0.61 . . . . 0.0 109.772 172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -125.99 124.14 40.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . 7.4 tp10 -77.68 -25.83 49.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.588 175.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 71.6 m . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.14 134.82 41.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 28.7 m -120.46 156.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -103.63 101.14 10.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.3 m -84.64 91.57 7.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.486 0.66 . . . . 0.0 110.61 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.77 -22.39 78.72 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.523 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.473 ' HA ' ' HG2' ' A' ' 107' ' ' GLU . . . -69.89 -15.83 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.136 0.493 . . . . 0.0 110.27 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.85 -65.27 0.99 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -167.19 -37.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 131.05 -4.15 5.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.364 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -77.34 174.68 10.52 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.112 0.456 . . . . 0.0 110.107 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -89.78 133.49 34.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.85 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 42.1 m-85 -119.78 166.89 12.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -104.62 144.38 31.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.272 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.412 ' HD2' HG11 ' A' ' 154' ' ' VAL . 52.1 mttt -146.09 150.93 36.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.911 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.12 130.35 39.08 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.504 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 6.0 m -65.14 2.96 0.67 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -95.21 -4.58 45.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.01 132.14 41.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.782 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -93.21 97.92 10.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.2 pp -129.05 166.11 27.48 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.588 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 14.8 Cg_exo -67.08 171.13 11.77 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.721 2.281 . . . . 0.0 112.233 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -137.77 174.33 10.69 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.498 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 93.2 mt -137.8 123.55 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 10.1 t -102.08 130.51 48.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 . . . . . 0 C--N 1.323 -0.57 0 CA-C-O 121.019 0.438 . . . . 0.0 109.967 -178.084 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.497 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 74.0 m-85 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.057 0.456 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 2.4 m -74.38 0.28 14.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.587 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.55 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -65.98 127.56 32.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -102.29 123.95 47.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.664 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -150.07 174.73 12.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.606 -177.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 82.5 p -80.61 166.57 20.98 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.382 0.427 . . . . 0.0 110.227 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.556 -177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -60.95 -41.71 96.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.359 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -54.99 -39.96 69.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.239 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.725 ' O ' HG12 ' A' ' 78' ' ' ILE . 37.7 m -64.09 -69.64 0.27 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.55 -44.6 73.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 19.9 t70 -60.52 -58.92 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.917 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -58.57 -42.06 87.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.16 0.287 . . . . 0.0 111.215 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 74' ' ' SER . 42.2 mm -57.51 -41.23 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.324 0.583 . . . . 0.0 110.413 175.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 t -72.64 -24.26 61.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.702 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.1 mmp_? -74.79 -10.33 59.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.386 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.01 37.72 5.63 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.004 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.68 -170.22 27.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.189 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -130.26 146.74 51.9 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.6 tt -63.32 138.03 58.39 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 84' ' ' LEU . 30.3 p -61.83 109.33 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.371 0.419 . . . . 0.0 111.579 -174.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.541 HG22 ' HA3' ' A' ' 113' ' ' GLY . 47.2 p -110.0 107.73 58.93 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.969 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 14.6 Cg_exo -68.5 111.33 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.085 1.857 . . . . 0.0 112.576 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' NE2' ' H ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -85.41 -27.96 25.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.6 p -129.56 173.18 10.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.61 -38.95 95.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.12 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -59.27 -43.41 92.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 87' ' ' PRO . 7.3 mm-40 -59.6 -47.81 84.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.997 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -64.14 -44.9 90.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.56 . . . . 0.0 110.203 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.02 -49.21 77.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.912 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.16 67.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.718 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.3 tp -70.64 -47.01 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -60.76 -35.55 76.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.317 0.579 . . . . 0.0 109.946 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.164 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 68.5 t80 -68.24 -27.57 66.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.513 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 22.9 mt -58.64 -54.85 42.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -58.83 -33.2 70.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.141 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 9.2 pt20 -91.62 0.98 57.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t -146.32 -59.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 -28.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.623 0.725 . . . . 0.0 110.698 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.3 119.0 4.55 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -165.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 66.9 t30 -51.54 -36.52 45.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.136 0.468 . . . . 0.0 111.749 -173.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.69 32.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.906 0.384 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.46 139.88 32.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 8.6 mm-40 -94.31 122.36 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -136.85 155.1 32.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.39 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.512 ' HB2' HD11 ' A' ' 84' ' ' LEU . 86.8 m95 -71.44 144.87 49.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.924 0.392 . . . . 0.0 110.694 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.69 -7.25 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -174.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.541 ' HA3' HG22 ' A' ' 86' ' ' THR . . . 81.11 -1.66 84.09 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.535 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 112' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 117.238 0.519 . . . . 0.0 110.112 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -79.83 156.26 27.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.932 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.13 130.18 71.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.762 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.448 ' OD1' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -73.19 164.69 26.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.403 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 17.9 mmt -61.23 -33.39 73.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.55 -5.86 49.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.108 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.75 64.27 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.54 166.72 10.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.061 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -112.53 118.62 35.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.331 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -57.95 150.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.873 174.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -105.79 -5.14 20.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 109.719 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -126.79 115.33 19.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.699 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 1.6 ptmm? -144.41 114.09 7.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.314 . . . . 0.0 111.071 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -136.3 112.31 9.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.588 ' HE1' ' HE2' ' A' ' 134' ' ' LYS . 4.4 m95 -112.43 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 164' ' ' PHE . 2.8 tp10 -68.88 -27.85 66.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.07 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.9 179.342 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.634 0.73 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.504 ' HB1' ' HZ3' ' A' ' 136' ' ' TRP . . . -82.04 131.36 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.961 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 166' ' ' LYS . 48.1 t -131.55 147.58 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.482 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 tt -100.98 125.22 47.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.7 t -114.27 98.5 6.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.156 0.503 . . . . 0.0 110.195 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -75.81 -22.24 75.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.294 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.36 -30.48 68.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.106 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.93 -58.68 3.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -176.94 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.384 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.74 -1.38 4.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.025 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.01 167.67 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.407 ' CZ3' ' HA ' ' A' ' 134' ' ' LYS . 46.7 m0 -87.26 144.26 26.89 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 68.8 m-85 -135.99 177.12 8.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.318 0.58 . . . . 0.0 111.418 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.637 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.516 ' HB2' HG21 ' A' ' 154' ' ' VAL . 10.7 tttp -152.85 -170.39 3.62 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -80.14 122.7 27.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.35 -25.3 61.81 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.36 8.77 39.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.6 131.83 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -92.95 96.83 10.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.013 0.435 . . . . 0.0 110.755 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 110' ' ' ILE . 3.1 pp -125.89 164.37 33.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.137 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 16.8 Cg_exo -67.04 -178.38 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.164 2.576 . . . . 0.0 113.011 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -160.51 168.08 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.639 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.497 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 4.4 mp -127.53 133.68 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 69.3 m -110.06 139.21 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.117 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 32.6 m-85 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 p -81.14 -0.95 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.544 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.82 122.72 17.59 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.046 0.451 . . . . 0.0 110.77 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -91.79 111.05 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.377 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.923 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -151.5 -177.14 5.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.372 -177.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.5 p -79.09 167.3 21.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -47.0 84.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.01 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -70.37 -32.64 70.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.38 -43.8 76.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.923 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.51 -38.35 69.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.842 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 78' ' ' ILE . 29.5 t -64.81 -65.71 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.775 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.48 -31.38 72.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.92 -44.76 84.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.18 0.514 . . . . 0.0 109.961 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.524 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 49.5 t -65.21 -45.05 86.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.367 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -60.28 -36.82 71.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.396 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 t -78.6 -19.54 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.629 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.4 ptp180 -91.7 -3.55 56.14 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.016 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.85 45.15 4.0 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.701 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.81 -179.33 36.41 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.104 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 p -135.75 157.41 46.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 ' HE3' ' A' ' 126' ' ' MET . 4.0 mm? -64.27 149.45 48.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -75.05 107.02 6.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.737 HG21 ' HB2' ' A' ' 125' ' ' ASP . 23.4 m -97.61 111.46 58.74 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.488 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HG2' HD22 ' A' ' 112' ' ' LEU . 3.4 Cg_exo -77.67 119.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.168 2.579 . . . . 0.0 112.271 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -13.64 16.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.786 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 92' ' ' GLU . 45.1 p -130.93 170.01 15.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.317 . . . . 0.0 110.679 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.98 65.63 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.189 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.6 p -66.38 -37.94 86.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.35 0.595 . . . . 0.0 110.718 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.584 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 14.8 tt0 -69.71 -40.3 76.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.155 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -61.87 -45.36 94.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.64 -36.74 79.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.76 99.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.979 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.73 -40.59 88.42 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 88.0 t80 -57.85 -45.87 85.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 15.7 mm-40 -68.62 -38.95 80.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.235 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' HE21 ' A' ' 102' ' ' GLN . 53.7 t80 -66.19 -48.11 71.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.875 HD22 HD11 ' A' ' 110' ' ' ILE . 0.9 OUTLIER -65.18 -34.3 78.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 47.5 ttt180 -54.62 -48.78 71.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.092 175.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 98' ' ' GLU . 27.1 pt20 -93.29 11.11 29.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.278 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -134.47 -61.41 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.642 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.526 HG21 HD11 ' A' ' 175' ' ' ILE . 2.9 t -87.79 -32.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.926 0.87 . . . . 0.0 109.61 -172.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 122.26 122.95 2.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.07 -37.58 4.31 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.745 0.418 . . . . 0.0 112.088 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.28 21.63 2.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.96 161.41 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.015 0.436 . . . . 0.0 111.585 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 39.6 mt-10 -121.81 122.37 39.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.711 176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.875 HD11 HD22 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -134.36 150.93 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.027 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -72.19 155.22 40.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.792 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 153' ' ' ALA . 55.5 mt -106.61 6.82 30.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.7 79.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 120.771 0.319 . . . . 0.0 111.109 -179.031 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 121.761 0.791 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.603 ' HH2' ' HA ' ' A' ' 152' ' ' CYS . 28.2 m95 -95.83 156.48 16.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.837 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -118.34 130.32 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.737 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.45 156.78 38.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.761 ' HE3' HD23 ' A' ' 84' ' ' LEU . 9.3 ptp -58.96 -30.25 67.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -173.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 t -106.38 6.75 30.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.239 0.542 . . . . 0.0 111.124 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.5 28.52 9.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.753 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.86 137.99 31.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.012 0.406 . . . . 0.0 110.558 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -91.63 116.14 28.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 38.4 pt -77.78 132.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.05 3.47 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.259 0.552 . . . . 0.0 110.459 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -133.67 116.8 16.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.33 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.01 100.87 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.674 0.749 . . . . 0.0 110.629 172.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -111.14 113.03 25.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.026 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HH2' ' HB2' ' A' ' 153' ' ' ALA . 23.8 m95 -112.99 113.45 25.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.366 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 162' ' ' LYS . 4.9 mm-40 -76.52 -23.83 53.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.62 0.724 . . . . 0.0 109.334 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' A' ' 164' ' ' PHE . 11.7 t . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.775 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.603 ' HA ' ' HH2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.52 108.81 8.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 166' ' ' LYS . 12.3 p -122.07 140.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.643 ' HB2' HD21 ' A' ' 112' ' ' LEU . 31.4 tp -90.03 115.38 27.26 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.0 m -110.74 100.19 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.416 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.98 -19.41 78.76 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.596 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.62 -19.55 65.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 111.412 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.62 -56.48 2.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.44 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -171.58 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 120.13 6.53 9.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.12 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 137' ' ' GLU . 2.2 mptm? -86.96 -178.75 6.36 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.621 -0.341 . . . . 0.0 110.381 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -88.98 131.75 35.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.683 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 95.8 m-85 -125.82 171.1 10.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.552 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 5.5 p-10 -113.25 141.23 47.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB2' HG11 ' A' ' 154' ' ' VAL . 31.5 tttp -145.82 174.87 10.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.669 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 59.7 mtm180 -64.5 124.28 21.42 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.307 0.38 . . . . 0.0 110.25 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.76 -21.49 61.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.69 15.16 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.676 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 3.8 t0 -87.77 166.01 14.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 68' ' ' LYS . 97.8 mt-30 -122.47 96.01 4.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.124 0.487 . . . . 0.0 111.331 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HB2' ' CD ' ' A' ' 173' ' ' PRO . 3.2 pp -126.29 172.32 6.59 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.741 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 14.7 Cg_exo -69.69 -178.63 2.41 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.563 2.175 . . . . 0.0 112.716 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -153.8 172.18 17.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 104' ' ' VAL . 95.9 mt -142.77 115.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 110.597 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 97.4 m -102.97 155.78 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.13 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 43.3 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.901 0.382 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -71.53 -12.35 61.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.989 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG2' ' HE1' ' A' ' 174' ' ' TYR . 14.2 pt20 -72.35 135.22 45.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.501 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 p -89.71 138.38 31.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.639 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -168.95 166.04 11.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 169' ' ' ARG . 30.4 p -81.94 168.12 18.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -56.22 -29.14 60.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.64 0.257 . . . . 0.0 110.571 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -60.6 -59.3 5.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.633 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 8.5 mp0 -65.43 -31.42 72.5 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.79 81.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.418 ' O ' HD13 ' A' ' 78' ' ' ILE . 44.5 t -72.64 -56.28 5.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.342 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 3.0 tp10 -56.39 -38.46 71.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.608 -173.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -72.1 -52.82 14.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.091 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 25.2 t -66.42 -37.25 84.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.221 -174.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -62.87 -37.28 78.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 0.0 110.131 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -79.09 -27.03 42.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.738 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.66 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.9 ptp180 -83.23 6.83 18.13 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.757 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.04 43.14 27.55 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.271 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 -171.38 17.57 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 2.1 m -150.43 145.2 25.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.526 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.5 mp -58.72 135.81 57.54 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.7 p -70.37 107.52 3.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.235 0.54 . . . . 0.0 110.814 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 95.0 m -99.9 120.95 55.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.05 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 12.1 Cg_exo -70.37 111.48 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.098 1.865 . . . . 0.0 112.219 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -103.64 -18.96 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.918 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -136.05 177.77 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.213 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.93 -35.51 91.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.275 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -56.45 -43.7 79.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.2 mp0 -60.43 -58.61 7.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.7 0.286 . . . . 0.0 111.187 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -66.19 -41.33 90.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.116 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -40.07 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.551 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.42 -31.45 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.38 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 2.5 tt -60.64 -46.11 91.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 88.5 t80 -59.83 -41.84 92.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.689 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.487 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 8.3 tp10 -68.7 -37.73 79.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.103 0.478 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 78.2 t80 -62.85 -35.62 80.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.513 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 66.5 mt -56.4 -48.98 75.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.487 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 42.9 mtp180 -64.95 -17.3 64.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.951 -173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 11.0 pt20 -116.18 9.94 14.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.0 m -153.58 -46.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.951 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 110' ' ' ILE . 30.1 t -104.77 -37.44 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.532 0.682 . . . . 0.0 110.473 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.38 128.56 3.01 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.509 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -55.92 -41.9 75.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.321 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.18 154.78 18.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.207 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 156' ' ' SER . 40.2 mt-10 -122.39 122.39 38.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.984 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 HG11 ' A' ' 104' ' ' VAL . 2.2 mp -121.2 147.51 25.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.069 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 73.5 m95 -71.65 138.89 48.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 155' ' ' LEU . 2.1 mm? -100.93 12.55 37.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.44 81.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.988 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 131' ' ' ILE . 8.4 mp . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.432 ' HB2' ' CD1' ' A' ' 131' ' ' ILE . 36.4 m95 -62.74 149.21 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.836 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.4 133.95 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.362 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.403 ' CB ' HG21 ' A' ' 86' ' ' THR . 4.1 p-10 -98.06 -165.47 1.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 0.0 111.123 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' A' ' 84' ' ' LEU . 20.1 mmt -65.37 -37.57 87.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.608 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 78.2 p -82.47 -20.62 36.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.79 0.329 . . . . 0.0 111.317 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.36 28.37 13.2 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.01 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.02 165.4 12.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.05 0.452 . . . . 0.0 110.54 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.409 ' HB2' ' HE ' ' A' ' 130' ' ' ARG . 15.5 ttm180 -99.33 106.96 19.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.526 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 114' ' ' LEU . 44.8 pt -62.41 124.87 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.257 0.551 . . . . 0.0 110.907 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.98 -10.97 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.447 0.641 . . . . 0.0 109.872 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -104.11 116.03 31.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.204 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -135.08 99.4 4.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.915 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.433 ' HA ' HD22 ' A' ' 135' ' ' ASN . 5.3 m120 -121.14 111.51 17.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.059 0.457 . . . . 0.0 110.309 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -122.03 124.71 44.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.883 ' HG2' HD21 ' A' ' 160' ' ' ASN . 5.1 tp10 -75.12 -29.03 60.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.644 0.735 . . . . 0.0 109.352 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.965 178.624 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.918 0.389 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -110.83 150.35 29.27 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.586 HG21 ' HG3' ' A' ' 166' ' ' LYS . 28.1 m -143.01 155.91 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.527 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.557 ' N ' HD21 ' A' ' 112' ' ' LEU . 50.8 tp -99.01 103.99 15.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 20.0 t -96.9 103.64 15.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 -175.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.24 -26.77 67.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.72 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.31 -19.09 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.301 0.572 . . . . 0.0 110.613 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.15 -61.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.189 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.883 HD21 ' HG2' ' A' ' 137' ' ' GLU . 15.3 p30 -174.67 -30.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.12 32.73 1.34 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.711 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 34.3 mmtp -119.66 177.73 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.437 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 49.5 m0 -78.42 124.92 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.184 0.516 . . . . 0.0 111.069 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 77.2 m-85 -127.17 178.91 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.493 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -115.92 138.57 51.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.87 0.367 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.586 ' HG3' HG21 ' A' ' 154' ' ' VAL . 17.1 mtmt -150.02 161.15 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.649 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.514 ' O ' ' HH2' ' A' ' 111' ' ' TRP . 1.9 mtm105 -60.35 132.48 54.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.595 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -63.47 -17.41 62.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.386 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.416 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 5.7 ptp85 -103.82 29.37 5.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.984 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.3 147.31 23.02 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -91.69 85.14 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.472 . . . . 0.0 110.408 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -128.63 164.44 38.21 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.227 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.1 Cg_exo -65.79 -177.1 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.48 2.787 . . . . 0.0 113.205 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.667 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.4 p90 -155.16 167.55 29.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 90.4 mt -141.23 131.0 25.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.934 0.397 . . . . 0.0 110.234 176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.446 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 74.5 m -104.54 157.93 16.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.963 177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.9 pt20 . . . . . 0 C--N 1.32 -0.691 0 CA-C-O 121.505 0.669 . . . . 0.0 109.64 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 121.066 0.46 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 t -71.47 13.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.9 138.65 48.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.332 0.587 . . . . 0.0 110.515 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -93.2 137.22 32.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.578 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.713 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -171.26 -178.5 2.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 178.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 15.2 p -77.37 166.09 23.59 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.322 0.389 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.1 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -63.28 -48.19 79.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 6.1 mm-40 -67.44 -40.54 85.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.275 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -54.52 -47.48 73.07 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.061 0.458 . . . . 0.0 110.306 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' HD13 ' A' ' 78' ' ' ILE . 17.5 m -65.03 -56.66 11.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.54 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.68 -41.42 99.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.901 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 35.0 t70 -71.91 -48.51 45.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.336 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.812 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 46.8 t -64.68 -39.36 93.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -64.4 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.156 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -63.52 -31.9 73.2 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 66.9 mtt180 -66.85 -17.47 64.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 19.04 13.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.699 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -130.93 -169.42 12.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.195 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 p -139.99 161.86 36.59 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 126' ' ' MET . 9.7 mp -75.52 153.61 37.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.556 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.8 t -82.26 107.24 14.79 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 82.7 p -97.47 120.08 61.49 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 6.9 Cg_endo -84.78 113.46 1.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.458 2.105 . . . . 0.0 112.107 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -109.44 -7.25 15.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.183 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.06 169.46 18.63 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.048 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.35 -36.64 92.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.668 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -58.32 -43.25 88.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.25 -48.85 79.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.693 0.282 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -64.38 -36.04 82.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.294 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.99 -48.44 76.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.645 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -33.6 76.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.158 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 52.6 mt -60.57 -62.66 1.7 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.222 173.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.739 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 48.9 t80 -53.39 -34.97 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.681 0.613 . . . . 0.0 112.005 -174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.44 -54.94 5.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 85.4 t80 -57.54 -34.43 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.831 0.824 . . . . 0.0 109.195 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.522 HD12 ' HB ' ' A' ' 104' ' ' VAL . 29.4 tp -53.83 -53.78 47.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.516 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.739 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 42.9 mtm105 -67.51 -19.06 65.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.969 -176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 3.8 pt20 -111.82 4.14 18.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.08 -44.24 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.968 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 110' ' ' ILE . 41.3 t -102.13 -49.62 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 109.679 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.4 129.48 1.56 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.988 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 t30 -46.01 -49.11 16.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.088 0.471 . . . . 0.0 111.006 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.9 OUTLIER -95.28 22.85 6.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.662 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.39 161.31 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.002 0.429 . . . . 0.0 110.99 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 41.3 mt-10 -124.47 125.45 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.834 HD11 HG11 ' A' ' 104' ' ' VAL . 1.8 mp -123.25 144.13 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.12 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CZ3' HG22 ' A' ' 154' ' ' VAL . 82.7 m95 -71.21 137.77 48.95 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' HD23 ' A' ' 114' ' ' LEU . 94.5 mt -83.11 -14.46 53.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . 76.51 15.76 81.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.371 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 111.349 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.568 0.699 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 114' ' ' LEU . 55.8 m95 -68.37 144.25 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.515 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -110.04 139.94 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -72.43 153.62 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 49.7 mtt -55.95 -25.06 41.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.207 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.2 t -88.51 4.1 47.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.236 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.68 37.92 9.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.341 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.39 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.768 0.284 . . . . 0.0 110.561 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -105.77 127.44 53.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 0.0 110.418 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.9 pt -69.95 151.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.409 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.09 3.11 14.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -141.13 124.29 16.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.805 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 20.4 pttp -136.99 130.51 31.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -133.72 111.48 10.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.415 ' HE1' ' HB2' ' A' ' 134' ' ' LYS . 18.5 m95 -121.04 128.04 52.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.37 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -72.87 -21.2 60.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.446 179.483 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.315 0 CA-C-O 121.503 0.668 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.71 133.44 40.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.402 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 17.3 t -126.17 141.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.473 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.584 ' HB2' HD21 ' A' ' 112' ' ' LEU . 63.8 tp -98.96 112.53 24.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 p -106.33 109.54 21.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.918 0.389 . . . . 0.0 111.171 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.83 -22.26 78.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.039 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -64.63 -25.1 67.81 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.0 -60.06 2.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.357 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.0 p30 176.91 -24.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.316 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 123.15 25.81 1.78 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.733 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -111.8 167.6 10.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.704 0.288 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -82.48 135.73 35.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.046 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -126.96 -169.03 1.96 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.071 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -143.02 139.06 30.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.0 110.687 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -139.31 164.98 28.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 167' ' ' ARG . 2.4 tpt180 -71.09 141.22 50.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 69' ' ' THR . 51.1 m -63.33 -5.9 4.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 13.7 ttp85 -112.94 20.19 16.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.9 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -90.94 145.14 24.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 mp0 -93.16 94.47 8.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 111.689 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -129.39 157.84 75.02 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.064 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 22.4 Cg_exo -64.28 179.13 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.006 2.47 . . . . 0.0 113.464 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.812 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -155.24 166.22 34.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.454 177.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 110' ' ' ILE . 90.5 mt -124.09 130.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 55.5 m -102.45 132.18 48.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.387 0.613 . . . . 0.0 111.436 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.317 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.616 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.785 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 58.5 m-85 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 p -84.51 5.2 28.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.896 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' OE1' ' HD3' ' A' ' 68' ' ' LYS . 17.5 tm0? -77.97 123.86 27.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -97.66 115.27 27.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.606 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -144.43 179.24 7.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.887 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.1 p -84.55 167.02 16.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.05 -20.27 62.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -72.5 -50.45 25.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.27 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 3.3 mp0 -70.42 -35.34 73.36 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.096 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.764 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -67.81 -18.58 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.747 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.578 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 10.3 p -91.97 -51.54 5.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.713 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.78 -29.6 65.85 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.869 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -65.66 -40.25 92.21 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.936 -175.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.715 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 33.6 m -72.28 -42.94 64.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.634 0.254 . . . . 0.0 111.211 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.72 -41.53 88.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 t -80.32 -15.8 56.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 9.9 ptp180 -91.7 4.78 51.95 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.67 38.77 31.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.432 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.74 -170.15 18.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.4 p -131.07 153.51 49.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 85' ' ' SER . 4.8 tt -73.4 146.41 45.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.622 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.3 m -62.6 109.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.972 0.415 . . . . 0.0 111.267 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 28.5 p -107.32 119.83 49.62 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.573 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 31.3 Cg_endo -92.36 123.05 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.659 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 3.6 pt20 -127.82 0.91 6.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 92' ' ' GLU . 68.6 p -129.58 173.65 10.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.38 -36.87 89.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.5 t -64.46 -52.63 57.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.0 110.705 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' OE1' ' HG2' ' A' ' 88' ' ' GLN . 9.3 pt-20 -75.02 -24.63 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.531 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' ' CB ' ' A' ' 87' ' ' PRO . 28.2 t-20 -66.59 -48.84 68.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.15 0.5 . . . . 0.0 110.284 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.35 -22.78 32.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.167 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.72 84.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.608 0.242 . . . . 0.0 110.966 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.09 -40.87 95.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 36.0 t80 -59.23 -43.69 92.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.454 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.36 -47.25 67.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.473 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.08 -38.69 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.51 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 110' ' ' ILE . 2.9 pp -68.01 -29.56 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.363 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 74.6 mtp180 -66.27 -26.31 67.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -98.83 5.84 47.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.877 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -153.67 -47.35 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 100' ' ' LEU . 4.5 t -88.25 -34.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.654 0.74 . . . . 0.0 109.349 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.28 124.2 3.78 Favored Glycine 0 N--CA 1.434 -1.433 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -50.95 -37.14 42.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.05 0.452 . . . . 0.0 111.26 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 158' ' ' ALA . 39.5 mt-10 -85.36 24.12 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.656 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.65 146.13 29.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 110.762 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 2.6 mm-40 -101.82 132.35 47.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.394 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.82 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -124.55 138.77 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 110' ' ' ILE . 83.1 m95 -71.01 148.04 48.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.6 mm? -96.1 5.2 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.98 16.97 69.16 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.317 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.428 ' HB3' ' CE3' ' A' ' 123' ' ' TRP . 7.5 mp . . . . . 0 C--N 1.326 -0.43 0 CA-C-O 120.648 0.261 . . . . 0.0 110.453 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 114' ' ' LEU . 23.5 m95 -62.05 146.59 49.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.501 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.76 162.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.226 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.51 166.29 22.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.578 ' HE1' ' HB3' ' A' ' 74' ' ' SER . 21.0 mmt -54.5 -19.63 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.893 172.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.8 -6.98 34.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 111.434 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.45 34.69 7.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.954 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.61 166.82 10.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -100.76 143.66 30.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.656 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -104.02 148.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 173.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.19 11.57 38.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.863 0.363 . . . . 0.0 111.059 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 48.3 t80 -107.63 111.06 23.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 -176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 98.41 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.989 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.08 111.71 6.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -128.01 127.31 42.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.814 ' HG3' HD21 ' A' ' 160' ' ' ASN . 3.3 tm-20 -66.31 -52.94 42.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.541 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 9.0 t . . . . . 0 C--N 1.315 -0.904 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.549 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.611 0.243 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.82 139.69 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -170.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.59 164.61 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.433 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 tt -109.8 103.7 12.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 25.8 p -89.85 108.2 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.89 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.03 -51.42 34.09 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.002 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . . . -59.67 -20.12 54.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.98 -52.17 11.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.814 HD21 ' HG3' ' A' ' 137' ' ' GLU . 12.3 p30 179.94 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.016 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.42 22.67 6.33 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.137 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 56.1 mmtt -113.76 179.27 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.044 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -77.22 122.57 25.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.545 0.688 . . . . 0.0 111.627 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.541 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 10.7 m-85 -117.2 178.23 4.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.069 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.26 144.59 51.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.105 0.478 . . . . 0.0 111.295 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.6 ' HD2' ' CD2' ' A' ' 172' ' ' LEU . 17.5 ptpt -153.24 -171.0 3.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.075 173.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 167' ' ' ARG . 40.7 ttm180 -83.34 138.28 33.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.797 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.2 m -70.82 -2.79 16.0 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -96.71 -5.42 38.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.457 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.06 133.0 48.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -92.47 97.25 10.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.649 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.6 ' CD2' ' HD2' ' A' ' 166' ' ' LYS . 3.2 pp -128.15 160.62 60.87 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.062 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 172' ' ' LEU . 40.7 Cg_exo -57.69 179.59 0.14 Allowed 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.461 2.774 . . . . 0.0 113.509 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.82 ' HA ' HG23 ' A' ' 110' ' ' ILE . 2.2 p90 -163.36 165.26 24.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.033 -0.417 . . . . 0.0 110.485 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.785 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.1 mt -128.46 116.56 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 5.9 t -104.24 147.36 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 0.0 110.658 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.482 ' HD1' ' CE2' ' A' ' 174' ' ' TYR . 54.6 m-85 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.038 0.446 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.547 HG22 HG13 ' A' ' 104' ' ' VAL . 9.1 p -72.46 -3.54 24.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.787 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 52.3 mt-30 -57.18 129.29 41.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.332 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 p -94.21 125.67 38.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.597 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.829 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -164.22 174.27 11.39 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.225 177.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 69.8 p -77.75 166.08 23.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 -176.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.79 -44.19 81.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.493 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.35 -45.77 91.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.084 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.23 -42.24 73.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.421 ' O ' HD13 ' A' ' 78' ' ' ILE . 36.0 m -60.22 -58.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.973 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.84 -16.79 62.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.323 . . . . 0.0 111.28 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 36.7 t70 -75.16 -50.01 17.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.033 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.544 ' HB2' HD12 ' A' ' 84' ' ' LEU . 65.7 m -67.24 -32.94 74.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.143 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -60.2 -41.63 87.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.3 p -79.26 -11.03 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.924 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 14.8 mmp_? -78.62 -14.29 59.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.77 37.77 3.36 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.299 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -177.71 -160.09 23.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.215 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 p -120.73 171.12 8.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 77' ' ' CYS . 9.5 mp -66.82 162.28 21.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 171.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 p -73.65 107.58 5.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 112' ' ' LEU . 35.8 p -110.46 105.81 57.43 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.145 0.498 . . . . 0.0 110.749 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.72 ' HG3' HD12 ' A' ' 96' ' ' LEU . 97.6 Cg_endo -88.03 139.24 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.466 2.111 . . . . 0.0 112.251 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.9 pt20 -135.25 9.03 3.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.748 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 p -141.53 168.64 19.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.906 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.68 98.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.8 m -59.95 -35.41 74.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.104 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -76.16 -37.01 58.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.074 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.93 -41.64 77.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.088 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.65 -36.1 81.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.173 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.03 79.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.72 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.2 mt -78.57 -4.99 51.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.626 0.25 . . . . 0.0 111.118 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -98.23 -37.66 9.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.57 -52.52 8.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.759 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 71.6 t80 -62.73 -35.27 79.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.519 0.676 . . . . 0.0 109.242 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 104' ' ' VAL . 8.0 tp -57.94 -48.09 80.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.284 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.543 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.02 -19.78 64.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.702 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 17.1 pt20 -110.3 8.06 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.827 -0.546 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 -65.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.608 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 65' ' ' THR . 2.5 t -83.56 -28.69 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 151.12 -77.84 0.22 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.147 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.411 ' CB ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 p-10 173.29 -40.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 6.7 pt-20 -113.39 45.76 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.785 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 100' ' ' LEU . . . -115.03 146.93 40.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.607 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 4.6 mp0 -94.54 130.96 40.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.369 174.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 175' ' ' ILE . 3.8 mp -125.63 145.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.588 177.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.89 132.55 45.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.9 mt -90.38 10.57 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.39 30.89 56.37 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 118.146 0.973 . . . . 0.0 110.26 176.631 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.763 0.316 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -64.16 137.3 57.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -107.9 139.09 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.745 ' OD2' HG22 ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.9 -179.77 4.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 0.0 110.441 -178.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.1 mtt -69.25 -32.32 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.745 HG22 ' OD2' ' A' ' 125' ' ' ASP . 12.4 t -81.03 -5.21 57.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.263 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.81 37.82 5.11 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.382 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.1 162.09 27.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.075 0.437 . . . . 0.0 110.834 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -99.19 126.14 44.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.495 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.64 126.18 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.407 0.623 . . . . 0.0 111.366 -174.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.72 -19.44 35.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.591 0.71 . . . . 0.0 110.02 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 41.1 t80 -120.41 115.23 23.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.305 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.0 120.14 10.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.997 0.427 . . . . 0.0 110.069 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -125.9 111.07 14.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.582 0.706 . . . . 0.0 110.502 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 3.2 m95 -111.5 118.49 35.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' HD21 ' A' ' 160' ' ' ASN . 4.1 tp10 -70.0 -41.22 74.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.576 0.703 . . . . 0.0 109.77 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.942 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.16 135.32 39.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.576 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.55 145.63 31.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.674 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 2.3 tm? -89.39 108.89 19.9 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 26.1 t -98.96 100.78 11.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.36 -23.9 74.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.771 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -69.67 -30.46 68.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 110.71 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.87 0.99 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.746 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.459 HD21 ' HG2' ' A' ' 137' ' ' GLU . 14.6 p30 -171.35 -27.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.055 -174.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.23 -2.25 11.5 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.839 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 1.1 mptm? -82.56 174.18 11.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -83.78 126.84 33.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.307 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.54 -171.84 2.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.97 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -141.72 146.16 35.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.081 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -147.53 176.8 9.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -72.25 144.09 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 -173.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -68.61 -14.62 63.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.008 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -93.59 -3.21 53.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 17.6 m-20 -73.55 136.06 44.0 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -110.31 106.16 15.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.819 0.819 . . . . 0.0 111.446 -176.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 1.5 pp -129.24 171.14 9.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.346 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 14.3 Cg_endo -57.12 174.67 0.42 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.552 2.168 . . . . 0.0 113.226 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.787 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 49.1 p90 -140.91 179.59 6.63 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.041 -0.412 . . . . 0.0 110.739 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.54 HG13 HG12 ' A' ' 110' ' ' ILE . 71.6 mt -145.51 132.42 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.461 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 84.9 m -99.49 155.81 17.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 6.0 tp60 . . . . . 0 C--N 1.316 -0.851 0 CA-C-O 121.512 0.672 . . . . 0.0 110.311 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.733 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 59.3 m-85 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -69.69 -8.11 44.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.003 -177.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.87 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 27.6 mt-30 -53.61 122.03 9.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 0.0 111.733 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 171' ' ' GLN . 17.6 p -97.02 113.53 25.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.511 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.885 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.82 -176.55 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.122 -178.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 169' ' ' ARG . 81.5 p -78.14 165.88 23.43 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.321 0.388 . . . . 0.0 110.129 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.31 -38.79 92.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.675 0.274 . . . . 0.0 110.946 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -63.33 -45.91 89.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -58.88 -37.08 75.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 78' ' ' ILE . 29.1 t -63.1 -60.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.41 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 11.2 pt-20 -70.69 -15.21 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.496 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.703 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 11.7 t70 -65.06 -59.01 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.3 m -59.28 -36.8 76.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 74' ' ' SER . 28.3 mm -54.17 -44.5 64.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 p -84.39 -14.09 50.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.397 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 20.4 mmt180 -74.46 -23.69 58.93 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.98 25.59 11.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.332 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.78 -170.26 13.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.1 p -116.14 165.81 12.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.535 HD23 ' HA2' ' A' ' 113' ' ' GLY . 19.4 tp -81.8 148.74 28.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -66.69 109.17 2.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.866 0.365 . . . . 0.0 111.219 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 4.7 t -117.51 118.5 35.27 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.905 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 2.0 Cg_endo -81.68 120.66 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.063 2.509 . . . . 0.0 112.311 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -104.28 -30.48 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.098 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.0 p -128.02 -171.0 2.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.71 -34.26 82.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.913 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -55.4 -49.81 71.37 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.834 0.454 . . . . 0.0 111.936 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 4.8 mp0 -61.66 -53.22 59.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.11 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.53 -37.75 88.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.92 -44.13 93.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.497 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.49 -32.96 58.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.7 tp -63.06 -47.66 81.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.018 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 91.4 t80 -60.08 -40.46 89.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.538 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.743 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -64.03 -33.33 75.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.617 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD11 HD12 ' A' ' 155' ' ' LEU . 72.6 mt -57.14 -44.72 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.141 0.496 . . . . 0.0 109.901 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 16.5 mtp180 -69.04 -9.38 52.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.62 -172.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -127.47 15.61 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.1 t -151.32 -51.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.359 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -105.85 -29.05 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.649 0.737 . . . . 0.0 110.391 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.49 130.49 4.97 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -30.82 64.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.893 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 5.1 mm-40 -80.44 6.76 11.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.027 -175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.32 15.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 0.0 112.197 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.463 ' C ' HD12 ' A' ' 110' ' ' ILE . 34.0 mt-10 -121.18 123.53 42.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.078 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 175' ' ' ILE . 2.6 mp -122.93 138.77 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 110.505 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 73.6 m95 -70.41 145.5 51.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 155' ' ' LEU . 95.3 mt -89.89 -2.31 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 82.73 5.81 89.08 Favored Glycine 0 C--N 1.324 -0.124 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.284 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 131' ' ' ILE . 7.2 mp . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.4 ' H ' HD11 ' A' ' 131' ' ' ILE . 14.1 m95 -72.96 148.18 44.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.014 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.11 129.22 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -83.3 164.31 20.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.771 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.552 ' HE1' ' HA ' ' A' ' 74' ' ' SER . 11.5 ptp -61.91 -43.54 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -92.56 -4.79 52.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 0.0 111.084 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.63 13.1 9.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.554 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 125' ' ' ASP . . . -77.85 128.3 33.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.039 0.447 . . . . 0.0 110.777 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -98.34 113.69 25.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.728 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 114' ' ' LEU . 43.4 pt -62.05 135.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.977 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -112.48 8.95 19.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.537 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 135' ' ' ASN . 80.2 t80 -105.52 102.95 12.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.246 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.505 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 13.9 tptp -105.6 96.78 6.74 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 46.1 t30 -157.6 111.72 2.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.505 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 4.0 m95 -137.98 156.21 48.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.795 -173.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 2.4 tm-20 -97.08 -49.97 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.604 -173.359 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.993 0.425 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.45 140.13 38.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.455 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.756 HG11 ' HG2' ' A' ' 166' ' ' LYS . 14.3 p -136.04 149.32 27.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.592 HD12 HD11 ' A' ' 100' ' ' LEU . 1.3 tm? -98.66 101.15 12.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.0 m -99.7 109.37 21.83 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.03 -40.17 73.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.806 -175.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.893 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -68.78 -11.51 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 111.287 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.05 -56.46 3.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -171.69 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.864 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.23 -0.97 37.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.946 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 66.9 mmtt -93.5 179.58 5.34 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 45.4 m0 -79.29 123.4 27.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 0.0 110.62 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -116.52 -168.82 1.51 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.232 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -134.4 138.21 44.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.756 ' HG2' HG11 ' A' ' 154' ' ' VAL . 12.4 mmmm -137.95 146.37 43.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -60.52 136.35 58.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.3 m -65.07 -7.1 10.66 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.548 ' HA ' HG22 ' A' ' 69' ' ' THR . 37.2 ttp180 -109.0 20.9 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.178 0.513 . . . . 0.0 110.243 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.42 141.22 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 2.0 mp0 -93.28 93.05 8.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 111' ' ' TRP . 3.9 pp -127.85 164.48 36.54 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.671 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 24.3 Cg_exo -63.41 -178.4 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.263 2.642 . . . . 0.0 113.745 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.87 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 6.5 p90 -154.58 176.92 11.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.15 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 110' ' ' ILE . 74.1 mt -145.63 128.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.583 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 83.6 m -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.555 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 176' ' ' CYS . 29.6 m-85 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 p -84.91 17.31 2.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.194 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 44.9 tt0 -84.97 139.35 31.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.255 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 p -98.05 127.43 43.99 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.646 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -158.28 -178.88 7.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.2 p -84.5 166.83 16.92 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.95 0.156 . . . . 0.0 110.868 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -48.26 82.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.476 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -63.32 -43.8 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.694 0.283 . . . . 0.0 110.298 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -64.48 -43.58 93.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.54 72.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' ILE . 16.1 t -59.55 -62.57 1.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.96 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.99 -39.44 81.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.272 0.558 . . . . 0.0 110.935 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.553 ' CG ' HH12 ' A' ' 80' ' ' ARG . 12.3 t70 -64.94 -47.37 77.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.735 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 42.3 t -79.26 -36.87 39.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.003 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 126' ' ' MET . 1.4 mp -57.26 -40.22 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.109 0.48 . . . . 0.0 110.457 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -76.44 -31.59 57.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.904 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.553 HH12 ' CG ' ' A' ' 76' ' ' ASP . 1.3 ptp85 -96.15 -18.02 20.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.053 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.16 -51.18 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.169 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.27 -46.33 0.97 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.112 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 p -145.58 155.64 43.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.608 0.242 . . . . 0.0 111.151 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -72.36 161.78 30.37 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB3' HD21 ' A' ' 96' ' ' LEU . 28.3 m -79.06 106.09 10.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 37.9 m -111.9 112.33 53.2 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.65 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 2.5 Cg_endo -79.85 117.22 3.57 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.936 2.424 . . . . 0.0 111.869 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB3' HG22 ' A' ' 131' ' ' ILE . 1.8 pt20 -115.89 -13.67 11.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.424 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.0 p -130.9 176.24 8.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.73 -26.32 66.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.745 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -56.21 -56.88 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.896 0.478 . . . . 0.0 111.521 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 9.6 mp0 -62.73 -48.61 78.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.383 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.57 -40.92 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.33 -39.66 94.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.18 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.035 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.5 mt -59.83 -46.11 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -62.19 -29.14 70.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.617 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.21 -42.7 22.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -67.68 -47.25 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' HG23 ' A' ' 104' ' ' VAL . 3.1 pp -63.58 -25.83 68.41 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 101' ' ' ARG . 9.6 ttm180 -61.04 -38.63 86.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.448 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.12 0.28 31.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.693 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.8 p -124.32 -50.2 1.78 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 100' ' ' LEU . 3.0 t -98.51 -33.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.672 0.749 . . . . 0.0 109.704 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.97 125.04 3.61 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -55.21 -26.29 38.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.046 0.423 . . . . 0.0 111.504 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 38.6 mt-10 -89.18 22.52 2.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.383 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.46 162.25 14.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.057 0.456 . . . . 0.0 110.951 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 10.5 pt-20 -128.46 130.92 48.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.835 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.0 mp -118.84 154.61 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.988 -174.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -70.08 149.65 47.41 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.903 0.382 . . . . 0.0 110.12 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 163' ' ' TRP . 0.2 OUTLIER -86.73 -6.11 58.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -171.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.33 6.95 66.68 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.468 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.212 -176.355 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 130' ' ' ARG . 30.9 m . . . . . 0 N--CA 1.446 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 131' ' ' ILE . 44.4 m95 -59.2 129.47 42.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.576 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.22 131.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . 5.1 t70 -73.89 161.09 30.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.468 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.464 ' SD ' HD11 ' A' ' 78' ' ' ILE . 4.4 ptp -53.61 -28.96 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.0 p -92.84 1.26 57.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.095 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.56 27.91 25.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.954 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 125' ' ' ASP . . . -92.63 149.53 21.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.841 0.353 . . . . 0.0 111.197 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 122' ' ' THR . 28.2 ttm180 -98.14 130.69 44.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.089 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.669 HG13 ' HE3' ' A' ' 134' ' ' LYS . 38.0 pt -92.33 128.46 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.065 0.46 . . . . 0.0 110.156 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.91 -19.84 24.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.243 0.544 . . . . 0.0 110.534 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -113.77 130.45 56.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.516 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.669 ' HE3' HG13 ' A' ' 131' ' ' ILE . 10.4 mptt -130.06 144.26 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.72 114.82 8.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' NE1' ' HB3' ' A' ' 134' ' ' LYS . 44.4 m95 -126.59 117.54 23.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.193 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.3 tp10 -71.08 -29.79 65.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.774 177.024 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.467 0.4 0 CA-C-O 121.642 0.734 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 112' ' ' LEU . . . -83.67 139.67 32.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.29 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 166' ' ' LYS . 21.3 t -133.5 142.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.918 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 49.6 tp -100.98 101.3 12.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 17.9 m -96.44 113.53 25.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.561 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.49 -30.95 47.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.853 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -67.52 -24.77 65.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.89 -59.02 2.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.976 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.447 HD21 ' HG2' ' A' ' 137' ' ' GLU . 10.7 p30 -177.58 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.33 19.23 3.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.343 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 34.4 mmtp -98.73 168.46 10.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CE2' HD11 ' A' ' 112' ' ' LEU . 49.6 m0 -84.25 132.61 34.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.248 0.547 . . . . 0.0 110.429 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.02 -179.21 4.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.33 156.64 22.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 167' ' ' ARG . 20.8 ttmm -154.35 167.65 29.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 110.518 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 33.1 mtm-85 -60.11 125.36 23.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.819 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.94 -22.56 67.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.783 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 169' ' ' ARG . 3.7 tpt180 -101.12 21.77 13.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.14 150.61 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.88 102.5 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.684 0.278 . . . . 0.0 111.23 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -130.49 167.77 19.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.0 Cg_exo -73.6 -179.24 4.32 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.966 2.444 . . . . 0.0 113.035 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.835 ' HA ' HG23 ' A' ' 110' ' ' ILE . 9.7 p90 -150.65 178.65 8.88 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.208 -0.308 . . . . 0.0 110.923 -176.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 84' ' ' LEU . 97.4 mt -144.39 134.73 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 45.0 m -102.79 136.88 41.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 111.984 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.628 178.427 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 49.8 m-85 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -78.08 -4.06 45.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.668 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 27.0 tt0 -66.89 136.32 55.21 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 p -104.42 134.64 47.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -165.64 176.86 7.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 73.6 p -78.33 166.32 22.81 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.305 0.378 . . . . 0.0 110.803 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.78 -35.84 77.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.168 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -64.2 -50.79 66.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.0 mt-10 -64.79 -35.83 82.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -60.97 -42.34 98.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.595 ' O ' HG12 ' A' ' 78' ' ' ILE . 43.4 m -60.75 -54.13 48.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.082 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.13 -42.36 76.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 14.4 t70 -60.02 -52.44 65.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 0.0 110.289 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.2 m -63.11 -36.4 83.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.975 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.925 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 22.8 mm -57.29 -42.27 79.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.209 0.528 . . . . 0.0 110.683 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -77.15 -19.19 57.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.195 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 59.8 mtt-85 -107.33 15.49 24.94 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.598 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.52 -49.22 0.42 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.639 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.925 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 120.71 7.19 8.95 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.02 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.824 HG23 ' HB2' ' A' ' 126' ' ' MET . 3.0 m -153.47 138.02 16.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.981 0.42 . . . . 0.0 111.439 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 85' ' ' SER . 6.2 tt -85.74 158.9 19.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.623 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.1 m -69.9 108.21 3.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.939 0.399 . . . . 0.0 110.912 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.2 m -110.12 112.83 57.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 66.7 Cg_endo -82.38 124.81 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.3 2.0 . . . . 0.0 111.982 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -5.87 11.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.386 -170.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.81 165.3 27.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.99 -39.02 77.87 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.029 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -54.27 -39.89 67.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.842 0.457 . . . . 0.0 112.134 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.97 -39.89 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.514 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 33.3 m-80 -66.18 -50.14 64.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.6 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.94 -35.36 80.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.8 65.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.106 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.3 tp -66.53 -44.86 81.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.727 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 110.279 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -65.3 -40.98 94.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.22 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.25 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.182 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 79.2 mt -55.96 -47.7 77.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -54.92 -37.7 66.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.543 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -96.1 -11.05 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.186 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -119.21 -64.06 1.32 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.892 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 110' ' ' ILE . 4.3 t -94.63 -34.27 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 110.406 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.45 125.21 2.99 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -170.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.85 -39.86 54.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.778 0.323 . . . . 0.0 110.151 177.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.64 15.09 1.82 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.81 160.3 14.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.984 0.421 . . . . 0.0 111.258 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 40.5 mt-10 -121.42 122.64 40.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.189 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.4 mp -121.15 148.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.491 ' O ' HG22 ' A' ' 110' ' ' ILE . 87.6 m95 -70.0 151.8 45.15 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.647 HD12 ' HB1' ' A' ' 153' ' ' ALA . 72.3 mt -99.54 4.46 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.94 -27.76 1.38 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' CD1' HD13 ' A' ' 131' ' ' ILE . 1.8 pt? . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 117.652 0.726 . . . . 0.0 110.935 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.417 ' CZ3' ' HB2' ' A' ' 153' ' ' ALA . 11.5 m0 -54.9 143.53 25.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.865 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.1 m -107.05 148.36 11.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.573 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.19 166.91 21.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.361 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.824 ' HB2' HG23 ' A' ' 83' ' ' THR . 49.0 mtt -58.67 -27.15 64.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.3 p -82.81 -12.09 57.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.738 0.304 . . . . 0.0 111.286 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.55 -0.11 53.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.819 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.17 155.57 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -109.03 149.75 28.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.477 HD13 ' CD1' ' A' ' 114' ' ' LEU . 48.6 pt -95.22 167.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.978 0.418 . . . . 0.0 111.413 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.1 5.22 3.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.888 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -118.92 119.41 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.279 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -138.44 98.71 3.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.996 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -127.68 111.52 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.526 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 32.9 m95 -125.36 123.21 38.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 4.3 mm-40 -72.97 -20.69 60.99 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 13.7 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.379 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.647 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.85 119.37 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 111.6 -175.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.79 140.52 47.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.998 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.1 tt -104.45 102.5 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.8 m -96.25 103.9 15.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.701 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.67 -20.55 76.35 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.461 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.43 -8.61 27.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.475 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.03 -66.43 1.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -148.67 -36.84 0.18 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.74 -0.64 36.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.073 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.724 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.1 mptm? -87.02 -179.17 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 34.0 m0 -81.36 131.7 35.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.632 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 90.6 m-85 -126.42 177.12 6.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.709 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -128.52 147.03 50.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.133 0.492 . . . . 0.0 110.665 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.74 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 34.8 ttmt -151.74 179.07 8.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.74 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 11.4 mtp180 -90.27 138.71 31.31 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -66.7 3.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -171.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 169' ' ' ARG . 69.4 mtt-85 -97.58 3.69 50.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.977 0.353 . . . . 0.0 111.743 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -84.52 140.45 31.43 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.597 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.707 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 7.7 mm100 -93.1 91.15 7.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.037 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 4.2 pp -125.05 167.32 16.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.811 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 32.6 Cg_exo -59.84 179.7 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.589 2.859 . . . . 0.0 114.271 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.668 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 28.3 p90 -151.85 163.96 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.569 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.4 mt -139.02 115.43 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 74.5 m -101.9 153.28 20.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 C--N 1.327 -0.372 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.194 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' ILE . 33.7 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -74.7 -8.77 57.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.631 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 23.5 tt0 -59.99 129.5 42.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.763 0.316 . . . . 0.0 110.245 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 p -98.74 131.04 45.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.754 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.884 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.37 179.87 7.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.769 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.8 p -78.77 166.0 22.95 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.46 0.475 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.24 -46.4 89.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.866 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.88 -39.67 79.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 0.0 109.658 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 87.0 tt0 -61.69 -38.13 86.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.662 176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.884 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -65.02 -46.95 79.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.596 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 78' ' ' ILE . 34.0 p -58.44 -57.2 13.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.913 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -60.17 -32.49 71.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 111.31 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 13.2 t70 -63.78 -54.17 39.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.045 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 99.1 m -61.07 -38.97 88.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.702 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 74' ' ' SER . 23.6 mm -52.51 -42.74 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -80.53 -34.16 35.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.137 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 33.3 mtt-85 -91.05 -25.19 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.11 -173.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.49 -40.87 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.416 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.75 -26.36 5.68 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.322 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 127' ' ' THR . 1.2 p -148.71 155.75 41.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.062 0.458 . . . . 0.0 111.961 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 85' ' ' SER . 6.9 tt -96.33 154.13 17.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.587 ' N ' HD23 ' A' ' 84' ' ' LEU . 31.6 m -70.51 108.53 4.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 0.0 111.306 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 114' ' ' LEU . 33.2 m -110.07 106.7 58.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 60.4 Cg_endo -84.01 115.95 2.08 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.484 2.123 . . . . 0.0 111.664 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 131' ' ' ILE . 3.7 pt20 -115.99 7.26 14.3 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.257 -171.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.9 p -138.06 176.21 8.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.916 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.58 -42.92 62.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.2 p -56.72 -45.7 81.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.389 . . . . 0.0 111.439 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.91 -29.0 60.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.511 -175.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 15.9 m-80 -81.11 -47.01 14.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.456 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.12 -30.87 71.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.28 62.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.832 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 31.0 tp -72.87 -44.59 61.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.484 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.88 -33.11 73.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 109.941 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.76 -44.98 69.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.558 . . . . 0.0 109.584 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.38 -32.47 72.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.147 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 74.2 mt -56.53 -41.61 77.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 110.146 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -66.57 -15.9 63.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.997 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -117.47 2.09 12.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -55.32 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 110' ' ' ILE . 3.4 t -100.35 -30.97 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.01 127.35 3.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -53.56 -35.93 61.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.929 0.395 . . . . 0.0 109.975 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.65 27.99 2.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.49 161.55 13.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.786 0.327 . . . . 0.0 111.108 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.1 mt-10 -118.65 128.05 54.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.633 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.814 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.9 mp -126.51 145.25 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.68 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 152' ' ' CYS . 83.1 m95 -70.66 149.9 46.53 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 83.7 mt -104.39 11.73 34.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.52 -25.35 0.74 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.472 ' HG ' ' HE3' ' A' ' 123' ' ' TRP . 1.8 pt? . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 117.958 0.879 . . . . 0.0 111.869 -170.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.444 -0.742 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.472 ' HE3' ' HG ' ' A' ' 114' ' ' LEU . 27.5 m0 -45.88 128.42 8.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.43 155.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 0.0 111.337 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.3 165.07 25.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -55.57 -30.16 60.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.298 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.412 HG23 HG21 ' A' ' 83' ' ' THR . 76.0 p -80.59 -18.88 46.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 111.148 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.71 1.92 28.91 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.401 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 150.89 45.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.633 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -99.59 159.43 15.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.003 0.43 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 46.2 pt -101.83 146.4 10.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.68 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -123.8 20.42 9.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 109.582 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -137.46 120.42 16.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.973 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 134' ' ' LYS . 9.5 mtpm? -135.17 97.29 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.87 110.23 17.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 46.6 m95 -129.68 135.99 49.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.263 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 61.2 mm-40 -91.9 -20.37 21.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.711 0.767 . . . . 0.0 108.948 171.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.988 179.305 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . 0.554 ' HB2' ' HZ3' ' A' ' 111' ' ' TRP . 5.9 m . . . . . 0 N--CA 1.444 -0.726 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.2 116.03 15.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.242 0.544 . . . . 0.0 112.003 -170.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.38 140.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.86 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 3.9 tt -100.23 100.21 11.0 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 14.0 m -88.94 98.55 11.81 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.973 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.68 -29.23 73.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.879 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -68.07 -10.28 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.962 0.411 . . . . 0.0 111.101 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.65 -57.8 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.528 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.5 -33.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.187 -172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 114.65 -5.03 22.85 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.341 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.586 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -86.5 176.93 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.595 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 39.5 m0 -80.79 131.75 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.183 0.516 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.78 172.17 9.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.632 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -124.6 143.09 50.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.492 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 27.6 ttmt -146.88 171.74 14.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 13.8 mtp85 -74.6 141.77 44.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.8 m -66.35 -7.19 17.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -96.81 13.16 29.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -89.2 137.98 31.83 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.094 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.684 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 8.7 mm100 -92.46 87.97 6.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.254 -176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -125.93 165.73 25.52 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.601 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 36.4 Cg_exo -61.44 -179.15 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.403 2.736 . . . . 0.0 113.712 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.814 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.73 169.28 24.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.451 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 76.8 mt -138.44 122.19 20.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 30.9 m -102.57 156.72 17.43 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.218 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.49 0.662 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.66 12.97 2.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.316 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 33.8 tt0 -80.91 137.69 36.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.219 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.8 p -95.2 130.43 41.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -156.11 178.94 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 173.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 ' HD2' ' A' ' 169' ' ' ARG . 46.2 p -85.96 165.98 16.29 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.522 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.91 87.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.647 0.261 . . . . 0.0 111.597 -173.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -60.76 -43.69 97.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 109.966 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.86 -46.67 80.86 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.277 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.9 -39.26 74.09 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.469 0.481 . . . . 0.0 111.396 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' HD13 ' A' ' 78' ' ' ILE . 15.5 t -58.21 -60.1 4.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.085 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.51 -32.93 74.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.02 -38.41 88.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.602 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 36.8 t -93.63 -37.03 12.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.271 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.4 mp -59.65 -36.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.065 0.459 . . . . 0.0 111.406 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -98.88 -0.51 42.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 8.8 ptm180 -105.74 -2.88 22.73 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.99 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.74 -55.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.074 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -174.2 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.741 -1.219 . . . . 0.0 112.778 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.728 HG21 HG22 ' A' ' 127' ' ' THR . 61.6 p -144.16 169.03 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.588 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD23 ' HE1' ' A' ' 126' ' ' MET . 2.9 mm? -67.98 162.86 23.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 96' ' ' LEU . 23.6 m -79.76 107.28 12.41 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 125' ' ' ASP . 18.4 m -100.06 119.03 60.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 68.8 Cg_endo -84.42 121.9 2.71 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.522 2.148 . . . . 0.0 111.949 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -119.09 2.82 11.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.96 177.35 10.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.452 176.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.25 96.34 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.525 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.4 m -53.21 -47.65 68.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 2.8 mp0 -68.54 -37.98 80.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.19 -44.71 94.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.53 -45.72 74.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.35 76.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.844 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 85' ' ' SER . 23.1 mt -60.41 -52.95 63.04 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.274 -0.17 . . . . 0.0 111.076 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.4 t80 -60.5 -36.39 78.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.925 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.99 -37.53 58.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.295 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -73.98 -42.5 60.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -64.9 -24.23 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 0.0 110.644 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 31.9 ttm-85 -65.74 -26.22 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.373 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.16 11.4 17.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.264 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.1 p -137.83 -52.38 0.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.83 -30.73 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.723 0.773 . . . . 0.0 109.905 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 112.85 126.37 4.55 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 4.8 t30 -59.99 -20.77 59.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.936 0.398 . . . . 0.0 111.146 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.53 17.14 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.299 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.26 161.95 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.653 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 172' ' ' LEU . 10.2 pt-20 -116.24 127.66 54.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.604 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.672 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -122.12 149.53 25.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.478 ' CE3' HG22 ' A' ' 154' ' ' VAL . 76.1 m95 -70.05 154.71 41.6 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -88.47 -0.65 57.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 71.09 12.71 72.14 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.852 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.745 0.307 . . . . 0.0 110.61 -177.508 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 121.393 0.616 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -78.57 134.37 37.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.32 134.54 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.76 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -87.17 159.82 18.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.601 0.238 . . . . 0.0 110.527 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.492 ' HE1' HD23 ' A' ' 84' ' ' LEU . 6.9 ptp -66.87 -28.61 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.728 HG22 HG21 ' A' ' 83' ' ' THR . 9.2 p -76.45 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.569 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.65 6.08 19.88 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.115 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.7 132.5 47.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -94.74 113.63 25.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -71.71 138.61 21.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 111.824 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.66 -18.2 13.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.842 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -80.9 122.13 26.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.295 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 88.7 mttt -139.19 122.72 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.085 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.21 113.25 13.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 134' ' ' LYS . 61.4 m95 -126.03 122.99 37.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HG2' HD21 ' A' ' 160' ' ' ASN . 19.4 tp10 -76.08 -20.63 57.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.448 0.642 . . . . 0.0 109.337 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.597 178.871 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 121.803 0.811 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.18 136.97 37.93 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.606 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 166' ' ' LYS . 58.5 t -135.48 143.91 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.968 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.4 tp -98.35 105.04 17.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.83 111.25 23.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 0.0 110.787 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 -28.19 57.08 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.016 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.26 62.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.975 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.44 -60.35 1.97 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.697 HD21 ' HG2' ' A' ' 137' ' ' GLU . 11.6 p30 -173.33 -34.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.447 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 119.35 15.22 5.57 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.604 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.435 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 33.2 mmtp -93.58 173.97 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -82.93 129.54 35.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.315 0.579 . . . . 0.0 110.614 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.08 -173.25 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.744 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -124.66 143.55 50.67 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.845 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 1.5 tmmm? -152.51 138.69 18.32 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 69.8 mtm180 -60.35 135.46 57.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.557 0.694 . . . . 0.0 111.826 -169.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.613 ' O ' ' HB ' ' A' ' 69' ' ' THR . 3.0 m -59.93 -21.29 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.338 -169.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.74 ' HD2' HG21 ' A' ' 69' ' ' THR . 16.6 tpt180 -97.52 6.33 48.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.381 . . . . 0.0 111.246 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.845 ' HB3' ' HE3' ' A' ' 166' ' ' LYS . 14.1 t70 -95.27 135.94 36.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -92.85 120.47 33.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -167.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.693 HD23 ' HZ1' ' A' ' 166' ' ' LYS . 3.7 pp -131.31 165.03 38.29 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.215 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.8 Cg_exo -73.05 178.12 6.92 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.366 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.672 ' HA ' HG23 ' A' ' 110' ' ' ILE . 4.5 p90 -147.08 175.77 10.45 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.607 -0.683 . . . . 0.0 111.982 -175.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 98.5 mt -141.18 124.07 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.015 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.02 145.33 29.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 0.0 112.23 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.575 176.338 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.679 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 65.0 m-85 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 m -71.52 -4.59 27.61 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 3.1 tt0 -59.17 127.28 31.39 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 50.7 p -102.72 126.36 49.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.162 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.901 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -156.06 174.37 15.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 76.2 p -84.18 165.96 17.98 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.088 0.242 . . . . 0.0 110.611 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' HZ ' ' HA ' ' A' ' 115' ' ' ASN . 85.9 t80 -55.62 -49.82 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -61.94 -41.7 98.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.894 0.378 . . . . 0.0 110.264 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -62.55 -45.33 93.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.993 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.901 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -57.06 -42.38 80.46 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.799 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' HD13 ' A' ' 78' ' ' ILE . 80.6 p -63.17 -36.53 83.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.66 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -93.76 -33.93 13.4 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.288 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.661 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.7 t70 -56.99 -59.56 4.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.881 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.442 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 47.2 t -59.68 -41.04 89.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.2 mp -60.43 -42.78 92.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.157 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.6 t -68.86 -26.8 65.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.889 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 30.1 mmt180 -73.47 -10.98 60.29 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.774 0.321 . . . . 0.0 110.792 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.42 43.42 2.54 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.04 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -171.15 -165.48 28.52 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.143 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -134.64 148.65 50.43 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.2 tt -61.46 136.37 58.0 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 84' ' ' LEU . 33.7 p -64.1 108.33 1.51 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.992 0.425 . . . . 0.0 111.481 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -109.84 111.12 58.93 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.475 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.34 112.0 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.242 1.962 . . . . 0.0 112.14 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -95.81 -13.46 24.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.186 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.67 158.6 37.13 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.63 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.22 95.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.08 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -58.6 -40.98 84.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 122.326 0.25 . . . . 0.0 111.284 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -64.61 -41.79 95.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.046 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -64.94 -43.95 91.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 109.995 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.51 -46.7 84.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.799 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.83 -32.94 74.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.309 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 15.7 tp -70.11 -40.67 74.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.303 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -65.51 -40.5 93.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.09 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -67.12 -34.98 78.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.202 0.525 . . . . 0.0 110.91 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -70.76 -25.2 62.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.95 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 58.4 mt -56.09 -55.22 35.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.741 0.305 . . . . 0.0 110.495 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.566 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 6.4 mmt180 -51.37 -36.89 45.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.575 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -99.42 15.06 27.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.99 -170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -153.95 -55.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.041 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.74 -27.1 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.549 0.69 . . . . 0.0 111.04 -171.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.43 127.26 5.68 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -168.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.566 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 3.8 t30 -50.61 -41.29 54.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 107' ' ' GLU . 9.4 pt-20 -94.77 36.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.206 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.58 160.68 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.982 178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.666 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 22.8 mm-40 -110.31 124.89 52.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.488 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -134.21 154.45 37.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.504 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.499 ' HB2' HD11 ' A' ' 84' ' ' LEU . 77.6 m95 -70.9 145.88 49.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 155' ' ' LEU . 0.3 OUTLIER -91.36 2.25 56.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.871 0.367 . . . . 0.0 111.795 -171.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 85.01 9.84 79.79 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.842 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.441 HD11 HD12 ' A' ' 131' ' ' ILE . 4.1 mm? -95.16 159.0 15.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.958 0.379 . . . . 0.0 109.991 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.494 ' HA ' ' HZ ' ' A' ' 70' ' ' PHE . 15.8 t-20 -98.87 100.24 11.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.494 ' HB3' ' HZ3' ' A' ' 123' ' ' TRP . 0.5 OUTLIER -87.52 39.54 0.88 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.928 -172.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -77.95 -135.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -81.61 43.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.82 -0.55 . . . . 0.0 111.162 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.85 79.28 3.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.857 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -80.65 126.17 30.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.03 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.91 -70.71 2.98 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.318 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -98.99 106.05 18.26 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.023 0.44 . . . . 0.0 110.923 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.494 ' HZ3' ' HB3' ' A' ' 116' ' ' ASP . 52.8 m95 -66.89 149.26 50.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.793 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.55 130.37 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.482 ' OD1' HG23 ' A' ' 131' ' ' ILE . 14.2 m-20 -74.49 172.95 11.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.778 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 22.7 mmt -64.8 -24.46 67.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.059 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 p -82.54 -6.38 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.558 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.44 21.42 58.42 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.478 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -112.93 167.11 10.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.329 . . . . 0.0 110.471 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -110.97 123.63 50.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.32 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.53 152.75 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 175.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -106.31 -6.1 18.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.263 0.554 . . . . 0.0 110.393 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -99.32 124.65 44.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.149 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 11.8 mmmm -122.32 108.67 13.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.453 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -152.24 111.69 3.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 109.942 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.645 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 7.7 m95 -136.66 151.11 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.632 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 8.7 tp10 -93.26 -30.68 15.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.0 p -109.47 24.83 12.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 40.6 tt0 -71.13 102.74 2.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.866 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.88 137.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.296 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.0 p -105.51 -22.84 12.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.178 0.514 . . . . 0.0 110.975 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.07 101.93 10.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.736 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -70.39 127.85 91.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.501 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.21 -65.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.772 2.315 . . . . 0.0 113.311 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -102.49 -34.87 8.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.986 0.422 . . . . 0.0 110.882 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 131.75 5.14 3.66 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.504 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.77 34.29 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 119.89 -1.148 . . . . 0.0 113.872 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -77.5 99.57 5.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.9 p -92.7 108.35 19.92 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -168.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -126.23 84.64 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 116' ' ' ASP . 8.9 t30 -135.63 126.79 28.07 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.042 -168.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -158.12 129.43 6.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.8 107.37 10.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.988 0.423 . . . . 0.0 111.483 -173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 166' ' ' LYS . 39.5 t -126.81 154.4 36.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.644 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.1 tt -111.83 122.59 48.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.0 t -109.21 98.56 7.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.151 0.501 . . . . 0.0 109.969 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -72.63 -23.85 77.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.426 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -72.47 -24.11 61.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.0 110.614 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.3 -53.23 7.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.65 -41.56 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.101 0.477 . . . . 0.0 110.415 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.68 -2.19 4.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.815 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 57.6 mttt -88.7 163.89 15.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -78.02 146.13 35.52 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.851 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.2 m-85 -135.74 -169.1 2.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.153 -172.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 6.6 p-10 -137.15 152.5 50.02 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.859 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.592 ' HB2' HG21 ' A' ' 154' ' ' VAL . 34.3 mttp -152.78 -167.16 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.79 175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.521 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 48.2 mtm180 -86.53 131.84 34.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 68.7 m -69.06 -11.6 60.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -97.52 5.91 48.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 110.823 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.521 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 34.0 m-20 -80.76 134.89 35.89 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -92.56 90.62 7.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.22 0.533 . . . . 0.0 110.508 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -116.83 163.38 22.88 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.913 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 25.0 Cg_exo -64.04 179.92 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.122 2.548 . . . . 0.0 113.106 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.442 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -157.75 163.17 38.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.566 178.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.679 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 79.8 mt -127.29 137.74 56.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 67.6 m -121.45 146.56 46.79 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 85' ' ' SER . 16.7 mm-40 -97.98 110.54 23.09 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -104.81 150.66 24.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.393 0.616 . . . . 0.0 112.11 -171.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -167.45 -122.16 0.6 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 181' ' ' VAL . 13.4 tt -145.09 -49.06 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 117.014 0.407 . . . . 0.0 110.503 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 180' ' ' ILE . 14.2 p . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.33 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.66 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 52.5 m-85 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 m -76.12 3.09 11.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.157 0.503 . . . . 0.0 111.168 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -75.29 137.04 40.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.631 177.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.2 p -97.21 129.41 44.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.652 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -161.63 172.45 16.27 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.755 -177.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.724 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 18.3 p -82.31 167.61 18.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -60.37 -27.3 67.29 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -62.99 -57.29 11.22 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.568 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 5.9 mp0 -63.69 -36.32 83.47 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -44.37 87.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.436 . . . . 0.0 110.717 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' HD13 ' A' ' 78' ' ' ILE . 22.7 t -72.58 -56.06 5.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.226 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.55 -45.18 77.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.498 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -64.97 -52.42 56.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.127 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.709 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 12.8 t -66.82 -34.11 77.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.909 0.385 . . . . 0.0 111.209 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -68.11 -34.0 64.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.184 0.516 . . . . 0.0 110.331 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -28.26 28.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.281 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 10.7 ptp180 -80.26 0.63 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.893 0.378 . . . . 0.0 110.612 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.99 52.16 8.26 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.032 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.51 -166.93 13.26 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -153.54 139.35 18.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.884 0.342 . . . . 0.0 110.233 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.6 mp -61.08 137.63 58.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.5 p -62.75 108.03 1.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.032 0.444 . . . . 0.0 110.194 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 7.5 m -106.52 109.24 62.99 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.036 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.8 Cg_exo -75.51 117.28 4.74 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.749 2.299 . . . . 0.0 112.258 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.79 -5.01 20.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.134 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.73 173.15 12.63 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.438 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.82 -39.17 97.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.654 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -56.34 -48.4 76.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.582 0.229 . . . . 0.0 111.51 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.3 -51.59 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.411 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -64.17 -41.4 97.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.48 -43.22 73.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.376 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -30.81 70.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.592 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -64.48 -48.79 73.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.24 -43.31 87.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.848 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.56 ' OE2' ' HD3' ' A' ' 101' ' ' ARG . 9.9 tp10 -63.44 -43.42 97.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.026 0.441 . . . . 0.0 110.344 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -63.4 -34.96 78.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.921 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 77.3 mt -54.35 -45.54 72.76 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.966 0.412 . . . . 0.0 110.435 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.56 ' HD3' ' OE2' ' A' ' 98' ' ' GLU . 52.2 mtp180 -58.5 -30.93 67.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.618 -173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -109.43 10.4 25.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.923 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.0 m -138.78 -57.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.623 HG11 HD11 ' A' ' 110' ' ' ILE . 25.1 t -103.43 -37.83 4.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.691 0.757 . . . . 0.0 110.55 -171.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 136.02 126.43 2.57 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -171.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -53.21 -37.13 61.72 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.698 0.285 . . . . 0.0 110.752 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -104.39 34.7 2.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.443 0.639 . . . . 0.0 111.404 -176.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.51 161.72 13.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.278 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 54.8 mt-10 -121.12 126.24 49.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.636 HG23 ' HA ' ' A' ' 174' ' ' TYR . 2.6 mp -124.27 146.73 29.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 83.1 m95 -71.3 137.22 48.34 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.1 mm? -87.2 3.92 44.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.906 0.384 . . . . 0.0 111.393 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 83.81 9.39 82.9 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.514 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 131' ' ' ILE . 9.5 mp -94.85 126.25 40.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.52 HD21 ' HB ' ' A' ' 124' ' ' VAL . 9.7 p30 -94.34 142.37 27.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.838 0.352 . . . . 0.0 110.652 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -87.86 84.63 7.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.506 0.67 . . . . 0.0 109.898 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 51.5 ttp -119.01 -35.09 3.72 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.94 116.99 28.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.082 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.36 -4.2 46.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.5 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -71.95 168.64 17.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.02 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.8 -7.88 50.55 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.614 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.424 HG22 ' HD3' ' A' ' 130' ' ' ARG . 0.8 OUTLIER -90.31 67.06 6.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.276 0.56 . . . . 0.0 111.053 177.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -68.61 157.36 36.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.399 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 115' ' ' ASN . 42.7 t -101.35 126.7 55.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.843 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.48 163.94 27.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.951 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 9.0 mmt -64.94 -26.65 68.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.071 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -83.89 -4.9 59.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.683 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.66 56.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.846 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.4 168.12 9.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.424 ' HD3' HG22 ' A' ' 122' ' ' THR . 3.4 tmm_? -110.97 125.41 53.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.458 HD13 HD21 ' A' ' 114' ' ' LEU . 23.1 pt -53.88 125.71 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.484 0.659 . . . . 0.0 112.343 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -92.95 -13.13 29.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.06 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -103.42 127.2 50.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.853 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -131.02 119.35 21.9 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.528 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -149.71 110.02 4.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.427 ' HB2' ' CB ' ' A' ' 139' ' ' GLU . 21.1 m95 -127.34 143.98 51.13 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -175.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.757 ' HG2' HD21 ' A' ' 160' ' ' ASN . 10.7 tp10 -91.13 -30.1 16.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 10.2 t -94.25 34.6 1.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.213 173.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 136' ' ' TRP . 15.0 tt0 -63.63 101.85 0.39 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.83 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tt -76.6 98.95 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.866 0.841 . . . . 0.0 111.547 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.6 p -121.31 -15.22 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.958 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.65 156.61 42.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.493 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -105.92 108.55 61.85 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.337 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.8 -64.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.905 2.404 . . . . 0.0 111.913 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -131.62 48.34 2.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.753 0.787 . . . . 0.0 108.977 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.03 -39.83 2.72 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 136.16 53.13 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.166 -0.54 . . . . 0.0 111.753 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 4.0 pttt -67.41 98.91 0.68 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.463 0.649 . . . . 0.0 109.983 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.7 p -139.45 143.78 37.72 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.747 -174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -87.33 148.19 25.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -86.89 146.42 26.19 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 27.5 m 83.37 143.9 0.07 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 124.689 1.243 . . . . 0.0 111.165 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -112.94 146.27 39.3 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.046 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.63 160.64 30.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.333 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 57.1 tp -100.34 103.07 14.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 23.3 t -97.17 104.8 16.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.132 0.491 . . . . 0.0 110.554 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.91 -22.15 77.33 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.721 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -73.81 -16.97 61.13 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.337 0.589 . . . . 0.0 110.594 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.141 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.757 HD21 ' HG2' ' A' ' 137' ' ' GLU . 16.7 p30 -174.51 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.692 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 126.18 15.22 2.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 32.8 mmtp -100.48 175.63 5.62 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -77.4 131.07 37.84 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.958 0.409 . . . . 0.0 110.472 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.531 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 50.6 m-85 -127.34 176.73 7.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.838 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -113.8 137.4 51.69 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.227 0.537 . . . . 0.0 111.001 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 9.1 mmmm -150.61 137.01 18.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.487 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -57.68 136.65 56.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.446 0.467 . . . . 0.0 110.978 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.724 ' O ' ' HB ' ' A' ' 69' ' ' THR . 5.3 m -60.21 -14.65 18.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.866 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -96.65 13.94 26.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.532 0.206 . . . . 0.0 111.548 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.6 146.27 23.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.12 88.47 6.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.106 0.479 . . . . 0.0 110.979 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.8 pp -128.09 158.08 72.06 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.62 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 24.6 Cg_exo -62.58 -178.5 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.367 2.711 . . . . 0.0 113.786 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 1.3 p90 -152.25 165.91 33.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 79.9 mt -139.4 130.65 33.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.925 0.393 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 72.0 m -108.92 143.64 37.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.019 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -89.54 111.0 21.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.494 0.664 . . . . 0.0 110.212 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -124.48 129.68 51.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.428 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.95 -168.49 22.42 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.858 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.07 -52.3 9.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.065 0.459 . . . . 0.0 110.252 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.218 179.223 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 174' ' ' TYR . 1.1 p90 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.0 p -72.25 -2.87 20.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.069 0.461 . . . . 0.0 110.766 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.716 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 34.1 tt0 -56.61 122.51 12.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.875 178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -89.94 121.13 31.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.339 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.875 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.53 -175.86 3.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.318 -179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.579 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 31.7 p -78.42 166.42 22.65 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 123.319 0.387 . . . . 0.0 110.425 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -61.35 -35.39 77.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.987 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -63.58 -51.14 66.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.928 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 4.7 mm-40 -66.7 -37.98 85.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.104 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.875 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -59.74 -40.85 89.46 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.131 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.4 t -66.79 -56.43 10.5 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.292 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.39 -48.22 81.34 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.668 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.707 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 12.2 t70 -59.91 -58.95 6.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.898 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.1 t -61.3 -38.85 88.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.171 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.85 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.597 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.9 m -74.23 -9.15 58.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.999 0.428 . . . . 0.0 110.659 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.707 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 12.8 mmt180 -88.43 -10.09 50.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.82 56.26 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.45 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -118.0 179.77 17.16 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.115 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.605 0.24 . . . . 0.0 110.751 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 113' ' ' GLY . 15.8 tp -68.68 139.61 55.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.5 p -62.11 109.77 1.4 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 111.487 -175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 5.2 t -118.87 130.32 24.89 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 23.6 Cg_endo -93.63 144.24 2.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.364 2.709 . . . . 0.0 113.139 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -108.19 -25.65 10.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.896 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.695 ' HA ' ' CB ' ' A' ' 133' ' ' TYR . 11.6 t -158.9 -169.99 2.88 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.128 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.25 -24.93 56.52 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 112.981 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.469 ' H ' HG23 ' A' ' 89' ' ' THR . 17.3 t -56.51 -52.59 64.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.664 0.269 . . . . 0.0 110.62 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -75.99 -37.97 57.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.292 . . . . 0.0 110.332 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.441 ' C ' HD22 ' A' ' 93' ' ' ASN . 0.2 OUTLIER -56.49 -45.21 81.11 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.177 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.51 -46.89 52.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.793 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -41.25 94.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.098 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.5 mt -64.12 -45.69 87.45 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.88 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.577 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 45.0 t80 -63.89 -34.62 78.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.623 . . . . 0.0 110.297 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -44.13 76.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.851 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.83 -34.08 64.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.394 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 97' ' ' TYR . 3.8 pp -71.34 -32.89 69.08 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.402 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.83 -30.85 71.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -102.56 22.31 13.78 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.078 -0.388 . . . . 0.0 111.642 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.4 m -151.69 -64.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.008 -0.432 . . . . 0.0 111.513 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.7 t -76.25 -32.45 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.176 0.513 . . . . 0.0 109.631 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.14 -74.76 0.29 Allowed Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.224 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.515 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER 172.98 -62.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -175.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.433 ' OE1' ' HB3' ' A' ' 106' ' ' ASN . 2.0 mp0 -86.3 37.46 0.73 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.13 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -98.1 149.05 22.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.04 -174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 35.4 mt-10 -108.58 127.33 53.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.747 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.587 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.6 mp -122.03 140.34 46.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 91.9 m95 -69.69 140.81 53.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.634 HD12 ' HB1' ' A' ' 153' ' ' ALA . 33.5 mt -80.54 0.29 34.46 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 86.68 -21.77 17.02 Favored Glycine 0 C--N 1.32 -0.342 0 C-N-CA 119.733 -1.222 . . . . 0.0 113.857 174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.92 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -94.05 151.97 19.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.228 0.537 . . . . 0.0 110.89 178.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -117.07 132.57 56.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.488 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 123' ' ' TRP . 6.1 p-10 -79.08 126.97 31.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.288 0.565 . . . . 0.0 110.036 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.18 -162.1 1.11 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.669 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.58 62.88 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.586 ' HB1' ' HB ' ' A' ' 122' ' ' THR . . . -70.49 85.25 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -62.47 108.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.96 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.2 -14.3 56.98 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.219 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.586 ' HB ' ' HB1' ' A' ' 119' ' ' ALA . 25.6 m -106.36 104.27 13.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.153 0.501 . . . . 0.0 110.307 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.469 ' CE3' HD23 ' A' ' 114' ' ' LEU . 74.9 m95 -85.03 120.13 26.2 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.631 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.98 129.53 66.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.92 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 5.1 p30 -86.21 -171.47 3.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.443 0.639 . . . . 0.0 112.45 -173.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.85 -11.18 59.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.172 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.0 p -93.96 -20.63 19.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.321 0.582 . . . . 0.0 109.95 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.29 24.84 9.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.642 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.8 154.17 18.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 110.551 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -109.26 122.0 46.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.812 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.0 pt -66.11 134.04 30.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.337 0.589 . . . . 0.0 111.589 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -113.64 17.29 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.61 0.719 . . . . 0.0 109.875 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 89' ' ' THR . 60.0 t80 -136.71 117.36 13.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.861 -177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -120.92 107.54 12.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 0.0 111.009 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.61 ' OD1' ' HG3' ' A' ' 162' ' ' LYS . 29.4 t-20 -133.31 110.22 9.92 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 139' ' ' GLU . 53.4 m95 -123.26 147.04 47.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.993 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.7 tm-20 -89.87 -42.38 11.27 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 164' ' ' PHE . 9.0 t -117.15 34.86 4.9 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.262 -172.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 136' ' ' TRP . 41.8 tt0 -69.22 106.13 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.686 -0.634 . . . . 0.0 109.776 176.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.621 HG12 ' H ' ' A' ' 142' ' ' ALA . 12.8 tt -116.16 134.9 58.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.986 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 p -102.51 0.84 34.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.181 0.515 . . . . 0.0 111.236 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.621 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -106.69 160.77 15.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.906 177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -107.1 100.99 35.74 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.194 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -76.98 -29.26 5.36 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.927 2.418 . . . . 0.0 113.288 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.404 ' CG ' ' HB3' ' A' ' 148' ' ' LYS . 10.3 t70 -64.78 -49.64 69.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 111.355 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.58 41.7 2.88 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.508 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.47 -42.31 0.72 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.639 -0.585 . . . . 0.0 111.639 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 145' ' ' ASP . 21.1 ttpp -95.97 126.81 41.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.119 0.485 . . . . 0.0 111.88 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.79 125.58 47.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 168.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.694 ' HG2' ' HD3' ' A' ' 167' ' ' ARG . 43.8 mt-10 -95.76 146.58 24.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.324 0.583 . . . . 0.0 111.691 -172.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 22.2 p-10 -126.02 176.94 6.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.351 -175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 151' ' ' ASN . 92.7 m 78.79 110.8 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.163 0.914 . . . . 0.0 111.033 -174.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -84.22 143.55 29.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.464 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 11.5 t -125.15 146.36 30.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.821 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.495 ' HB2' HD21 ' A' ' 112' ' ' LEU . 69.0 tp -98.8 100.81 12.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 170.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.4 m -93.44 98.51 11.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.383 0.611 . . . . 0.0 110.405 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.13 -13.04 76.3 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.439 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . . . -67.78 -18.22 64.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.826 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.75 -63.99 1.19 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.062 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -177.72 -19.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.499 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.23 3.59 14.87 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.256 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.61 ' HG3' ' OD1' ' A' ' 135' ' ' ASN . 0.7 OUTLIER -81.26 154.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -75.35 137.71 41.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.137 0.494 . . . . 0.0 111.301 -175.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.578 ' HA ' HG22 ' A' ' 138' ' ' THR . 21.9 m-85 -121.68 -179.24 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.608 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -135.41 138.74 43.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.145 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.8 162.89 40.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 168.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.694 ' HD3' ' HG2' ' A' ' 150' ' ' GLU . 8.1 tpt180 -62.7 144.7 56.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.819 0.342 . . . . 0.0 110.758 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.579 ' O ' ' HB ' ' A' ' 69' ' ' THR . 12.3 m -59.99 -11.74 6.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -100.74 8.97 42.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.545 ' OD2' HD23 ' A' ' 172' ' ' LEU . 29.4 t70 -74.76 139.04 43.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.706 ' OE1' ' HA ' ' A' ' 68' ' ' LYS . 66.9 mm-40 -92.6 83.05 4.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.817 -174.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.545 HD23 ' OD2' ' A' ' 170' ' ' ASP . 3.7 pp -125.13 161.69 48.09 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 172' ' ' LEU . 24.3 Cg_exo -63.11 -177.92 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.594 2.863 . . . . 0.0 113.713 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.716 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 7.4 p90 -155.04 178.03 10.66 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.036 -0.415 . . . . 0.0 110.352 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 96.6 mt -145.23 135.27 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 93.9 m -108.52 147.08 32.25 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 175.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 111.34 22.24 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.577 0.703 . . . . 0.0 109.589 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.73 119.4 36.24 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.478 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -170.14 174.03 44.21 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.36 118.13 55.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.686 179.316 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.594 ' HZ ' ' HE1' ' A' ' 178' ' ' PHE . 45.4 m-85 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.607 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 13.5 t -74.99 -0.29 18.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.202 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 13.5 mp0 -64.6 124.93 23.14 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.426 0.631 . . . . 0.0 111.416 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -91.01 122.29 33.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.291 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.742 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.81 -175.4 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 p -81.74 166.89 19.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 115' ' ' ASN . 81.8 t80 -62.45 -31.31 72.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.653 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -67.05 -52.37 43.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.93 -38.6 89.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.922 0.392 . . . . 0.0 110.366 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -60.61 -30.41 69.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.087 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 30.6 m -74.48 -63.6 1.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.305 177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.5 -42.61 99.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.332 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -71.73 -25.03 61.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.885 0.374 . . . . 0.0 111.587 -174.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 34.9 t -87.16 -43.12 12.48 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -61.61 -43.58 97.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.274 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 t -71.4 -13.66 61.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.901 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -92.22 11.01 27.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.475 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.45 35.21 81.21 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.222 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.74 175.87 21.52 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -142.41 138.87 31.42 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.128 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 174' ' ' TYR . 0.2 OUTLIER -58.86 127.3 31.52 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 174.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.42 ' OG ' HD21 ' A' ' 96' ' ' LEU . 23.0 t -55.04 122.49 11.05 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.393 0.433 . . . . 0.0 110.953 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.585 ' HB ' ' OD1' ' A' ' 125' ' ' ASP . 52.3 p -108.94 108.9 60.97 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.213 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 93' ' ' ASN . 70.8 Cg_endo -84.87 110.75 1.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.378 2.052 . . . . 0.0 112.529 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -101.96 -16.19 16.58 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.732 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.3 p -129.89 167.99 17.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.226 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.59 91.61 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.271 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.9 m -64.34 -28.75 69.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.041 0.448 . . . . 0.0 111.11 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -79.11 -34.14 43.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.557 ' HA ' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -71.25 -55.85 7.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.002 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -68.02 -17.42 64.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.9 78.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.447 . . . . 0.0 110.309 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.42 HD21 ' OG ' ' A' ' 85' ' ' SER . 64.8 mt -66.98 -38.92 86.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.204 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.556 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 89.9 t80 -59.17 -35.87 74.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.32 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -71.11 -46.89 60.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.91 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -67.18 -43.76 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.488 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HD11 ' A' ' 175' ' ' ILE . 2.9 pp -63.0 -31.0 72.04 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.579 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 32.5 ttp-105 -65.32 -36.33 83.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.031 177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.58 13.56 25.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 m -149.42 -46.66 0.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 110' ' ' ILE . 3.5 p -106.65 -23.92 4.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.28 0.562 . . . . 0.0 110.539 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.45 126.26 4.05 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.579 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 8.7 t30 -59.37 -34.03 71.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.424 0.612 . . . . 0.0 111.042 -174.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -88.8 24.06 2.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.385 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -98.11 161.48 13.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.985 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.584 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.3 mt-10 -118.38 126.51 52.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.683 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.801 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -120.2 152.45 23.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.548 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 76.3 m95 -70.62 146.53 49.98 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.65 HD12 ' HB1' ' A' ' 153' ' ' ALA . 40.2 mt -80.88 -2.5 47.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -173.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 74.66 6.3 76.75 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.882 -173.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.43 126.91 40.0 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 70' ' ' PHE . 39.6 t30 -93.34 130.13 39.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.09 -176.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -78.61 80.58 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.716 0.77 . . . . 0.0 110.866 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -108.82 -59.34 1.89 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.86 54.44 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.151 168.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -124.36 3.05 8.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.139 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.42 87.67 6.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.241 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 134' ' ' LYS . . . 81.38 -70.83 3.03 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.787 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.509 ' HB ' ' HG2' ' A' ' 130' ' ' ARG . 1.5 p -99.42 100.82 11.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.054 0.454 . . . . 0.0 111.933 -176.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.4 157.38 34.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.755 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.6 125.18 54.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.056 0.455 . . . . 0.0 110.651 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.585 ' OD1' ' HB ' ' A' ' 86' ' ' THR . 12.8 m-20 -72.32 162.2 29.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.237 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 18.5 mmt -55.52 -30.73 61.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.884 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.0 t -85.23 0.16 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.067 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.33 44.58 9.48 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.583 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -127.55 165.12 20.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.734 0.302 . . . . 0.0 110.954 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.509 ' HG2' ' HB ' ' A' ' 122' ' ' THR . 6.8 mtp85 -112.49 120.07 40.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.106 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.652 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -70.68 141.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 111.578 -178.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.2 -21.22 18.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.832 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -88.4 115.97 26.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 121' ' ' GLY . 7.8 mtmp? -137.96 107.39 6.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.686 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -137.8 112.92 9.17 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.933 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 5.5 m95 -119.38 114.49 22.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.809 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' HB3' ' CE1' ' A' ' 164' ' ' PHE . 28.7 tt0 -70.97 -37.0 72.75 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.823 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 164' ' ' PHE . 6.8 t -97.09 22.91 7.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.472 -176.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.933 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 43.2 tt0 -58.5 114.1 2.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.097 0.475 . . . . 0.0 111.034 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 tt -99.95 104.24 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 121.79 0.805 . . . . 0.0 109.676 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.447 HG23 ' HG2' ' A' ' 139' ' ' GLU . 1.6 p -105.59 12.98 30.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.955 -178.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -96.77 150.32 20.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.857 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.626 ' NE2' ' HA2' ' A' ' 146' ' ' GLY . 44.2 tt0 -88.33 113.15 53.98 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -78.63 -62.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.356 2.038 . . . . 0.0 113.599 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.544 ' HB3' ' HG2' ' A' ' 148' ' ' LYS . 34.6 t70 -129.53 48.17 2.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.168 0.508 . . . . 0.0 112.081 -172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.626 ' HA2' ' NE2' ' A' ' 143' ' ' GLN . . . 78.29 12.05 84.71 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.549 -0.834 . . . . 0.0 114.784 170.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.71 -42.47 0.71 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.453 -1.355 . . . . 0.0 113.69 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' A' ' 145' ' ' ASP . 19.2 ptpt -60.09 136.17 57.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.38 0.59 . . . . 0.0 110.109 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.8 p -131.8 121.62 24.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.345 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -78.41 105.11 9.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -137.83 148.04 45.09 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.333 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.468 ' HB3' ' H ' ' A' ' 166' ' ' LYS . 5.4 t -172.29 165.94 5.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -111.82 106.86 15.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.48 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 166' ' ' LYS . 45.9 t -131.96 140.3 48.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.986 0.422 . . . . 0.0 111.127 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.55 HD23 HD21 ' A' ' 112' ' ' LEU . 1.5 tm? -106.4 100.91 10.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 175.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.1 m -98.43 112.03 24.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.327 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.64 -23.03 68.31 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.968 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.39 -28.82 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 111.26 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.95 -62.67 1.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.481 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -169.68 -25.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.017 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.87 20.23 7.33 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.67 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 162' ' ' LYS . 10.4 mmpt? -93.12 -179.18 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.552 ' CH2' HG13 ' A' ' 131' ' ' ILE . 40.3 m0 -82.25 123.91 29.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.008 0.433 . . . . 0.0 111.215 -176.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.546 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 87.3 m-85 -126.05 -179.29 4.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.543 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -130.1 154.57 47.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.525 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.4 tttp -153.69 -152.68 0.43 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mmt-85 -100.21 121.9 42.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.548 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 14.2 m -65.33 -2.48 3.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 ttt85 -112.19 -0.47 15.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.788 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.15 149.68 21.35 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.19 107.7 19.46 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -165.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.9 pp -129.41 167.46 19.94 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.426 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 19.3 Cg_exo -67.01 -177.68 1.09 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.133 2.555 . . . . 0.0 113.445 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.801 ' HA ' HG23 ' A' ' 110' ' ' ILE . 34.9 p90 -143.87 179.67 7.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.304 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 100' ' ' LEU . 76.3 mt -143.1 116.96 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 29.1 m -112.57 133.73 54.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.146 0.498 . . . . 0.0 112.17 -176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -94.01 122.02 36.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.177 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.594 ' HE1' ' HZ ' ' A' ' 64' ' ' PHE . 45.9 p90 -135.11 151.85 51.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.778 0.323 . . . . 0.0 110.607 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 120.54 -142.6 15.94 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.657 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.5 tp -164.82 111.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.196 0.522 . . . . 0.0 110.457 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.442 -0.79 . . . . 0.0 109.466 177.393 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 56.1 m-85 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.001 0.429 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -68.34 -13.89 62.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.852 -177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 15.7 mm100 -60.25 132.65 54.58 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.895 0.379 . . . . 0.0 111.029 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.553 ' HB ' ' HG2' ' A' ' 171' ' ' GLN . 41.3 p -101.48 143.22 31.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.668 -174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.73 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -166.01 -179.2 5.06 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.229 0.331 . . . . 0.0 110.114 178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 71.8 p -84.93 166.47 16.77 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.49 0.186 . . . . 0.0 110.524 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.18 -49.69 76.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -70.79 -26.44 63.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.688 0.756 . . . . 0.0 109.636 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 68' ' ' LYS . 36.2 tt0 -76.67 -32.49 57.96 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.704 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -66.38 -43.17 86.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 4.5 p -63.6 -54.21 39.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.651 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -59.62 -39.56 84.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.254 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -64.7 -59.22 4.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.375 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.657 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 22.6 t -61.08 -36.52 79.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.907 0.384 . . . . 0.0 110.483 -176.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 74' ' ' SER . 1.5 mp -65.82 -34.62 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.8 t -78.8 -29.13 44.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.657 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 16.3 ptm180 -88.29 1.26 54.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.688 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.68 66.26 1.51 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.493 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.17 167.23 38.77 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.667 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -114.16 133.0 55.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 85' ' ' SER . 5.5 tt -60.46 134.13 56.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.482 ' N ' HD23 ' A' ' 84' ' ' LEU . 39.6 m -54.09 109.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.805 0.691 . . . . 0.0 112.156 -174.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 1.6 t -108.23 118.65 51.93 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.52 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 3.1 Cg_exo -75.75 110.91 3.18 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.57 2.18 . . . . 0.0 111.149 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 88' ' ' GLN . 2.9 pt20 -117.38 -10.19 10.76 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.619 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.1 p -136.83 164.87 27.27 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.528 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.06 95.3 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.628 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -61.34 -45.13 95.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.933 0.397 . . . . 0.0 110.876 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -61.94 -46.51 88.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.517 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -67.75 -37.58 82.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.58 -52.72 64.33 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.139 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.06 83.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.389 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -61.46 -51.69 67.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.006 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -62.49 -39.69 94.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.723 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -64.16 -41.49 97.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -64.07 -35.8 81.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.71 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.9 mt -54.75 -48.99 71.91 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.204 0.526 . . . . 0.0 109.845 175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -59.02 -27.81 65.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.375 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -111.36 17.29 20.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.892 -172.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.5 m -153.63 -54.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -100.85 -36.65 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.734 0.778 . . . . 0.0 110.15 -171.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 129.5 130.25 3.23 Favored Glycine 0 N--CA 1.433 -1.501 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.106 -171.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -35.9 45.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.761 0.315 . . . . 0.0 110.455 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.85 27.83 2.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.848 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.32 161.61 15.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 111.318 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.571 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 4.6 pt-20 -122.87 121.64 36.71 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.643 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.709 HG23 ' HA ' ' A' ' 174' ' ' TYR . 34.3 mm -120.01 153.36 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.404 ' CE3' HG12 ' A' ' 154' ' ' VAL . 83.2 m95 -70.65 149.26 47.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 170.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.85 HD12 ' HB1' ' A' ' 153' ' ' ALA . 73.7 mt -89.08 -1.78 58.25 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.41 9.97 69.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.76 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.461 HD21 HD13 ' A' ' 131' ' ' ILE . 8.3 mp -94.78 127.06 40.51 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.747 0.419 . . . . 0.0 110.286 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -118.44 136.15 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.923 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -80.57 132.07 35.6 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.1 0.476 . . . . 0.0 110.693 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -123.37 -36.66 2.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.063 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.15 11.61 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 63.7 45.49 4.52 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 110.84 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -123.58 168.48 12.56 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.3 0.572 . . . . 0.0 111.804 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 -1.94 90.1 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.9 m -90.93 77.89 6.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -68.11 152.36 45.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.453 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.08 158.19 16.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.19 175.87 6.44 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.39 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.37 -20.56 65.58 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.5 p -87.25 -7.63 57.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.162 0.437 . . . . 0.0 111.117 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.55 21.16 29.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.837 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.08 164.54 11.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.914 0.387 . . . . 0.0 110.424 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -108.02 133.63 52.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.106 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.461 HD13 HD21 ' A' ' 114' ' ' LEU . 42.8 pt -75.96 125.92 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.279 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.34 -22.81 28.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.608 . . . . 0.0 109.727 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -92.3 120.83 33.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.534 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.55 ' HG3' ' CD1' ' A' ' 136' ' ' TRP . 55.1 tttt -144.01 119.1 10.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 111.006 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -156.66 113.17 3.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.55 ' CD1' ' HG3' ' A' ' 134' ' ' LYS . 42.5 m95 -124.31 140.94 52.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.44 -170.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 162' ' ' LYS . 17.7 mm-40 -89.75 -11.86 41.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.251 174.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 8.3 t -133.33 17.13 4.05 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -170.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -103.6 137.76 41.21 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.392 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.476 ' HB ' ' OE1' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -94.64 161.73 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.043 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.1 p -110.79 -74.98 0.63 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.846 0.355 . . . . 0.0 111.385 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -109.2 90.39 3.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.398 0.618 . . . . 0.0 110.879 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.476 ' OE1' ' HB ' ' A' ' 140' ' ' ILE . 11.4 mp0 -133.19 136.29 27.1 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.977 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.08 -15.43 23.19 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.205 1.937 . . . . 0.0 111.48 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.62 -56.34 0.31 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.532 172.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 54.61 23.23 27.76 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.585 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.82 53.27 4.33 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -62.9 99.44 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.489 . . . . 0.0 110.516 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 68.9 p -132.76 144.32 50.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.863 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.82 108.92 11.41 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.685 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 3.9 p-10 -129.95 175.53 8.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.859 -165.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 35.4 m -137.97 132.42 32.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.271 0.558 . . . . 0.0 111.163 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.85 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.6 133.24 39.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.567 -171.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.404 HG12 ' CE3' ' A' ' 111' ' ' TRP . 27.3 m -128.26 164.2 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.629 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 112' ' ' LEU . 55.8 tp -111.75 107.33 16.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.48 103.77 14.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.976 0.417 . . . . 0.0 110.601 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.7 -32.18 74.08 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.243 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.54 -22.89 65.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.95 0.405 . . . . 0.0 111.026 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.58 -54.15 8.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.478 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 162' ' ' LYS . 9.6 p30 175.61 -29.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.029 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 127.16 -11.88 6.82 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.534 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.515 ' HG2' ' OD1' ' A' ' 160' ' ' ASN . 31.5 mmtp -83.72 176.67 8.79 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.433 0.616 . . . . 0.0 109.981 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.472 ' HB3' HD11 ' A' ' 112' ' ' LEU . 43.1 m0 -85.86 136.85 33.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 23.6 m-85 -127.55 -168.01 1.83 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.465 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.685 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 2.8 t70 -133.86 140.88 47.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.134 0.492 . . . . 0.0 111.382 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HE2' HD23 ' A' ' 172' ' ' LEU . 9.2 ttpt -145.88 146.8 31.24 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 165.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -73.53 140.34 46.28 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.806 0.812 . . . . 0.0 112.538 -163.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.9 m -56.78 -25.33 55.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.907 -1.497 . . . . 0.0 114.59 -161.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -99.08 15.99 24.1 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.733 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.16 -176.24 6.08 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.553 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 31.7 tt0 -132.33 97.65 4.17 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.544 -171.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.1 pp -130.2 168.01 18.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.681 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.597 ' O ' HD12 ' A' ' 172' ' ' LEU . 17.1 Cg_exo -67.26 -178.98 1.61 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 123.188 2.592 . . . . 0.0 113.321 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.709 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -159.05 158.72 33.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.241 -0.287 . . . . 0.0 110.368 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.432 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 58.2 mt -126.49 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.61 126.17 49.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.264 0.554 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -100.93 115.37 30.27 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.197 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -141.89 159.14 42.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -104.85 -59.68 0.66 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 38.8 mt -107.04 -70.89 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 172.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.0 t . . . . . 0 C--O 1.251 1.156 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.306 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.767 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 70.4 m-85 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 121.044 0.45 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.5 m -72.9 -4.07 29.68 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.442 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 1.2 tm0? -58.1 122.15 12.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.204 0.525 . . . . 0.0 110.083 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -96.56 113.41 24.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.46 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.673 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -148.39 177.03 9.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.741 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.1 p -77.51 165.7 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.474 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 85.5 t80 -59.17 -38.53 79.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.687 0.28 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -59.73 -53.14 61.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.779 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -63.15 -37.8 88.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.516 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.673 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -56.95 -43.29 81.39 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.43 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.575 ' O ' HD13 ' A' ' 78' ' ' ILE . 19.4 m -66.93 -59.69 3.28 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.311 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -53.21 -44.38 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.761 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.683 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 6.3 t70 -70.36 -41.95 72.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.727 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -62.45 -31.87 72.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.362 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 74' ' ' SER . 1.4 mp -58.92 -36.47 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.387 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.66 -14.32 28.26 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 21.4 mmt180 -87.61 -24.68 23.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.886 0.374 . . . . 0.0 110.968 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.68 -41.05 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.892 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.29 -37.57 0.98 Allowed Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.889 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 p -146.83 158.34 43.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.147 0.473 . . . . 0.0 111.942 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 85' ' ' SER . 5.7 tt -90.8 150.75 21.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 171.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 84' ' ' LEU . 20.9 m -60.94 109.05 0.96 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.915 0.388 . . . . 0.0 111.179 -177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 112' ' ' LEU . 18.0 p -113.14 106.02 55.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.484 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.31 135.23 13.31 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.232 1.955 . . . . 0.0 111.858 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 31.7 mm-40 -107.69 -26.02 11.02 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 110.073 -177.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.1 m -136.15 165.84 24.78 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.903 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -56.19 -28.13 53.68 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.337 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 p -61.2 -50.05 74.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.635 0.255 . . . . 0.0 111.07 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -70.76 -39.13 73.42 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.034 0.445 . . . . 0.0 109.986 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -59.42 -48.37 81.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.328 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.93 -34.88 69.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.691 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.19 -31.04 72.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.562 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.48 -45.61 93.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.769 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.702 ' CE2' ' HA2' ' A' ' 161' ' ' GLY . 78.5 m-85 -59.92 -40.78 90.05 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.287 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.421 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 5.3 mm-40 -59.97 -44.68 94.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.294 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -75.81 -39.62 56.51 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.642 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HA ' HG23 ' A' ' 104' ' ' VAL . 1.9 pp -67.99 -37.14 81.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.265 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 105' ' ' GLY . 25.9 mtm180 -69.73 -8.63 49.59 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 98' ' ' GLU . 46.7 mt-30 -119.2 17.25 13.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.598 0.237 . . . . 0.0 111.027 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.4 m -152.07 -62.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.166 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 100' ' ' LEU . 1.4 t -76.76 -35.57 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 146.17 -76.92 0.27 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.146 173.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.493 HD22 ' HG2' ' A' ' 101' ' ' ARG . 2.7 t-20 173.8 -57.46 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -172.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.81 39.65 0.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.863 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.45 139.81 36.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 111.749 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HB3' HG21 ' A' ' 154' ' ' VAL . 2.9 mp0 -99.55 124.38 44.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.271 171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.933 HG23 ' HA ' ' A' ' 174' ' ' TYR . 5.2 mp -126.24 143.76 38.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.044 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 45.6 m95 -70.61 150.77 45.71 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.299 -0.259 . . . . 0.0 110.299 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.7 mt -97.25 6.4 48.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.406 . . . . 0.0 112.01 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 61.92 16.39 52.04 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.733 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 123' ' ' TRP . 5.0 mp -109.33 134.15 52.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 122.731 0.412 . . . . 0.0 111.0 -175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -122.39 137.26 54.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.87 0.367 . . . . 0.0 110.441 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -118.58 129.07 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.903 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -117.09 -24.38 7.57 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.338 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.78 14.26 26.96 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 62.72 42.54 8.07 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.69 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.6 163.92 13.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.705 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.25 -14.17 59.22 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -89.78 79.56 6.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.53 0.681 . . . . 0.0 110.105 173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.424 ' HB2' HD23 ' A' ' 114' ' ' LEU . 26.6 m95 -68.6 147.55 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.282 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.87 134.59 48.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.209 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 172.1 13.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.973 0.416 . . . . 0.0 110.532 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.3 ptp -55.8 -32.62 63.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.8 p -84.25 -23.13 30.53 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.542 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.96 4.74 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.981 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -108.34 154.7 21.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.043 0.449 . . . . 0.0 110.827 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -109.01 146.45 33.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.832 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.685 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -87.46 163.32 2.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.514 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.88 13.78 11.5 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.377 0.608 . . . . 0.0 110.018 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 25.5 t80 -139.39 124.34 18.71 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.861 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.477 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 51.5 pttt -143.32 115.71 8.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.836 0.35 . . . . 0.0 110.836 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -120.32 113.17 19.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.477 ' HE1' ' HD2' ' A' ' 134' ' ' LYS . 55.2 m95 -112.93 128.29 56.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.299 -174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -88.05 -47.63 8.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p -84.06 39.56 0.71 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.822 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -61.25 102.28 0.21 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.9 tt -88.33 110.04 20.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.401 0.62 . . . . 0.0 109.632 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.28 -24.11 18.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -127.61 127.05 43.17 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.169 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.593 ' NE2' ' HA2' ' A' ' 147' ' ' GLY . 16.6 mt-30 -82.75 106.13 6.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 89.8 Cg_endo -77.98 -27.7 5.55 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.639 2.226 . . . . 0.0 113.437 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.22 -38.42 14.26 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.281 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.24 -10.28 5.34 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.593 ' HA2' ' NE2' ' A' ' 143' ' ' GLN . . . 151.65 36.56 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.08 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -83.42 109.87 17.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 28.9 p -111.57 131.84 54.97 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.624 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -95.21 143.5 26.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.463 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -122.45 158.68 29.23 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 57.4 m 70.94 100.13 0.06 Allowed 'General case' 0 N--CA 1.463 0.196 0 O-C-N 124.045 0.841 . . . . 0.0 110.367 -177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.96 145.33 38.18 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.19 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 166' ' ' LYS . 13.2 p -125.94 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.322 0.582 . . . . 0.0 110.618 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.583 ' HB2' HD21 ' A' ' 112' ' ' LEU . 7.9 tt -91.73 123.62 35.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.2 t -108.96 121.04 44.29 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.67 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . -74.23 -53.75 6.68 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 114.218 -170.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -95.08 -1.05 52.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.734 0.302 . . . . 0.0 111.698 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.21 -35.23 66.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.743 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -177.78 -27.67 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.702 ' HA2' ' CE2' ' A' ' 97' ' ' TYR . . . 92.28 29.89 10.71 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.329 -1.415 . . . . 0.0 111.481 -171.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 72.6 mmtt -126.49 175.9 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -85.66 138.1 32.38 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.53 171.76 10.26 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.751 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.9 150.1 39.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.004 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.52 ' HB2' HG11 ' A' ' 154' ' ' VAL . 34.7 tttt -153.51 -174.81 5.09 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -74.07 126.9 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 42.9 t -60.33 -22.99 63.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -99.77 17.65 20.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.621 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.26 137.51 36.64 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -93.04 99.52 12.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.284 0.564 . . . . 0.0 111.106 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 2.5 pp -128.88 164.23 40.13 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.605 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 36.8 Cg_endo -64.49 178.2 1.79 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.661 2.241 . . . . 0.0 113.191 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.933 ' HA ' HG23 ' A' ' 110' ' ' ILE . 12.1 p90 -152.69 174.2 14.29 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.554 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.0 mp -131.51 126.89 58.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.599 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 2.4 t -102.21 149.46 24.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.794 0.331 . . . . 0.0 110.873 -172.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.53 126.93 54.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.783 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -132.17 171.0 14.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.441 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.616 ' O ' HG12 ' A' ' 180' ' ' ILE . . . 84.79 -51.59 4.58 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.189 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 179' ' ' GLY . 7.4 pt 63.15 -24.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 125.614 1.566 . . . . 0.0 113.998 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 179' ' ' GLY . 3.3 p . . . . . 0 C--O 1.248 0.976 0 O-C-N 122.049 -0.407 . . . . 0.0 110.44 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.525 0.678 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.51 HG23 HG13 ' A' ' 104' ' ' VAL . 1.5 m -71.53 -10.39 59.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.887 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 8.1 mm-40 -64.18 141.82 58.63 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.201 0.524 . . . . 0.0 110.258 174.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -95.61 147.79 23.21 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.177 -172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.56 172.29 8.25 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.078 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.493 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 80.8 p -82.43 166.52 19.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 67.3 t80 -60.89 -36.4 79.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.626 0.251 . . . . 0.0 111.52 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -59.52 -50.36 74.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.21 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -64.83 -40.74 95.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.222 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.48 -39.85 73.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.871 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.3 m -64.53 -61.9 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.573 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.86 -37.29 86.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.895 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 13.3 t70 -66.84 -47.14 72.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.794 0.331 . . . . 0.0 110.377 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 42.0 t -66.02 -30.35 70.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.378 . . . . 0.0 110.62 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.473 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -59.06 -32.09 47.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.153 0.501 . . . . 0.0 110.179 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.9 t -83.21 -32.37 26.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.888 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.589 ' HB2' ' SG ' ' A' ' 176' ' ' CYS . 29.0 mmt180 -77.99 -26.03 48.4 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.679 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.49 -57.33 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.017 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 140.42 -23.79 2.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.605 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 p -141.23 136.45 31.72 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 85' ' ' SER . 5.1 tt -77.21 151.83 35.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.607 ' N ' HD23 ' A' ' 84' ' ' LEU . 7.5 t -67.23 108.88 2.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.102 0.477 . . . . 0.0 110.344 -176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 125' ' ' ASP . 55.7 m -113.58 114.75 47.25 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.341 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 163' ' ' TRP . 11.5 Cg_exo -71.82 112.04 3.29 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.79 2.326 . . . . 0.0 111.794 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.87 -13.18 16.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.89 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.21 154.91 50.22 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.527 -174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.82 -53.09 44.29 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.384 -0.436 . . . . 0.0 112.337 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -56.77 -38.23 72.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 110.829 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.29 -42.48 93.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.131 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -70.02 -43.09 72.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.066 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -62.98 -39.16 93.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.396 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.84 88.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.941 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 20.9 tp -67.11 -45.64 76.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.979 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.53 -40.23 93.9 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.501 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.49 -46.08 90.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.18 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -63.01 -31.61 72.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.026 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 80.7 mt -56.89 -44.16 82.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.699 0.285 . . . . 0.0 110.658 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 36.0 mtm180 -71.9 -10.07 59.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.995 -173.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.19 18.17 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.5 t -154.87 -58.92 0.11 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 110' ' ' ILE . 12.2 t -96.36 -36.61 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-O 121.449 0.642 . . . . 0.0 110.086 -170.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.6 128.67 3.19 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 -55.29 -33.88 63.62 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.013 0.435 . . . . 0.0 110.352 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.688 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 45.9 mt-10 -93.01 26.18 2.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.132 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -100.11 160.16 14.54 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.445 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -125.7 124.05 40.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.296 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.774 HG23 ' HA ' ' A' ' 174' ' ' TYR . 42.5 mm -116.03 146.24 20.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.164 -174.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.541 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 71.6 m95 -71.33 147.71 47.79 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 171.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.574 ' HB2' HD22 ' A' ' 114' ' ' LEU . 3.2 mm? -107.22 8.74 30.12 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.259 -0.276 . . . . 0.0 111.668 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 59.22 43.48 97.15 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.256 0.462 . . . . 0.0 114.256 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 153' ' ' ALA . 1.5 pt? -139.17 155.42 47.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.14 159.27 44.55 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.564 0.221 . . . . 0.0 111.441 -174.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -117.25 150.65 38.42 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.2 ttp -126.31 -49.01 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.844 0.354 . . . . 0.0 111.649 -176.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.49 -65.23 1.12 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.059 0.456 . . . . 0.0 111.259 -174.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 147' ' ' GLY . . . -166.18 50.71 0.08 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.183 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.44 108.02 17.68 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.623 -171.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.9 -35.13 58.42 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.6 p -103.29 95.21 5.95 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 169.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.449 ' HB2' HD12 ' A' ' 114' ' ' LEU . 13.3 m0 -51.64 153.72 2.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.144 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.418 HG22 ' HD2' ' A' ' 130' ' ' ARG . 31.6 t -96.56 132.48 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.638 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' HB3' HG21 ' A' ' 86' ' ' THR . 5.1 p30 -83.1 -171.82 3.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.142 0.496 . . . . 0.0 111.3 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 57.4 mtt -82.16 -14.51 55.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 t -98.89 0.39 44.05 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.737 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.29 24.32 16.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.431 171.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -120.65 166.42 13.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.961 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.418 ' HD2' HG22 ' A' ' 124' ' ' VAL . 2.1 mpp_? -100.6 133.22 45.36 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.479 HD12 ' HZ3' ' A' ' 163' ' ' TRP . 26.5 pt -58.99 124.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.268 0.556 . . . . 0.0 111.175 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.9 12.59 31.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.524 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -140.67 127.88 20.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 22.5 mtmt -135.21 118.2 16.34 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.802 0.334 . . . . 0.0 111.722 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -131.72 111.18 11.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.806 0.812 . . . . 0.0 109.332 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.794 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 38.3 m95 -132.29 137.83 47.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.699 -174.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.731 ' HB2' ' HD3' ' A' ' 162' ' ' LYS . 20.3 tt0 -97.57 -18.78 18.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 171.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -104.11 24.95 10.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.843 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.794 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 8.3 tp10 -64.85 102.54 0.6 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.844 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 15.0 tt -99.56 137.34 27.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.1 0.476 . . . . 0.0 110.263 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.1 p -113.44 0.84 14.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.666 -175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.57 115.23 27.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.885 175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.44 ' CD ' ' H ' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -93.6 116.06 65.94 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.059 -177.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 5.7 Cg_exo -75.0 -51.2 0.12 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.836 2.357 . . . . 0.0 111.541 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -94.1 -36.73 11.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.302 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.93 -9.64 1.0 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.343 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 119' ' ' ALA . . . 146.18 13.42 0.19 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.009 -1.091 . . . . 0.0 114.204 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -111.6 143.18 42.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.674 0.737 . . . . 0.0 109.733 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.499 ' HB ' HD22 ' A' ' 151' ' ' ASN . 15.5 p -132.48 121.13 22.88 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.599 -0.44 . . . . 0.0 112.166 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -72.17 84.34 1.03 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.167 0.508 . . . . 0.0 109.656 174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.499 HD22 ' HB ' ' A' ' 149' ' ' THR . 1.8 p30 -168.2 167.12 12.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.42 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 94.2 m -127.89 133.2 49.29 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.818 ' HB3' HD21 ' A' ' 114' ' ' LEU . . . -75.26 139.93 42.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.959 0.409 . . . . 0.0 111.466 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.634 HG11 ' HG3' ' A' ' 166' ' ' LYS . 28.2 m -129.12 159.9 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.157 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -106.75 100.18 9.7 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.4 m -87.97 101.19 13.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.693 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -65.16 -42.83 96.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.151 -173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -63.27 -25.05 68.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 111.239 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.31 46.6 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.311 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 160' ' ' ASN . 0.2 OUTLIER 178.82 -40.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 124.41 2.36 8.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.691 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.731 ' HD3' ' HB2' ' A' ' 137' ' ' GLU . 25.8 mttt -83.62 168.45 16.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.488 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 54.6 m0 -85.17 134.62 34.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.251 0.548 . . . . 0.0 110.482 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -123.78 177.06 5.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.881 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -108.59 153.5 23.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.344 0.592 . . . . 0.0 111.623 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.634 ' HG3' HG11 ' A' ' 154' ' ' VAL . 37.8 mmtt -149.87 149.27 30.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.65 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -70.34 129.12 38.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 13.4 m -64.36 -1.1 1.52 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -171.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -96.32 2.65 52.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.62 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -77.17 136.37 38.58 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.475 ' HG3' ' N ' ' A' ' 68' ' ' LYS . 9.6 tt0 -98.49 90.24 4.7 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.279 0.562 . . . . 0.0 110.888 -172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.1 pp -125.87 168.83 12.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.576 -176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.429 ' O ' HD12 ' A' ' 172' ' ' LEU . 12.4 Cg_exo -69.31 174.64 8.82 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.79 2.327 . . . . 0.0 112.369 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.774 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.3 p90 -152.39 172.62 16.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 94.5 mt -133.97 129.7 54.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 80' ' ' ARG . 8.2 t -102.16 136.3 42.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.043 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -96.97 110.73 23.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.984 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -115.09 159.71 20.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.171 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -103.93 -164.49 24.98 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.854 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 180' ' ' ILE . 28.3 mt 70.55 17.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.19 0.995 . . . . 0.0 109.428 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.702 179.334 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 55.7 m-85 . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.269 0.557 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.458 HG23 HG13 ' A' ' 104' ' ' VAL . 2.0 m -73.31 -6.18 44.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.284 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 12.3 mm-40 -63.91 134.1 54.52 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.531 0.681 . . . . 0.0 111.289 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -94.01 133.39 37.52 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.987 -174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.45 177.23 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.434 175.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -77.61 165.27 24.5 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.533 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 89.1 t80 -62.28 -37.65 86.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.211 0.529 . . . . 0.0 110.554 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -62.97 -46.51 87.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.16 -38.77 82.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -57.75 -35.92 71.39 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.434 ' O ' HD13 ' A' ' 78' ' ' ILE . 48.1 m -64.67 -58.67 5.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.383 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -57.66 -43.5 85.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.347 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.665 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 23.0 t70 -64.26 -59.09 4.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.075 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.98 -30.28 70.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.714 0.293 . . . . 0.0 111.406 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 74' ' ' SER . 1.2 mp -60.82 -29.82 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.7 p -98.76 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.619 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 32.4 mmt180 -80.4 -25.78 38.88 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.018 0.437 . . . . 0.0 110.757 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.71 -50.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.678 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.15 -41.03 1.19 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.519 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.4 p -142.37 139.6 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.595 0.198 . . . . 0.0 110.867 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 85' ' ' SER . 6.6 tt -77.33 147.11 36.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.8 m -62.28 108.67 1.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.877 0.37 . . . . 0.0 111.048 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 125' ' ' ASP . 15.8 p -107.63 110.53 62.74 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.378 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.45 ' HG3' HD22 ' A' ' 112' ' ' LEU . 97.5 Cg_endo -80.59 140.94 13.56 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.584 2.189 . . . . 0.0 111.509 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.4 pt20 -129.52 -10.25 4.56 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.305 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.6 p -141.9 177.39 8.23 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.98 68.93 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.952 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -61.85 -48.91 78.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.317 0.247 . . . . 0.0 111.271 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -68.84 -37.82 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.539 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.39 -39.74 88.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.867 0.365 . . . . 0.0 110.15 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.625 ' O ' ' HG2' ' A' ' 98' ' ' GLU . 36.0 t70 -68.42 -49.75 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.097 177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.8 -43.95 77.36 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.424 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.59 -42.81 91.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.6 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.521 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 2.0 t80 -61.17 -36.21 79.22 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.348 0.594 . . . . 0.0 109.96 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 9.8 mm-40 -70.08 -46.38 65.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.3 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.0 -39.7 75.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.216 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.639 HD13 ' HB3' ' A' ' 108' ' ' ALA . 4.1 pp -65.55 -34.47 78.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.677 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.578 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 66.8 mtm180 -71.98 -9.58 58.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.698 0.285 . . . . 0.0 111.437 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -111.23 12.09 21.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.748 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -59.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.001 0.429 . . . . 0.0 111.085 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' ALA . 2.1 t -77.94 -33.3 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.163 0.506 . . . . 0.0 109.896 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 138.09 -73.56 0.42 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.579 176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 2.8 t-20 175.29 -54.69 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -172.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.842 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 46.0 mt-10 -78.91 36.48 0.28 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 100' ' ' LEU . . . -79.61 130.38 35.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.095 -174.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.05 121.54 44.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.828 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.5 mp -126.8 141.42 46.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -70.46 148.96 47.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 153' ' ' ALA . 90.1 mt -98.93 5.95 47.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.728 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.53 9.31 43.53 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.518 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.1 mp -100.35 136.7 39.84 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 122.437 0.295 . . . . 0.0 111.07 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -133.13 133.34 42.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.874 0.368 . . . . 0.0 110.567 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -117.38 119.21 34.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.787 173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -116.96 -37.58 3.56 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.636 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.09 22.3 15.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.759 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 65.7 63.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.378 0.609 . . . . 0.0 111.218 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -102.52 129.13 48.95 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.403 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.33 -33.64 58.65 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.788 HG22 ' HB2' ' A' ' 130' ' ' ARG . 21.1 m -97.25 86.09 3.84 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -52.12 141.64 18.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.954 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.4 t -103.16 138.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.519 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -88.24 178.7 6.53 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.422 ' HG2' ' H ' ' A' ' 126' ' ' MET . 6.8 ptp -64.52 -32.64 74.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.9 p -76.56 -22.77 53.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.014 -175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 113.22 20.6 6.22 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.61 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.85 160.59 17.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.951 0.405 . . . . 0.0 110.707 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.788 ' HB2' HG22 ' A' ' 122' ' ' THR . 0.0 OUTLIER -109.81 154.19 23.33 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.839 177.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -88.09 143.63 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -96.15 -18.46 20.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.153 0.501 . . . . 0.0 110.522 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 20.3 t80 -119.52 120.7 37.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.644 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -144.34 131.4 20.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.868 0.366 . . . . 0.0 111.151 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -147.99 136.09 21.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.413 0.625 . . . . 0.0 110.189 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -129.99 123.3 30.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.066 -171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 164' ' ' PHE . 67.3 mm-40 -74.72 -27.05 60.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.285 0.564 . . . . 0.0 109.873 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.662 HG23 ' HD2' ' A' ' 164' ' ' PHE . 11.5 p -84.55 15.37 3.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.236 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -56.19 104.86 0.16 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.846 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 143' ' ' GLN . 10.3 tt -98.96 121.09 49.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.109 -175.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.1 p -105.22 -25.25 12.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.117 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.63 102.05 8.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.267 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.638 ' HA ' HD11 ' A' ' 140' ' ' ILE . 25.6 mt-30 -76.42 109.34 8.28 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.139 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.534 ' HD3' HD11 ' A' ' 140' ' ' ILE . 5.5 Cg_exo -72.53 -61.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.11 2.54 . . . . 0.0 112.67 -171.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -67.86 -33.11 74.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.992 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.5 -25.23 1.68 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.976 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.33 18.58 0.06 OUTLIER Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.378 -0.915 . . . . 0.0 114.237 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.551 ' NZ ' ' HB3' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -66.62 106.74 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 174.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.8 p -125.83 163.43 22.92 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.081 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 166' ' ' LYS . 22.9 mm-40 -87.39 178.3 6.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 110.965 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 14.8 m120 -133.05 132.32 41.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.419 -173.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 151' ' ' ASN . 80.7 m 75.72 141.02 0.07 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.148 0.499 . . . . 0.0 110.999 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.618 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -91.91 139.17 30.92 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.878 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.7 p -133.41 141.43 44.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.681 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.616 ' HB2' HD21 ' A' ' 112' ' ' LEU . 2.4 tt -91.22 123.53 34.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.5 t -108.4 106.19 16.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.175 0.512 . . . . 0.0 110.633 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.18 1.61 84.43 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.668 -0.697 . . . . 0.0 112.11 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.842 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -101.27 5.38 42.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.104 0.478 . . . . 0.0 110.556 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -119.8 -53.17 2.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.778 -175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -173.38 -32.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.723 0.296 . . . . 0.0 111.332 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 111.74 -2.57 27.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.886 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 34.9 mmtp -76.31 -179.04 4.86 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HZ3' HG13 ' A' ' 131' ' ' ILE . 49.9 m0 -94.39 134.02 37.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.241 0.543 . . . . 0.0 109.796 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.662 ' HD2' HG23 ' A' ' 138' ' ' THR . 91.9 m-85 -126.02 165.28 19.09 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.883 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -116.54 144.21 44.63 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.698 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 72.6 tttt -144.93 -171.89 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.698 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 1.2 mmt180 -72.54 125.54 27.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 70' ' ' PHE . 9.4 t -69.54 -19.82 63.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.386 0.612 . . . . 0.0 110.076 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -94.73 12.31 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.233 174.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 20.0 t70 -80.59 136.1 36.19 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -93.8 93.44 7.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.229 0.538 . . . . 0.0 110.945 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.56 169.69 9.29 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.736 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 16.6 Cg_exo -68.77 -179.1 2.27 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.995 2.464 . . . . 0.0 113.049 -176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.828 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.2 p90 -156.57 171.55 20.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.874 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.15 125.96 67.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 13.8 t -102.29 133.91 46.42 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -92.24 111.06 22.48 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -110.76 174.28 5.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.513 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 100.83 -36.64 4.04 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.2 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.614 HG12 ' H ' ' A' ' 181' ' ' VAL . 0.1 OUTLIER 34.8 -96.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.331 1.053 . . . . 0.0 113.286 -177.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.614 ' H ' HG12 ' A' ' 180' ' ' ILE . 3.7 p . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.994 -0.527 . . . . 0.0 110.378 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 121.031 0.443 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 16.8 p -77.14 -8.54 57.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 13.6 mm-40 -64.96 141.92 58.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.2 p -99.06 144.49 28.14 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.769 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.781 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -168.59 -179.7 3.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.34 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 74.4 p -80.3 164.97 22.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . 85.3 t80 -62.34 -35.35 78.84 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -59.37 -52.14 66.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.329 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.6 mt-10 -64.25 -37.14 86.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.697 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.781 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -61.52 -43.65 98.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.581 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.409 ' O ' HD13 ' A' ' 78' ' ' ILE . 20.9 m -65.67 -55.92 14.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.805 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -60.92 -34.27 74.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.883 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 17.1 t70 -69.95 -51.63 31.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.45 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 53.3 t -63.07 -34.33 77.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 1.3 mp -56.85 -31.03 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 110.498 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.4 t -84.68 -37.59 20.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.59 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 31.6 mmt180 -71.8 -26.56 62.46 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.885 0.374 . . . . 0.0 111.072 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.25 -48.95 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.884 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 131.82 -26.37 3.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.972 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 p -135.14 128.09 31.45 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.924 0.362 . . . . 0.0 111.429 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 85' ' ' SER . 6.1 tt -74.88 146.53 41.82 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.555 ' N ' HD23 ' A' ' 84' ' ' LEU . 5.0 t -65.68 108.94 2.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.155 0.502 . . . . 0.0 110.448 -172.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.538 HG21 ' HB3' ' A' ' 125' ' ' ASP . 28.3 m -116.27 114.1 40.94 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.344 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 2.1 Cg_endo -79.56 137.97 13.34 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.663 2.242 . . . . 0.0 112.076 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -114.51 -13.55 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.276 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.65 165.08 28.45 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.981 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -57.82 -42.97 94.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.755 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.6 p -55.76 -44.53 77.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 111.428 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -42.64 94.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.85 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -65.38 -45.51 83.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.547 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -38.95 91.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.046 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.53 84.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.893 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.6 tp -66.07 -43.38 87.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -59.74 -40.78 89.23 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.601 176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.12 -36.88 77.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -63.29 -36.8 84.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 59.7 mt -54.39 -52.08 62.81 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.101 0.477 . . . . 0.0 109.75 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.5 ttm-85 -56.54 -33.35 66.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.006 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -101.4 -1.46 33.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.2 t -140.16 -50.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.797 HG11 HD11 ' A' ' 110' ' ' ILE . 7.3 t -98.02 -30.15 3.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.605 0.717 . . . . 0.0 110.503 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.37 125.54 3.63 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -171.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.497 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -49.89 -42.49 48.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 158' ' ' ALA . 45.6 mt-10 -94.21 47.83 1.22 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 111.263 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.74 145.54 41.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 10.9 mm-40 -98.52 123.82 42.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.862 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.797 HD11 HG11 ' A' ' 104' ' ' VAL . 43.0 mm -121.83 142.85 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.367 -0.133 . . . . 0.0 111.192 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 152' ' ' CYS . 64.0 m95 -70.61 145.84 50.44 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 82.2 mt -111.03 16.49 21.13 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.3 -27.67 0.83 Allowed Glycine 0 CA--C 1.53 0.994 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.562 HD12 ' HB2' ' A' ' 123' ' ' TRP . 1.6 pt? -94.56 142.08 27.85 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.123 0.962 . . . . 0.0 110.913 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -145.06 161.66 38.88 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.046 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -102.86 141.98 34.75 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 53.0 ttp -127.46 -43.15 1.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.848 0.356 . . . . 0.0 111.75 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.65 -67.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.408 -174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -169.22 62.91 0.05 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.61 137.6 32.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.294 -169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.69 -53.69 1.91 Allowed Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 170.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.56 105.35 17.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 169.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.562 ' HB2' HD12 ' A' ' 114' ' ' LEU . 16.9 m0 -62.3 150.03 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.205 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.47 138.19 30.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.72 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.66 ' OD2' HG22 ' A' ' 127' ' ' THR . 1.1 p-10 -99.89 -162.12 0.92 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.055 0.455 . . . . 0.0 110.947 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.3 mtt -77.94 -33.57 51.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.375 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.66 HG22 ' OD2' ' A' ' 125' ' ' ASP . 14.4 t -83.03 -21.4 33.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 0.0 110.024 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.84 32.05 6.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.498 175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.19 157.54 15.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 130' ' ' ARG . 0.3 OUTLIER -107.97 118.39 36.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.128 177.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 131' ' ' ILE . 45.6 pt -64.34 125.41 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.341 0.591 . . . . 0.0 111.011 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -91.84 -20.75 21.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.528 0.68 . . . . 0.0 109.904 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -110.65 127.55 55.32 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.765 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -129.53 114.44 16.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.617 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -129.41 111.21 12.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.381 0.61 . . . . 0.0 109.772 172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.994 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 31.6 m95 -125.99 124.14 40.05 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . 7.4 tp10 -77.68 -25.83 49.8 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 14.5 p -103.23 25.09 9.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.588 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.994 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 40.2 tt0 -61.7 137.15 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.787 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.406 HG12 ' H ' ' A' ' 142' ' ' ALA . 12.6 tt -123.18 119.01 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 p -75.63 -3.57 35.19 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -127.42 91.31 3.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.04 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 2.7 pt20 -67.64 113.06 12.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.686 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 73.3 Cg_exo -48.99 -67.12 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.041 3.161 . . . . 0.0 114.539 -168.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -95.32 17.31 14.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.055 0.455 . . . . 0.0 111.394 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.42 -24.03 27.0 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.668 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 122.69 50.34 0.23 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.369 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 148' ' ' LYS . 8.6 ttpp -123.89 105.9 10.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.676 0.274 . . . . 0.0 110.534 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.9 p -136.16 157.08 47.68 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.663 0.268 . . . . 0.0 110.647 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -90.15 80.94 6.21 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.98 150.89 31.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.216 0.532 . . . . 0.0 110.411 -177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 111' ' ' TRP . 71.6 m -125.24 136.99 54.09 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.14 134.82 41.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.972 0.415 . . . . 0.0 111.51 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 28.7 m -120.46 156.16 23.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.909 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 1.5 tt -103.63 101.14 10.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 33.3 m -84.64 91.57 7.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.486 0.66 . . . . 0.0 110.61 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -71.77 -22.39 78.72 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.523 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.473 ' HA ' ' HG2' ' A' ' 107' ' ' GLU . . . -69.89 -15.83 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.136 0.493 . . . . 0.0 110.27 177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.85 -65.27 0.99 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.124 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -167.19 -37.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 131.05 -4.15 5.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.364 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -77.34 174.68 10.52 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.112 0.456 . . . . 0.0 110.107 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -89.78 133.49 34.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.85 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 42.1 m-85 -119.78 166.89 12.66 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.879 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -104.62 144.38 31.79 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.272 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.412 ' HD2' HG11 ' A' ' 154' ' ' VAL . 52.1 mttt -146.09 150.93 36.87 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.911 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -75.12 130.35 39.08 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.504 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 6.0 m -65.14 2.96 0.67 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -95.21 -4.58 45.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.01 132.14 41.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.782 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -93.21 97.92 10.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 173' ' ' PRO . 3.2 pp -129.05 166.11 27.48 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.855 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.588 ' HB3' ' HA ' ' A' ' 65' ' ' THR . 14.8 Cg_exo -67.08 171.13 11.77 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.721 2.281 . . . . 0.0 112.233 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -137.77 174.33 10.69 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.498 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 93.2 mt -137.8 123.55 25.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 173.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 10.1 t -102.08 130.51 48.69 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -91.46 110.58 21.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.019 0.438 . . . . 0.0 109.967 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -118.59 135.2 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.167 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -115.8 -177.52 18.4 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.567 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.1 mt 62.2 67.5 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.468 0.651 . . . . 0.0 110.019 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.744 -178.652 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 74.0 m-85 . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.057 0.456 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' A' ' 173' ' ' PRO . 2.4 m -74.38 0.28 14.99 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.587 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.55 ' OE1' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -65.98 127.56 32.55 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -102.29 123.95 47.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.664 -174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.55 ' HB3' ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -150.07 174.73 12.43 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.606 -177.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 82.5 p -80.61 166.57 20.98 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.382 0.427 . . . . 0.0 110.227 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' HZ ' ' HA ' ' A' ' 115' ' ' ASN . 91.6 t80 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 121.182 -0.207 . . . . 0.0 111.556 -177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -60.95 -41.71 96.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.16 -38.25 81.9 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.359 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -54.99 -39.96 69.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.239 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.725 ' O ' HG12 ' A' ' 78' ' ' ILE . 37.7 m -64.09 -69.64 0.27 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.268 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.55 -44.6 73.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.984 -173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 19.9 t70 -60.52 -58.92 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.917 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -58.57 -42.06 87.13 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.16 0.287 . . . . 0.0 111.215 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 74' ' ' SER . 42.2 mm -57.51 -41.23 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.324 0.583 . . . . 0.0 110.413 175.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.2 t -72.64 -24.26 61.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.702 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.1 mmp_? -74.79 -10.33 59.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.386 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.01 37.72 5.63 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.004 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.68 -170.22 27.21 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.189 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 t -130.26 146.74 51.9 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 111' ' ' TRP . 2.6 tt -63.32 138.03 58.39 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 84' ' ' LEU . 30.3 p -61.83 109.33 1.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.371 0.419 . . . . 0.0 111.579 -174.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.541 HG22 ' HA3' ' A' ' 113' ' ' GLY . 47.2 p -110.0 107.73 58.93 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.969 177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . 14.6 Cg_exo -68.5 111.33 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.085 1.857 . . . . 0.0 112.576 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' NE2' ' H ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -85.41 -27.96 25.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.338 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.6 p -129.56 173.18 10.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.825 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.61 -38.95 95.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.089 -0.576 . . . . 0.0 112.12 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -59.27 -43.41 92.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 111.001 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 87' ' ' PRO . 7.3 mm-40 -59.6 -47.81 84.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.997 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -64.14 -44.9 90.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.277 0.56 . . . . 0.0 110.203 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -58.02 -49.21 77.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.912 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.16 67.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.718 -178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 40.3 tp -70.64 -47.01 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.65 0.262 . . . . 0.0 110.617 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -60.76 -35.55 76.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.317 0.579 . . . . 0.0 109.946 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.54 -34.99 72.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.164 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 68.5 t80 -68.24 -27.57 66.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.513 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 106' ' ' ASN . 22.9 mt -58.64 -54.85 42.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -58.83 -33.2 70.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.141 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 9.2 pt20 -91.62 0.98 57.45 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.0 t -146.32 -59.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.17 -28.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.623 0.725 . . . . 0.0 110.698 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 104.3 119.0 4.55 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -165.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 66.9 t30 -51.54 -36.52 45.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.136 0.468 . . . . 0.0 111.749 -173.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.69 32.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.906 0.384 . . . . 0.0 111.871 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -97.46 139.88 32.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.813 0.34 . . . . 0.0 110.372 178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.62 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 8.6 mm-40 -94.31 122.36 36.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.481 ' HA ' HD13 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -136.85 155.1 32.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.39 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.512 ' HB2' HD11 ' A' ' 84' ' ' LEU . 86.8 m95 -71.44 144.87 49.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.924 0.392 . . . . 0.0 110.694 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -84.69 -7.25 59.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.368 -174.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.541 ' HA3' HG22 ' A' ' 86' ' ' THR . . . 81.11 -1.66 84.09 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.535 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 112' ' ' LEU . 3.6 mm? -93.49 139.36 30.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.238 0.519 . . . . 0.0 110.112 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.516 ' HA ' ' HZ ' ' A' ' 70' ' ' PHE . 28.4 t-20 -91.54 154.05 19.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.081 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 151' ' ' ASN . 6.4 p-10 -99.37 10.99 40.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -169.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.503 ' HB2' ' OD1' ' A' ' 115' ' ' ASN . 3.0 tmm? -69.77 -163.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.38 88.77 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.062 0.458 . . . . 0.0 111.023 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 123' ' ' TRP . . . -127.3 85.0 2.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.712 177.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -80.14 88.62 5.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.597 0.713 . . . . 0.0 110.689 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 89.0 -45.48 3.19 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.4 ' O ' ' HB1' ' A' ' 119' ' ' ALA . 26.8 m -95.66 103.16 15.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.784 0.326 . . . . 0.0 110.62 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.416 ' HA ' ' HB1' ' A' ' 119' ' ' ALA . 58.2 m95 -79.83 156.26 27.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.932 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.1 t -116.13 130.18 71.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.762 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.448 ' OD1' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -73.19 164.69 26.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.403 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 17.9 mmt -61.23 -33.39 73.41 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.41 174.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.55 -5.86 49.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.108 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.75 64.27 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.54 166.72 10.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.407 -0.396 . . . . 0.0 110.061 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -112.53 118.62 35.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.331 173.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -57.95 150.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.175 0.512 . . . . 0.0 110.873 174.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -105.79 -5.14 20.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.621 0.724 . . . . 0.0 109.719 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -126.79 115.33 19.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.699 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.588 ' HE2' ' HE1' ' A' ' 136' ' ' TRP . 1.6 ptmm? -144.41 114.09 7.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.314 . . . . 0.0 111.071 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -136.3 112.31 9.65 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.93 ' HB2' ' HG3' ' A' ' 139' ' ' GLU . 4.4 m95 -112.43 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 164' ' ' PHE . 2.8 tp10 -68.88 -27.85 66.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.07 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 13.9 p -97.63 25.38 5.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.9 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.93 ' HG3' ' HB2' ' A' ' 136' ' ' TRP . 15.2 mt-10 -65.49 102.79 0.74 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.048 0.451 . . . . 0.0 110.836 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 14.9 tt -107.04 124.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.665 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.8 p -106.79 4.19 27.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.873 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.99 148.82 48.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -77.9 120.86 82.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-O 121.015 0.436 . . . . 0.0 110.211 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.542 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 22.6 Cg_endo -64.84 -72.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.26 1.973 . . . . 0.0 111.418 177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 148' ' ' LYS . 6.4 p-10 -103.34 -11.27 18.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.658 . . . . 0.0 109.227 172.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.44 -18.05 1.68 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.962 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.6 53.04 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.567 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.542 ' H ' ' HG2' ' A' ' 144' ' ' PRO . 0.1 OUTLIER -87.45 97.07 10.62 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 174.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.5 p -140.07 170.09 16.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.117 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -114.02 148.52 36.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 5.0 m-20 -93.16 175.64 6.7 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 79.3 m 75.73 119.18 0.05 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.634 0.73 . . . . 0.0 112.029 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.504 ' HB1' ' HZ3' ' A' ' 136' ' ' TRP . . . -82.04 131.36 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.961 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.516 HG21 ' HB2' ' A' ' 166' ' ' LYS . 48.1 t -131.55 147.58 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.482 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 tt -100.98 125.22 47.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 31.7 t -114.27 98.5 6.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.156 0.503 . . . . 0.0 110.195 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -75.81 -22.24 75.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.294 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.36 -30.48 68.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.009 0.433 . . . . 0.0 110.106 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.93 -58.68 3.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.678 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -176.94 -37.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.908 0.385 . . . . 0.0 110.384 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 132.74 -1.38 4.71 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.025 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.01 167.67 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.407 ' CZ3' ' HA ' ' A' ' 134' ' ' LYS . 46.7 m0 -87.26 144.26 26.89 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 137' ' ' GLU . 68.8 m-85 -135.99 177.12 8.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.318 0.58 . . . . 0.0 111.418 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.53 157.39 24.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.637 172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.516 ' HB2' HG21 ' A' ' 154' ' ' VAL . 10.7 tttp -152.85 -170.39 3.62 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -80.14 122.7 27.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.35 -25.3 61.81 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.36 8.77 39.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.71 -176.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -82.6 131.83 35.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -92.95 96.83 10.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.013 0.435 . . . . 0.0 110.755 -176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 110' ' ' ILE . 3.1 pp -125.89 164.37 33.62 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.137 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 16.8 Cg_exo -67.04 -178.38 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.164 2.576 . . . . 0.0 113.011 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -160.51 168.08 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.639 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.497 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 4.4 mp -127.53 133.68 67.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 69.3 m -110.06 139.21 45.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.114 0.483 . . . . 0.0 111.397 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -93.83 111.28 22.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 173.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -117.66 134.97 54.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.131 0.491 . . . . 0.0 111.307 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -156.57 -113.05 0.4 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.787 HG12 HG12 ' A' ' 181' ' ' VAL . 6.3 tt -161.61 -68.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.595 0.197 . . . . 0.0 111.067 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.787 HG12 HG12 ' A' ' 180' ' ' ILE . 8.8 p . . . . . 0 C--O 1.245 0.868 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 32.6 m-85 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 p -81.14 -0.95 42.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.544 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.82 122.72 17.59 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.046 0.451 . . . . 0.0 110.77 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -91.79 111.05 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.377 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.923 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -151.5 -177.14 5.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.372 -177.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 65.5 p -79.09 167.3 21.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -47.0 84.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.01 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -70.37 -32.64 70.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.578 0.228 . . . . 0.0 111.344 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.38 -43.8 76.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.923 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.51 -38.35 69.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.842 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 78' ' ' ILE . 29.5 t -64.81 -65.71 0.64 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.775 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.48 -31.38 72.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.92 -44.76 84.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.18 0.514 . . . . 0.0 109.961 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.524 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 49.5 t -65.21 -45.05 86.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.367 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.476 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -60.28 -36.82 71.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.396 177.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.9 t -78.6 -19.54 52.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.629 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.4 ptp180 -91.7 -3.55 56.14 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.016 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.85 45.15 4.0 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.701 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.81 -179.33 36.41 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.104 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.5 p -135.75 157.41 46.94 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 ' HE3' ' A' ' 126' ' ' MET . 4.0 mm? -64.27 149.45 48.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -75.05 107.02 6.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.737 HG21 ' HB2' ' A' ' 125' ' ' ASP . 23.4 m -97.61 111.46 58.74 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.488 -178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HG2' HD22 ' A' ' 112' ' ' LEU . 3.4 Cg_exo -77.67 119.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.168 2.579 . . . . 0.0 112.271 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -13.64 16.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.786 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 92' ' ' GLU . 45.1 p -130.93 170.01 15.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.317 . . . . 0.0 110.679 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.98 65.63 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.189 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.6 p -66.38 -37.94 86.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.35 0.595 . . . . 0.0 110.718 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.584 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 14.8 tt0 -69.71 -40.3 76.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.155 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -61.87 -45.36 94.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.64 -36.74 79.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.25 -42.76 99.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.979 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.7 tp -66.73 -40.59 88.42 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 88.0 t80 -57.85 -45.87 85.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.607 176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 15.7 mm-40 -68.62 -38.95 80.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.235 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' HA ' HE21 ' A' ' 102' ' ' GLN . 53.7 t80 -66.19 -48.11 71.73 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.723 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.875 HD22 HD11 ' A' ' 110' ' ' ILE . 0.9 OUTLIER -65.18 -34.3 78.04 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 47.5 ttt180 -54.62 -48.78 71.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.092 175.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 98' ' ' GLU . 27.1 pt20 -93.29 11.11 29.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.278 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -134.47 -61.41 0.77 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.642 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.526 HG21 HD11 ' A' ' 175' ' ' ILE . 2.9 t -87.79 -32.53 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.926 0.87 . . . . 0.0 109.61 -172.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 122.26 122.95 2.86 Favored Glycine 0 N--CA 1.433 -1.505 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -172.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -45.07 -37.58 4.31 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 122.745 0.418 . . . . 0.0 112.088 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.28 21.63 2.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.96 161.41 17.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.015 0.436 . . . . 0.0 111.585 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 39.6 mt-10 -121.81 122.37 39.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.711 176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.875 HD11 HD22 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -134.36 150.93 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.027 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -72.19 155.22 40.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.792 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 153' ' ' ALA . 55.5 mt -106.61 6.82 30.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.7 79.48 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.546 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -94.58 126.61 39.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.771 0.319 . . . . 0.0 111.109 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -102.14 149.4 24.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -78.65 124.81 28.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.216 0.531 . . . . 0.0 111.227 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.3 tmm? -126.27 -55.29 1.46 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.043 173.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.25 -22.38 9.45 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.759 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 68.63 -64.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.008 0.817 . . . . 0.0 111.482 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 120' ' ' GLU . 10.1 pt-20 -74.55 95.23 2.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.527 0.679 . . . . 0.0 111.077 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.28 -70.32 0.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.841 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t -108.78 113.69 26.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.761 0.791 . . . . 0.0 112.063 -174.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.603 ' HH2' ' HA ' ' A' ' 152' ' ' CYS . 28.2 m95 -95.83 156.48 16.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.837 170.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -118.34 130.32 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.737 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -72.45 156.78 38.69 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.947 -179.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.761 ' HE3' HD23 ' A' ' 84' ' ' LEU . 9.3 ptp -58.96 -30.25 67.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -173.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 t -106.38 6.75 30.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.239 0.542 . . . . 0.0 111.124 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.5 28.52 9.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.753 171.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.86 137.99 31.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 117.012 0.406 . . . . 0.0 110.558 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -91.63 116.14 28.63 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 38.4 pt -77.78 132.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.938 0.399 . . . . 0.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.05 3.47 24.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.259 0.552 . . . . 0.0 110.459 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -133.67 116.8 16.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.33 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.01 100.87 3.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.674 0.749 . . . . 0.0 110.629 172.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -111.14 113.03 25.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.026 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.493 ' HH2' ' HB2' ' A' ' 153' ' ' ALA . 23.8 m95 -112.99 113.45 25.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.366 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.402 ' HG2' ' CB ' ' A' ' 162' ' ' LYS . 4.9 mm-40 -76.52 -23.83 53.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.62 0.724 . . . . 0.0 109.334 174.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.683 ' HB ' ' HD2' ' A' ' 164' ' ' PHE . 11.7 t -87.71 39.56 0.89 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.775 -177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -55.68 107.4 0.33 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 140' ' ' ILE . 40.3 pt -67.78 116.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.617 0.722 . . . . 0.0 110.887 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.0 p -124.12 5.79 8.55 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.497 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.46 126.65 40.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.768 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -116.19 103.36 53.21 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.202 0.525 . . . . 0.0 109.969 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.72 -62.95 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.024 2.483 . . . . 0.0 112.524 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.88 -40.17 69.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.25 -17.49 1.34 Allowed Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 150.74 -26.17 1.05 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.138 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 24.4 pttt -78.01 98.99 5.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.633 0.73 . . . . 0.0 110.332 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.8 p -136.37 147.88 47.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.789 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 167' ' ' ARG . 47.4 mt-10 -79.55 100.71 7.89 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 165' ' ' ASP . 8.5 p30 -134.09 121.24 21.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.604 0.716 . . . . 0.0 110.52 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.603 ' HA ' ' HH2' ' A' ' 123' ' ' TRP . 0.8 OUTLIER -149.07 165.92 30.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.481 174.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.52 108.81 8.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -168.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.521 HG11 ' HB2' ' A' ' 166' ' ' LYS . 12.3 p -122.07 140.39 46.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.509 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.643 ' HB2' HD21 ' A' ' 112' ' ' LEU . 31.4 tp -90.03 115.38 27.26 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.0 m -110.74 100.19 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.057 0.456 . . . . 0.0 110.416 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.98 -19.41 78.76 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.596 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.62 -19.55 65.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.082 0.468 . . . . 0.0 111.412 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.62 -56.48 2.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.44 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -171.58 -32.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 120.13 6.53 9.9 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.12 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 137' ' ' GLU . 2.2 mptm? -86.96 -178.75 6.36 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.621 -0.341 . . . . 0.0 110.381 175.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -88.98 131.75 35.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.127 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.683 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 95.8 m-85 -125.82 171.1 10.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.552 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 152' ' ' CYS . 5.5 p-10 -113.25 141.23 47.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.521 ' HB2' HG11 ' A' ' 154' ' ' VAL . 31.5 tttp -145.82 174.87 10.85 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.669 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . 59.7 mtm180 -64.5 124.28 21.42 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 123.307 0.38 . . . . 0.0 110.25 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 150' ' ' GLU . 55.7 m -72.76 -21.49 61.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.997 0.427 . . . . 0.0 110.797 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.69 15.16 16.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.676 174.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 167' ' ' ARG . 3.8 t0 -87.77 166.01 14.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 68' ' ' LYS . 97.8 mt-30 -122.47 96.01 4.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.124 0.487 . . . . 0.0 111.331 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.437 ' HB2' ' CD ' ' A' ' 173' ' ' PRO . 3.2 pp -126.29 172.32 6.59 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.741 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 14.7 Cg_exo -69.69 -178.63 2.41 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.563 2.175 . . . . 0.0 112.716 -177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.634 ' O ' ' HB3' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -153.8 172.18 17.74 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 104' ' ' VAL . 95.9 mt -142.77 115.84 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 110.597 178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.571 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 97.4 m -102.97 155.78 18.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.109 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -89.89 134.73 34.05 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -134.34 174.87 10.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -171.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.26 94.77 0.05 OUTLIER Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.479 -0.391 . . . . 0.0 112.725 177.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 13.4 tt -99.14 -19.47 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.151 0.501 . . . . 0.0 110.837 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.328 -178.607 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.645 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 43.3 m-85 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.901 0.382 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 m -71.53 -12.35 61.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.989 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG2' ' HE1' ' A' ' 174' ' ' TYR . 14.2 pt20 -72.35 135.22 45.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.099 0.476 . . . . 0.0 110.501 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 p -89.71 138.38 31.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.639 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -168.95 166.04 11.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 169' ' ' ARG . 30.4 p -81.94 168.12 18.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 115' ' ' ASN . 31.4 t80 -56.22 -29.14 60.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.64 0.257 . . . . 0.0 110.571 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -60.6 -59.3 5.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.633 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 8.5 mp0 -65.43 -31.42 72.5 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.79 81.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.614 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.418 ' O ' HD13 ' A' ' 78' ' ' ILE . 44.5 t -72.64 -56.28 5.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.342 178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 3.0 tp10 -56.39 -38.46 71.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.608 -173.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -72.1 -52.82 14.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.091 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 25.2 t -66.42 -37.25 84.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.221 -174.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.418 HD13 ' O ' ' A' ' 74' ' ' SER . 1.5 mp -62.87 -37.28 78.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.999 0.428 . . . . 0.0 110.131 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -79.09 -27.03 42.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.738 -176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.66 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 11.9 ptp180 -83.23 6.83 18.13 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.757 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.04 43.14 27.55 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.271 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 -171.38 17.57 Favored Glycine 0 N--CA 1.439 -1.135 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 2.1 m -150.43 145.2 25.9 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.526 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 9.5 mp -58.72 135.81 57.54 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.7 p -70.37 107.52 3.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.235 0.54 . . . . 0.0 110.814 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 95.0 m -99.9 120.95 55.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.05 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.539 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 12.1 Cg_exo -70.37 111.48 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.098 1.865 . . . . 0.0 112.219 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -103.64 -18.96 14.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.918 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -136.05 177.77 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.213 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.93 -35.51 91.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.275 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -56.45 -43.7 79.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.539 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 3.2 mp0 -60.43 -58.61 7.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.7 0.286 . . . . 0.0 111.187 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -66.19 -41.33 90.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.116 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.62 -40.07 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.551 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.42 -31.45 26.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.38 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 2.5 tt -60.64 -46.11 91.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 88.5 t80 -59.83 -41.84 92.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 0.0 110.689 178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.487 ' OE1' ' HD3' ' A' ' 101' ' ' ARG . 8.3 tp10 -68.7 -37.73 79.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.103 0.478 . . . . 0.0 110.348 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 78.2 t80 -62.85 -35.62 80.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.513 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 66.5 mt -56.4 -48.98 75.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 175.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.487 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 42.9 mtp180 -64.95 -17.3 64.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.951 -173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 11.0 pt20 -116.18 9.94 14.79 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.0 m -153.58 -46.45 0.09 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.951 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.729 HG11 HD11 ' A' ' 110' ' ' ILE . 30.1 t -104.77 -37.44 4.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.532 0.682 . . . . 0.0 110.473 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.38 128.56 3.01 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.509 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -55.92 -41.9 75.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.85 33.47 1.04 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.321 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.18 154.78 18.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.207 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 156' ' ' SER . 40.2 mt-10 -122.39 122.39 38.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.984 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 HG11 ' A' ' 104' ' ' VAL . 2.2 mp -121.2 147.51 25.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.069 -174.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CH2' ' HA ' ' A' ' 168' ' ' CYS . 73.5 m95 -71.65 138.89 48.98 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.557 HD21 ' N ' ' A' ' 155' ' ' LEU . 2.1 mm? -100.93 12.55 37.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.761 0.315 . . . . 0.0 110.919 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.44 81.93 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.988 -176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 131' ' ' ILE . 8.4 mp -94.58 125.87 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 70' ' ' PHE . 31.9 p-10 -124.29 161.0 26.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.539 ' HB2' ' N ' ' A' ' 152' ' ' CYS . 15.2 t70 -80.1 68.63 6.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.669 0.747 . . . . 0.0 110.525 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -103.84 -44.8 4.95 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.34 104.84 12.19 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.062 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.69 -4.58 52.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.404 0.621 . . . . 0.0 110.272 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.5 163.21 25.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.883 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -26.86 62.93 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.095 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p -86.59 72.88 10.17 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.624 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.432 ' HB2' ' CD1' ' A' ' 131' ' ' ILE . 36.4 m95 -62.74 149.21 44.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.836 176.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.4 133.95 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.362 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.403 ' CB ' HG21 ' A' ' 86' ' ' THR . 4.1 p-10 -98.06 -165.47 1.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 0.0 111.123 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' A' ' 84' ' ' LEU . 20.1 mmt -65.37 -37.57 87.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.608 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 78.2 p -82.47 -20.62 36.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.79 0.329 . . . . 0.0 111.317 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.36 28.37 13.2 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.01 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.02 165.4 12.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.05 0.452 . . . . 0.0 110.54 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.409 ' HB2' ' HE ' ' A' ' 130' ' ' ARG . 15.5 ttm180 -99.33 106.96 19.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.526 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 114' ' ' LEU . 44.8 pt -62.41 124.87 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.257 0.551 . . . . 0.0 110.907 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.98 -10.97 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.447 0.641 . . . . 0.0 109.872 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -104.11 116.03 31.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.204 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -135.08 99.4 4.26 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.915 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.433 ' HA ' HD22 ' A' ' 135' ' ' ASN . 5.3 m120 -121.14 111.51 17.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.059 0.457 . . . . 0.0 110.309 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.898 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 36.3 m95 -122.03 124.71 44.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.883 ' HG2' HD21 ' A' ' 160' ' ' ASN . 5.1 tp10 -75.12 -29.03 60.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.644 0.735 . . . . 0.0 109.352 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.8 t -100.92 27.62 5.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.965 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.898 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 32.1 tt0 -67.64 102.11 1.13 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.673 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.523 HG12 ' H ' ' A' ' 142' ' ' ALA . 16.8 tt -110.21 122.6 65.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.278 0.561 . . . . 0.0 109.721 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.7 p -95.11 8.64 42.36 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.243 0.544 . . . . 0.0 111.012 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' H ' HG12 ' A' ' 140' ' ' ILE . . . -127.7 172.45 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.737 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -82.79 121.7 77.83 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.472 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.68 -46.88 6.1 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.083 1.855 . . . . 0.0 111.715 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -165.83 38.64 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.017 0.913 . . . . 0.0 109.049 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 115.65 -45.75 1.26 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.314 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.25 53.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.093 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.41 99.87 10.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.757 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 46.8 p -138.03 164.65 28.54 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.026 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -91.3 144.16 25.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.084 0.469 . . . . 0.0 109.987 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' CYS . 12.2 m120 -88.17 128.58 35.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.282 -175.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.539 ' N ' ' HB2' ' A' ' 116' ' ' ASP . 73.0 m 96.56 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.966 1.416 . . . . 0.0 111.1 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -110.83 150.35 29.27 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.586 HG21 ' HG3' ' A' ' 166' ' ' LYS . 28.1 m -143.01 155.91 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.527 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.557 ' N ' HD21 ' A' ' 112' ' ' LEU . 50.8 tp -99.01 103.99 15.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 20.0 t -96.9 103.64 15.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.144 0.497 . . . . 0.0 110.405 -175.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 106' ' ' ASN . . . -74.24 -26.77 67.49 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.72 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.31 -19.09 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.301 0.572 . . . . 0.0 110.613 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.15 -61.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.189 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.883 HD21 ' HG2' ' A' ' 137' ' ' GLU . 15.3 p30 -174.67 -30.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.305 -178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 118.12 32.73 1.34 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.711 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 34.3 mmtp -119.66 177.73 4.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.437 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 49.5 m0 -78.42 124.92 28.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.184 0.516 . . . . 0.0 111.069 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 137' ' ' GLU . 77.2 m-85 -127.17 178.91 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.493 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -115.92 138.57 51.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.87 0.367 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.586 ' HG3' HG21 ' A' ' 154' ' ' VAL . 17.1 mtmt -150.02 161.15 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.649 175.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.514 ' O ' ' HH2' ' A' ' 111' ' ' TRP . 1.9 mtm105 -60.35 132.48 54.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.595 ' HA ' ' CH2' ' A' ' 111' ' ' TRP . 0.1 OUTLIER -63.47 -17.41 62.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.386 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.416 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 5.7 ptp85 -103.82 29.37 5.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.984 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -92.3 147.31 23.02 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -91.69 85.14 5.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.09 0.472 . . . . 0.0 110.408 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -128.63 164.44 38.21 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.227 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.463 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.1 Cg_exo -65.79 -177.1 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.48 2.787 . . . . 0.0 113.205 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.667 ' HA ' HG23 ' A' ' 110' ' ' ILE . 1.4 p90 -155.16 167.55 29.99 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 90.4 mt -141.23 131.0 25.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.934 0.397 . . . . 0.0 110.234 176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.446 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 74.5 m -104.54 157.93 16.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.963 177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 83' ' ' THR . 16.9 pt20 -88.56 111.32 21.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.505 0.669 . . . . 0.0 109.64 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.7 113.14 16.94 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.193 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.13 156.5 8.45 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.988 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 64.3 mt -97.58 -43.71 12.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.25 0.548 . . . . 0.0 109.905 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.079 179.194 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 121.066 0.46 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.6 t -71.47 13.39 0.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -71.9 138.65 48.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.332 0.587 . . . . 0.0 110.515 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.0 p -93.2 137.22 32.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.578 -175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.713 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -171.26 -178.5 2.4 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.571 178.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 15.2 p -77.37 166.09 23.59 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 123.322 0.389 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -63.45 -36.58 84.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.1 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -63.28 -48.19 79.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.657 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 6.1 mm-40 -67.44 -40.54 85.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.275 178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -54.52 -47.48 73.07 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.061 0.458 . . . . 0.0 110.306 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.484 ' O ' HD13 ' A' ' 78' ' ' ILE . 17.5 m -65.03 -56.66 11.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.54 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -62.68 -41.42 99.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.901 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 35.0 t70 -71.91 -48.51 45.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.336 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.812 ' HB2' ' HE2' ' A' ' 174' ' ' TYR . 46.8 t -64.68 -39.36 93.54 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.014 0.435 . . . . 0.0 110.386 -178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -64.4 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.156 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -63.52 -31.9 73.2 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.959 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.585 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 66.9 mtt180 -66.85 -17.47 64.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.707 178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 19.04 13.91 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.699 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -130.93 -169.42 12.45 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.195 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 p -139.99 161.86 36.59 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 126' ' ' MET . 9.7 mp -75.52 153.61 37.36 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.556 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.8 t -82.26 107.24 14.79 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 82.7 p -97.47 120.08 61.49 Favored Pre-proline 0 N--CA 1.443 -0.782 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 6.9 Cg_endo -84.78 113.46 1.6 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.458 2.105 . . . . 0.0 112.107 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -109.44 -7.25 15.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.183 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.06 169.46 18.63 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.048 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.35 -36.64 92.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.668 -177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -58.32 -43.25 88.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.25 -48.85 79.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.693 0.282 . . . . 0.0 111.281 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -64.38 -36.04 82.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.294 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.99 -48.44 76.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.645 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -33.6 76.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.158 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' CD1' ' HG3' ' A' ' 87' ' ' PRO . 52.6 mt -60.57 -62.66 1.7 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.222 173.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.739 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 48.9 t80 -53.39 -34.97 59.75 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.681 0.613 . . . . 0.0 112.005 -174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -77.44 -54.94 5.82 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 85.4 t80 -57.54 -34.43 69.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.831 0.824 . . . . 0.0 109.195 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.522 HD12 ' HB ' ' A' ' 104' ' ' VAL . 29.4 tp -53.83 -53.78 47.57 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 111.516 174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.739 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 42.9 mtm105 -67.51 -19.06 65.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.969 -176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 3.8 pt20 -111.82 4.14 18.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.1 t -139.08 -44.24 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.968 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.834 HG11 HD11 ' A' ' 110' ' ' ILE . 41.3 t -102.13 -49.62 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 0.0 109.679 -176.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 151.4 129.48 1.56 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.988 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.561 ' HA ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 t30 -46.01 -49.11 16.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.088 0.471 . . . . 0.0 111.006 174.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 0.9 OUTLIER -95.28 22.85 6.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.662 -174.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.39 161.31 17.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.002 0.429 . . . . 0.0 110.99 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 41.3 mt-10 -124.47 125.45 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.663 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.834 HD11 HG11 ' A' ' 104' ' ' VAL . 1.8 mp -123.25 144.13 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.12 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.421 ' CZ3' HG22 ' A' ' 154' ' ' VAL . 82.7 m95 -71.21 137.77 48.95 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.622 ' HB3' HD23 ' A' ' 114' ' ' LEU . 94.5 mt -83.11 -14.46 53.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 126' ' ' MET . . . 76.51 15.76 81.27 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.371 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 112' ' ' LEU . 3.8 mm? -94.91 144.02 26.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.833 0.349 . . . . 0.0 111.349 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -135.96 111.23 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.664 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 123' ' ' TRP . 8.1 p-10 -72.91 104.37 4.03 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.746 0.784 . . . . 0.0 111.449 -177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -86.05 -30.68 22.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.956 174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.014 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -98.64 101.08 12.39 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.63 -36.38 15.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.955 -1.02 . . . . 0.0 113.544 -168.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 2.6 pm0 -82.69 84.31 7.35 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.941 0.877 . . . . 0.0 111.78 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 60.95 16.21 46.37 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 114.973 -1.012 . . . . 0.0 114.552 168.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 1.014 ' HB ' ' HB3' ' A' ' 118' ' ' ALA . 11.3 m -116.34 80.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 117.777 0.789 . . . . 0.0 111.386 -176.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 116' ' ' ASP . 55.8 m95 -68.37 144.25 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.515 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.6 t -110.04 139.94 31.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -72.43 153.62 41.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.598 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 49.7 mtt -55.95 -25.06 41.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.207 172.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.2 t -88.51 4.1 47.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.236 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.68 37.92 9.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.341 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.39 20.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.768 0.284 . . . . 0.0 110.561 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -105.77 127.44 53.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.811 0.338 . . . . 0.0 110.418 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.9 pt -69.95 151.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.409 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -115.09 3.11 14.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -141.13 124.29 16.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.805 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.415 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 20.4 pttp -136.99 130.51 31.58 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -133.72 111.48 10.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.621 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 18.5 m95 -121.04 128.04 52.27 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.37 -175.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -72.87 -21.2 60.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 170.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 t -105.36 26.16 9.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.446 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 8.2 tp10 -64.38 102.56 0.55 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.8 pt -94.29 148.81 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 0.0 111.275 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 p -119.37 13.22 12.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.653 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.79 144.76 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.078 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 94.5 mt-30 -103.09 129.26 25.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.509 -178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 14.5 Cg_exo -69.03 -62.37 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.769 2.312 . . . . 0.0 112.543 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -97.52 -37.52 9.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.13 -177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 147.28 -19.48 1.54 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.983 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.47 32.45 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 119.754 -1.212 . . . . 0.0 113.999 175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -89.21 120.8 30.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 p -122.62 125.27 45.31 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 150' ' ' GLU . 5.6 pt-20 -103.16 126.19 50.21 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 166.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -128.71 123.63 33.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -165.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.97 97.43 0.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.789 171.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -75.71 133.44 40.78 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.402 -170.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG22 ' CZ3' ' A' ' 111' ' ' TRP . 17.3 t -126.17 141.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.473 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.584 ' HB2' HD21 ' A' ' 112' ' ' LEU . 63.8 tp -98.96 112.53 24.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 173.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 p -106.33 109.54 21.5 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.918 0.389 . . . . 0.0 111.171 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -73.83 -22.26 78.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.039 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -64.63 -25.1 67.81 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.0 -60.06 2.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.357 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 17.0 p30 176.91 -24.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.316 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 123.15 25.81 1.78 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.733 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -111.8 167.6 10.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.704 0.288 . . . . 0.0 110.545 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -82.48 135.73 35.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.046 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -126.96 -169.03 1.96 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.071 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -143.02 139.06 30.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.782 0.325 . . . . 0.0 110.687 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -139.31 164.98 28.39 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' A' ' 167' ' ' ARG . 2.4 tpt180 -71.09 141.22 50.84 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.577 ' O ' ' HB ' ' A' ' 69' ' ' THR . 51.1 m -63.33 -5.9 4.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 69' ' ' THR . 13.7 ttp85 -112.94 20.19 16.62 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.9 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -90.94 145.14 24.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 1.7 mp0 -93.16 94.47 8.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.226 0.536 . . . . 0.0 111.689 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.4 pp -129.39 157.84 75.02 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.064 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 22.4 Cg_exo -64.28 179.13 1.28 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.006 2.47 . . . . 0.0 113.464 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.812 ' HE2' ' HB2' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -155.24 166.22 34.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.454 177.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 110' ' ' ILE . 90.5 mt -124.09 130.43 73.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 55.5 m -102.45 132.18 48.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.387 0.613 . . . . 0.0 111.436 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -90.63 110.63 21.79 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 171.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -135.22 121.93 20.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.951 0.405 . . . . 0.0 111.581 -167.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.07 60.01 2.49 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.898 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.3 tt -75.5 78.39 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 122.409 1.099 . . . . 0.0 109.961 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 C--O 1.247 0.924 0 CA-C-N 114.645 -1.162 . . . . 0.0 109.062 -178.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.785 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 58.5 m-85 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 p -84.51 5.2 28.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.896 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' OE1' ' HD3' ' A' ' 68' ' ' LYS . 17.5 tm0? -77.97 123.86 27.32 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -97.66 115.27 27.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.606 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -144.43 179.24 7.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.887 179.061 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.1 p -84.55 167.02 16.71 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -61.05 -20.27 62.35 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -72.5 -50.45 25.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.27 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 3.3 mp0 -70.42 -35.34 73.36 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.096 177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.764 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -67.81 -18.58 64.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.747 -176.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.578 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 10.3 p -91.97 -51.54 5.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.713 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -70.78 -29.6 65.85 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.869 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -65.66 -40.25 92.21 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.936 -175.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.715 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 33.6 m -72.28 -42.94 64.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.634 0.254 . . . . 0.0 111.211 178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.72 -41.53 88.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.2 t -80.32 -15.8 56.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.011 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.715 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 9.9 ptp180 -91.7 4.78 51.95 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.39 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.67 38.77 31.19 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.432 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.74 -170.15 18.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.323 -0.941 . . . . 0.0 112.32 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 42.4 p -131.07 153.51 49.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 85' ' ' SER . 4.8 tt -73.4 146.41 45.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.622 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.3 m -62.6 109.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.972 0.415 . . . . 0.0 111.267 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 28.5 p -107.32 119.83 49.62 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.573 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 86' ' ' THR . 31.3 Cg_endo -92.36 123.05 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.186 2.591 . . . . 0.0 112.257 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.659 ' HG2' ' OE1' ' A' ' 92' ' ' GLU . 3.6 pt20 -127.82 0.91 6.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 92' ' ' GLU . 68.6 p -129.58 173.65 10.4 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.38 -36.87 89.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.655 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 31.5 t -64.46 -52.63 57.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.69 0.281 . . . . 0.0 110.705 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' OE1' ' HG2' ' A' ' 88' ' ' GLN . 9.3 pt-20 -75.02 -24.63 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.531 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' ' CB ' ' A' ' 87' ' ' PRO . 28.2 t-20 -66.59 -48.84 68.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.15 0.5 . . . . 0.0 110.284 176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.35 -22.78 32.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.167 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.72 84.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.608 0.242 . . . . 0.0 110.966 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.6 mt -65.09 -40.87 95.22 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 36.0 t80 -59.23 -43.69 92.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.454 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -68.36 -47.25 67.92 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.473 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -62.08 -38.69 89.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.51 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 110' ' ' ILE . 2.9 pp -68.01 -29.56 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.363 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 74.6 mtp180 -66.27 -26.31 67.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -98.83 5.84 47.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.877 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.6 t -153.67 -47.35 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' HA ' ' A' ' 100' ' ' LEU . 4.5 t -88.25 -34.22 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.654 0.74 . . . . 0.0 109.349 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 115.28 124.2 3.78 Favored Glycine 0 N--CA 1.434 -1.433 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -50.95 -37.14 42.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.05 0.452 . . . . 0.0 111.26 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 158' ' ' ALA . 39.5 mt-10 -85.36 24.12 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.656 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.65 146.13 29.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 110.762 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 2.6 mm-40 -101.82 132.35 47.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.394 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.82 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -124.55 138.77 52.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.448 ' O ' HG22 ' A' ' 110' ' ' ILE . 83.1 m95 -71.01 148.04 48.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 112' ' ' LEU . 3.6 mm? -96.1 5.2 51.64 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.98 16.97 69.16 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.317 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.428 ' HB3' ' CE3' ' A' ' 123' ' ' TRP . 7.5 mp -94.98 126.1 40.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.648 0.261 . . . . 0.0 110.453 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.497 ' O ' HG22 ' A' ' 124' ' ' VAL . 2.6 m-20 -124.32 132.61 53.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.089 -177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.5 133.06 55.86 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.556 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -126.77 -75.53 0.58 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.047 0.451 . . . . 0.0 110.141 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 1.42 13.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.516 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.99 52.59 2.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -59.28 112.01 1.57 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.121 -166.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.99 -13.62 29.04 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.747 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.4 p -135.3 100.44 4.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.757 0.313 . . . . 0.0 110.74 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 114' ' ' LEU . 23.5 m95 -62.05 146.59 49.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.501 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 115' ' ' ASN . 29.8 m -116.76 162.59 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.226 175.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -71.51 166.29 22.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.578 ' HE1' ' HB3' ' A' ' 74' ' ' SER . 21.0 mmt -54.5 -19.63 6.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.893 172.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -96.8 -6.98 34.84 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.676 0.274 . . . . 0.0 111.434 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.45 34.69 7.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.954 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -110.61 166.82 10.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -100.76 143.66 30.65 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.656 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.627 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -104.02 148.17 9.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 173.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -102.19 11.57 38.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.863 0.363 . . . . 0.0 111.059 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 48.3 t80 -107.63 111.06 23.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.619 -176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 98.41 6.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.989 172.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -144.08 111.71 6.07 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -128.01 127.31 42.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.814 ' HG3' HD21 ' A' ' 160' ' ' ASN . 3.3 tm-20 -66.31 -52.94 42.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.541 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 9.0 t -91.67 40.31 1.03 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.549 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -51.31 107.57 0.19 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.467 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.4 pt -90.41 153.68 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.973 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.2 p -104.26 68.71 0.89 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.74 98.27 0.38 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.3 -176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 145' ' ' ASP . 13.3 mm100 -93.27 127.39 46.98 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.03 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 148' ' ' LYS . 56.2 Cg_endo -71.44 37.31 0.32 Allowed 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.971 2.447 . . . . 0.0 111.022 174.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 143' ' ' GLN . 30.0 t70 -142.4 -6.26 0.93 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.201 -169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.75 52.94 0.02 OUTLIER Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.081 -1.056 . . . . 0.0 111.86 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.74 18.08 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.763 -1.208 . . . . 0.0 114.493 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 144' ' ' PRO . 28.5 pttt -103.79 134.07 47.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.517 0.659 . . . . 0.0 109.413 167.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 p -135.67 170.85 15.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.12 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -88.92 92.21 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.276 0.56 . . . . 0.0 110.358 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 165' ' ' ASP . 2.8 p-10 -140.27 147.63 40.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.107 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 1.2 p -117.17 167.84 10.83 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.783 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.82 139.69 30.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -170.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.59 164.61 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.433 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.0 tt -109.8 103.7 12.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 25.8 p -89.85 108.2 19.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.89 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -68.03 -51.42 34.09 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.002 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . . . -59.67 -20.12 54.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.98 -52.17 11.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.814 HD21 ' HG3' ' A' ' 137' ' ' GLU . 12.3 p30 179.94 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.016 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 110.42 22.67 6.33 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.137 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 56.1 mmtt -113.76 179.27 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.044 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -77.22 122.57 25.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.545 0.688 . . . . 0.0 111.627 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.541 ' HA ' ' CG2' ' A' ' 138' ' ' THR . 10.7 m-85 -117.2 178.23 4.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.069 175.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.484 ' HB2' HD22 ' A' ' 151' ' ' ASN . 9.3 p-10 -130.26 144.59 51.46 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.105 0.478 . . . . 0.0 111.295 -178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.6 ' HD2' ' CD2' ' A' ' 172' ' ' LEU . 17.5 ptpt -153.24 -171.0 3.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.075 173.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 167' ' ' ARG . 40.7 ttm180 -83.34 138.28 33.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.797 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 80.2 m -70.82 -2.79 16.0 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 32.4 ttt-85 -96.71 -5.42 38.76 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.457 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.06 133.0 48.26 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -92.47 97.25 10.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.649 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.6 ' CD2' ' HD2' ' A' ' 166' ' ' LYS . 3.2 pp -128.15 160.62 60.87 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.062 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.59 ' O ' HD12 ' A' ' 172' ' ' LEU . 40.7 Cg_exo -57.69 179.59 0.14 Allowed 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.461 2.774 . . . . 0.0 113.509 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.82 ' HA ' HG23 ' A' ' 110' ' ' ILE . 2.2 p90 -163.36 165.26 24.23 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.033 -0.417 . . . . 0.0 110.485 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.785 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.1 mt -128.46 116.56 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 174' ' ' TYR . 5.9 t -104.24 147.36 27.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.829 0.347 . . . . 0.0 110.658 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.41 117.17 29.87 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.487 ' HE2' ' HD3' ' A' ' 80' ' ' ARG . 1.3 t80 -112.52 116.93 31.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.534 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 132.38 -154.56 21.11 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.8 tp -138.04 136.44 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.836 0.351 . . . . 0.0 110.254 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.197 179.278 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' HD1' ' CE2' ' A' ' 174' ' ' TYR . 54.6 m-85 . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 121.038 0.446 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.547 HG22 HG13 ' A' ' 104' ' ' VAL . 9.1 p -72.46 -3.54 24.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.787 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 52.3 mt-30 -57.18 129.29 41.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.332 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 p -94.21 125.67 38.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.597 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.829 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -164.22 174.27 11.39 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.225 177.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 69.8 p -77.75 166.08 23.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 -176.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.79 -44.19 81.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.493 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -64.19 -45.45 88.32 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.35 -45.77 91.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.084 177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -55.23 -42.24 73.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.998 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.421 ' O ' HD13 ' A' ' 78' ' ' ILE . 36.0 m -60.22 -58.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.973 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.84 -16.79 62.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.777 0.323 . . . . 0.0 111.28 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 36.7 t70 -75.16 -50.01 17.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.033 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.544 ' HB2' HD12 ' A' ' 84' ' ' LEU . 65.7 m -67.24 -32.94 74.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.143 175.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.3 mp -60.2 -41.63 87.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.3 p -79.26 -11.03 59.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.974 0.416 . . . . 0.0 110.924 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 14.8 mmp_? -78.62 -14.29 59.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 173.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.77 37.77 3.36 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.299 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -177.71 -160.09 23.72 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.215 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.4 p -120.73 171.12 8.82 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 77' ' ' CYS . 9.5 mp -66.82 162.28 21.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 171.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 p -73.65 107.58 5.99 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 112' ' ' LEU . 35.8 p -110.46 105.81 57.43 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.145 0.498 . . . . 0.0 110.749 -178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.72 ' HG3' HD12 ' A' ' 96' ' ' LEU . 97.6 Cg_endo -88.03 139.24 4.44 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.466 2.111 . . . . 0.0 112.251 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' TYR . 2.9 pt20 -135.25 9.03 3.45 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.748 -178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 p -141.53 168.64 19.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.906 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.57 -43.68 98.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.8 m -59.95 -35.41 74.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 111.104 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -76.16 -37.01 58.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.91 0.386 . . . . 0.0 111.074 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -68.93 -41.64 77.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.088 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.65 -36.1 81.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.173 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.03 79.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.72 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.2 mt -78.57 -4.99 51.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.626 0.25 . . . . 0.0 111.118 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -98.23 -37.66 9.6 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -78.57 -52.52 8.35 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.759 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' HA ' ' HG2' ' A' ' 102' ' ' GLN . 71.6 t80 -62.73 -35.27 79.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.519 0.676 . . . . 0.0 109.242 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD12 ' HB ' ' A' ' 104' ' ' VAL . 8.0 tp -57.94 -48.09 80.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.284 172.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.543 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -63.02 -19.78 64.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.702 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 99' ' ' TYR . 17.1 pt20 -110.3 8.06 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.827 -0.546 . . . . 0.0 111.723 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 -65.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.608 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 65' ' ' THR . 2.5 t -83.56 -28.69 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 101' ' ' ARG . . . 151.12 -77.84 0.22 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.147 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.411 ' CB ' ' HG2' ' A' ' 101' ' ' ARG . 5.1 p-10 173.29 -40.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 158' ' ' ALA . 6.7 pt-20 -113.39 45.76 1.36 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.785 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 100' ' ' LEU . . . -115.03 146.93 40.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.607 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 4.6 mp0 -94.54 130.96 40.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.369 174.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.54 HG12 HG13 ' A' ' 175' ' ' ILE . 3.8 mp -125.63 145.43 33.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.588 177.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -70.89 132.55 45.42 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' A' ' 155' ' ' LEU . 78.9 mt -90.38 10.57 24.51 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 55.39 30.89 56.37 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.378 0.911 . . . . 0.0 115.378 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -134.09 141.74 47.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.146 0.973 . . . . 0.0 110.26 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' HA ' ' CE3' ' A' ' 123' ' ' TRP . 25.8 p-10 -154.68 141.6 19.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 110.587 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.928 ' HB2' ' HA ' ' A' ' 123' ' ' TRP . 21.0 t0 -120.23 121.81 39.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.882 177.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptm -127.53 -18.35 4.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.642 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.43 -59.74 1.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -171.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.39 68.82 3.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.54 107.07 0.46 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.653 -165.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.22 -6.48 8.15 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.687 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 p -141.29 101.62 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.763 0.316 . . . . 0.0 111.207 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.928 ' HA ' ' HB2' ' A' ' 116' ' ' ASP . 25.4 m95 -64.16 137.3 57.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.766 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.1 p -107.9 139.09 31.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.745 ' OD2' HG22 ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.9 -179.77 4.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.9 0.381 . . . . 0.0 110.441 -178.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 54.1 mtt -69.25 -32.32 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.745 HG22 ' OD2' ' A' ' 125' ' ' ASP . 12.4 t -81.03 -5.21 57.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.263 -178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.81 37.82 5.11 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.382 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.1 162.09 27.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.075 0.437 . . . . 0.0 110.834 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -99.19 126.14 44.91 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.495 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -62.64 126.18 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.407 0.623 . . . . 0.0 111.366 -174.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.72 -19.44 35.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.591 0.71 . . . . 0.0 110.02 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 88' ' ' GLN . 41.1 t80 -120.41 115.23 23.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.305 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.0 120.14 10.78 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.997 0.427 . . . . 0.0 110.069 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -125.9 111.07 14.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.582 0.706 . . . . 0.0 110.502 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 1.033 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 3.2 m95 -111.5 118.49 35.9 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG2' HD21 ' A' ' 160' ' ' ASN . 4.1 tp10 -70.0 -41.22 74.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.576 0.703 . . . . 0.0 109.77 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.17 23.11 6.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.942 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 1.033 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -71.1 102.16 2.41 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 140' ' ' ILE . 19.4 pt -115.87 99.98 9.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.756 0.788 . . . . 0.0 109.476 173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.9 t -88.35 62.9 6.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 122.513 1.149 . . . . 0.0 110.206 -173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -112.81 94.31 4.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.868 171.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HG3' ' HA2' ' A' ' 147' ' ' GLY . 20.7 mm-40 -100.41 104.04 27.59 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.56 -172.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 5.6 Cg_exo -76.98 -20.86 12.75 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.792 2.328 . . . . 0.0 111.758 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -84.38 -34.64 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.223 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.24 -36.75 1.1 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.256 -0.974 . . . . 0.0 112.237 -176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.612 ' HA2' ' HG3' ' A' ' 143' ' ' GLN . . . 151.72 21.03 0.06 OUTLIER Glycine 0 CA--C 1.52 0.362 0 C-N-CA 119.992 -1.099 . . . . 0.0 114.08 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 142.89 51.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.369 0.584 . . . . 0.0 109.636 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.6 p -138.08 137.25 37.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.734 0.302 . . . . 0.0 111.086 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.41 92.32 9.13 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.562 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 3.5 p-10 -152.43 168.32 25.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.583 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 69.5 m -140.1 124.2 17.65 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.197 0.522 . . . . 0.0 110.465 -176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.16 135.32 39.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.576 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.55 145.63 31.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.674 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 2.3 tm? -89.39 108.89 19.9 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 26.1 t -98.96 100.78 11.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.36 -23.9 74.49 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.771 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 107' ' ' GLU . . . -69.67 -30.46 68.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.227 0.537 . . . . 0.0 110.71 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.87 0.99 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.746 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.459 HD21 ' HG2' ' A' ' 137' ' ' GLU . 14.6 p30 -171.35 -27.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.055 -174.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.23 -2.25 11.5 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.839 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 1.1 mptm? -82.56 174.18 11.28 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -83.78 126.84 33.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.307 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.54 -171.84 2.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.97 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.562 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 12.8 t70 -141.72 146.16 35.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.081 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -147.53 176.8 9.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HB2' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -72.25 144.09 48.54 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 -173.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -68.61 -14.62 63.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.008 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -93.59 -3.21 53.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 167' ' ' ARG . 17.6 m-20 -73.55 136.06 44.0 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -110.31 106.16 15.45 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.819 0.819 . . . . 0.0 111.446 -176.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.578 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 1.5 pp -129.24 171.14 9.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.346 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 172' ' ' LEU . 14.3 Cg_endo -57.12 174.67 0.42 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 122.552 2.168 . . . . 0.0 113.226 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.787 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 49.1 p90 -140.91 179.59 6.63 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.041 -0.412 . . . . 0.0 110.739 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.54 HG13 HG12 ' A' ' 110' ' ' ILE . 71.6 mt -145.51 132.42 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 168.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.461 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 84.9 m -99.49 155.81 17.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 177' ' ' GLN . 6.0 tp60 -87.93 108.51 19.22 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.512 0.672 . . . . 0.0 110.311 -175.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -135.06 134.26 40.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.775 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 180' ' ' ILE . . . 123.95 126.67 3.12 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -172.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 179' ' ' GLY . 81.7 mt 73.27 -48.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 168.383 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.733 ' HB3' ' O ' ' A' ' 174' ' ' TYR . 59.3 m-85 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -69.69 -8.11 44.94 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.003 -177.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.87 ' HB2' ' HE1' ' A' ' 174' ' ' TYR . 27.6 mt-30 -53.61 122.03 9.0 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 0.0 111.733 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 171' ' ' GLN . 17.6 p -97.02 113.53 25.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.511 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.885 ' HE3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -154.82 -176.55 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.122 -178.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 169' ' ' ARG . 81.5 p -78.14 165.88 23.43 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.321 0.388 . . . . 0.0 110.129 -177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -63.31 -38.79 92.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.675 0.274 . . . . 0.0 110.946 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -63.33 -45.91 89.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . . . -58.88 -37.08 75.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.899 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.614 ' O ' HG12 ' A' ' 78' ' ' ILE . 29.1 t -63.1 -60.06 3.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.41 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . 11.2 pt-20 -70.69 -15.21 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.496 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.703 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 11.7 t70 -65.06 -59.01 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.3 m -59.28 -36.8 76.21 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 74' ' ' SER . 28.3 mm -54.17 -44.5 64.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.935 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 p -84.39 -14.09 50.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.397 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 20.4 mmt180 -74.46 -23.69 58.93 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 172.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.98 25.59 11.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.332 -174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.78 -170.26 13.83 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.423 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.1 p -116.14 165.81 12.73 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.535 HD23 ' HA2' ' A' ' 113' ' ' GLY . 19.4 tp -81.8 148.74 28.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.3 m -66.69 109.17 2.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.866 0.365 . . . . 0.0 111.219 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 4.7 t -117.51 118.5 35.27 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.905 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 2.0 Cg_endo -81.68 120.66 3.55 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.063 2.509 . . . . 0.0 112.311 179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -104.28 -30.48 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.098 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.0 p -128.02 -171.0 2.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.71 -34.26 82.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.913 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -55.4 -49.81 71.37 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.834 0.454 . . . . 0.0 111.936 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 4.8 mp0 -61.66 -53.22 59.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.11 -177.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -64.53 -37.75 88.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.92 -44.13 93.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.497 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.49 -32.96 58.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.405 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.576 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.7 tp -63.06 -47.66 81.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.018 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' ARG . 91.4 t80 -60.08 -40.46 89.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.333 . . . . 0.0 110.538 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.743 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -64.03 -33.33 75.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.617 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD11 HD12 ' A' ' 155' ' ' LEU . 72.6 mt -57.14 -44.72 83.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.141 0.496 . . . . 0.0 109.901 176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' TYR . 16.5 mtp180 -69.04 -9.38 52.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.62 -172.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -127.47 15.61 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.1 t -151.32 -51.85 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.359 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 110' ' ' ILE . 2.8 t -105.85 -29.05 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.649 0.737 . . . . 0.0 110.391 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.49 130.49 4.97 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.88 -30.82 64.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.191 0.52 . . . . 0.0 109.735 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.893 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 5.1 mm-40 -80.44 6.76 11.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.027 -175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.76 161.32 15.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 0.0 112.197 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.463 ' C ' HD12 ' A' ' 110' ' ' ILE . 34.0 mt-10 -121.18 123.53 42.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.078 176.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 175' ' ' ILE . 2.6 mp -122.93 138.77 51.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 110.505 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.503 ' HB2' HD21 ' A' ' 84' ' ' LEU . 73.6 m95 -70.41 145.5 51.02 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 155' ' ' LEU . 95.3 mt -89.89 -2.31 58.16 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -172.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 84' ' ' LEU . . . 82.73 5.81 89.08 Favored Glycine 0 C--N 1.324 -0.124 0 C-N-CA 120.257 -0.973 . . . . 0.0 112.284 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 131' ' ' ILE . 7.2 mp -93.27 125.47 37.89 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -93.87 145.75 24.39 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.758 -169.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -76.26 66.75 2.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.403 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -128.33 -57.71 1.21 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.531 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -115.48 123.83 49.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.414 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -131.19 -1.81 4.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 88.69 4.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.481 0.658 . . . . 0.0 110.789 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.65 -70.32 2.88 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.62 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p -99.89 100.95 11.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.4 ' H ' HD11 ' A' ' 131' ' ' ILE . 14.1 m95 -72.96 148.18 44.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.014 176.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.11 129.22 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.108 0.48 . . . . 0.0 111.652 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 129' ' ' ALA . 0.0 OUTLIER -83.3 164.31 20.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.771 177.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.552 ' HE1' ' HA ' ' A' ' 74' ' ' SER . 11.5 ptp -61.91 -43.54 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 t -92.56 -4.79 52.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 0.0 111.084 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.63 13.1 9.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.554 172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 125' ' ' ASP . . . -77.85 128.3 33.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.039 0.447 . . . . 0.0 110.777 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -98.34 113.69 25.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.728 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 114' ' ' LEU . 43.4 pt -62.05 135.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.977 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -112.48 8.95 19.54 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.537 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 135' ' ' ASN . 80.2 t80 -105.52 102.95 12.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.246 -177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.505 ' HD2' ' HE1' ' A' ' 136' ' ' TRP . 13.9 tptp -105.6 96.78 6.74 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.462 ' HB3' ' CE2' ' A' ' 133' ' ' TYR . 46.1 t30 -157.6 111.72 2.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 139' ' ' GLU . 4.0 m95 -137.98 156.21 48.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.795 -173.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 162' ' ' LYS . 2.4 tm-20 -97.08 -49.97 4.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 29.66 6.64 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.604 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 136' ' ' TRP . 17.1 pt-20 -67.39 151.8 46.81 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.83 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 pt -72.92 133.7 31.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.489 0.661 . . . . 0.0 111.244 -173.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.7 p -116.24 -15.21 11.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.432 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.26 129.99 50.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.62 100.3 51.21 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -22.18 8.19 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.683 2.256 . . . . 0.0 112.62 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.19 46.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.537 0.684 . . . . 0.0 109.94 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.81 -36.19 3.3 Favored Glycine 0 C--O 1.228 -0.278 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.485 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.77 34.75 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.03 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -60.69 100.4 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 p -138.42 129.26 26.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.916 0.389 . . . . 0.0 111.748 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.91 102.73 7.41 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 172.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.498 ' HB2' ' OD1' ' A' ' 165' ' ' ASP . 5.1 p-10 -169.41 173.09 6.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.794 -173.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 94.7 m -126.9 132.12 50.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.993 0.425 . . . . 0.0 111.207 -174.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.45 140.13 38.66 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.455 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.756 HG11 ' HG2' ' A' ' 166' ' ' LYS . 14.3 p -136.04 149.32 27.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.867 -176.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.592 HD12 HD11 ' A' ' 100' ' ' LEU . 1.3 tm? -98.66 101.15 12.48 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.0 m -99.7 109.37 21.83 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.03 -40.17 73.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.806 -175.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.893 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -68.78 -11.51 60.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.274 0.559 . . . . 0.0 111.287 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -85.05 -56.46 3.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.886 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -171.69 -32.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.864 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.23 -0.97 37.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.946 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' GLU . 66.9 mmtt -93.5 179.58 5.34 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.415 ' HZ2' ' HB2' ' A' ' 87' ' ' PRO . 45.4 m0 -79.29 123.4 27.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.049 0.452 . . . . 0.0 110.62 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -116.52 -168.82 1.51 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.232 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 5.6 t70 -134.4 138.21 44.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.073 -177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.756 ' HG2' HG11 ' A' ' 154' ' ' VAL . 12.4 mmmm -137.95 146.37 43.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 171.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -60.52 136.35 58.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 29.3 m -65.07 -7.1 10.66 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.548 ' HA ' HG22 ' A' ' 69' ' ' THR . 37.2 ttp180 -109.0 20.9 17.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.178 0.513 . . . . 0.0 110.243 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.42 141.22 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' A' ' 68' ' ' LYS . 2.0 mp0 -93.28 93.05 8.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.965 0.412 . . . . 0.0 111.026 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 111' ' ' TRP . 3.9 pp -127.85 164.48 36.54 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.671 176.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 24.3 Cg_exo -63.41 -178.4 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.263 2.642 . . . . 0.0 113.745 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.87 ' HE1' ' HB2' ' A' ' 66' ' ' GLN . 6.5 p90 -154.58 176.92 11.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.15 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.621 HG13 HG12 ' A' ' 110' ' ' ILE . 74.1 mt -145.63 128.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.583 ' SG ' ' HE2' ' A' ' 174' ' ' TYR . 83.6 m -100.07 161.37 13.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -89.11 110.39 21.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.14 113.22 16.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.441 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -105.95 -85.09 1.79 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.242 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.825 ' H ' HD13 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -84.12 -31.82 8.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.814 0.34 . . . . 0.0 110.67 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 180' ' ' ILE . 57.6 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.378 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 176' ' ' CYS . 29.6 m-85 . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.4 p -84.91 17.31 2.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.194 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 44.9 tt0 -84.97 139.35 31.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.255 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.9 p -98.05 127.43 43.99 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.646 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -158.28 -178.88 7.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.2 p -84.5 166.83 16.92 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.95 0.156 . . . . 0.0 110.868 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -48.26 82.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.476 -174.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -63.32 -43.8 96.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.694 0.283 . . . . 0.0 110.298 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -64.48 -43.58 93.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.14 -37.54 72.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.191 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.451 ' O ' HD13 ' A' ' 78' ' ' ILE . 16.1 t -59.55 -62.57 1.78 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.96 177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -58.99 -39.44 81.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.272 0.558 . . . . 0.0 110.935 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.553 ' CG ' HH12 ' A' ' 80' ' ' ARG . 12.3 t70 -64.94 -47.37 77.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.735 -176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.438 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 42.3 t -79.26 -36.87 39.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.003 -178.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 126' ' ' MET . 1.4 mp -57.26 -40.22 72.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.109 0.48 . . . . 0.0 110.457 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -76.44 -31.59 57.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.904 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.553 HH12 ' CG ' ' A' ' 76' ' ' ASP . 1.3 ptp85 -96.15 -18.02 20.42 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.053 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.16 -51.18 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.169 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.27 -46.33 0.97 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.112 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 p -145.58 155.64 43.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.608 0.242 . . . . 0.0 111.151 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 175' ' ' ILE . 0.1 OUTLIER -72.36 161.78 30.37 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 171.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB3' HD21 ' A' ' 96' ' ' LEU . 28.3 m -79.06 106.09 10.86 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 37.9 m -111.9 112.33 53.2 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.65 -176.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' A' ' 92' ' ' GLU . 2.5 Cg_endo -79.85 117.22 3.57 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.936 2.424 . . . . 0.0 111.869 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB3' HG22 ' A' ' 131' ' ' ILE . 1.8 pt20 -115.89 -13.67 11.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.424 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 67.0 p -130.9 176.24 8.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 171.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.73 -26.32 66.73 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.745 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m -56.21 -56.88 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 122.896 0.478 . . . . 0.0 111.521 -177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 87' ' ' PRO . 9.6 mp0 -62.73 -48.61 78.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.383 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.57 -40.92 98.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -64.33 -39.66 94.34 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.18 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.035 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD12 ' HG3' ' A' ' 87' ' ' PRO . 22.5 mt -59.83 -46.11 90.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -62.19 -29.14 70.16 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.617 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.21 -42.7 22.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -67.68 -47.25 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.435 ' HA ' HG23 ' A' ' 104' ' ' VAL . 3.1 pp -63.58 -25.83 68.41 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 101' ' ' ARG . 9.6 ttm180 -61.04 -38.63 86.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.448 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.12 0.28 31.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.693 -173.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.8 p -124.32 -50.2 1.78 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 100' ' ' LEU . 3.0 t -98.51 -33.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.672 0.749 . . . . 0.0 109.704 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.97 125.04 3.61 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -171.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -55.21 -26.29 38.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.046 0.423 . . . . 0.0 111.504 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 158' ' ' ALA . 38.6 mt-10 -89.18 22.52 2.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.685 0.278 . . . . 0.0 111.383 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -107.46 162.25 14.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.057 0.456 . . . . 0.0 110.951 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 10.5 pt-20 -128.46 130.92 48.26 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.835 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.0 mp -118.84 154.61 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.988 -174.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -70.08 149.65 47.41 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-O 120.903 0.382 . . . . 0.0 110.12 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 163' ' ' TRP . 0.2 OUTLIER -86.73 -6.11 58.92 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -171.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.33 6.95 66.68 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.468 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.6 mp -93.38 128.57 39.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 110.212 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 115' ' ' ASN . 0.9 OUTLIER -93.3 118.44 31.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 0.0 110.558 -176.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -79.41 96.84 6.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.031 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 53.4 ttp -126.55 -47.74 1.56 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.55 -169.7 1.51 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.25 15.61 7.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.274 0.559 . . . . 0.0 110.741 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -86.76 166.72 15.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.94 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.02 -16.78 75.09 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.584 177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.637 HG23 ' HG3' ' A' ' 130' ' ' ARG . 30.9 m -80.22 77.69 6.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.219 0.533 . . . . 0.0 110.508 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.491 ' HB2' HD11 ' A' ' 131' ' ' ILE . 44.4 m95 -59.2 129.47 42.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.576 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.6 t -97.22 131.86 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' ALA . 5.1 t70 -73.89 161.09 30.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.468 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.464 ' SD ' HD11 ' A' ' 78' ' ' ILE . 4.4 ptp -53.61 -28.96 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.0 p -92.84 1.26 57.38 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.095 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.56 27.91 25.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.954 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 125' ' ' ASP . . . -92.63 149.53 21.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.841 0.353 . . . . 0.0 111.197 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.637 ' HG3' HG23 ' A' ' 122' ' ' THR . 28.2 ttm180 -98.14 130.69 44.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.089 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.669 HG13 ' HE3' ' A' ' 134' ' ' LYS . 38.0 pt -92.33 128.46 43.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.065 0.46 . . . . 0.0 110.156 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.91 -19.84 24.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.243 0.544 . . . . 0.0 110.534 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -113.77 130.45 56.45 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.516 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.669 ' HE3' HG13 ' A' ' 131' ' ' ILE . 10.4 mptt -130.06 144.26 51.24 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -142.72 114.82 8.3 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.564 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 44.4 m95 -126.59 117.54 23.0 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.193 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HB2' ' CB ' ' A' ' 162' ' ' LYS . 8.3 tp10 -71.08 -29.79 65.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.358 0.599 . . . . 0.0 109.427 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.2 t -108.4 38.38 2.24 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.774 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 34.1 tt0 -56.21 121.57 9.76 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.292 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.7 pt -84.88 132.97 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.238 0.542 . . . . 0.0 110.867 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.1 p -116.66 2.2 12.94 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.159 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.16 161.87 28.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.355 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -100.45 111.35 62.52 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.083 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.35 -82.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.063 2.508 . . . . 0.0 114.183 -174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 148' ' ' LYS . 8.0 m-20 -88.68 21.12 3.12 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.78 20.07 76.83 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.552 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 151.93 -47.43 0.57 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.876 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 3.0 tmpt? -65.67 122.15 16.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.3 p -116.82 165.32 13.45 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.556 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.96 149.44 43.36 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.55 161.53 24.75 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -167.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 89.1 m 68.12 105.99 0.05 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 124.263 0.977 . . . . 0.0 112.567 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 112' ' ' LEU . . . -83.67 139.67 32.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.29 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 166' ' ' LYS . 21.3 t -133.5 142.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.918 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 49.6 tp -100.98 101.3 12.06 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 17.9 m -96.44 113.53 25.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.561 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -78.49 -30.95 47.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.853 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' A' ' 107' ' ' GLU . . . -67.52 -24.77 65.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.02 0.438 . . . . 0.0 110.619 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.89 -59.02 2.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.976 175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.447 HD21 ' HG2' ' A' ' 137' ' ' GLU . 10.7 p30 -177.58 -35.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 121.33 19.23 3.56 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.343 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.51 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 34.4 mmtp -98.73 168.46 10.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.512 ' CE2' HD11 ' A' ' 112' ' ' LEU . 49.6 m0 -84.25 132.61 34.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.248 0.547 . . . . 0.0 110.429 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.02 -179.21 4.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.41 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -112.33 156.64 22.11 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 167' ' ' ARG . 20.8 ttmm -154.35 167.65 29.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 110.518 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.469 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 33.1 mtm-85 -60.11 125.36 23.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.819 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.94 -22.56 67.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.783 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.453 ' HD2' ' HA ' ' A' ' 169' ' ' ARG . 3.7 tpt180 -101.12 21.77 13.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.492 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.14 150.61 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.88 102.5 13.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.684 0.278 . . . . 0.0 111.23 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -130.49 167.77 19.69 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.559 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.0 Cg_exo -73.6 -179.24 4.32 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.966 2.444 . . . . 0.0 113.035 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.835 ' HA ' HG23 ' A' ' 110' ' ' ILE . 9.7 p90 -150.65 178.65 8.88 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.208 -0.308 . . . . 0.0 110.923 -176.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 84' ' ' LEU . 97.4 mt -144.39 134.73 20.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 45.0 m -102.79 136.88 41.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 111.984 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -104.76 115.65 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.628 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -142.16 158.6 43.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.352 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.26 1.34 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.995 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 60.3 mt -81.05 101.21 5.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.837 0.351 . . . . 0.0 110.653 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.691 177.794 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' HD1' ' HA ' ' A' ' 175' ' ' ILE . 49.8 m-85 . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -78.08 -4.06 45.41 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.668 ' HB3' ' HE1' ' A' ' 174' ' ' TYR . 27.0 tt0 -66.89 136.32 55.21 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.2 p -104.42 134.64 47.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -165.64 176.86 7.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 168' ' ' CYS . 73.6 p -78.33 166.32 22.81 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.305 0.378 . . . . 0.0 110.803 178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.78 -35.84 77.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.168 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -64.2 -50.79 66.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 68' ' ' LYS . 34.0 mt-10 -64.79 -35.83 82.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.338 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -60.97 -42.34 98.13 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.74 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.595 ' O ' HG12 ' A' ' 78' ' ' ILE . 43.4 m -60.75 -54.13 48.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.082 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -56.13 -42.36 76.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 14.4 t70 -60.02 -52.44 65.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 0.0 110.289 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 70.2 m -63.11 -36.4 83.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.975 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.925 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 22.8 mm -57.29 -42.27 79.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.209 0.528 . . . . 0.0 110.683 176.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.9 t -77.15 -19.19 57.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.195 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 59.8 mtt-85 -107.33 15.49 24.94 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.598 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.52 -49.22 0.42 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.639 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.925 ' HA2' ' HA ' ' A' ' 78' ' ' ILE . . . 120.71 7.19 8.95 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.02 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.824 HG23 ' HB2' ' A' ' 126' ' ' MET . 3.0 m -153.47 138.02 16.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.981 0.42 . . . . 0.0 111.439 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 85' ' ' SER . 6.2 tt -85.74 158.9 19.91 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.623 ' N ' HD23 ' A' ' 84' ' ' LEU . 19.1 m -69.9 108.21 3.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.939 0.399 . . . . 0.0 110.912 -177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.2 m -110.12 112.83 57.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.468 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 66.7 Cg_endo -82.38 124.81 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.3 2.0 . . . . 0.0 111.982 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -5.87 11.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.386 -170.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.81 165.3 27.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -55.99 -39.02 77.87 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.029 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -54.27 -39.89 67.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.842 0.457 . . . . 0.0 112.134 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.97 -39.89 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.969 0.414 . . . . 0.0 110.514 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 33.3 m-80 -66.18 -50.14 64.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.6 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.94 -35.36 80.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.8 65.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.106 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 24.3 tp -66.53 -44.86 81.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.727 -178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -59.92 -42.63 94.34 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.963 0.411 . . . . 0.0 110.279 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -65.3 -40.98 94.49 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.22 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -65.25 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.182 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 79.2 mt -55.96 -47.7 77.13 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -54.92 -37.7 66.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.543 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -96.1 -11.05 26.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.186 -174.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.6 t -119.21 -64.06 1.32 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.892 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 110' ' ' ILE . 4.3 t -94.63 -34.27 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 110.406 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.45 125.21 2.99 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -170.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -50.85 -39.86 54.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.778 0.323 . . . . 0.0 110.151 177.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.64 15.09 1.82 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.81 160.3 14.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.984 0.421 . . . . 0.0 111.258 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.564 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 40.5 mt-10 -121.42 122.64 40.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.189 177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.4 mp -121.15 148.91 24.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.491 ' O ' HG22 ' A' ' 110' ' ' ILE . 87.6 m95 -70.0 151.8 45.15 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.647 HD12 ' HB1' ' A' ' 153' ' ' ALA . 72.3 mt -99.54 4.46 45.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.94 -27.76 1.38 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 174.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' CD1' HD13 ' A' ' 131' ' ' ILE . 1.8 pt? -94.84 155.66 16.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 117.652 0.726 . . . . 0.0 110.935 -176.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.457 ' HA ' ' CE3' ' A' ' 123' ' ' TRP . 7.8 p30 -154.0 159.8 41.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.698 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -105.9 133.37 50.73 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 170.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -121.79 5.22 9.97 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.224 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 119' ' ' ALA . . . -116.12 -68.93 0.89 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 118' ' ' ALA . . . 158.78 -15.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.24 0.963 . . . . 0.0 110.63 -170.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.29 168.86 15.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.132 0.492 . . . . 0.0 111.66 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.67 -15.54 58.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.71 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -84.13 80.48 9.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.457 ' CE3' ' HA ' ' A' ' 115' ' ' ASN . 11.5 m0 -54.9 143.53 25.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.865 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.1 m -107.05 148.36 11.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.573 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -79.19 166.91 21.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.361 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.824 ' HB2' HG23 ' A' ' 83' ' ' THR . 49.0 mtt -58.67 -27.15 64.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 76.3 p -82.81 -12.09 57.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.738 0.304 . . . . 0.0 111.286 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.55 -0.11 53.1 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.819 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.17 155.57 40.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -109.03 149.75 28.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.477 HD13 ' CD1' ' A' ' 114' ' ' LEU . 48.6 pt -95.22 167.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.978 0.418 . . . . 0.0 111.413 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.1 5.22 3.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.888 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -118.92 119.41 34.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.279 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -138.44 98.71 3.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.996 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -127.68 111.52 13.8 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.526 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 32.9 m95 -125.36 123.21 38.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 4.3 mm-40 -72.97 -20.69 60.99 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 164' ' ' PHE . 13.7 t -100.01 19.85 15.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.379 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.38 115.13 2.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.29 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.9 pt -103.36 150.4 6.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.011 0.434 . . . . 0.0 111.061 -177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.9 p -123.72 4.98 8.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.493 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.24 153.21 47.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.758 0.314 . . . . 0.0 111.084 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 42.9 mt-30 -81.75 122.81 80.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.645 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 17.0 Cg_exo -67.63 -73.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.965 2.443 . . . . 0.0 112.367 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -123.04 47.83 1.91 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.676 0.75 . . . . 0.0 110.068 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.55 23.75 27.84 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.069 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 86.82 -46.64 3.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.0 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.59 103.29 0.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.467 0.651 . . . . 0.0 111.152 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -140.29 149.44 42.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.512 176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 2.4 pm0 -79.27 87.15 4.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.597 0.713 . . . . 0.0 109.425 173.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -88.16 114.04 24.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.776 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.6 m -122.03 124.78 44.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.768 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.647 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -76.85 119.37 20.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.973 0.416 . . . . 0.0 111.6 -175.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.79 140.52 47.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.998 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' A' ' 112' ' ' LEU . 4.1 tt -104.45 102.5 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.8 m -96.25 103.9 15.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.701 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.67 -20.55 76.35 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.461 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -66.43 -8.61 27.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.475 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -112.03 -66.43 1.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.277 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -148.67 -36.84 0.18 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 -172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 106.74 -0.64 36.39 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.073 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.724 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.1 mptm? -87.02 -179.17 6.44 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.526 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 34.0 m0 -81.36 131.7 35.3 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.632 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 137' ' ' GLU . 90.6 m-85 -126.42 177.12 6.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.709 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -128.52 147.03 50.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.133 0.492 . . . . 0.0 110.665 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.74 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 34.8 ttmt -151.74 179.07 8.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.74 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 11.4 mtp180 -90.27 138.71 31.31 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 69' ' ' THR . 28.7 m -66.7 3.07 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -171.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 169' ' ' ARG . 69.4 mtt-85 -97.58 3.69 50.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.977 0.353 . . . . 0.0 111.743 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -84.52 140.45 31.43 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.597 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.707 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 7.7 mm100 -93.1 91.15 7.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.037 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 173' ' ' PRO . 4.2 pp -125.05 167.32 16.5 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.811 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 109' ' ' GLU . 32.6 Cg_exo -59.84 179.7 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 123.589 2.859 . . . . 0.0 114.271 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.668 ' HE1' ' HB3' ' A' ' 66' ' ' GLN . 28.3 p90 -151.85 163.96 38.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.31 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.569 ' HA ' ' HD1' ' A' ' 64' ' ' PHE . 61.4 mt -139.02 115.43 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 74.5 m -101.9 153.28 20.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -90.39 110.12 21.22 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 80' ' ' ARG . 8.4 t80 -103.43 138.31 40.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.464 -173.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -50.52 4.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.77 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 49.8 mm 72.96 105.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.229 0.612 . . . . 0.0 110.654 -178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.604 -178.063 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 175' ' ' ILE . 33.7 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.2 t -74.7 -8.77 57.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.631 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 23.5 tt0 -59.99 129.5 42.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.763 0.316 . . . . 0.0 110.245 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.0 p -98.74 131.04 45.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.754 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.884 ' HD3' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -163.37 179.87 7.03 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.769 -178.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.8 p -78.77 166.0 22.95 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 123.46 0.475 . . . . 0.0 111.238 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -62.24 -46.4 89.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.866 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -68.88 -39.67 79.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.237 0.541 . . . . 0.0 109.658 -177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 87.0 tt0 -61.69 -38.13 86.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.662 176.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.884 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -65.02 -46.95 79.21 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.596 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.599 ' O ' HG12 ' A' ' 78' ' ' ILE . 34.0 p -58.44 -57.2 13.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.913 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -60.17 -32.49 71.11 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.739 0.304 . . . . 0.0 111.31 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 13.2 t70 -63.78 -54.17 39.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.045 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 99.1 m -61.07 -38.97 88.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.702 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 74' ' ' SER . 23.6 mm -52.51 -42.74 40.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.901 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.0 m -80.53 -34.16 35.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.137 -174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 76' ' ' ASP . 33.3 mtt-85 -91.05 -25.19 19.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.11 -173.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.49 -40.87 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.416 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 124.75 -26.36 5.68 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.322 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 127' ' ' THR . 1.2 p -148.71 155.75 41.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.062 0.458 . . . . 0.0 111.961 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 85' ' ' SER . 6.9 tt -96.33 154.13 17.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.587 ' N ' HD23 ' A' ' 84' ' ' LEU . 31.6 m -70.51 108.53 4.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.827 0.346 . . . . 0.0 111.306 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 114' ' ' LEU . 33.2 m -110.07 106.7 58.39 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' ND2' ' A' ' 93' ' ' ASN . 60.4 Cg_endo -84.01 115.95 2.08 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.484 2.123 . . . . 0.0 111.664 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 131' ' ' ILE . 3.7 pt20 -115.99 7.26 14.3 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.257 -171.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.9 p -138.06 176.21 8.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.916 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.58 -42.92 62.21 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.2 p -56.72 -45.7 81.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.918 0.389 . . . . 0.0 111.439 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.91 -29.0 60.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.511 -175.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 87' ' ' PRO . 15.9 m-80 -81.11 -47.01 14.08 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.456 -178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -67.12 -30.87 71.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.996 0.427 . . . . 0.0 110.5 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.28 62.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.832 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 31.0 tp -72.87 -44.59 61.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.484 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.88 -33.11 73.61 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.031 0.443 . . . . 0.0 109.941 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -69.76 -44.98 69.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.271 0.558 . . . . 0.0 109.584 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -61.38 -32.47 72.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.147 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 74.2 mt -56.53 -41.61 77.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.923 0.392 . . . . 0.0 110.146 176.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -66.57 -15.9 63.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.997 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -117.47 2.09 12.39 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -55.32 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 110' ' ' ILE . 3.4 t -100.35 -30.97 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -171.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.01 127.35 3.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -171.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 HD22 ' C ' ' A' ' 106' ' ' ASN . 0.2 OUTLIER -53.56 -35.93 61.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.929 0.395 . . . . 0.0 109.975 178.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.65 27.99 2.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.039 -176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.49 161.55 13.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.786 0.327 . . . . 0.0 111.108 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 173' ' ' PRO . 38.1 mt-10 -118.65 128.05 54.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.633 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.814 HG23 ' HA ' ' A' ' 174' ' ' TYR . 3.9 mp -126.51 145.25 34.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.68 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.554 ' HZ3' ' HB2' ' A' ' 152' ' ' CYS . 83.1 m95 -70.66 149.9 46.53 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.573 HD21 ' HB2' ' A' ' 155' ' ' LEU . 83.7 mt -104.39 11.73 34.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.52 -25.35 0.74 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 115.553 0.981 . . . . 0.0 115.553 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.472 ' HG ' ' HE3' ' A' ' 123' ' ' TRP . 1.8 pt? -92.46 139.48 30.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 117.958 0.879 . . . . 0.0 111.869 -170.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -156.82 136.48 12.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.701 175.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.603 ' HB2' ' HA ' ' A' ' 123' ' ' TRP . 24.9 t70 -112.31 135.73 52.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 171.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -126.25 16.73 7.76 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.669 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -99.27 -63.01 1.16 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.508 -173.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.42 -30.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.2 146.48 24.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.252 0.549 . . . . 0.0 111.466 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -4.54 78.43 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.442 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -82.08 75.04 9.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.603 ' HA ' ' HB2' ' A' ' 116' ' ' ASP . 27.5 m0 -45.88 128.42 8.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.43 155.24 3.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 0.0 111.337 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.3 165.07 25.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 66.4 mtt -55.57 -30.16 60.3 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.298 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.412 HG23 HG21 ' A' ' 83' ' ' THR . 76.0 p -80.59 -18.88 46.89 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 111.148 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.71 1.92 28.91 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.401 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 150.89 45.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.815 0.34 . . . . 0.0 110.633 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -99.59 159.43 15.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.003 0.43 . . . . 0.0 110.992 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.496 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 46.2 pt -101.83 146.4 10.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.68 176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -123.8 20.42 9.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.553 0.692 . . . . 0.0 109.582 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -137.46 120.42 16.51 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.973 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 134' ' ' LYS . 9.5 mtpm? -135.17 97.29 3.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.0 111.033 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.87 110.23 17.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.595 ' CZ2' ' HE3' ' A' ' 163' ' ' TRP . 46.6 m95 -129.68 135.99 49.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.263 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 162' ' ' LYS . 61.2 mm-40 -91.9 -20.37 21.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.711 0.767 . . . . 0.0 108.948 171.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 9.7 t -98.56 18.7 16.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.988 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 7.9 tp10 -56.7 117.3 3.77 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.31 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.9 pt -97.57 140.55 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 111.344 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.3 p -120.8 4.95 10.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.365 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' O ' ' HD3' ' A' ' 144' ' ' PRO . . . -127.49 162.55 26.13 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 -177.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -92.17 102.55 6.55 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.755 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 142' ' ' ALA . 4.7 Cg_exo -78.95 -72.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.087 2.524 . . . . 0.0 112.976 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 148' ' ' LYS . 30.3 t70 -100.09 46.06 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.814 0.816 . . . . 0.0 110.222 -175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.9 42.14 6.1 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.417 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 84.9 -10.68 62.03 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.049 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -135.98 159.88 40.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.5 p -138.58 143.23 39.29 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.75 81.16 5.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.015 0.912 . . . . 0.0 108.821 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.786 ' HB2' ' HB2' ' A' ' 165' ' ' ASP . 8.9 p30 -118.61 151.44 37.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.555 -172.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . 0.554 ' HB2' ' HZ3' ' A' ' 111' ' ' TRP . 5.9 m -135.24 140.1 44.98 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -75.2 116.03 15.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.242 0.544 . . . . 0.0 112.003 -170.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.38 140.69 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.86 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.573 ' HB2' HD21 ' A' ' 112' ' ' LEU . 3.9 tt -100.23 100.21 11.0 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 173.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 109' ' ' GLU . 14.0 m -88.94 98.55 11.81 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.973 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.68 -29.23 73.69 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.879 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -68.07 -10.28 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.962 0.411 . . . . 0.0 111.101 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.65 -57.8 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.528 -177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -170.5 -33.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.187 -172.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 114.65 -5.03 22.85 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.341 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.586 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -86.5 176.93 7.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.595 ' HE3' ' CZ2' ' A' ' 136' ' ' TRP . 39.5 m0 -80.79 131.75 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.183 0.516 . . . . 0.0 110.575 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.78 172.17 9.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.632 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.786 ' HB2' ' HB2' ' A' ' 151' ' ' ASN . 5.3 p-10 -124.6 143.09 50.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.492 ' HG2' ' H ' ' A' ' 167' ' ' ARG . 27.6 ttmt -146.88 171.74 14.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 173.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' H ' ' HG2' ' A' ' 166' ' ' LYS . 13.8 mtp85 -74.6 141.77 44.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 14.8 m -66.35 -7.19 17.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -96.81 13.16 29.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -89.2 137.98 31.83 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.094 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.684 ' NE2' ' HA ' ' A' ' 68' ' ' LYS . 8.7 mm100 -92.46 87.97 6.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.254 -176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 173' ' ' PRO . 4.0 pp -125.93 165.73 25.52 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.601 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 36.4 Cg_exo -61.44 -179.15 0.32 Allowed 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 123.403 2.736 . . . . 0.0 113.712 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.814 ' HA ' HG23 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.73 169.28 24.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.463 179.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.451 ' HA ' ' CD1' ' A' ' 64' ' ' PHE . 76.8 mt -138.44 122.19 20.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 30.9 m -102.57 156.72 17.43 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -89.56 109.51 20.45 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -110.63 137.45 48.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.121 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.09 -28.8 2.85 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.081 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 45.9 mm 60.33 87.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.106 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.979 -173.225 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.49 0.662 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.66 12.97 2.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.316 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.547 ' O ' ' HA ' ' A' ' 173' ' ' PRO . 33.8 tt0 -80.91 137.69 36.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.219 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.8 p -95.2 130.43 41.93 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HE3' ' CD1' ' A' ' 174' ' ' TYR . 0.0 OUTLIER -156.11 178.94 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 173.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.74 HG21 ' HD2' ' A' ' 169' ' ' ARG . 46.2 p -85.96 165.98 16.29 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.522 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.91 87.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.647 0.261 . . . . 0.0 111.597 -173.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -60.76 -43.69 97.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.104 0.478 . . . . 0.0 109.966 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.86 -46.67 80.86 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.277 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . . . -56.9 -39.26 74.09 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 123.469 0.481 . . . . 0.0 111.396 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.456 ' O ' HD13 ' A' ' 78' ' ' ILE . 15.5 t -58.21 -60.1 4.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.085 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.51 -32.93 74.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.152 0.501 . . . . 0.0 110.807 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.02 -38.41 88.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.254 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.602 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 36.8 t -93.63 -37.03 12.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.271 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 1.4 mp -59.65 -36.18 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.065 0.459 . . . . 0.0 111.406 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -98.88 -0.51 42.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HA ' ' A' ' 77' ' ' CYS . 8.8 ptm180 -105.74 -2.88 22.73 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.99 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 177.74 -55.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.074 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 78' ' ' ILE . . . -174.2 -92.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.741 -1.219 . . . . 0.0 112.778 -173.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.728 HG21 HG22 ' A' ' 127' ' ' THR . 61.6 p -144.16 169.03 18.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.588 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD23 ' HE1' ' A' ' 126' ' ' MET . 2.9 mm? -67.98 162.86 23.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 167.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.439 ' HB2' HD21 ' A' ' 96' ' ' LEU . 23.6 m -79.76 107.28 12.41 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.76 HG21 ' HB2' ' A' ' 125' ' ' ASP . 18.4 m -100.06 119.03 60.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.994 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 92' ' ' GLU . 68.8 Cg_endo -84.42 121.9 2.71 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.522 2.148 . . . . 0.0 111.949 176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -119.09 2.82 11.47 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.96 177.35 10.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.452 176.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.25 96.34 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.525 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.4 m -53.21 -47.65 68.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' CB ' ' HA ' ' A' ' 87' ' ' PRO . 2.8 mp0 -68.54 -37.98 80.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -60.19 -44.71 94.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.148 0.499 . . . . 0.0 109.677 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -67.53 -45.72 74.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.652 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.35 76.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.844 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 85' ' ' SER . 23.1 mt -60.41 -52.95 63.04 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.274 -0.17 . . . . 0.0 111.076 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 68.4 t80 -60.5 -36.39 78.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.303 0.573 . . . . 0.0 110.925 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -75.99 -37.53 58.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.295 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -73.98 -42.5 60.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -64.9 -24.23 67.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.679 0.276 . . . . 0.0 110.644 -177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 31.9 ttm-85 -65.74 -26.22 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.373 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -114.16 11.4 17.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.264 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.1 p -137.83 -52.38 0.63 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 t -99.83 -30.73 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 121.723 0.773 . . . . 0.0 109.905 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 112.85 126.37 4.55 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' HB2' ' HG3' ' A' ' 101' ' ' ARG . 4.8 t30 -59.99 -20.77 59.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.936 0.398 . . . . 0.0 111.146 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.53 17.14 7.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.299 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.26 161.95 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.244 0.545 . . . . 0.0 111.653 -174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 172' ' ' LEU . 10.2 pt-20 -116.24 127.66 54.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.604 175.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.672 HG23 ' HA ' ' A' ' 174' ' ' TYR . 4.4 mp -122.12 149.53 25.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.478 ' CE3' HG22 ' A' ' 154' ' ' VAL . 76.1 m95 -70.05 154.71 41.6 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 110.417 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -88.47 -0.65 57.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -172.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 126' ' ' MET . . . 71.09 12.71 72.14 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.852 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 mp -94.78 149.22 21.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.745 0.307 . . . . 0.0 110.61 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -96.94 111.49 23.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 151' ' ' ASN . 16.8 t70 -76.93 98.33 4.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.25 0.548 . . . . 0.0 110.876 -177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 48.6 ttp -126.37 -27.23 3.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.546 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.9 150.3 39.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.247 -174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -95.47 6.88 47.83 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.962 0.887 . . . . 0.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.26 169.26 10.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.802 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.36 -4.63 60.91 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.333 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m -77.24 67.57 3.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.393 0.616 . . . . 0.0 110.666 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -78.57 134.37 37.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.778 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.32 134.54 49.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.76 ' HB2' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -87.17 159.82 18.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.601 0.238 . . . . 0.0 110.527 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.492 ' HE1' HD23 ' A' ' 84' ' ' LEU . 6.9 ptp -66.87 -28.61 68.47 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.728 HG22 HG21 ' A' ' 83' ' ' THR . 9.2 p -76.45 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.569 -176.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 114.65 6.08 19.88 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.115 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.7 132.5 47.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -94.74 113.63 25.43 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 41.5 pt -71.71 138.61 21.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.335 0.588 . . . . 0.0 111.824 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -108.66 -18.2 13.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.842 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -80.9 122.13 26.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.295 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 88.7 mttt -139.19 122.72 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.085 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.21 113.25 13.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 1.071 ' HB2' ' HB2' ' A' ' 139' ' ' GLU . 61.4 m95 -126.03 122.99 37.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.195 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HG2' HD21 ' A' ' 160' ' ' ASN . 19.4 tp10 -76.08 -20.63 57.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.448 0.642 . . . . 0.0 109.337 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.5 t -115.24 27.89 9.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.597 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 1.071 ' HB2' ' HB2' ' A' ' 136' ' ' TRP . 41.2 tt0 -62.64 113.95 3.29 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.95 0.405 . . . . 0.0 110.366 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 36.4 pt -73.63 131.28 35.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.9 p -91.92 -23.81 19.49 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.516 0.674 . . . . 0.0 109.708 174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.86 147.95 50.46 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.218 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.494 ' OE1' ' HA2' ' A' ' 147' ' ' GLY . 30.2 tt0 -76.34 110.01 10.11 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 143' ' ' GLN . 12.4 Cg_exo -69.61 -65.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.219 2.613 . . . . 0.0 114.156 -167.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 9.0 t0 -84.97 45.28 1.15 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 0.0 111.436 -170.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 51.05 36.75 35.44 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.991 174.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' HA2' ' OE1' ' A' ' 143' ' ' GLN . . . 122.67 -34.84 3.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.221 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 8.0 ttpt -82.58 136.85 34.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.773 0.321 . . . . 0.0 110.165 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.1 p -137.72 142.5 41.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.362 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -64.7 143.3 58.02 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.577 ' HB2' ' OD1' ' A' ' 116' ' ' ASP . 27.4 p-10 -122.65 175.8 6.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -171.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' CYS . . . . . . . . . . . . . 19.2 m 69.12 106.93 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.258 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.18 136.97 37.93 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.606 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 166' ' ' LYS . 58.5 t -135.48 143.91 35.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.968 -177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.4 tp -98.35 105.04 17.13 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.5 m -101.83 111.25 23.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.882 0.372 . . . . 0.0 110.787 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 -28.19 57.08 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.016 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.26 62.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.975 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.44 -60.35 1.97 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.697 HD21 ' HG2' ' A' ' 137' ' ' GLU . 11.6 p30 -173.33 -34.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.447 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 119.35 15.22 5.57 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.604 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.435 ' CB ' ' HB2' ' A' ' 137' ' ' GLU . 33.2 mmtp -93.58 173.97 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 52.5 m0 -82.93 129.54 35.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.315 0.579 . . . . 0.0 110.614 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -124.08 -173.25 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.744 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -124.66 143.55 50.67 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.845 ' HE3' ' HB3' ' A' ' 170' ' ' ASP . 1.5 tmmm? -152.51 138.69 18.32 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 166' ' ' LYS . 69.8 mtm180 -60.35 135.46 57.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.557 0.694 . . . . 0.0 111.826 -169.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.613 ' O ' ' HB ' ' A' ' 69' ' ' THR . 3.0 m -59.93 -21.29 60.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.338 -169.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.74 ' HD2' HG21 ' A' ' 69' ' ' THR . 16.6 tpt180 -97.52 6.33 48.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.901 0.381 . . . . 0.0 111.246 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.845 ' HB3' ' HE3' ' A' ' 166' ' ' LYS . 14.1 t70 -95.27 135.94 36.24 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -92.85 120.47 33.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -167.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.693 HD23 ' HZ1' ' A' ' 166' ' ' LYS . 3.7 pp -131.31 165.03 38.29 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.215 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 3.8 Cg_exo -73.05 178.12 6.92 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.004 2.469 . . . . 0.0 112.366 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.672 ' HA ' HG23 ' A' ' 110' ' ' ILE . 4.5 p90 -147.08 175.77 10.45 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 121.607 -0.683 . . . . 0.0 111.982 -175.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 98.5 mt -141.18 124.07 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.015 175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 22.5 m -102.02 145.33 29.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 0.0 112.23 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -114.93 108.57 16.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.575 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -144.3 145.34 31.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.533 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 108.61 127.89 5.65 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.582 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.5 mt -98.12 101.46 12.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.913 0.387 . . . . 0.0 110.167 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.931 178.671 . . . . . . . . 0 0 . 1 stop_ save_